{"PMC7291179": [["BackgroundChildhood injuries continue to be a major United States (U.S.) public health burden, both economically and as a source of morbidity and mortality (Butchart et al. 2008).", [["Childhood injuries", "DISEASE", 10, 28], ["BackgroundChildhood injuries", "PROBLEM", 0, 28], ["morbidity", "PROBLEM", 132, 141]]], ["Of all childhood injuries, unintentional injuries have been reported as the leading cause of premature mortality (Rezendes 2006).", [["injuries", "DISEASE", 17, 25], ["unintentional injuries", "DISEASE", 27, 49], ["all childhood injuries", "PROBLEM", 3, 25], ["unintentional injuries", "PROBLEM", 27, 49], ["premature mortality", "PROBLEM", 93, 112], ["all", "OBSERVATION_MODIFIER", 3, 6], ["childhood", "OBSERVATION_MODIFIER", 7, 16], ["injuries", "OBSERVATION", 17, 25]]], ["When looking at injuries associated with consumer products, bicycle-related injuries rank second as a cause of injury, behind only motor vehicles (MV) (United States Consumer Product Safety Commission n.d.).", [["injuries", "DISEASE", 16, 24], ["injuries", "DISEASE", 76, 84], ["MV", "SPECIES", 147, 149], ["injuries", "PROBLEM", 16, 24], ["injury", "PROBLEM", 111, 117], ["injury", "OBSERVATION", 111, 117]]], ["Bicycling continues to be a popular recreational activity and a mode of transportation for many children, which can carry considerable risk for injury based on those exposures.", [["Bicycling", "DISEASE", 0, 9], ["children", "ORGANISM", 96, 104], ["children", "SPECIES", 96, 104], ["injury", "PROBLEM", 144, 150]]], ["Riding in environments deemed unsafe has previously been shown to increase the risk of serious injury, particularly in motor vehicle collisions (MVC) (Rivara et al. 1997).", [["motor vehicle collisions", "DISEASE", 119, 143], ["serious injury", "PROBLEM", 87, 101], ["serious", "OBSERVATION_MODIFIER", 87, 94], ["injury", "OBSERVATION", 95, 101]]], ["Further research claimed roughly 75% of all bicycle-related mortality is secondary to head injuries, and that 85% of those injuries could have been prevented by simply by wearing a bicycle helmet (Brainline: All about brain injury and PTSD n.d.).", [["head", "ANATOMY", 86, 90], ["brain", "ANATOMY", 218, 223], ["injuries", "DISEASE", 91, 99], ["injuries", "DISEASE", 123, 131], ["brain injury", "DISEASE", 218, 230], ["PTSD", "DISEASE", 235, 239], ["head", "ORGANISM_SUBDIVISION", 86, 90], ["brain", "ORGAN", 218, 223], ["head injuries", "PROBLEM", 86, 99], ["those injuries", "PROBLEM", 117, 131], ["brain injury", "PROBLEM", 218, 230], ["head", "ANATOMY", 86, 90], ["injuries", "OBSERVATION", 91, 99]]], ["Younger children appear to be at greater risk of head injuries than adults, yet despite legislation and ordinances requiring helmet use among younger riders, helmet use has reportedly remained low (Schroeder and Wilbur 2013).", [["head", "ANATOMY", 49, 53], ["head injuries", "DISEASE", 49, 62], ["children", "ORGANISM", 8, 16], ["head", "ORGANISM_SUBDIVISION", 49, 53], ["children", "SPECIES", 8, 16], ["head injuries", "PROBLEM", 49, 62], ["head", "ANATOMY", 49, 53], ["injuries", "OBSERVATION", 54, 62]]], ["In theory, helmets would be inherently protective against head injury, and establishing the real-world effectiveness of helmets involved in MVC resulting in pediatric traumatic injuries is important.", [["head", "ANATOMY", 58, 62], ["head injury", "DISEASE", 58, 69], ["MVC", "DISEASE", 140, 143], ["traumatic injuries", "DISEASE", 167, 185], ["head", "ORGANISM_SUBDIVISION", 58, 62], ["helmets", "TREATMENT", 11, 18], ["head injury", "PROBLEM", 58, 69], ["helmets", "TREATMENT", 120, 127], ["pediatric traumatic injuries", "PROBLEM", 157, 185], ["injuries", "OBSERVATION", 177, 185]]], ["Previous reports found bicycle helmets more effective in single bicycle crashes than in collisions with motor vehicles (H\u00f8ye 2018) A Cochrane review of controlled studies evaluating the effect of bicycle helmets on injuries found helmets provide up to a 63\u201388% reduction in the risk of head, brain, and severe brain injury for cyclists of all ages (Thompson et al. 1999).BackgroundAs those studies looked at all bicycle-related crashes, often involving a single bicyclist or a fall from a bicycle, as well as adult riders, it is difficult to determine how effective bicycle helmets are at reducing head injuries among children when involved in an MVC.", [["head", "ANATOMY", 286, 290], ["brain", "ANATOMY", 292, 297], ["brain", "ANATOMY", 310, 315], ["head", "ANATOMY", 598, 602], ["injuries", "DISEASE", 215, 223], ["brain injury", "DISEASE", 310, 322], ["crashes", "DISEASE", 428, 435], ["injuries", "DISEASE", 603, 611], ["head", "ORGANISM_SUBDIVISION", 286, 290], ["brain", "ORGAN", 292, 297], ["brain", "ORGAN", 310, 315], ["head", "ORGANISM_SUBDIVISION", 598, 602], ["children", "ORGANISM", 618, 626], ["children", "SPECIES", 618, 626], ["bicycle helmets", "PROBLEM", 23, 38], ["controlled studies", "TEST", 152, 170], ["bicycle helmets", "TREATMENT", 196, 211], ["injuries", "PROBLEM", 215, 223], ["head, brain, and severe brain injury", "PROBLEM", 286, 322], ["those studies", "TEST", 384, 397], ["bicycle helmets", "OBSERVATION", 23, 38], ["head", "ANATOMY", 286, 290], ["brain", "ANATOMY", 292, 297], ["severe", "OBSERVATION_MODIFIER", 303, 309], ["brain", "ANATOMY", 310, 315], ["injury", "OBSERVATION", 316, 322]]], ["The objective of this study was to determine whether bicycle helmets are associated with decreased incidence and severity of head injury among pediatric bicyclists involved in a bicycle crash with an MV.MethodsWe performed a retrospective medical record review of patients aged \u226418 years old hospitalized for bicycle vs. MV collision injuries at a level I pediatric trauma center between January 1, 2008, and December 31, 2018.", [["head", "ANATOMY", 125, 129], ["head injury", "DISEASE", 125, 136], ["collision injuries", "DISEASE", 324, 342], ["trauma", "DISEASE", 366, 372], ["head", "ORGANISM_SUBDIVISION", 125, 129], ["patients", "ORGANISM", 264, 272], ["patients", "SPECIES", 264, 272], ["MV", "SPECIES", 200, 202], ["MV", "SPECIES", 321, 323], ["this study", "TEST", 17, 27], ["bicycle helmets", "PROBLEM", 53, 68], ["head injury", "PROBLEM", 125, 136], ["Methods", "TREATMENT", 203, 210], ["MV collision injuries", "PROBLEM", 321, 342], ["head", "ANATOMY", 125, 129], ["injury", "OBSERVATION", 130, 136]]], ["Patients from the trauma registry were identified using International Classification of Diseases, Ninth & Tenth Revisions, Clinical Modification (ICD-9-CM & ICD-10-CM) external-cause-of-injury codes (E-codes), depending on data year, since ICD-10-CM was the replacement for ICD-9-CM, effective October 1, 2015 (International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) n.d.).", [["trauma", "DISEASE", 18, 24], ["CM", "DISEASE", 152, 154], ["CM", "DISEASE", 164, 166], ["CM", "DISEASE", 247, 249], ["CM", "DISEASE", 280, 282], ["Patients", "ORGANISM", 0, 8], ["Patients", "SPECIES", 0, 8], ["Diseases", "PROBLEM", 88, 96], ["Ninth & Tenth Revisions", "TREATMENT", 98, 121], ["Clinical Modification (ICD", "TREATMENT", 123, 149], ["ICD", "TREATMENT", 157, 160], ["ICD", "TREATMENT", 240, 243], ["the replacement", "TREATMENT", 254, 269], ["ICD", "TREATMENT", 274, 277], ["Diseases", "PROBLEM", 343, 351], ["Tenth Revision", "TREATMENT", 353, 367], ["Clinical Modification (ICD", "TREATMENT", 369, 395], ["Diseases", "OBSERVATION", 88, 96], ["injury", "OBSERVATION", 186, 192], ["ICD", "OBSERVATION", 274, 277], ["Diseases", "OBSERVATION", 343, 351]]], ["The ICD-9-CM E-code E813.6 (MVA Traffic, Collision w/ Other Vehicle - Pedal Cyclist), the ICD-10-CM codes V13.4-.9XXA (Pedal cycle driver injured in collision with a car, pick-up truck or van in a traffic accident, initial encounter) and V14.4-.9XXA (Pedal cycle driver injured in collision with heavy transport vehicle or bus in a traffic accident, initial encounter), and medical record injury narratives were used to identify bicycle crashes in traffic with an MV, as well as documented helmet use.", [["CM", "DISEASE", 97, 99], ["crashes", "DISEASE", 437, 444], ["MV", "SPECIES", 464, 466], ["The ICD", "TEST", 0, 7], ["the ICD", "TREATMENT", 86, 93], ["ICD", "OBSERVATION", 4, 7], ["Pedal", "ANATOMY", 70, 75], ["ICD", "OBSERVATION", 90, 93], ["Pedal", "ANATOMY", 119, 124], ["helmet", "OBSERVATION", 490, 496]]], ["Further confirmation to identify bicycle crashes in traffic with a motor vehicle was performed by scanning the mechanism of injury narratives.", [["crashes", "DISEASE", 41, 48], ["Further confirmation", "TEST", 0, 20], ["injury", "PROBLEM", 124, 130], ["injury", "OBSERVATION", 124, 130]]], ["Helmet use was documented by trauma registrars who compiled data from multiple sources of the medical record, including Emergency Medical Service (EMS) trip sheets, Emergency Department (ED) Notes, trauma notes, and case management notes.MethodsThe institutional trauma registrars were trained to perform a daily census of all trauma credentialed floors and actively search for patients with ICD-9/10-CM traumatic injury codes to capture all admitted trauma patients.", [["Helmet", "CHEMICAL", 0, 6], ["trauma", "DISEASE", 29, 35], ["trauma", "DISEASE", 198, 204], ["trauma", "DISEASE", 263, 269], ["trauma", "DISEASE", 327, 333], ["CM", "DISEASE", 401, 403], ["trauma", "DISEASE", 451, 457], ["patients", "ORGANISM", 378, 386], ["patients", "ORGANISM", 458, 466], ["patients", "SPECIES", 378, 386], ["patients", "SPECIES", 458, 466], ["ICD", "TREATMENT", 392, 395], ["CM traumatic injury", "PROBLEM", 401, 420]]], ["Medical record data were abstracted and uniformly entered electronically in Digital Innovations Collector/CV-4, a software template that includes an ICD-9/10 Tri-coder.", [["ICD-9/10 Tri-coder", "DNA", 149, 167], ["a software template", "TREATMENT", 112, 131], ["an ICD", "TREATMENT", 146, 152], ["ICD", "OBSERVATION", 149, 152]]], ["Inter-rater reliability checks were run monthly for many of the elements collected within the database.MethodsData abstracted from the institutional trauma registry and electronic medical record included demographics, clinical information, anatomic diagnoses, outcomes, and injury severity.", [["trauma", "DISEASE", 149, 155], ["Inter-rater reliability checks", "TEST", 0, 30], ["injury severity", "PROBLEM", 274, 289]]], ["Head injury severity was determined using the Abbreviated Injury Scale (AIS\u00a9), an anatomically based, consensus derived, global severity scoring system that classifies an individual injury by body region according to its relative severity on a 6-point scale (1 = minor and 6 = maximal).", [["body", "ANATOMY", 192, 196], ["Head injury", "DISEASE", 0, 11], ["body", "ORGANISM_SUBDIVISION", 192, 196], ["Head injury severity", "PROBLEM", 0, 20], ["the Abbreviated Injury Scale", "PROBLEM", 42, 70], ["global severity scoring system", "PROBLEM", 121, 151], ["an individual injury", "PROBLEM", 168, 188], ["injury", "OBSERVATION", 5, 11], ["individual", "OBSERVATION_MODIFIER", 171, 181], ["injury", "OBSERVATION", 182, 188]]], ["AIS is the basis for the Injury Severity Score (ISS) calculation of the multiply injured patient (Abbreviated Injury Scale (AIS) - Overview 2019).", [["Abbreviated Injury", "DISEASE", 98, 116], ["patient", "ORGANISM", 89, 96], ["patient", "SPECIES", 89, 96], ["the Injury Severity Score", "PROBLEM", 21, 46]]], ["These scores provided standardized injury descriptor capabilities and injury severity assessment, important in clinical trauma management and epidemiological study.MethodsThese data were analyzed utilizing descriptive statistics and univariate/multivariate logistic regression.", [["trauma", "DISEASE", 120, 126], ["standardized injury descriptor capabilities", "PROBLEM", 22, 65], ["injury severity assessment", "TEST", 70, 96], ["clinical trauma management", "TREATMENT", 111, 137], ["epidemiological study", "TEST", 142, 163]]], ["The data were analyzed using IBM SPSS Statistics v25 (Armonk, NY) (IBM Corp n.d.).", [["The data", "TEST", 0, 8]]], ["Our study was approved by the University of Pittsburgh Medical Center Institutional Review Board (PRO18100096).MethodsMultivariate analysis was done using multiple logistic regression to assess the relationship between helmet status and head injury and the level of head injury severity, as measured by the AIS.", [["head", "ANATOMY", 237, 241], ["head", "ANATOMY", 266, 270], ["head injury", "DISEASE", 237, 248], ["AIS", "DISEASE", 307, 310], ["helmet", "ORGANISM_SUBDIVISION", 219, 225], ["head", "ORGANISM_SUBDIVISION", 237, 241], ["head", "ORGANISM_SUBDIVISION", 266, 270], ["Our study", "TEST", 0, 9], ["Multivariate analysis", "TEST", 118, 139], ["multiple logistic regression", "TREATMENT", 155, 183], ["head injury", "PROBLEM", 237, 248], ["head injury severity", "PROBLEM", 266, 286], ["head", "ANATOMY", 237, 241], ["injury", "OBSERVATION", 242, 248], ["head", "ANATOMY", 266, 270], ["injury", "OBSERVATION", 271, 277]]], ["The AIS outcomes was dichotomized as severe (4), critical (5) or maximal (6) vs AIS < 4 (Abbreviated Injury Scale (AIS) - Overview 2019).", [["AIS", "DISEASE", 80, 83], ["Abbreviated Injury", "DISEASE", 89, 107], ["critical (5) or maximal (6) vs AIS", "PROBLEM", 49, 83], ["Abbreviated Injury Scale (AIS", "PROBLEM", 89, 118], ["severe", "OBSERVATION_MODIFIER", 37, 43]]], ["Backward stepwise multivariable logistic regression with a P-value < 0.05 was used to identify clinical factors independently associated with the risk of head injury status or head injury severity following an MVC.", [["head", "ANATOMY", 154, 158], ["head", "ANATOMY", 176, 180], ["head", "ORGANISM_SUBDIVISION", 154, 158], ["head", "ORGANISM_SUBDIVISION", 176, 180], ["Backward stepwise multivariable logistic regression", "PROBLEM", 0, 51], ["a P-value", "TEST", 57, 66], ["head injury status", "PROBLEM", 154, 172], ["head injury severity", "PROBLEM", 176, 196], ["head", "ANATOMY", 154, 158], ["injury", "OBSERVATION", 159, 165]]], ["Variables entered in the first step of this analysis were all those that showed a univariable association with the risk of head injury status or head injury severity, with a P-value < 0.10, as well as the age (continuous variable), sex, and race of the patient.", [["head", "ANATOMY", 123, 127], ["head", "ANATOMY", 145, 149], ["head injury", "DISEASE", 123, 134], ["head", "ORGANISM_SUBDIVISION", 123, 127], ["head", "ORGANISM_SUBDIVISION", 145, 149], ["patient", "ORGANISM", 253, 260], ["patient", "SPECIES", 253, 260], ["this analysis", "TEST", 39, 52], ["head injury status", "PROBLEM", 123, 141], ["head injury severity", "PROBLEM", 145, 165], ["a P-value", "TEST", 172, 181], ["head", "ANATOMY", 123, 127], ["injury", "OBSERVATION", 128, 134], ["head", "ANATOMY", 145, 149], ["injury", "OBSERVATION", 150, 156]]], ["Helmet status (p < 0.01) retained a statistically significant, independent association with the risk of head injury status or head injury severity at the last step of the backward stepwise process.", [["head", "ANATOMY", 104, 108], ["head", "ANATOMY", 126, 130], ["head", "ORGANISM_SUBDIVISION", 104, 108], ["head", "ORGANISM_SUBDIVISION", 126, 130], ["head injury status", "PROBLEM", 104, 122], ["head injury severity", "PROBLEM", 126, 146], ["head", "ANATOMY", 104, 108], ["injury", "OBSERVATION", 109, 115]]], ["These variables formed the final multivariable model.ResultsLooking at the 11 years of trauma registry data, we identified 226 children who were treated for injuries sustained from being struck by a motor vehicle in traffic while riding a bike.", [["trauma", "DISEASE", 87, 93], ["injuries", "DISEASE", 157, 165], ["children", "ORGANISM", 127, 135], ["children", "SPECIES", 127, 135], ["trauma registry data", "TEST", 87, 107], ["injuries", "PROBLEM", 157, 165]]], ["The median age of the children treated was 11 years (interquartile range (IQR): 8 to 13).", [["children", "ORGANISM", 22, 30], ["children", "SPECIES", 22, 30]]], ["Males made up 83% (187/226) of the patients seen.", [["patients", "ORGANISM", 35, 43], ["patients", "SPECIES", 35, 43]]], ["The patient\u2019s race was recorded as 71% white, 25% black and 4% other or unknown, which was reflective of the catchment area.", [["patient", "ORGANISM", 4, 11], ["patient", "SPECIES", 4, 11], ["The patient\u2019s race", "TEST", 0, 18], ["catchment", "OBSERVATION", 109, 118]]], ["The median overall injury severity score (ISS) was moderate at 9 (IQR 5\u201312).", [["The median overall injury severity score", "PROBLEM", 0, 40], ["ISS", "TEST", 42, 45], ["median", "OBSERVATION_MODIFIER", 4, 10], ["overall", "OBSERVATION_MODIFIER", 11, 18], ["injury", "OBSERVATION", 19, 25], ["moderate", "OBSERVATION_MODIFIER", 51, 59]]], ["Hospital length of stay was a median of 2 days (IQR 1\u20133), and no appreciable time was spent in the Intensive Care Unit (ICU) or on a ventilator.ResultsHelmets were reportedly worn by 27 (12%) of the patients.", [["patients", "ORGANISM", 199, 207], ["patients", "SPECIES", 199, 207], ["a ventilator", "TREATMENT", 131, 143]]], ["The only significant difference observed in demographics when comparing helmeted bicyclists (n = 27) to unhelmeted bicyclists (n = 199) was age.", [["significant", "OBSERVATION_MODIFIER", 9, 20], ["difference", "OBSERVATION_MODIFIER", 21, 31]]]], "PMC7176243": [["Cantilevers ::: TechniqueMechanical sensors consist of a fixed and a movable part.", [["TechniqueMechanical sensors", "TEST", 16, 43]]], ["The movable part can be a thin membrane, a plate or a beam, fixed at one or both ends.", [["membrane", "ANATOMY", 31, 39], ["membrane", "CELLULAR_COMPONENT", 31, 39], ["a thin membrane", "PROBLEM", 24, 39], ["a beam", "TREATMENT", 52, 58]]], ["A cantilever is defined here as a microfabricated rectangular bar-shaped structure that is longer than it is wide and has a thickness that is much smaller than its length or width.", [["a microfabricated rectangular bar-shaped structure", "TREATMENT", 32, 82], ["microfabricated", "OBSERVATION_MODIFIER", 34, 49], ["rectangular", "OBSERVATION_MODIFIER", 50, 61], ["bar", "OBSERVATION_MODIFIER", 62, 65], ["shaped", "OBSERVATION_MODIFIER", 66, 72], ["structure", "OBSERVATION", 73, 82], ["longer", "OBSERVATION_MODIFIER", 91, 97], ["wide", "OBSERVATION_MODIFIER", 109, 113], ["thickness", "OBSERVATION_MODIFIER", 124, 133], ["much", "OBSERVATION_MODIFIER", 142, 146], ["smaller", "OBSERVATION_MODIFIER", 147, 154], ["length", "OBSERVATION_MODIFIER", 164, 170], ["width", "OBSERVATION_MODIFIER", 174, 179]]], ["It is a horizontal structural element supported only at one end on a chip body; the other end is free (Fig. 15.1).", [["body", "ANATOMY", 74, 78], ["a horizontal structural element", "PROBLEM", 6, 37], ["a chip body", "TREATMENT", 67, 78], ["horizontal", "OBSERVATION_MODIFIER", 8, 18], ["structural element", "OBSERVATION", 19, 37], ["free", "OBSERVATION_MODIFIER", 97, 101]]], ["Most often it is used as a mechanical probe to image the topography of a sample in a technique called atomic force microscopy (AFM ) or scanning force microscopy (SFM ) [15.1], invented by Binnig et al. in the mid 1980s [15.1].", [["sample", "ANATOMY", 73, 79], ["a mechanical probe", "TREATMENT", 25, 43], ["atomic force microscopy", "TEST", 102, 125], ["scanning force microscopy", "TEST", 136, 161]]], ["For AFM a microfabricated sharp tip is located at the apex of the cantilever that serves as a local probe to scan the sample surface.", [["sample surface", "ANATOMY", 118, 132], ["AFM a microfabricated sharp tip", "TREATMENT", 4, 35], ["microfabricated", "OBSERVATION_MODIFIER", 10, 25], ["sharp", "OBSERVATION_MODIFIER", 26, 31], ["tip", "OBSERVATION_MODIFIER", 32, 35], ["apex", "ANATOMY_MODIFIER", 54, 58], ["cantilever", "ANATOMY_MODIFIER", 66, 76], ["surface", "OBSERVATION_MODIFIER", 125, 132]]], ["The distance between tip and surface is controlled via sensitive measurement of interatomic forces in the piconewton range.Cantilevers ::: TechniqueBy scanning the tip across a conductive or nonconductive surface using an x-y-z actuator system (e. g., a piezoelectric scanner), an image of the topography is obtained by recording for all positions x and y the correction signal that has to be applied to the z-actuation drive to keep the interaction between tip and sample surface constant.", [["surface", "ANATOMY", 29, 36], ["surface", "ANATOMY", 205, 212], ["sample surface", "ANATOMY", 466, 480], ["tip", "MULTI-TISSUE_STRUCTURE", 21, 24], ["surface", "CELLULAR_COMPONENT", 29, 36], ["a conductive or nonconductive surface", "TREATMENT", 175, 212], ["an x-y-z actuator system", "TREATMENT", 219, 243], ["a piezoelectric scanner", "TEST", 252, 275], ["an image of the topography", "TEST", 278, 304], ["distance", "OBSERVATION_MODIFIER", 4, 12], ["tip", "OBSERVATION_MODIFIER", 21, 24], ["surface", "OBSERVATION_MODIFIER", 29, 36], ["sensitive", "OBSERVATION_MODIFIER", 55, 64], ["interatomic forces", "OBSERVATION", 80, 98], ["piconewton range", "OBSERVATION", 106, 122], ["tip", "OBSERVATION_MODIFIER", 164, 167], ["tip", "OBSERVATION_MODIFIER", 458, 461], ["surface", "OBSERVATION_MODIFIER", 473, 480]]], ["Beyond imaging of surfaces, cantilevers have been used for many other purposes, e. g., structuring of surfaces.", [["imaging of surfaces", "TEST", 7, 26], ["cantilevers", "TREATMENT", 28, 39], ["surfaces", "OBSERVATION_MODIFIER", 102, 110]]], ["Here, we focus on the application as mechanical sensor devices, responding by mechanical bending or change in resonance frequency.History of\u00a0Cantilever Sensors ::: TechniqueThe idea to use beams of silicon as sensors to measure deflections or changes in resonance frequency is actually quite old.", [["silicon", "CHEMICAL", 198, 205], ["mechanical sensor devices", "TREATMENT", 37, 62], ["change in resonance frequency", "PROBLEM", 100, 129], ["beams of silicon", "TREATMENT", 189, 205], ["changes in resonance frequency", "PROBLEM", 243, 273], ["mechanical bending", "OBSERVATION", 78, 96]]], ["First reports go back to 1968, when Wilfinger et al. [15.2] investigated silicon cantilever structures of", [["silicon", "CHEMICAL", 73, 80], ["silicon cantilever structures", "TREATMENT", 73, 102]]]], "3d49541744f56965d1960f2624ff8a84d66e6bf6": [["Since December 2019, the outbreak of novel coronavirus disease 2019 has become a global pandemic and widespread disaster.", [["coronavirus disease", "DISEASE", 43, 62], ["novel coronavirus disease", "PROBLEM", 37, 62], ["a global pandemic", "PROBLEM", 79, 96], ["coronavirus disease", "OBSERVATION", 43, 62], ["global", "OBSERVATION_MODIFIER", 81, 87], ["pandemic", "OBSERVATION", 88, 96], ["widespread", "OBSERVATION_MODIFIER", 101, 111], ["disaster", "OBSERVATION", 112, 120]]], ["1 Although the COVID-19 epidemic has become well controlled in China, as of May 31, 2020, it had spread to 215 countries, areas or territories.", [["the COVID", "TEST", 11, 20], ["epidemic", "PROBLEM", 24, 32]]], ["2 The number of cases is still growing at an stable alarming speed.", [["stable", "OBSERVATION_MODIFIER", 45, 51]]], ["The total number of people infected reached 6,750,521, and the death toll was 395,779.", [["death", "DISEASE", 63, 68], ["people", "ORGANISM", 20, 26], ["people", "SPECIES", 20, 26], ["total", "OBSERVATION_MODIFIER", 4, 9], ["number", "OBSERVATION_MODIFIER", 10, 16], ["infected", "OBSERVATION", 27, 35]]], ["3, 4 The mortality rates are currently the highest in France and the United Kingdom (19.43 % and 14.21 %, respectively).", [["The mortality rates", "TEST", 5, 24], ["highest", "OBSERVATION_MODIFIER", 43, 50]]]], "e5675e96fd84d3aa397b5cbc549a59b46796757a": [["IntroductionCommodity exports drive current global tropical-forest loss (Fearnside 2005; Nepstad et al. 2006; Koh and Wilcove 2008; Rudel et al. 2009; Koh and Ghazoul 2010) , which increased by 2101 km 2 year \u22121 between 2001 and 2012 (Hansen et al. 2013 ).", [["tropical-forest loss", "DISEASE", 51, 71], ["forest loss", "PROBLEM", 60, 71], ["forest loss", "OBSERVATION", 60, 71]]], ["This effect is attributed to more medium and large clearings (Austin et al. 2017 ).", [["attributed to", "UNCERTAINTY", 15, 28], ["more medium", "OBSERVATION_MODIFIER", 29, 40], ["large", "OBSERVATION_MODIFIER", 45, 50]]], ["Annual deforestation rates in the Brazilian Amazon decreased by 80% from 2005 to 2012, associated with lower participation of large and medium landholders (Godar et al. 2012) due to commodity price decreases and unfavorable currency exchange rates, policy interventions, and voluntary market agreements (Ricketts et al. 2010; Nepstad et al. 2014; Fearnside 2017a, b; West et al. 2019) .", [["Annual deforestation rates", "PROBLEM", 0, 26], ["large and medium landholders", "PROBLEM", 126, 154], ["policy interventions", "TREATMENT", 249, 269], ["deforestation", "OBSERVATION", 7, 20], ["large", "OBSERVATION_MODIFIER", 126, 131]]], ["Nevertheless, by 2019 the annual deforestation rate in Brazilian Amazonia had increased by 122% since the low point in 2012 (Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020) .IntroductionThere are important reasons to be alarmed by accelerated deforestation in the Amazon basin.", [["the annual deforestation rate", "TEST", 22, 51]]], ["First are the concerns about the so-called \"tipping point\" involving the breakdown in rainfall recycling that sustains moisture conditions and, therefore, Amazonia's rainforest ecosystems.", [["the breakdown", "PROBLEM", 69, 82], ["rainfall recycling", "TREATMENT", 86, 104], ["breakdown", "OBSERVATION_MODIFIER", 73, 82], ["moisture conditions", "OBSERVATION", 119, 138]]], ["Climate models project that the tipping point will be reached in only 15-30 years, at which time a considerable portion of Amazonia's rainforest would transition into a new equilibrium state of either savanna or woody scrub vegetation (Oyama and Nobre 2003; Sampaio et al. 2007 Sampaio et al. , 2018 Lovejoy et al. 2018; Asher 2020) .", [["Amazonia's rainforest", "TREATMENT", 123, 144], ["woody scrub vegetation", "PROBLEM", 212, 234], ["woody", "OBSERVATION_MODIFIER", 212, 217], ["scrub vegetation", "OBSERVATION", 218, 234]]], ["Amazonian deforestation also affects precipitation in other parts of South America, North America, and Europe (Gedney and Valdes 2000; Werth and Avissar 2002; Avissar and Werth 2005; Hasler et al. 2009; Arraut et al. 2012) .", [["Amazonian deforestation", "TREATMENT", 0, 23], ["precipitation", "OBSERVATION_MODIFIER", 37, 50]]], ["A decrease in precipitation in the midwestern and eastern United States and in southern South America would jeopardize the production of agricultural commodities and threaten regional and continental food security (Lapola et al. 2011 ).IntroductionSecond, we should be worried about the increase in greenhouse gas (GHG) emissions from forest clearing.", [["GHG", "CHEMICAL", 315, 318], ["decrease", "OBSERVATION_MODIFIER", 2, 10], ["precipitation", "OBSERVATION_MODIFIER", 14, 27]]], ["Brazil is the world's sixth largest GHG emitter, but different from other countries, around half of its emissions come from land-use change (SEEG 2020) .", [["GHG emitter", "OBSERVATION", 36, 47]]], ["While there has been a global reduction in GHG emissions with the COVID-19 pandemic (IEA 2020), estimates for Brazil indicate an increase of 10-20% due to Amazonian deforestation.", [["a global reduction in GHG emissions", "PROBLEM", 21, 56], ["the COVID", "TEST", 62, 71], ["Amazonian deforestation", "PROBLEM", 155, 178], ["global", "OBSERVATION_MODIFIER", 23, 29], ["reduction", "OBSERVATION_MODIFIER", 30, 39], ["GHG emissions", "OBSERVATION", 43, 56], ["increase", "OBSERVATION_MODIFIER", 129, 137], ["Amazonian deforestation", "OBSERVATION", 155, 178]]], ["Brazil's emissions for 2020 are expected be 2.1-2.3 GtCO 2 -eq, thus swamping the country's efforts to honor its commitment under the Paris Agreement to reduce emissions to 1.3 GtCO 2 -eq by 2025 (SEEG 2020).", [["Brazil's emissions", "TREATMENT", 0, 18]]], ["Finally, the combination of climatic events, reduced moisture, and increased forest fragmentation produce more frequent and intense droughts, creating positive feedbacks with fire and resulting in more-damaging fire seasons (Cochrane and Barber 2009; Davidson et al. 2012) .", [["climatic events", "PROBLEM", 28, 43], ["reduced moisture", "PROBLEM", 45, 61], ["increased forest fragmentation", "PROBLEM", 67, 97], ["reduced", "OBSERVATION_MODIFIER", 45, 52], ["moisture", "OBSERVATION_MODIFIER", 53, 61], ["increased", "OBSERVATION_MODIFIER", 67, 76], ["forest fragmentation", "OBSERVATION", 77, 97]]], ["Forest fires increase fuel loads, fire intensity, and the susceptibility of forests to fire, meaning that successive fire outbreaks can accelerate the process in which large areas of tropical forests become scrubby savanna (Balch et al. 2015) .", [["tropical forests", "TREATMENT", 183, 199], ["fuel loads", "OBSERVATION", 22, 32], ["large", "OBSERVATION_MODIFIER", 168, 173], ["areas", "OBSERVATION_MODIFIER", 174, 179], ["tropical forests", "OBSERVATION", 183, 199]]], ["Thus, besides massive loss of habitats and the region's enormous terrestrial biodiversity (Stropp et al. 2009; Malhado et al. 2013) , Amazonian forest loss influences rainfall regimes at global scales and reduces agricultural yields far beyond the region's boundaries.", [["forest loss", "DISEASE", 144, 155], ["massive loss of habitats", "PROBLEM", 14, 38], ["the region", "PROBLEM", 43, 53], ["Amazonian forest loss influences rainfall regimes", "TREATMENT", 134, 183], ["massive", "OBSERVATION_MODIFIER", 14, 21], ["loss", "OBSERVATION_MODIFIER", 22, 26], ["enormous", "OBSERVATION_MODIFIER", 56, 64], ["terrestrial biodiversity", "OBSERVATION", 65, 89], ["Amazonian", "OBSERVATION", 134, 143], ["forest loss", "OBSERVATION", 144, 155]]], ["The tipping point could come quickly if deforestation follows an accelerated pace, given the rapidity of infrastructure construction Walker et al. 2019) .IntroductionCurrent high deforestation rates are found at the central basin, mainly in the Tapaj\u00f3s and Madeira River sub-basins in southwestern Par\u00e1 and southern Amazonas, respectively (Walker et al. 2019; Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020) .", [["deforestation", "PROBLEM", 40, 53], ["an accelerated pace", "TREATMENT", 62, 81], ["central", "ANATOMY_MODIFIER", 216, 223], ["basin", "ANATOMY_MODIFIER", 224, 229]]], ["Par\u00e1 State continues to have Amazonia's highest annual forest loss, although this loss now takes place primarily in the southwestern part of the state, unlike earlier decades.", [["forest loss", "DISEASE", 55, 66], ["Amazonia", "PROBLEM", 29, 37], ["forest loss", "OBSERVATION", 55, 66]]], ["The state of Amazonas, which contributed to only 4.8% of the country's annual Amazonian deforestation during the 1990s and 2000s, increased to 12% during the 2010-2019 period (Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020) .", [["Amazonian deforestation", "OBSERVATION", 78, 101]]], ["This current scenario for deforestation is not well represented in the literature on Amazonian land-use change.", [["deforestation", "PROBLEM", 26, 39], ["Amazonian land", "TREATMENT", 85, 99]]], ["It is also known that transaction costs for southern Amazonas are declining due to mounting government investments in infrastructure, which increases agricultural profitability (Margulis 2003; Simmons et al. 2007; Walker and Richards 2013; Simmons et al. 2018 ).", [["agricultural", "OBSERVATION_MODIFIER", 150, 162], ["profitability", "OBSERVATION_MODIFIER", 163, 176]]], ["These issues have been well explored elsewhere and will not be the focus of this paper.IntroductionThis paper aims to analyze colonization and deforestation trajectories at the level of the decision-maker in Apu\u00ed, southern Amazonas, showing how deforestation patterns reflect economic and political events at the national and regional levels.", [["analyze colonization", "PROBLEM", 118, 138], ["deforestation trajectories", "PROBLEM", 143, 169], ["economic and political events at the national and regional levels", "PROBLEM", 276, 341], ["economic", "OBSERVATION_MODIFIER", 276, 284]]], ["We show that decisions involving current deforestation might differ from those that were made decades ago in other regions of the basin.", [["basin", "ANATOMY_MODIFIER", 130, 135]]], ["We focus on understanding the immediate processes of land-use change related to colonization and deforestation trajectories over 35 years at three scales of analysis: the entire landscape, cohorts of settlement lots grouped by occupation periods, and lots grouped by class of landholding size per household.", [["colonization", "PROBLEM", 80, 92], ["deforestation trajectories", "PROBLEM", 97, 123], ["size", "OBSERVATION_MODIFIER", 288, 292]]], ["Because settlements like the one in Apu\u00ed serve as logistical, service, social, and labor hubs in these remote areas, it is crucial to understand how the different processes and actors in settlements contribute to the region's deforestation and economy.IntroductionWe use the case of the PA Rio Juma settlement to illustrate this agricultural development process.", [["the PA Rio Juma settlement", "TREATMENT", 283, 309], ["this agricultural development process", "PROBLEM", 324, 361]]], ["We first describe agrarian reform in Amazonia, the processes of establishing settlement projects, and their contribution to overall deforestation.", [["overall deforestation", "PROBLEM", 124, 145], ["deforestation", "OBSERVATION", 132, 145]]], ["We discuss the process of land accumulation (concentration of farm lots in the hands of a few families).", [["land accumulation", "TREATMENT", 26, 43]]], ["After explaining the methods used in our study, we present results for the three scales of analysis, focusing on identifying factors that influence decisions to speed up forest loss in settlement projects and the relation of these decisions to the profiles of different groups of land managers.", [["our study", "TEST", 37, 46], ["analysis", "TEST", 91, 99]]], ["We end by discussing land tenure and landspeculation issues affecting Apu\u00ed's high deforestation rates and the implications for future research.Land Tenure and Agrarian ReformBrazil's Land Statute, or the \"Estatuto da Terra\" (Law 4330 of 1964), provides instructions for land expropriation and distribution, while the 1988 Constitution lists the \"social function of the land\" as a fundamental right of citizens (Article 5) and as a means of promoting agrarian reform (Article 186).", [["landspeculation issues", "PROBLEM", 37, 59], ["right", "ANATOMY_MODIFIER", 392, 397]]], ["Brazil's National Institute of Colonization and Agrarian Reform (INCRA) was created in 1970 and has since been the primary federal agency for land administration.", [["land administration", "TREATMENT", 142, 161]]], ["Based on these rights as operationalized by INCRA, different ways for public lands to become private property have prevailed in different political periods.Land Tenure and Agrarian ReformDuring the military regime , sealed tenders (licita\u00e7\u00f5es) favored large private owners, but lots were also sold to small farmers in settlement projects at token prices and financed by low interest loans with 5-year grace periods before beginning payment (Hecht 1985; Fearnside 2001) .", [["public lands", "TREATMENT", 70, 82], ["the military regime", "TREATMENT", 194, 213], ["Agrarian", "OBSERVATION_MODIFIER", 172, 180], ["large", "OBSERVATION_MODIFIER", 252, 257]]], ["From that time onwards what motivated creation of private land was private interests capturing land rents propelled by government investments in infrastructure, cattle ranching, and mining.", [["cattle", "SPECIES", 161, 167], ["cattle ranching", "TREATMENT", 161, 176]]], ["Investments grew rapidly with the PoloAmaz\u00f4nia (Polos Agropecu\u00e1rios e Agrominerais da Amaz\u00f4nia) program and through subsidies for large cattle ranches provided by the regional development agency SUDAM (Superintend\u00eancia do Desenvolvimento da Amaz\u00f4nia) in Par\u00e1 and Mato Grosso states (Hecht et al. 1988; Mahar 1989) .Land Tenure and Agrarian ReformFrom 1985 onwards, informal \"occupations\" (i.e., squatter invasions) of public lands with later government sanction were the primary approach for converting public land into private property (Fearnside 2001) , while a significant portion of more-recent settlements has been from expropriating private landholdings (Pacheco 2009 ).", [["SUDAM", "CHEMICAL", 195, 200], ["cattle", "SPECIES", 136, 142], ["cattle", "SPECIES", 136, 142], ["the PoloAmaz\u00f4nia (Polos Agropecu\u00e1rios e Agrominerais da Amaz\u00f4nia) program", "TREATMENT", 30, 103], ["large cattle ranches", "TREATMENT", 130, 150], ["large", "OBSERVATION_MODIFIER", 130, 135], ["cattle ranches", "OBSERVATION", 136, 150]]], ["PAs consist of groups of individual farm lots, each with 50-100 ha (Yanai et al. 2016) .", [["PAs", "TEST", 0, 3]]], ["PAs are similar to PICs in that both are for promoting agricultural production.", [["PICs", "TREATMENT", 19, 23], ["PICs", "OBSERVATION", 19, 23], ["agricultural production", "OBSERVATION", 55, 78]]], ["However, PAs did not have the same level of support that the PICs received from government infrastructure investments and agricultural credit.", [["the PICs", "TREATMENT", 57, 65]]], ["PAs are created by INCRA, but the stimulus to create them usually comes from individuals and groups who used the Land Statute and other legislation to promote agrarian reform for themselves, which became known as \"directaction land reform\" (Simmons et al. 2010) .", [["INCRA", "PROTEIN", 19, 24], ["PAs", "TEST", 0, 3]]], ["Other categories of \"special settlements\" were also created from mid-1990s onwards, such as Sustainable Development Projects (PDSes), Agroforestry Projects, and Agroextractive Projects (PAEs).", [["Agroforestry Projects", "TREATMENT", 134, 155]]], ["Agricultural conversion in these special settlements should (theoretically) be minimal, and livelihoods should rely primarily on forest extraction in a regime of communal lands (Yanai et al. 2016) .", [["Agricultural conversion", "TREATMENT", 0, 23], ["forest extraction", "TREATMENT", 129, 146]]], ["By 2010, 670,000 farm lots had been distributed, while more than 300,000 squatters were waiting to be legally titled (Tourneau and Bursztyn 2010).Deforestation in Settlement ProjectsMunicipalities (counties) currently considered to be deforestation hotspots are those receiving major infrastructure projects (i.e., hydroelectric dams, ports, waterways, and road paving) (see Branford and Torres 2017; Walker and Simmons 2018) , or those with abundant accessible forests into which settlement projects often expand (see Tourneau and Bursztyn 2010; Alencar et al. 2016; Gouv\u00eaa et al. 2009 ).", [["Deforestation", "DISEASE", 146, 159]]], ["Over time, deforestation in settlement projects has increased as a contribution to total deforestation.", [["deforestation in settlement", "TREATMENT", 11, 38], ["total deforestation", "TREATMENT", 83, 102], ["deforestation", "OBSERVATION", 11, 24], ["increased", "OBSERVATION_MODIFIER", 52, 61]]], ["Settlements were responsible for 11.3% of total Amazonian deforestation up to 2003 (Pacheco 2009 ), for 24% from 2004 to 2008, and for 30% from 2010 to 2014 (Alencar et al. 2016; Yanai et al. 2016) .", [["total Amazonian deforestation", "TREATMENT", 42, 71]]], ["By 2014, the PA category accounted for 72% of the total deforestation in settlements (Yanai et al. 2016) .Deforestation in Settlement ProjectsAt the municipality level, settlements are spatially linked to deforestation and fire events (Schneider and Peres 2015) .", [["deforestation", "DISEASE", 56, 69], ["the PA category", "TEST", 9, 24], ["Deforestation", "TREATMENT", 106, 119]]], ["The infrastructure projects form new population clusters, change productive patterns, and influence the creation of new municipalities and districts (administrative units within a municipality) (Heredia et al. 2003; Franco and Lima 2008; Simmons et al. 2010) .", [["new population clusters", "PROBLEM", 33, 56], ["infrastructure", "OBSERVATION", 4, 18], ["new", "OBSERVATION_MODIFIER", 33, 36], ["population", "OBSERVATION_MODIFIER", 37, 47], ["clusters", "OBSERVATION_MODIFIER", 48, 56], ["change", "OBSERVATION_MODIFIER", 58, 64], ["productive", "OBSERVATION_MODIFIER", 65, 75], ["patterns", "OBSERVATION_MODIFIER", 76, 84], ["new", "OBSERVATION_MODIFIER", 116, 119]]], ["Deforestation seems to be especially favored by the creation of new municipalities, as this brings a variety of government money transfers (\"repasses\") and infrastructure investments.Deforestation in Settlement ProjectsThe contribution of agrarian reform to Amazonian deforestation is contingent on spatiotemporal dynamics (Pacheco 2009; Yanai et al. 2016 ).", [["Deforestation", "DISEASE", 0, 13], ["Deforestation", "TREATMENT", 183, 196], ["Amazonian deforestation", "TREATMENT", 258, 281], ["new", "OBSERVATION_MODIFIER", 64, 67], ["agrarian", "OBSERVATION_MODIFIER", 239, 247], ["Amazonian deforestation", "OBSERVATION", 258, 281]]], ["Up to 2010 most deforestation was confined to the southern and eastern flanks of the basin (known as the \"arc of deforestation\"), an area that now has consolidated agricultural lands (Sathler et al. 2018; Schielein and B\u00f6rner 2018) .", [["consolidated", "OBSERVATION_MODIFIER", 151, 163], ["agricultural lands", "OBSERVATION", 164, 182]]], ["For the 2013-2018 period, the 20 municipalities with the most substantial cumulative deforestation lay closer to the center of the basin, and these municipalities were responsible for 90% of the total area deforested in the entire Brazilian Amazon (Fig. 1) .", [["basin", "ANATOMY", 131, 136]]], ["In some of these 20 municipalities, such as Porto-Velho (Rond\u00f4nia), Altamira and Novo Progresso (Par\u00e1), deforestation is mostly driven by large infrastructure projects (i.e., hydroelectric dams and paved roads) (Fearnside 2015; Walker and Simmons 2018) .", [["Porto-Velho (Rond\u00f4nia)", "TREATMENT", 44, 66], ["Altamira and Novo Progresso (Par\u00e1)", "TREATMENT", 68, 102], ["deforestation", "TREATMENT", 104, 117], ["large", "OBSERVATION_MODIFIER", 138, 143], ["infrastructure", "OBSERVATION", 144, 158]]], ["For the other municipalities, deforestation is driven only by agricultural expansion centered on settlement projects, such as Apu\u00ed, Novo Aripuan\u00e3, L\u00e1brea, Boca do Acre, and Manicor\u00e9 (Amazonas), Machadinho D'Oeste and Cujubim (Rond\u00f4nia), and Colniza (Mato Grosso) (Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020) .Land Concentration in Settlement ProjectsVarious scholars have reported on the consequences of migration and the settling of landless people in the Amazon.", [["people", "ORGANISM", 460, 466], ["people", "SPECIES", 460, 466], ["deforestation", "TREATMENT", 30, 43], ["Machadinho D'Oeste and Cujubim (Rond\u00f4nia)", "TREATMENT", 194, 235], ["migration", "OBSERVATION", 421, 430]]], ["During the 1980s, Rond\u00f4nia and Par\u00e1 states experienced massive waves of land speculation with state-led colonization and spontaneous migration, with landholdings of squatters (posseiros) being deforested and sold to more-capitalized actors (Alston et al. 1995; Fearnside 1989; Mahar 1989) .", [["massive waves of land speculation", "PROBLEM", 55, 88], ["state-led colonization", "PROBLEM", 94, 116], ["spontaneous migration", "PROBLEM", 121, 142], ["massive", "OBSERVATION_MODIFIER", 55, 62], ["spontaneous", "OBSERVATION_MODIFIER", 121, 132], ["migration", "OBSERVATION_MODIFIER", 133, 142]]], ["These landconcentration processes have intensified deforestation (Moran 1977; Fearnside 1986 Fearnside , 1989 Mahar 1989; Walker et al. 2000) and created conflicts between wealthy landed elites and small homesteaders (Alston et al. 2000; Aldrich et al. 2012) .", [["small", "OBSERVATION_MODIFIER", 198, 203]]], ["Figure 2 indicates that land concentration is also severe in settlement projects with recent extensive cumulative deforestation.", [["recent extensive cumulative deforestation", "TREATMENT", 86, 127], ["severe", "OBSERVATION_MODIFIER", 51, 57], ["extensive", "OBSERVATION_MODIFIER", 93, 102], ["cumulative deforestation", "OBSERVATION", 103, 127]]], ["When we analyze the size of areas deforested in the 20 settlements with the largest cumulative deforestation for the 2013-2018 period, only 15.8% of this area was in patches <10 ha in area.", [["size", "OBSERVATION_MODIFIER", 20, 24], ["areas", "OBSERVATION_MODIFIER", 28, 33], ["largest", "OBSERVATION_MODIFIER", 76, 83]]], ["As Fig. 2 shows, 45.7% of the area deforested was in polygons 10-50 ha in area, 15.6% in those with 50-100 ha, 19.2% with 100-500 ha, and 3.6% over 500 ha, including three polygons larger than 1000 ha.Land Concentration in Settlement ProjectsStudies have reported that isolation, lack of infrastructure and land titling, and poor implementation of public services lead to high lot turnover, with colonists illegally selling their farm lots to more-capitalized farmers (Fearnside 1989 (Fearnside , 2001 Ludewigs et al. 2009; Parry et al. 2010; Carrero and Fearnside 2011) .", [["polygons", "TEST", 53, 61], ["ha", "TEST", 107, 109], ["ha", "TEST", 130, 132], ["public services", "TREATMENT", 348, 363], ["high lot turnover", "PROBLEM", 372, 389]]], ["This farm turnover has promoted land concentration in settlements in Par\u00e1 (Fearnside 1986 (Fearnside , 2001 Pacheco 2009; Godar et al. 2012) , Amazonas (Carrero and Fearnside 2011) , Rond\u00f4nia (Fearnside 1989) , and Acre (Franco and Lima 2008; Ludewigs et al. 2009 ).", [["Lima", "ANATOMY", 232, 236]]], ["Nevertheless, the questions of how land accumulation occurs and evolves over time and how it contributes to the local economy have not been well explored by scholars.Land Concentration in Settlement ProjectsCapitalized actors from urban areas have been investing in buying farms in settlement projects (Simmons 2004; Carrero and Fearnside 2011; Yanai et al. 2020 ).", [["Land Concentration", "TREATMENT", 166, 184]]], ["These become medium and largeholders who benefit from being in settlements because it allows them to use the labor pool and infrastructure in these areas, as well as helping them hide from law enforcement because they are harder to find when their landholding is a collection of small lots surrounded by those of smallholders (Alencar et al. 2016) .", [["the labor pool", "PROBLEM", 105, 119], ["medium", "OBSERVATION_MODIFIER", 13, 19], ["small", "OBSERVATION_MODIFIER", 279, 284]]], ["Worse, in special settlements such as PDSes or PAEs, the land is not officially separated into individual farm lots, which makes it more challenging to find the real culprits for deforestation.Land Concentration in Settlement ProjectsWe now address the case of PA Rio Juma in Apu\u00ed as an example of how settlements have contributed to the agricultural expansion in southern Amazonas and other recent deforestation frontiers.", [["PAEs", "CHEMICAL", 47, 51], ["the agricultural expansion", "PROBLEM", 334, 360], ["agricultural", "OBSERVATION_MODIFIER", 338, 350], ["expansion", "OBSERVATION", 351, 360], ["deforestation", "OBSERVATION", 399, 412]]], ["By analyzing colonization and deforestation trajectories of households in this settlement, we provide an account of the mechanisms through which deforestation decision-making responds to economic and policy shifts and find evidence of why deforestation has been accelerating in the region.The Study AreaApu\u00ed municipality in southeastern Amazonas (7.20\u00b0S latitude, 59.89\u00b0W longitude) has annual precipitation between 2200 and 2800 mm, and a yearly average temperature of 26\u00b0C. The predominant soil type is red-yellow latosol in the Brazilian classification (a haplic ferralsol) (Brazil, EMBRAPA Empresa Brasileira de Pesquisa Agropecua\u0155ia 2006) .", [["why deforestation", "PROBLEM", 235, 252], ["annual precipitation", "PROBLEM", 387, 407], ["a haplic ferralsol", "TREATMENT", 557, 575], ["colonization", "OBSERVATION", 13, 25], ["predominant", "OBSERVATION_MODIFIER", 480, 491], ["soil type", "OBSERVATION", 492, 501]]], ["Apui's population totaled 22,000 inhabitants in 2018 (Brazil, IBGE Instituto Brasileiro de Geografia e Estat\u00edstica 2018).", [["Apui's population", "PROBLEM", 0, 17]]], ["The primary sector represented 55% of its gross domestic product (GDP) in 2016 (Brazil, IBGE Instituto Brasileiro de Geografia e Estat\u00edstica 2018), mainly from cattle ranching, with more than 160,000 head in 2015 (da Silva and Carrero 2017).", [["head", "ANATOMY", 200, 204], ["head", "ORGANISM_SUBDIVISION", 200, 204], ["cattle", "SPECIES", 160, 166], ["cattle", "SPECIES", 160, 166]]], ["Around 25,000 animals are slaughtered yearly (Carrero et al. 2015) , and annual milk production totals 7.5 million liters (da Silva and Carrero 2017).", [["milk", "ORGANISM_SUBSTANCE", 80, 84]]], ["Credit for cattle ranching has been a significant government investment in Apu\u00ed, with R$6 million (US$1.5 million) in 2013 alone (Carrero et al. 2014) .The Study AreaApu\u00ed was declared a municipality in 1987.", [["cattle", "SPECIES", 11, 17], ["significant", "OBSERVATION_MODIFIER", 38, 49]]], ["It grew from the central village of the PA Rio Juma settlement, created in 1982.", [["central", "ANATOMY_MODIFIER", 17, 24]]], ["The settlement represents roughly 12% of Apu\u00ed's area, is located along a 150-km stretch of the Transamazon Highway (BR-230), and has more than 140 access roads (\"vicinais\") totaling roughly 1300 km.", [["BR-230", "CHEMICAL", 116, 122], ["Apu\u00ed's area", "TREATMENT", 41, 52], ["settlement", "OBSERVATION_MODIFIER", 4, 14], ["roughly", "OBSERVATION_MODIFIER", 26, 33]]], ["However, during the rainy season (December to April), the same trips may take several days, or the roads may be impassable for weeks, thus jeopardizing the local economy.", [["local economy", "OBSERVATION", 156, 169]]], ["Such conditions make transportation of agricultural output from rural properties-either to the town of Apu\u00ed or to more distant markets-time-consuming and more expensive than in most of Brazil's agricultural areas.The Study AreaPA Rio Juma's area was initially composed of 98% ombrophilous (\"shade-loving\" or closed) rainforest; 50.3% dense submontane, and 47.7% open lowland forests with palms (Brazil, IBGE Instituto Brasileiro de Geografia e Estat\u00edstica 2004) with average total biomasses (above + belowground) of 385 and 363 Mg ha \u22121 , respectively ( Table 5 in Nogueira et al. 2008) .", [["palms", "ORGANISM_SUBDIVISION", 388, 393], ["The Study", "TEST", 213, 222], ["average total biomasses", "TEST", 467, 490]]], ["Species of economic interest in submontane forests include Handroanthus spp., Cedrela spp., Parkia spp., Dinizia excelsa Ducke, Bertholletia excelsa Bonpl., and Aniba rosaeodora Ducke, whereas in open lowland forests include Copaiffera spp, Caryocar villosum (Aubl.)Pers., and the palms Euterpe precatoria Mart., Oenocarpus spp., and Mauritia flexuosa (L.f) (Carrero et al. 2017) .Mapping Deforestation in the Farm Lots of PA Rio JumaThe PA Rio Juma layer was obtained from an INCRA cartographic map of polylines at 1:100,000 scale.", [["Handroanthus spp.", "ORGANISM", 59, 76], ["Cedrela spp.", "ORGANISM", 78, 90], ["Parkia spp.", "ORGANISM", 92, 103], ["Dinizia excelsa Ducke", "ORGANISM", 105, 126], ["Bertholletia excelsa Bonpl.", "ORGANISM", 128, 155], ["Aniba rosaeodora Ducke", "ORGANISM", 161, 183], ["Copaiffera spp", "ORGANISM", 225, 239], ["Caryocar villosum", "ORGANISM", 241, 258], ["palms", "ORGANISM", 281, 286], ["Euterpe precatoria Mart.", "ORGANISM", 287, 311], ["Oenocarpus spp.", "ORGANISM", 313, 328], ["Mauritia flexuosa", "ORGANISM", 334, 351], ["polylines", "SIMPLE_CHEMICAL", 503, 512], ["Handroanthus spp.", "SPECIES", 59, 76], ["Cedrela spp.", "SPECIES", 78, 90], ["Parkia spp.", "SPECIES", 92, 103], ["Dinizia excelsa", "SPECIES", 105, 120], ["Bertholletia excelsa", "SPECIES", 128, 148], ["Aniba rosaeodora", "SPECIES", 161, 177], ["Copaiffera spp", "SPECIES", 225, 239], ["Caryocar villosum", "SPECIES", 241, 258], ["Euterpe precatoria", "SPECIES", 287, 305], ["Oenocarpus spp.", "SPECIES", 313, 328], ["Mauritia flexuosa", "SPECIES", 334, 351], ["Handroanthus spp.", "SPECIES", 59, 76], ["Cedrela spp.", "SPECIES", 78, 90], ["Parkia spp.", "SPECIES", 92, 103], ["Dinizia excelsa", "SPECIES", 105, 120], ["Bertholletia excelsa", "SPECIES", 128, 148], ["Aniba rosaeodora", "SPECIES", 161, 177], ["Caryocar villosum", "SPECIES", 241, 258], ["Euterpe precatoria", "SPECIES", 287, 305], ["Oenocarpus spp.", "SPECIES", 313, 328], ["Mauritia flexuosa", "SPECIES", 334, 351], ["submontane forests", "TREATMENT", 32, 50], ["Oenocarpus spp.", "PROBLEM", 313, 328], ["Mapping Deforestation", "TREATMENT", 381, 402], ["The PA Rio Juma layer", "TREATMENT", 434, 455], ["an INCRA cartographic map of polylines", "TREATMENT", 474, 512], ["palms", "ANATOMY", 281, 286]]], ["The polylines are subsequently converted into polygons of farm lots.", [["polylines", "SIMPLE_CHEMICAL", 4, 13], ["The polylines", "TREATMENT", 0, 13]]], ["We applied a 5-km buffer surrounding the 420,243-ha area of demarcated lots to delimit a study area totaling 700,338 ha.", [["a 5-km buffer", "TREATMENT", 11, 24], ["a study area", "TEST", 87, 99]]], ["The area encompassing all individual farm lots includes some medium and large landholdings that predate the settlement's creation.Mapping Deforestation in the Farm Lots of PA Rio JumaWe used 13 remotely sensed images from Landsat 5, 7, and 8 (path 230, row 65), Landsat 2 (path 247, row 65), and ResourceSat-2 (path 314, row 83) ( Table 1) to analyze PA Rio Juma\u00b4s deforestation.", [["some medium and large landholdings", "PROBLEM", 56, 90], ["Mapping Deforestation", "TREATMENT", 130, 151], ["remotely sensed images", "TEST", 194, 216], ["Landsat", "TEST", 222, 229], ["Landsat", "TEST", 262, 269], ["ResourceSat", "TEST", 296, 307], ["area", "OBSERVATION_MODIFIER", 4, 8], ["all", "OBSERVATION_MODIFIER", 22, 25], ["individual", "OBSERVATION_MODIFIER", 26, 36], ["farm", "OBSERVATION_MODIFIER", 37, 41], ["lots", "OBSERVATION_MODIFIER", 42, 46], ["some medium", "OBSERVATION_MODIFIER", 56, 67], ["large", "OBSERVATION_MODIFIER", 72, 77], ["landholdings", "OBSERVATION", 78, 90]]], ["Images downloaded from the Division for Imagery Generation of Brazil's National Institute of Space Research (http://www.dgi.inpe.br/CDSR/) are shown in Table 1 1 .", [["Images", "TEST", 0, 6], ["Brazil's", "TREATMENT", 62, 70]]], ["The deforestation polygons were delimited by visual interpretation at a fixed scale of 1:30,000 using a false-color composition (shortwave infrared-Red, near-infrared-Green, and red-Blue), producing an information layer for each date.", [["a fixed scale", "TEST", 70, 83], ["deforestation polygons", "OBSERVATION", 4, 26]]], ["Polygons of deforestation were drawn over all visible areas of bare soil on the image.", [["deforestation", "TREATMENT", 12, 25], ["deforestation", "OBSERVATION", 12, 25], ["bare soil", "OBSERVATION", 63, 72]]], ["This layer was used together with the next image, and a group of polygons for the next image was drawn.", [["the next image", "TEST", 34, 48], ["the next image", "TEST", 78, 92]]], ["Polygons in each subsequent year were overlaid with the polygons of the previous year and then clipped to ensure no overlap of deforestation between information layers.", [["deforestation", "OBSERVATION", 127, 140]]], ["Areas of non-forest vegetation (savanna) identified by PRODES (Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020) were not included in the total deforested area.", [["non-forest vegetation", "PROBLEM", 9, 30], ["non-forest vegetation", "OBSERVATION", 9, 30]]], ["The resulting map represents the total cumulative deforestation.", [["the total cumulative deforestation", "TREATMENT", 29, 63], ["total", "OBSERVATION_MODIFIER", 33, 38], ["cumulative deforestation", "OBSERVATION", 39, 63]]], ["This does not consider as \"deforestation\" the clearing of vegetation under secondary regrowth.Mapping Deforestation in the Farm Lots of PA Rio JumaThe minimum unit manually mapped was 1200 m 2 (0.12 ha, or four pixels of 30 \u00d7 30 m), which is smaller than the minimum unit used by the National Institute for Space Research (INPE) in its PRODES dataset, which is 6.25 ha (Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020) .", [["vegetation", "PROBLEM", 58, 68], ["secondary regrowth", "PROBLEM", 75, 93], ["Mapping Deforestation", "TREATMENT", 94, 115], ["clearing", "OBSERVATION_MODIFIER", 46, 54], ["vegetation", "OBSERVATION", 58, 68], ["secondary regrowth", "OBSERVATION", 75, 93], ["smaller", "OBSERVATION_MODIFIER", 242, 249]]], ["Although impractical in large areas, our manual mapping method identifies areas deforested by smallholders, which is considered to be critical for our analysis.", [["impractical in large areas", "PROBLEM", 9, 35], ["our manual mapping method", "TEST", 37, 62], ["our analysis", "TEST", 147, 159], ["large", "OBSERVATION_MODIFIER", 24, 29], ["areas", "OBSERVATION_MODIFIER", 30, 35]]], ["Even though small areas are needed, in order to control for possible geolocation errors we excluded polygons smaller than 1 ha (i.e., 2.5% of the total deforested area mapped).", [["small areas", "PROBLEM", 12, 23], ["geolocation errors", "PROBLEM", 69, 87], ["the total deforested area", "TREATMENT", 142, 167], ["small", "OBSERVATION_MODIFIER", 12, 17], ["areas", "OBSERVATION_MODIFIER", 18, 23], ["smaller", "OBSERVATION_MODIFIER", 109, 116]]], ["To restrict consideration to farm lots that are actively being managed, the analysis considered only those with more than 2 ha of cumulative deforestation by 2016.", [["the analysis", "TEST", 72, 84]]], ["This value is based on the size of the area that newly arrived families clear in a year using only family labor for planting annual crops (e.g., Moran 1981; Fearnside 1986; Vosti et al. 2002) .Deforestation Trajectories in PA Rio JumaThe deforested area was used to conduct temporal analyses over 35 years in three different units or scales: first, for the entire landscape of PA Rio Juma and its 5-km buffer; second, for the farm lots across cohorts or groups of landholdings representing the same occupation period; and lastly, for the landholdings of households, meaning that the same household may have one or several farm lots.", [["This value", "TEST", 0, 10], ["The deforested area", "PROBLEM", 234, 253], ["size", "OBSERVATION_MODIFIER", 27, 31]]], ["By looking into these three units of analysis, nesting farm lots and households in regional, spatial, and temporal scales, we shed light on what processes contribute to forest clearing over time.", [["analysis", "TEST", 37, 45]]], ["Scholars usually depict these as three different groups of processes related to deforestation: the time of arrival (\"cohort effect\"), the farm land-use consolidation (\"aging effect\"), and external events, which are shaped by policies and economic impacts of particular periods (\"period effects\") (for more detail, see Perz 2001; Brondizio et al. 2002; Walker 2004 ).", [["deforestation", "DISEASE", 80, 93], ["consolidation", "PROBLEM", 152, 165], ["external events", "PROBLEM", 188, 203], ["consolidation", "OBSERVATION", 152, 165], ["shaped", "OBSERVATION_MODIFIER", 215, 221]]], ["There is a fourth process related to a spatial effect of economies of agglomeration and the role of new institutional economics, in which clustering farms could help with market information and innovation exchange and could affect deforestation either positively or negatively at a given location (Jepson 2006; Garrett et al. 2013; Richards 2017) .Regional Deforestation and Colonization PhasesWe present an analysis of colonization and deforestation trajectories for PA Rio Juma contrasted with what has happened in Brazilian Amazonia as a whole (represented by the arc of deforestation).", [["agglomeration", "DISEASE", 70, 83], ["a fourth process", "PROBLEM", 9, 25], ["agglomeration", "PROBLEM", 70, 83], ["Regional Deforestation", "PROBLEM", 348, 370], ["colonization", "PROBLEM", 420, 432], ["spatial", "OBSERVATION_MODIFIER", 39, 46], ["effect", "OBSERVATION_MODIFIER", 47, 53], ["economies", "OBSERVATION_MODIFIER", 57, 66], ["agglomeration", "OBSERVATION", 70, 83], ["new", "OBSERVATION_MODIFIER", 100, 103], ["Deforestation", "OBSERVATION", 357, 370], ["Colonization", "OBSERVATION", 375, 387]]], ["Workshop participants divided Apui's history into five main phases of colonization to reflect the successive waves of migration to the area: Phase 0-pre-settlement occupation (<1981); Phase 1-first colonist wave to PA Rio Juma (1982 -1992 ; Phase [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] ; Phase 3-capitalized farmers' wave (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) ; and Phase 4-highly capitalized actors' wave (2011 to present).Modeling Deforestation at the Farm-Lot Level across CohortsWe used generalized additive models (GAMs) for analyzing the quantity and frequency of deforestation in lots grouped into cohorts by the time of first deforestation, where the impact of the predictive variables is captured through nonparametric smoothing terms.", [["participants", "SPECIES", 9, 21], ["colonization", "PROBLEM", 70, 82], ["Phase", "TEST", 141, 146], ["Phase", "TEST", 184, 189], ["Phase", "TEST", 326, 331], ["Phase", "TEST", 429, 434], ["Modeling Deforestation", "PROBLEM", 487, 509], ["generalized additive models (GAMs)", "TREATMENT", 554, 588], ["deforestation", "TREATMENT", 633, 646], ["colonization", "OBSERVATION", 70, 82], ["Deforestation", "OBSERVATION", 496, 509], ["deforestation", "OBSERVATION", 633, 646]]], ["For Model 1, we used only farm lots smaller than 200 ha (n = 4516) to control for the size of clearings.", [["size", "OBSERVATION_MODIFIER", 86, 90]]], ["The dependent variable was the annual area deforested (ha) in each lot for each period, that is, the total area deforested in the period divided by the number of years in the period (Table 1) .", [["dependent", "OBSERVATION_MODIFIER", 4, 13], ["variable", "OBSERVATION_MODIFIER", 14, 22], ["annual", "OBSERVATION_MODIFIER", 31, 37], ["area", "OBSERVATION_MODIFIER", 38, 42], ["total", "OBSERVATION_MODIFIER", 101, 106], ["area", "OBSERVATION_MODIFIER", 107, 111]]], ["Model 1 relies on a scaled t model to account for potential outliers .", [["a scaled t model", "TREATMENT", 18, 34], ["potential outliers", "PROBLEM", 50, 68]]], ["Model 2 is a logistic regression that considers the presence or absence of deforestation in each farm lot in each period as the dependent variable.", [["a logistic regression", "PROBLEM", 11, 32], ["deforestation", "OBSERVATION", 75, 88], ["dependent", "OBSERVATION_MODIFIER", 128, 137], ["variable", "OBSERVATION_MODIFIER", 138, 146]]], ["Both models relied on smoothing splines, in which a 2D penalized thin-plate spline on the geographical coordinates is used to account for spatial correlation, and a 1D penalized cubic spline is used to model time trends (Wood 2018) .", [["smoothing splines", "TREATMENT", 22, 39], ["a 2D penalized thin-plate spline", "TREATMENT", 50, 82], ["a 1D penalized cubic spline", "TREATMENT", 163, 190], ["smoothing splines", "OBSERVATION", 22, 39]]], ["We ran both models for all lots together and for the lots grouped into cohorts corresponding to Phases 0-4.Deforestation by Class of Landholding Size per HouseholdWe analyzed a combined sample of 407 households.", [["Deforestation", "DISEASE", 107, 120], ["Phases", "TEST", 96, 102], ["Size", "OBSERVATION_MODIFIER", 145, 149]]], ["Data on landholding size per household were combined from three sources.", [["size", "OBSERVATION_MODIFIER", 20, 24]]], ["One is the household survey presented in Carrero and Fearnside (2011) , which consists of a random sample (n = 83) that has all landholding size classes.", [["a random sample", "TEST", 90, 105], ["size", "OBSERVATION_MODIFIER", 140, 144]]], ["These informants also provided information on the costs and labor arrangements for forest clearing presented in the results.", [["labor arrangements", "TREATMENT", 60, 78]]], ["Deforestation data were overlaid on the farm lot or lots comprising each landholding, and descriptive statistics for the area were calculated for subsets of the data based on landholding sizes and colonization phases.", [["Deforestation data", "TEST", 0, 18], ["the data", "TEST", 157, 165]]], ["An analysis of variance was used to compare the means of annual deforestation among the colonization phases and among landholding sizes, with Tukey HSD used to distinguish differences between means.Results and DiscussionIn this section we first present the colonization process in the Rio Juma settlement and its deforestation trajectory, which contrasts with what happened in the Brazilian Amazon as a whole.", [["An analysis of variance", "TEST", 0, 23], ["annual deforestation", "TREATMENT", 57, 77], ["the colonization phases", "TREATMENT", 84, 107], ["Tukey HSD", "TEST", 142, 151], ["this section", "TREATMENT", 223, 235], ["the colonization process", "PROBLEM", 253, 277]]], ["We then present and discuss the contribution of the landholding size classes per household to forest clearing over time, as well as the region's deforestation economy.", [["size", "OBSERVATION_MODIFIER", 64, 68]]], ["Finally, we discuss the current underlying forces of deforestation in Brazil and the mechanisms through which these forces affected land-use change in PA Rio Juma.Colonization and Deforestation in PA Rio JumaThirteen lot sub-cohorts were generated based on the year in which farm lots first reached the threshold of 2 ha deforested.", [["Colonization", "PROBLEM", 163, 175], ["Deforestation", "TREATMENT", 180, 193], ["Deforestation", "OBSERVATION", 180, 193]]], ["These sub-cohorts were grouped into five cohort classes totaling 4546 farm lots (Table 2 ) averaging 77.7 ha (SD \u00b1 49.2), representing the pre-colonization phase and four colonization phases according to the workshop results.", [["the pre-colonization phase", "TEST", 135, 161]]], ["The spatial configuration of the colonization process in PA Rio Juma is presented in Fig. 4 , where the farm lots are colored by the period of occupation related to the colonization phases.", [["the colonization process", "PROBLEM", 29, 53], ["spatial", "OBSERVATION_MODIFIER", 4, 11], ["configuration", "OBSERVATION_MODIFIER", 12, 25], ["colonization process", "OBSERVATION", 33, 53], ["Fig", "OBSERVATION_MODIFIER", 85, 88], ["colored", "OBSERVATION", 118, 125]]], ["The total cumulative area deforested within the 5-km buffer by 2016 was 217,556 ha, which comprises more than 80% of the total deforestation in the municipality of Apu\u00ed (Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020).", [["The total cumulative area", "PROBLEM", 0, 25], ["ha", "PROBLEM", 80, 82], ["the total deforestation", "TREATMENT", 117, 140], ["total", "OBSERVATION_MODIFIER", 4, 9], ["cumulative", "OBSERVATION_MODIFIER", 10, 20], ["area", "OBSERVATION_MODIFIER", 21, 25]]], ["PA Rio Juma's deforestation trajectory is overlaid with the trajectory in the Brazilian Amazon in Fig. 5 , showing that the first peak of deforestation in the Brazilian Amazon in 1995, a result of macro-economic effects (i.e., Plano Real economic stabilization), appears to be reflected in Apu\u00ed with a delay of 2 years.", [["PA Rio Juma's deforestation trajectory", "TREATMENT", 0, 38], ["macro-economic effects", "PROBLEM", 197, 219], ["Plano Real economic stabilization", "TREATMENT", 227, 260], ["deforestation", "OBSERVATION", 14, 27], ["deforestation", "OBSERVATION", 138, 151]]], ["In PA Rio Juma the first peak (1996) (1997) (1998) during Phase 2 was enlarged by the massive arrival of a second colonist wave with the occupation of 1954 farm lots (42% of all occupied farm lots); deforestation also increased thanks to optimal conditions for burning the felled forest due to prolonged dry seasons induced by the El Ni\u00f1o phenomenon (1997) (1998) .", [["deforestation", "PROBLEM", 199, 212], ["burning", "PROBLEM", 261, 268], ["prolonged dry seasons", "PROBLEM", 294, 315], ["enlarged", "OBSERVATION", 70, 78], ["massive", "OBSERVATION_MODIFIER", 86, 93]]], ["This phase was also marked by the first investments in perennial crops (coffee and cacao) by the Program for Special Credit for Agrarian Reform (PROCERA) under the Constitutional Fund for Financing in the North.", [["cacao", "ORGANISM_SUBDIVISION", 83, 88], ["cacao", "SPECIES", 83, 88], ["cacao", "SPECIES", 83, 88], ["marked", "OBSERVATION_MODIFIER", 20, 26]]], ["A significant portion of these crops failed due to lack of experience in farming in the Amazonian region and lack of market access, leading some colonists to abandon their landholdings or to switch to cattle ranching (Carrero 2009 ).Colonization and Deforestation in PA Rio JumaSimilarly, deforestation in PA Rio Juma's second deforestation peak (2006) (2007) , in Phase 3, was also delayed by 2 years when compared to the peak in the Brazilian Amazon (2004).", [["cattle", "SPECIES", 201, 207], ["these crops", "TREATMENT", 25, 36], ["Colonization", "PROBLEM", 233, 245], ["Deforestation", "PROBLEM", 250, 263], ["deforestation", "PROBLEM", 289, 302], ["significant", "OBSERVATION_MODIFIER", 2, 13], ["portion", "OBSERVATION_MODIFIER", 14, 21], ["Amazonian", "ANATOMY_MODIFIER", 88, 97], ["Deforestation", "OBSERVATION", 250, 263]]], ["The 2004 Amazon-wide deforestation peak reflected investments in cattle and soy expansion and intensification in response to growing global demand (Walker et al. 2009; Pacheco and Poccard-Chapuis 2012) .", [["cattle", "ORGANISM", 65, 71], ["soy", "ORGANISM_SUBDIVISION", 76, 79], ["cattle", "SPECIES", 65, 71], ["cattle", "SPECIES", 65, 71], ["Amazon-wide deforestation", "TREATMENT", 9, 34], ["cattle and soy expansion", "TREATMENT", 65, 89]]], ["To respond to this peak, the government created the Plan of Action to Prevent and Control Deforestation in Legal Amazonia in the same year, with surveillance concentrated in Mato Grosso, Par\u00e1, and Rond\u00f4nia.", [["Legal Amazonia", "OBSERVATION", 107, 121]]], ["Furthermore, Amazonas had a substantial reduction in the price of arable land in 2006, while other regions had increased prices (Gasques and Bastos 2008) .", [["substantial", "OBSERVATION_MODIFIER", 28, 39], ["reduction", "OBSERVATION_MODIFIER", 40, 49], ["increased", "OBSERVATION_MODIFIER", 111, 120]]], ["The abundant unregulated lands with little surveillance in southern Amazonas were a major attraction for those seeking to capture rents from land and cattle in Amazonia (Carrero and Fearnside 2011; Waroux et al. 2017; Faleiros and S\u00e1 2018) .", [["cattle", "SPECIES", 150, 156], ["cattle", "SPECIES", 150, 156], ["abundant", "OBSERVATION_MODIFIER", 4, 12], ["unregulated", "OBSERVATION_MODIFIER", 13, 24], ["lands", "OBSERVATION_MODIFIER", 25, 30], ["little", "OBSERVATION_MODIFIER", 36, 42]]], ["In Apu\u00ed this migration is evident as shown by Carrero and Fearnside (2011) , where 41% of sampled households migrated from Rond\u00f4nia in the 2000s and bought farms from colonists or occupied forested lands, thus helping speed forest clearing and land accumulation with the purchase of multiple farm lots.", [["land accumulation", "PROBLEM", 244, 261], ["migration", "OBSERVATION", 13, 22], ["forested lands", "OBSERVATION", 189, 203]]], ["For old residents, the adoption of cattle ranching can be explained in part by the socioeconomic life-cycle theory of colonists, known as the \"aging effect\" related to household economic activities.", [["cattle", "ORGANISM", 35, 41], ["cattle", "SPECIES", 35, 41], ["cattle", "SPECIES", 35, 41], ["cattle ranching", "TREATMENT", 35, 50]]], ["The aging effect results in families that started with annual crops later switching to perennial crops and pasture (e.g., Brondizio et al. 2002; McCracken et al. 2002; Walker et al. 2002 Walker et al. , 2003 .", [["annual crops", "TREATMENT", 55, 67], ["perennial crops", "TREATMENT", 87, 102]]], ["Cattle-ranching investments and credit were much less pronounced in Apu\u00ed than in other areas because the outputs of ranching were not export-oriented.", [["Cattle-ranching investments", "TREATMENT", 0, 27], ["less pronounced", "OBSERVATION_MODIFIER", 49, 64]]], ["Nevertheless, a dairy plant was constructed, and credit lines (state and federal) were available to promote raising cattle for both beef and dairy, which might have influenced the deforestation peak in 2006-2007.", [["cattle", "ORGANISM", 116, 122], ["cattle", "SPECIES", 116, 122], ["beef", "SPECIES", 132, 136], ["cattle", "SPECIES", 116, 122], ["beef", "SPECIES", 132, 136]]], ["The most striking trend was the steep increase in deforestation in PA Rio Juma at the end of the \"Phase 4\" period, rising from 99 km 2 year \u22121 in 2013 to 241 km 2 year \u22121 in 2016 -an increase of 143% (Fig. 5) .", [["deforestation in PA Rio Juma", "TREATMENT", 50, 78], ["steep", "OBSERVATION_MODIFIER", 32, 37], ["increase", "OBSERVATION_MODIFIER", 38, 46], ["deforestation", "OBSERVATION", 50, 63]]], ["The most critical policy change in the period was the weakening of environmental protection through the approval of the new Forest Code (Law 12,651 of 2012) that pardoned illegal deforestation done up to 2008.", [["most", "OBSERVATION_MODIFIER", 4, 8], ["critical", "OBSERVATION_MODIFIER", 9, 17], ["policy", "OBSERVATION", 18, 24]]], ["Workshop participants claimed that PA Rio Juma was invaded by very wealthy individuals and other capitalized groups that are amassing large areas (dozens of farm lots at once) as the most significant contributors to the high deforestation rates recently reported.", [["participants", "SPECIES", 9, 21], ["the high deforestation rates", "PROBLEM", 216, 244], ["large", "OBSERVATION_MODIFIER", 134, 139], ["areas", "OBSERVATION_MODIFIER", 140, 145]]], ["We will discuss this current trend in more detail after exploring the deforestation trajectories of farm lots and cohorts.Deforestation Trajectories for Cohorts of Farm Lots in PA JumaThe GAM results for Models 1 and 2 indicate that time and location were statistically significant variables when considering deforestation for all lots (cohorts) (p < 0.001).", [["GAM", "PROTEIN", 188, 191], ["The GAM", "TEST", 184, 191], ["Models", "TEST", 204, 210]]], ["Interestingly, there were very similar period effects across all cohorts in both models (Fig. 6 ).", [["very", "OBSERVATION_MODIFIER", 26, 30], ["similar", "OBSERVATION_MODIFIER", 31, 38], ["period", "OBSERVATION_MODIFIER", 39, 45], ["effects", "OBSERVATION_MODIFIER", 46, 53]]], ["This trend of very marked period effects influencing all lots is shown in the top row of each graph in Fig. 6 , with narrow dashed lines representing the 95% confidence intervals.Deforestation Trajectories for Cohorts of Farm Lots in PA JumaModel 1 shows that deforestation rates are higher in the lots of more-recent cohorts (3 and 4).", [["lines", "CELL", 131, 136], ["narrow dashed lines", "TREATMENT", 117, 136], ["Farm Lots", "TEST", 221, 230], ["PA JumaModel", "TEST", 234, 246], ["deforestation rates", "TEST", 260, 279], ["very", "OBSERVATION_MODIFIER", 14, 18], ["marked", "OBSERVATION_MODIFIER", 19, 25], ["narrow", "OBSERVATION_MODIFIER", 117, 123], ["dashed lines", "OBSERVATION", 124, 136], ["deforestation", "OBSERVATION", 260, 273], ["higher", "OBSERVATION_MODIFIER", 284, 290]]], ["The initial rates show similar patterns for Cohorts 0, 1, and 2, remaining at <2 ha year \u22121 (on average) up to the 2000s.", [["The initial rates", "TEST", 0, 17], ["Cohorts", "TEST", 44, 51]]], ["Cohort 4 exhibits an annual average area deforested per farm lot that is double that of other cohorts, with high variation.", [["an annual average area", "PROBLEM", 18, 40], ["high variation", "OBSERVATION", 108, 122]]], ["Lots in this cohort could be part of small, medium, or large ranches that consist of several lots and are performing more extensive forest clearings.Deforestation Trajectories for Cohorts of Farm Lots in PA JumaThe logistic regression GAM model (Model 2) shows the proportion of lots that had deforestation activity in each period.", [["small, medium, or large ranches", "PROBLEM", 37, 68], ["Farm Lots", "TEST", 191, 200], ["GAM model", "TEST", 235, 244], ["small", "OBSERVATION_MODIFIER", 37, 42], ["medium", "OBSERVATION_MODIFIER", 44, 50], ["large", "OBSERVATION_MODIFIER", 55, 60], ["ranches", "OBSERVATION", 61, 68], ["deforestation activity", "OBSERVATION", 293, 315]]], ["Cohorts exhibit similar valleys in , 1982-1985) divided by the number of years in the interval.", [["similar", "OBSERVATION_MODIFIER", 16, 23], ["valleys", "OBSERVATION_MODIFIER", 24, 31]]], ["Deforestation rates in the Rio Juma settlement are based on satellite imagery interpreted in the present study 1992, 2007, and 2015, and peaks in 1998, 2010, and 2016 , indicating similar period effects on the proportion of lots being cleared across all cohorts.", [["Deforestation rates", "TEST", 0, 19], ["satellite imagery", "TEST", 60, 77]]], ["Again, there is a much greater width of the 95% confidence intervals for Cohorts 0, 3, and 4, whereas Cohorts 1 and 2 have much narrower intervals.", [["Cohorts", "TEST", 73, 80], ["much", "OBSERVATION_MODIFIER", 18, 22], ["greater", "OBSERVATION_MODIFIER", 23, 30], ["width", "OBSERVATION_MODIFIER", 31, 36]]], ["The higher heterogeneity for Cohort 0 is likely Fig. 6 Results of Model 1 for deforestation/year (ha) in farm lots <200 ha in area for all lots, and for lots grouped into cohorts representing five phases of occupation of the Rio Juma settlement; results of Model 2 for the proportion of lots deforesting per period, for all lots, and for lots grouped by cohorts representing five phases of occupation.", [["higher", "OBSERVATION_MODIFIER", 4, 10], ["heterogeneity", "OBSERVATION", 11, 24]]], ["Solid lines are the predicted means and dashed lines are the 95% confidence intervals because the model does not account for deforestation that took place from 1974 to 1981.Deforestation Trajectories for Cohorts of Farm Lots in PA JumaMigration waves affected the rates of colonization and farm-lot occupation, whereas the trajectories of deforestation rates and events appear to be most affected by period effects influencing all farm lots, although with different intensities.", [["Solid lines", "ANATOMY", 0, 11], ["Solid lines", "CELL", 0, 11], ["lines", "CELL", 47, 52], ["dashed lines", "CELL_LINE", 40, 52], ["Solid lines", "TREATMENT", 0, 11], ["dashed lines", "TREATMENT", 40, 52], ["deforestation", "PROBLEM", 125, 138], ["Farm Lots", "TEST", 215, 224], ["PA JumaMigration waves", "PROBLEM", 228, 250], ["colonization", "PROBLEM", 273, 285], ["lines", "OBSERVATION", 6, 11], ["dashed", "OBSERVATION_MODIFIER", 40, 46], ["lines", "OBSERVATION_MODIFIER", 47, 52], ["does not account for", "UNCERTAINTY", 104, 124], ["deforestation", "OBSERVATION", 125, 138], ["colonization", "OBSERVATION_MODIFIER", 273, 285]]], ["The results suggest weak effects related to household characteristics and occupation (i.e., aging effect and cohort effect) than would be expected based on the colonist footprint (Brondizio et al. 2002) .", [["weak effects", "PROBLEM", 20, 32], ["weak", "OBSERVATION", 20, 24]]], ["Thus, because most farm lots changed hands at least once and often many times, deforestation and farm consolidation processes do not reflect the action of one single household, but rather of successive households over time.", [["hands", "ORGANISM_SUBDIVISION", 37, 42], ["deforestation and farm consolidation processes", "PROBLEM", 79, 125], ["consolidation", "OBSERVATION", 102, 115]]], ["This high lot turnover in the remote area of PA Rio Juma seems to be related to the contagious nature of the deforestation process, which is dispersed through roads to areas that lack formal protection (Pfaff et al. 2007; Rosa et al. 2013 ) and have relatively easy access to land available to be either claimed or bought at low prices (Waroux et al. 2017 ).Deforestation by Household Area ClassLand and total cumulative deforestation by the 407 household samples are presented in Table 3 , resulting in 38,695 ha (59% of the total area analyzed) being deforested by 2016.", [["Deforestation", "DISEASE", 358, 371], ["This high lot turnover", "PROBLEM", 0, 22], ["the deforestation process", "PROBLEM", 105, 130], ["total cumulative deforestation", "TREATMENT", 404, 434], ["high", "OBSERVATION_MODIFIER", 5, 9], ["lot", "OBSERVATION_MODIFIER", 10, 13], ["turnover", "OBSERVATION_MODIFIER", 14, 22], ["contagious", "OBSERVATION_MODIFIER", 84, 94], ["deforestation", "OBSERVATION", 109, 122]]], ["Largeholders represented 2% of landholders but were responsible for 29% of deforestation.", [["deforestation", "PROBLEM", 75, 88]]], ["Thus, small, medium, and large landholders who are not INCRA-settled colonists might own all other occupied lots (around 4200).", [["small, medium, and large landholders", "PROBLEM", 6, 42], ["small", "OBSERVATION_MODIFIER", 6, 11], ["medium", "OBSERVATION_MODIFIER", 13, 19], ["large", "OBSERVATION_MODIFIER", 25, 30]]], ["Considering the total area occupied in 2016 (353,267 ha, Table 2 ), colonists represented <6% of this area, and they were not responsible for most of the deforestation.Deforestation by Household Area ClassAverage annual deforestation per class of landholding over time is presented in Fig. 7 .", [["Deforestation", "DISEASE", 168, 181], ["colonists", "TEST", 68, 77], ["total", "OBSERVATION_MODIFIER", 16, 21], ["area", "OBSERVATION_MODIFIER", 22, 26], ["deforestation", "OBSERVATION", 154, 167]]], ["Household means of Phases 3 (2003-2010) and 4 (2011-2016) were significantly different (TSD Tukey test, p < 0.05) from Phases 0, 1, and 2, which did not differ significantly from each other.", [["TSD Tukey test", "TEST", 88, 102], ["Phases", "TEST", 119, 125]]], ["All differences between deforestation means of the different landholding area classes were highly significant (p < 0.01), although when microholders were compared to smallholders, the significance was 0.02, still below 0.05.Apu\u00ed's Deforestation Economy and ActorsBased on the key-informant interviews, households of all sizes depend on hiring labor for deforestation through informal agreements that average R$645 per hectare deforested, burned, and sowed with grass seeds.", [["the different landholding area classes", "PROBLEM", 47, 85], ["deforestation", "OBSERVATION", 24, 37], ["significant", "OBSERVATION_MODIFIER", 98, 109]]], ["Medium and largeholders form groups to jointly hire the services of small airplanes for areas larger than 100 ha, which reduces costs of labor input by 25-40%, depending on the distance from the airport.", [["labor", "DISEASE", 137, 142], ["small airplanes", "PROBLEM", 68, 83], ["labor input", "PROBLEM", 137, 148], ["small", "OBSERVATION_MODIFIER", 68, 73]]], ["Back-of-the-envelope calculations suggest that forest clearing and pasture formation activities in 2016 poured R $10.32 million (US$3.17 million) into local markets for tools, equipment, seeds, fuel, and labor.", [["envelope calculations", "TEST", 12, 33], ["forest clearing and pasture formation activities", "PROBLEM", 47, 95], ["labor", "PROBLEM", 204, 209], ["forest clearing", "OBSERVATION", 47, 62]]], ["Without considering logistical costs and revenues from illegal logging, this amount corresponds to 29% of the municipality's GDP from services in that year (Brazil, IBGE Instituto Brasileiro de Geografia e Estat\u00edstica 2018).", [["GDP", "CHEMICAL", 125, 128], ["GDP", "SIMPLE_CHEMICAL", 125, 128], ["illegal logging", "OBSERVATION", 55, 70]]], ["All landholders' investments in deforestation must come from external sources because returns from current activities on their properties do not provide enough capital (Margulis 2003, p.", [["All landholders' investments", "TREATMENT", 0, 28]]], ["These actors are wealthy, active, respected citizens who have local political influence.", [["active", "OBSERVATION_MODIFIER", 26, 32]]], ["Although it is not possible to infer how much each of these sources contributes to the advancement of large-scale deforestation in Apu\u00ed, it is highly likely that illegal sources are present and causing extensive deforestation, such as a single 1200ha polygon deforested in June 2018 (Weisse and Lyons 2018; Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020) .", [["large-scale deforestation", "TREATMENT", 102, 127], ["not possible", "UNCERTAINTY", 15, 27], ["large", "OBSERVATION_MODIFIER", 102, 107], ["highly likely", "UNCERTAINTY", 143, 156], ["extensive", "OBSERVATION_MODIFIER", 202, 211], ["deforestation", "OBSERVATION", 212, 225]]], ["We documented evidence that these groups offset deforestation costs by selling standing trees to loggers.", [["offset", "OBSERVATION_MODIFIER", 41, 47], ["deforestation", "OBSERVATION_MODIFIER", 48, 61]]], ["Loggers use subterfuges to make illegal timber appear to be legal (known as \"warming-up\" the timber) and sell it on international markets (Brindis 2014; Brancalion et al. 2018; Keating 2018; Carvalho et al. 2019 ).Political and Economic Effects on the Current Deforestation ScenarioA combination of political and economic factors is motivating the current increase in deforestation rates in tropical forests.", [["the Current Deforestation ScenarioA", "TREATMENT", 248, 283], ["political and economic factors", "TREATMENT", 299, 329], ["deforestation rates", "TREATMENT", 368, 387], ["tropical forests", "TREATMENT", 391, 407], ["Economic", "OBSERVATION_MODIFIER", 228, 236], ["increase", "OBSERVATION_MODIFIER", 356, 364], ["tropical forests", "OBSERVATION", 391, 407]]], ["This increase is rooted in the shift from state-sponsored to export-oriented industrial-scale deforestation for agricultural production (Rudel et al. 2009; Lambin and Meyfroidt 2011; Austin et al. 2017 ).", [["agricultural production", "PROBLEM", 112, 135], ["increase", "OBSERVATION_MODIFIER", 5, 13]]], ["In the Brazilian Amazon, after a period of reduced deforestation (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) , these economic forces have rebounded and deforestation rates have been rising since 2012 (Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020) .", [["deforestation rates", "TEST", 164, 183], ["reduced", "OBSERVATION_MODIFIER", 43, 50], ["deforestation", "OBSERVATION_MODIFIER", 51, 64]]], ["A significant part of this increase is due to the political power of the \"ruralists,\" a coalition of legislative representatives of large landowners and agribusiness interests.", [["large landowners", "PROBLEM", 132, 148], ["significant", "OBSERVATION_MODIFIER", 2, 13], ["increase", "OBSERVATION", 27, 35], ["large", "OBSERVATION_MODIFIER", 132, 137], ["landowners", "OBSERVATION", 138, 148]]], ["These politicians have taken the lead in the National Congress and since 2012 have been pushing constitutional amendments that weaken environmental protection and facilitate infrastructure development and agribusiness 2 (Metzger et al. 2010; Soares-Filho et al. 2014; Fearnside 2016 Fearnside , 2017a Tollefson 2018) .", [["constitutional amendments", "TREATMENT", 96, 121], ["environmental protection", "TREATMENT", 134, 158]]], ["The ruralists' impact on legislation has increased substantially since president Jair Bolsonaro took office in January 2019 (Ferrante and Fearnside 2019) 3 .", [["increased", "OBSERVATION_MODIFIER", 41, 50]]], ["The resulting changes in the laws undermine the likelihood of future compliance with environmental measures that are preconditions for the many investments in infrastructure being made in the region (Meirelles et al. 2018; Simmons et al. 2018) .", [["environmental measures", "TREATMENT", 85, 107]]], ["The infrastructure also prompts more migration .Political and Economic Effects on the Current Deforestation ScenarioWe argue that these changes in markets, policies, and institutions influence local processes related to deforestation with greater intensity on agricultural frontiers that have abundant forestland, such as Apu\u00ed, where deforestation has sky-rocketed since 2016.", [["the Current Deforestation ScenarioWe", "TREATMENT", 82, 118], ["infrastructure", "OBSERVATION", 4, 18], ["more", "OBSERVATION_MODIFIER", 32, 36], ["migration", "OBSERVATION_MODIFIER", 37, 46], ["Economic", "OBSERVATION_MODIFIER", 62, 70]]], ["More roads, higher agricultural prices, lower wages, and shortages of off-farm employment generally lead to more deforestation (Angelsen and Kaimowitz 1999; Chomitz 2007; Pfaff et al. 2007) .", [["deforestation", "DISEASE", 113, 126], ["higher", "OBSERVATION_MODIFIER", 12, 18], ["agricultural prices", "OBSERVATION", 19, 38]]], ["A local complicating factor has been the population's misinterpretation of the conflicting federal and state laws concerning land titling and environmental issues, which has led Apu\u00ed residents to deforest more (Cenamo and Lima 2015) 4 .Political and Economic Effects on the Current Deforestation ScenarioAmazonas produces only 30% of the beef its population consumes (Carrero et al. 2015) , and, assuming no intensification, the state would have to increase its area of pastures at the expense of forests to meet its domestic demand for 2 As one of the major moves toward the \"flexibilization\" of laws, Provisional Measure (MP) 867 would completely dismantle the Forest Code, removing obligations such as the need to restore around five million hactares of forests in areas that were illegally deforested (before 2000) outside Amazonia, and, unless formally notified, landholders would be exempted from registering in the \"Rural Environmental Registry\" (CAR) under the Program of Environmental Regularization (Domingues 2019) .", [["ScenarioAmazonas", "CHEMICAL", 296, 312], ["beef", "SPECIES", 338, 342], ["the Current Deforestation ScenarioAmazonas", "TREATMENT", 270, 312], ["obligations", "TREATMENT", 685, 696], ["Economic", "OBSERVATION_MODIFIER", 250, 258]]], ["3 This extreme conservative president has been using authoritarian measures to dismantle environmental protection and education programs and the government's environmental agencies, as well as pushing proposed laws and constitutional amendments that promote resource extraction (minerals, oil, and agribusiness) for export at the expense of environmental destruction (Ferrante and Fearnside 2019; The Guardian 2019a, b) .", [["oil", "ORGANISM_SUBSTANCE", 289, 292], ["authoritarian measures", "TREATMENT", 53, 75], ["education programs", "TREATMENT", 118, 136], ["constitutional amendments", "TREATMENT", 219, 244], ["resource extraction (minerals, oil", "TREATMENT", 258, 292], ["destruction", "OBSERVATION", 355, 366]]], ["Increased deforestation for pasture has also been motivated by Amazonas State having gained its longawaited status of being free of foot-and-mouth disease, which was declared in December 2017 (Brazil, MAPA Minist\u00e9rio da Agropecu\u00e1ria e Abastecimento 2017) .", [["mouth", "ANATOMY", 141, 146], ["foot-and-mouth disease", "DISEASE", 132, 154], ["foot", "ORGANISM_SUBDIVISION", 132, 136], ["mouth", "ORGAN", 141, 146], ["foot-and-mouth", "SPECIES", 132, 146], ["Increased deforestation", "PROBLEM", 0, 23], ["mouth disease", "PROBLEM", 141, 154], ["deforestation", "OBSERVATION", 10, 23], ["foot", "ANATOMY", 132, 136], ["mouth", "ANATOMY", 141, 146], ["disease", "OBSERVATION", 147, 154]]], ["With the prospect of exporting frozen beef and live animals to other states and countries, Amazonas might now expand pastures for cattle fattening by largeholders and produce calves among smallholders as an input for more productive areas in other states.", [["cattle", "ORGANISM", 130, 136], ["calves", "ORGANISM", 175, 181], ["cattle", "SPECIES", 130, 136], ["calves", "SPECIES", 175, 181], ["beef", "SPECIES", 38, 42], ["cattle", "SPECIES", 130, 136], ["exporting frozen beef", "TREATMENT", 21, 42], ["cattle fattening", "PROBLEM", 130, 146]]], ["This new exporting opportunity triggers forces that foreshadow increased forest clearing for pasture establishment, corroborated by the fact that Apu\u00ed's deforestation in 2019 totaled 288.7 km 2 , or 69.8% more than its previous record in 2017 (Brazil, INPE Instituto Nacional de Pesquisas Espaciais 2020) .Political and Economic Effects on the Current Deforestation ScenarioFinally, the relative improvement in infrastructure, services, and credit has spurred the growth of the rural sector in Apu\u00ed, enabling products to supply the Manaus market and stimulating investments in the rural economy in a positivefeedback process (Sathler et al. 2018 ).", [["Apu\u00ed's deforestation", "TEST", 146, 166], ["Economic Effects", "OBSERVATION", 320, 336], ["improvement", "OBSERVATION_MODIFIER", 396, 407], ["growth", "OBSERVATION_MODIFIER", 464, 470]]], ["By clearing more land for agricultural expansion, household assets grow via increases in income, which results in the accumulation of wealth over the long term (Mullan et al. 2017 ).", [["agricultural expansion", "PROBLEM", 26, 48]]], ["In sum, economic and political momentum has enabled households to clear larger patches of forest independent of landholding size.", [["political momentum", "OBSERVATION", 21, 39], ["larger", "OBSERVATION_MODIFIER", 72, 78], ["size", "OBSERVATION_MODIFIER", 124, 128]]], ["The activity of large landholders has significantly increased in an attempt to capture land and production rents.", [["large landholders", "PROBLEM", 16, 33], ["activity", "OBSERVATION_MODIFIER", 4, 12], ["large", "OBSERVATION_MODIFIER", 16, 21], ["landholders", "OBSERVATION", 22, 33], ["significantly", "OBSERVATION_MODIFIER", 38, 51], ["increased", "OBSERVATION_MODIFIER", 52, 61]]], ["Recent changes in laws (Fearnside 2020 ) signaled that illegal deforesters will again be pardoned in future \"amnesties\" (as many violators were in 2012 under the new Forest Code), in addition to the presumption that they would not be caught due to the paucity of law enforcement.Land-Tenure Insecurity and Land SpeculationFor researchers focused on frontier land-use change, tropical forests are considered to be open-access resources, and the agents deforest if the costs involved lead to additional profits, whether from agriculture or from land sales (Rindfuss et al. 2007; Barbier et al. 2011) .", [["Land Speculation", "TEST", 306, 322], ["tropical forests", "TREATMENT", 375, 391], ["the agents", "TREATMENT", 440, 450]]], ["The lower and middle-income tropical countries are experiencing foreign investors acquiring large swathes of land for agricultural development that already totaled forty million hectares (Agrawal et al. 2019) .", [["lower", "ANATOMY_MODIFIER", 4, 9], ["middle", "ANATOMY_MODIFIER", 14, 20]]], ["Such land grabs also occur in Brazil, where land tenure and regulation represent an unsolved issue that has persisted for centuries, contributing to high land concentration and unproductive latifundios (very large estates), and promoted continuous speculation in markets for rural properties (Deininger and Byerlee 2012; Sauer and Leite 2012; Reydon et al. 2015) .Land-Tenure Insecurity and Land SpeculationBrazil has fifty-four to sixty-five million hectares of undesignated public lands that are open to land grabbing (Azevedo-Ramos and Moutinho 2018; Sparovek et al. 2019) .", [["high land concentration", "PROBLEM", 149, 172], ["unproductive latifundios", "PROBLEM", 177, 201], ["Land SpeculationBrazil", "TREATMENT", 391, 413]]], ["Thus, lack of secure land tenure and the unsustainable nature of rural settlement policies promote high deforestation rates and represent essential underlying factors of deforestation in the Brazilian Amazon (Alston et al. 1995 (Alston et al. , 2000 Fearnside 2001; Caviglia-Harris and Harris 2011; Alencar et al. 2016; Moutinho et al. 2018) .", [["rural settlement policies", "TREATMENT", 65, 90], ["high deforestation", "OBSERVATION", 99, 117]]], ["Lack of property rights and weak government control of forests rich in timber and minerals induce the typical behavior of a race for rentseeking from extractive activities, with short-term, high-payoff investments (Barbier 2004) .Land-Tenure Insecurity and Land SpeculationOnly 18% of the households in Apu\u00ed had land titles in 2008 (Carrero and Fearnside 2011) , and many colonists and capitalized ranchers who bought land claims only have as documentation an INCRA registration or a purchase contract that has no legal value (contrato de gaveta).", [["weak", "OBSERVATION_MODIFIER", 28, 32]]], ["Both titled and untitled landholdings have often been sold to newcomers, while public forest areas became new pasturelands and ranches, thus expanding the land markets.", [["new pasturelands and ranches", "PROBLEM", 106, 134], ["new", "OBSERVATION_MODIFIER", 106, 109]]], ["INCRA's lack of personnel and resources to do inspections for issuing titles in this region, where lot turnover and land accumulation are persistent, has resulted in a legal imbroglio that has been awaiting a solution for decades.", [["lot turnover and land accumulation", "PROBLEM", 99, 133], ["land accumulation", "OBSERVATION", 116, 133], ["persistent", "OBSERVATION_MODIFIER", 138, 148]]], ["The land-tenure system in the Amazon is a central institutional failure that favors excessive deforestation and might push forest loss beyond what would otherwise be possible (Grainger 1995; Barbier et al. 2011; Reydon et al. 2015) .", [["a central institutional failure", "PROBLEM", 40, 71], ["excessive deforestation", "PROBLEM", 84, 107], ["push forest loss", "PROBLEM", 118, 134], ["failure", "OBSERVATION", 64, 71], ["favors", "UNCERTAINTY", 77, 83], ["excessive", "OBSERVATION_MODIFIER", 84, 93], ["deforestation", "OBSERVATION", 94, 107]]], ["Brazil must end its practice of \"regularizing\" illegal land claims if the country is to end the pattern of invasion, deforestation, and subsequent titling that continues to drive forest loss in Amazonia (Fearnside 1979 (Fearnside , 2001 .", [["invasion", "DISEASE", 107, 115], ["deforestation", "DISEASE", 117, 130], ["forest loss", "DISEASE", 179, 190], ["invasion", "PROBLEM", 107, 115], ["deforestation", "PROBLEM", 117, 130], ["forest loss", "PROBLEM", 179, 190], ["invasion", "OBSERVATION", 107, 115]]], ["Deforestation is considered an \"improvement\" (benfeitoria), helping to justify granting land titles.Land-Tenure Insecurity and Land SpeculationLegislative changes led by the ruralists have favored speculative land markets.", [["Deforestation", "DISEASE", 0, 13], ["Land SpeculationLegislative changes", "TREATMENT", 127, 162], ["land markets", "OBSERVATION", 209, 221]]], ["This law modified a number of laws with the result that land titling was facilitated for the large holdings of rural elites, with payments to the government for illegally occupied land at prices well below market value; the law also regularized illegal land sales in settlement projects (Sauer 2017; Leite et al. 2018 ).", [["large", "OBSERVATION_MODIFIER", 93, 98]]], ["On the other hand, these changes significantly increase the possibility of land titling occurring after illegal occupation.", [["land titling", "PROBLEM", 75, 87]]], ["This scenario attracts more actors seeking rents from land speculation, after which the land could be subdivided into parcels and sold to small farmers.Land-Tenure Insecurity and Land SpeculationOn 10 December 2019 President Bolsonaro issued a provisional measure (MP-910) allowing titles to be granted for illegal land claims on the basis of a mere \"self-declaration.\"", [["MP-910", "CHEMICAL", 265, 271], ["small", "OBSERVATION_MODIFIER", 138, 143], ["farmers", "OBSERVATION", 144, 151]]], ["Provisional measures remain in effect for 120 days, after which their continued validity requires a congressional vote.", [["Provisional measures", "TREATMENT", 0, 20]]], ["Approval is likely given the presidential administration's support and the strong ruralist influence in the National Congress.Land-Tenure Insecurity and Land SpeculationIn sum, land speculation in southern Amazonas is more attractive than in the arc of deforestation.", [["the presidential administration's support", "TREATMENT", 25, 66], ["Land SpeculationIn sum", "TREATMENT", 153, 175], ["more attractive", "OBSERVATION_MODIFIER", 218, 233], ["deforestation", "OBSERVATION", 253, 266]]], ["Land grabbing is particularly evident in PA Rio Juma, where large landholdings (1000-6000 ha) are present in a settlement that is supposed to have only micro landholdings (up to 100 ha).", [["large landholdings", "PROBLEM", 60, 78], ["micro landholdings", "PROBLEM", 152, 170], ["large", "OBSERVATION_MODIFIER", 60, 65]]], ["The impact of land concentration in speeding deforestation and undermining agrarian-reform objectives has also been found in the PA Matupi settlement area, also in southern Amazonas (Yanai et al. 2020) .", [["land concentration", "TREATMENT", 14, 32], ["speeding deforestation", "TREATMENT", 36, 58]]], ["Thus, land speculation is still a crucial deforestation factor (Mann et al. 2014) .", [["a crucial deforestation factor", "PROBLEM", 32, 62]]], ["Speculation makes extensive cattle ranching highly profitable on remote forest frontiers in Amazonia (Bowman et al. 2012; Miranda et al. 2019) .ConclusionsThis study unveils processes of land accumulation and the economic importance of deforestation in frontier areas in the Brazilian Amazon where settlement projects function as centers that agglutinate agents of forest destruction.", [["cattle", "SPECIES", 28, 34], ["extensive cattle ranching", "PROBLEM", 18, 43], ["This study", "TEST", 155, 165], ["land accumulation", "PROBLEM", 187, 204], ["deforestation", "TREATMENT", 236, 249], ["agglutinate agents", "TREATMENT", 343, 361], ["forest destruction", "PROBLEM", 365, 383], ["extensive", "OBSERVATION_MODIFIER", 18, 27], ["cattle", "OBSERVATION_MODIFIER", 28, 34], ["ranching", "OBSERVATION_MODIFIER", 35, 43], ["highly", "OBSERVATION_MODIFIER", 44, 50], ["profitable", "OBSERVATION_MODIFIER", 51, 61], ["land accumulation", "OBSERVATION", 187, 204], ["forest destruction", "OBSERVATION", 365, 383]]], ["Up to 2012, the deforestation trajectory in the Rio Juma settlement project followed the same trend as deforestation rates in Brazilian Amazonia as a whole, but with a delay of 1-2 years, reflecting similar political and economic period effects.ConclusionsApu\u00ed is a deforestation hotspot where annual rates of clearing have been increasing much faster than in Brazilian Amazonia as a whole.", [["a deforestation hotspot", "PROBLEM", 264, 287], ["economic period", "OBSERVATION", 221, 236], ["increasing", "OBSERVATION_MODIFIER", 329, 339], ["much", "OBSERVATION_MODIFIER", 340, 344], ["faster", "OBSERVATION_MODIFIER", 345, 351]]], ["The findings reported for the Rio Juma settlement confirm that the areas deforested in hectares per lot and per household have increased sharply, similar to what has been observed in other highly deforested settlement projects in Amazonia.", [["the Rio Juma settlement", "TREATMENT", 26, 49], ["areas", "OBSERVATION_MODIFIER", 67, 72], ["increased", "OBSERVATION_MODIFIER", 127, 136], ["sharply", "OBSERVATION_MODIFIER", 137, 144], ["Amazonia", "OBSERVATION", 230, 238]]], ["All sizes of landholdings are deforesting much more than before; the Rio Juma settlement has evolved from an area intended for agriculture by \"micro\" farmers living in isolated conditions to a regional center of cattle ranching that is market-oriented.ConclusionsWhat seems to be different, though, is that the current scenario of mounting deforestation in Apu\u00ed stems from wealthy individual and group actors who are investing in forest clearing and pasture formation, illegally amassing dozens of farm lots in the Rio Juma settlement as a form of land speculation, likely using undeclared funds (money laundering).", [["cattle", "SPECIES", 212, 218], ["cattle ranching", "TREATMENT", 212, 227], ["sizes", "OBSERVATION_MODIFIER", 4, 9], ["landholdings", "OBSERVATION", 13, 25], ["cattle ranching", "OBSERVATION", 212, 227]]], ["With both a strong coalition of \"ruralists\" in the National Congress and the presidential administration signaling impunity regarding deforestation, southern Amazonas is being incorporated into the \"arc of deforestation\" as this area of intense clearing activity spreads northward from the southern edge of the Amazon biome.ConclusionsThe findings of this study have significant implications for future research and policies on Amazonia's current frontiers.", [["this study", "TEST", 351, 361], ["Amazonia", "TREATMENT", 428, 436], ["strong", "OBSERVATION_MODIFIER", 12, 18], ["coalition", "OBSERVATION", 19, 28], ["intense", "OBSERVATION_MODIFIER", 237, 244], ["clearing", "OBSERVATION_MODIFIER", 245, 253], ["activity", "OBSERVATION_MODIFIER", 254, 262], ["Amazon biome", "OBSERVATION", 311, 323]]], ["In addition to individuals investing in agricultural production, there appears to be an array of actors involved in land grabbing.", [["appears to be", "UNCERTAINTY", 71, 84]]], ["What is the source of capital inflow to the region and how does it affect labor regimes and social and environmental outcomes?", [["labor regimes", "PROBLEM", 74, 87], ["capital inflow", "OBSERVATION", 22, 36]]], ["How do different actors coordinate to exploit land and natural resources for speculative purposes?", [["speculative purposes", "TEST", 77, 97]]], ["Research efforts focused on finding such answers will offer insights into the role of the illegal land trade on agricultural expansion and environmental change in Amazonia, allowing better responses to the current scenario by those policymakers who see environmental protection as important.", [["agricultural expansion", "TREATMENT", 112, 134]]]], "PMC7300595": [["However, the Covid\u201019 (Coronavirus) poses a major challenge to the majority of companies within these industries and may reduce their commitment to sustainable development.", [["Covid\u201019", "CHEMICAL", 13, 21], ["Covid\u201019", "GENE_OR_GENE_PRODUCT", 13, 21], ["the Covid\u201019 (Coronavirus)", "TREATMENT", 9, 35]]], ["Emily Salter, an analyst at Global data, the data analytics and consulting company, for example, was reported as claiming \u201cmaking changes to materials, logistics and production processes to improve the sustainability of products and operations will slow, as sustainability is no longer top of retailers' and consumers' agendas\u201d (365RETAIL, 2020).", [["no longer", "UNCERTAINTY", 276, 285]]], ["Hence, it is more urgent than ever to establish global strategies for the conservation of historic and natural patrimony, considering them as a main source of sustainable development\u201d (Hospitality Net, 2020).", [["global strategies", "TREATMENT", 48, 65]]], ["With these thoughts in mind, this commentary paper explores sustainability within the retail and hospitality industries through the lens of the COVID\u201019 crisis.", [["crisis", "PROBLEM", 153, 159]]], ["The paper was written in April 2020, while the authors were on lockdown, and as such it offers a snap shot in time of their perceptions of sustainability as illuminated by the COVID\u201019 crisis, at a very testing time for the service industries.THE COVID\u201019 CRISISCOVID\u201019 is an infectious disease caused by SARS\u2010CoV\u20102, a newly discovered coronavirus.", [["infectious disease", "DISEASE", 277, 295], ["SARS", "DISEASE", 306, 310], ["coronavirus", "DISEASE", 337, 348], ["SARS\u2010CoV\u20102", "ORGANISM", 306, 316], ["coronavirus", "ORGANISM", 337, 348], ["SARS\u2010CoV", "SPECIES", 306, 314], ["an infectious disease", "PROBLEM", 274, 295], ["coronavirus", "PROBLEM", 337, 348], ["infectious", "OBSERVATION", 277, 287], ["coronavirus", "OBSERVATION", 337, 348]]], ["Coronaviruses are part of a large family of viruses that can affect birds and mammals, including humans.", [["Coronaviruses", "GENE_OR_GENE_PRODUCT", 0, 13], ["birds", "ORGANISM", 68, 73], ["humans", "ORGANISM", 97, 103], ["humans", "SPECIES", 97, 103], ["humans", "SPECIES", 97, 103], ["Coronaviruses", "PROBLEM", 0, 13], ["large", "OBSERVATION_MODIFIER", 28, 33], ["viruses", "OBSERVATION", 44, 51]]], ["In recent years this family of viruses have been responsible for several outbreaks around the world, including Severe Acute Respiratory Syndrome (SARS) in 2002\u20132003 and the Middle East Respiratory Syndrome (MERS) first reported in South Korea in 2012.", [["Acute Respiratory Syndrome", "DISEASE", 118, 144], ["SARS", "DISEASE", 146, 150], ["Respiratory Syndrome", "DISEASE", 185, 205], ["MERS", "DISEASE", 207, 211], ["viruses", "PROBLEM", 31, 38], ["Severe Acute Respiratory Syndrome", "PROBLEM", 111, 144], ["SARS", "PROBLEM", 146, 150], ["the Middle East Respiratory Syndrome", "PROBLEM", 169, 205], ["viruses", "OBSERVATION", 31, 38], ["Severe", "OBSERVATION_MODIFIER", 111, 117], ["Acute", "OBSERVATION_MODIFIER", 118, 123], ["Respiratory Syndrome", "OBSERVATION", 124, 144], ["Middle", "ANATOMY_MODIFIER", 173, 179], ["Respiratory Syndrome", "OBSERVATION", 185, 205]]], ["COVID\u201019 primarily affects the lungs and airways leading to mainly respiratory symptoms (e.g., cough and shortness of breath) and fevers.", [["lungs", "ANATOMY", 31, 36], ["airways", "ANATOMY", 41, 48], ["respiratory", "ANATOMY", 67, 78], ["respiratory symptoms", "DISEASE", 67, 87], ["cough", "DISEASE", 95, 100], ["shortness of breath", "DISEASE", 105, 124], ["fevers", "DISEASE", 130, 136], ["lungs", "ORGAN", 31, 36], ["airways", "MULTI-TISSUE_STRUCTURE", 41, 48], ["mainly respiratory symptoms", "PROBLEM", 60, 87], ["cough", "PROBLEM", 95, 100], ["shortness of breath", "PROBLEM", 105, 124], ["fevers", "PROBLEM", 130, 136], ["lungs", "ANATOMY", 31, 36], ["airways", "ANATOMY", 41, 48], ["mainly", "OBSERVATION_MODIFIER", 60, 66], ["respiratory symptoms", "OBSERVATION", 67, 87], ["fevers", "OBSERVATION", 130, 136]]], ["The majority of people with COVID\u201019 experience mild disease and recover without requiring special treatment.", [["COVID", "DISEASE", 28, 33], ["people", "ORGANISM", 16, 22], ["people", "SPECIES", 16, 22], ["COVID\u2010", "TREATMENT", 28, 34], ["mild disease", "PROBLEM", 48, 60], ["special treatment", "TREATMENT", 91, 108], ["mild", "OBSERVATION_MODIFIER", 48, 52], ["disease", "OBSERVATION", 53, 60]]], ["However older people, and those with underlying medical problems such as cardiovascular disease, diabetes, chronic respiratory disease and those with a weakened immune system are more likely to develop serious illness and are at an increased risk of dying from the disease.THE COVID\u201019 CRISISThe disease can spread from person to person through small droplets from the nose or mouth which are spread when a person with COVID\u201019 coughs, sneezes or exhales.", [["cardiovascular", "ANATOMY", 73, 87], ["respiratory", "ANATOMY", 115, 126], ["immune system", "ANATOMY", 161, 174], ["nose", "ANATOMY", 369, 373], ["mouth", "ANATOMY", 377, 382], ["cardiovascular disease", "DISEASE", 73, 95], ["diabetes", "DISEASE", 97, 105], ["chronic respiratory disease", "DISEASE", 107, 134], ["coughs", "DISEASE", 428, 434], ["sneezes", "DISEASE", 436, 443], ["people", "ORGANISM", 14, 20], ["nose", "ORGAN", 369, 373], ["mouth", "ORGAN", 377, 382], ["people", "SPECIES", 14, 20], ["person", "SPECIES", 320, 326], ["person", "SPECIES", 330, 336], ["person", "SPECIES", 407, 413], ["underlying medical problems", "PROBLEM", 37, 64], ["cardiovascular disease", "PROBLEM", 73, 95], ["diabetes", "PROBLEM", 97, 105], ["chronic respiratory disease", "PROBLEM", 107, 134], ["a weakened immune system", "PROBLEM", 150, 174], ["serious illness", "PROBLEM", 202, 217], ["the disease", "PROBLEM", 261, 272], ["The disease", "PROBLEM", 292, 303], ["sneezes", "PROBLEM", 436, 443], ["exhales", "PROBLEM", 447, 454], ["cardiovascular", "ANATOMY", 73, 87], ["disease", "OBSERVATION", 88, 95], ["chronic", "OBSERVATION_MODIFIER", 107, 114], ["respiratory disease", "OBSERVATION", 115, 134], ["more likely", "UNCERTAINTY", 179, 190], ["increased", "OBSERVATION_MODIFIER", 232, 241], ["disease", "OBSERVATION", 265, 272], ["disease", "OBSERVATION", 296, 303], ["nose", "ANATOMY", 369, 373], ["mouth", "ANATOMY", 377, 382]]], ["These droplets land on objects and surfaces around the person.", [["person", "SPECIES", 55, 61], ["surfaces", "OBSERVATION_MODIFIER", 35, 43]]], ["Other people then catch COVID\u201019 by touching these objects or surfaces, then touching their eyes, nose or mouth.", [["eyes", "ANATOMY", 92, 96], ["nose", "ANATOMY", 98, 102], ["mouth", "ANATOMY", 106, 111], ["people", "ORGANISM", 6, 12], ["eyes", "ORGAN", 92, 96], ["nose", "ORGANISM_SUBDIVISION", 98, 102], ["mouth", "ORGANISM_SUBDIVISION", 106, 111], ["people", "SPECIES", 6, 12], ["eyes", "ANATOMY", 92, 96], ["nose", "ANATOMY", 98, 102], ["mouth", "ANATOMY", 106, 111]]], ["People can also catch COVID\u201019 if they breathe in droplets from a person with COVID\u201019 who coughs, sneezes or exhales droplets.", [["People", "ORGANISM", 0, 6], ["People", "SPECIES", 0, 6], ["person", "SPECIES", 66, 72], ["coughs", "PROBLEM", 91, 97]]], ["Precise details of the origins and initial spread of COVID\u201019 are hard to confirm, but there is some agreement that the disease originated in a wholesale market in Wuhan, a city of some 11 million people, in Eastern China, and that some of the market traders may have contracted the disease following contact with animals at the market.THE COVID\u201019 CRISISOn December 31, 2019 China alerted the World Health Organization to several cases of unusual pneumonia in Wuhan, and several of those infected, worked at one of the city's market.", [["pneumonia", "DISEASE", 448, 457], ["people", "ORGANISM", 197, 203], ["people", "SPECIES", 197, 203], ["the disease", "PROBLEM", 116, 127], ["the disease", "PROBLEM", 279, 290], ["unusual pneumonia", "PROBLEM", 440, 457], ["disease", "OBSERVATION", 120, 127], ["disease", "OBSERVATION", 283, 290], ["unusual", "OBSERVATION_MODIFIER", 440, 447], ["pneumonia", "OBSERVATION", 448, 457], ["infected", "OBSERVATION", 489, 497]]], ["Early in 2020 the disease spread rapidly, first to other regions of China, and then to the majority of the world's countries, and the World Health Organization declared the global outbreak of COVID\u201019 a pandemic on March 11, 2020.", [["COVID", "DISEASE", 192, 197], ["the disease spread", "PROBLEM", 14, 32], ["disease", "OBSERVATION", 18, 25]]], ["Though the nature of the response to the crisis has varied from one country to another, all medical authorities and governments have struggled to combat COVID\u201019.", [["the crisis", "PROBLEM", 37, 47]]], ["Medical pressures included providing large numbers of bed spaces and specialist equipment to treat seriously ill patients, sufficient numbers of, and personal protection equipment for, medical staff, and adequate testing facilities.", [["patients", "ORGANISM", 113, 121], ["patients", "SPECIES", 113, 121], ["Medical pressures", "TEST", 0, 17], ["specialist equipment", "TREATMENT", 69, 89], ["pressures", "OBSERVATION_MODIFIER", 8, 17], ["large", "OBSERVATION_MODIFIER", 37, 42], ["numbers", "OBSERVATION_MODIFIER", 43, 50]]], ["The policies adopted by many governments have centred on enforcing social distancing by strongly recommending restrictions on the movement of people, popularly described as lockdown, and instructing many businesses to close down, in an attempt to prevent the spread of the disease.THE COVID\u201019 CRISISThe impact of the COVID\u201019 crisis on the global economy has been devastating, threatening national and global growth, with the closure of many manufacturing plants and production facilities, the large\u2010scale disruption of supply chains, reductions in the production output and profitability of large multinational corporations, and reduced trade in consumer goods from less developed economies.", [["people", "ORGANISM", 142, 148], ["people", "SPECIES", 142, 148], ["the disease", "PROBLEM", 269, 280], ["the COVID\u2010", "TREATMENT", 314, 324], ["the closure", "TREATMENT", 423, 434], ["production facilities", "TREATMENT", 468, 489], ["the large\u2010scale disruption of supply chains", "PROBLEM", 491, 534], ["the production output", "PROBLEM", 550, 571], ["disease", "OBSERVATION", 273, 280], ["devastating", "OBSERVATION_MODIFIER", 365, 376], ["growth", "OBSERVATION_MODIFIER", 410, 416], ["many", "OBSERVATION_MODIFIER", 438, 442], ["manufacturing plants", "OBSERVATION", 443, 463], ["supply chains", "OBSERVATION", 521, 534], ["reductions", "OBSERVATION_MODIFIER", 536, 546], ["production output", "OBSERVATION", 554, 571], ["large", "OBSERVATION_MODIFIER", 593, 598], ["multinational", "OBSERVATION_MODIFIER", 599, 612], ["corporations", "OBSERVATION", 613, 625], ["reduced", "OBSERVATION_MODIFIER", 631, 638], ["trade", "OBSERVATION_MODIFIER", 639, 644]]], ["The COVID\u201019 crisis has had a very damaging impact on sectoral economies.", [["sectoral economies", "OBSERVATION", 54, 72]]], ["In April 2020, the United Nations Department of Economic and Social Affairs (2020) suggested \u201cgrowing restrictions on the movement of people and lockdowns in Europe and North America are hitting the service sector hard, particularly industries that involve physical interactions such as retail trade, leisure and hospitality, recreation and transportation services.\u201dTHE COVID\u201019 CRISISWithin the retail industries, for example, there have been impacts throughout supply chains covering consumer behaviour, product demand, store operations, distribution and production.", [["people", "ORGANISM", 134, 140], ["people", "SPECIES", 134, 140], ["impacts", "OBSERVATION_MODIFIER", 444, 451], ["store operations", "OBSERVATION", 522, 538], ["distribution", "OBSERVATION_MODIFIER", 540, 552]]], ["In a similar vein, Stephanie Segal (2020, webpage), for example, writing under the banner of the Centre for Strategic and International Studies, claimed \u201cat the sectoral level, tourism and travel\u2010related industries will be among the hardest hit as authorities encourage social distancing and consumers stay indoors.\u201dSUSTAINABILITY AND THE COVID\u201019 CRISISThe relationship between the COVID\u201019 crisis and sustainability within the service industries can be seen in a number of ways.", [["vein", "ANATOMY", 13, 17], ["vein", "MULTI-TISSUE_STRUCTURE", 13, 17], ["International Studies", "TEST", 122, 143], ["similar vein", "ANATOMY", 5, 17]]], ["Initially, a number of environmental improvements were identified including marked reductions in pollution levels and greenhouse gas emissions following the closure of many power generation plants and factories, the dramatic fall in the volume of air travel and the restrictions on the movement of people in motor vehicles on journeys to work or shopping trips within towns and cities.", [["people", "ORGANISM", 298, 304], ["people", "SPECIES", 298, 304], ["marked reductions in pollution levels", "PROBLEM", 76, 113], ["greenhouse gas emissions", "PROBLEM", 118, 142], ["the closure", "TREATMENT", 153, 164], ["many power generation plants", "TREATMENT", 168, 196], ["the dramatic fall", "PROBLEM", 212, 229], ["marked", "OBSERVATION_MODIFIER", 76, 82], ["reductions", "OBSERVATION_MODIFIER", 83, 93], ["greenhouse", "OBSERVATION", 118, 128], ["gas emissions", "OBSERVATION", 129, 142], ["dramatic", "OBSERVATION_MODIFIER", 216, 224], ["fall", "OBSERVATION_MODIFIER", 225, 229], ["volume", "OBSERVATION_MODIFIER", 237, 243], ["air travel", "OBSERVATION", 247, 257]]], ["Inger Anderson, Head of the United Nations Environment Programme, for example, was reported as arguing \u201cwe need to take on board the environmental signals and what they mean for our future and wellbeing because COVID\u201019 is by no means a silver lining for the environment,\u201d that \u201cvisible positive impacts \u2013 whether through improved air quality \u2013 are but temporary because they come on the back of tragic economic slowdown and human distress\u201d (Hospitality Net, 2020).", [["human distress", "DISEASE", 425, 439], ["silver", "CHEMICAL", 237, 243], ["human", "ORGANISM", 425, 430], ["human", "SPECIES", 425, 430], ["human", "SPECIES", 425, 430], ["human distress", "PROBLEM", 425, 439]]], ["Inger Anderson also suggested \u201cthe pandemic will also result in an increase in amounts of medical and hazardous waste generated.", [["medical and hazardous waste", "TREATMENT", 90, 117], ["increase", "OBSERVATION_MODIFIER", 67, 75]]], ["This is no one's model of environmental response, least of all an environmentalist's.\u201d", [["no", "UNCERTAINTY", 8, 10]]], ["(United Nations News, 2020).SUSTAINABILITY AND THE COVID\u201019 CRISISHowever, although the COVID\u201019 crisis has brought some environmental gains, it has also caused devastating economic and social problems throughout the world and had very damaging consequences for economic and social sustainability.", [["crisis", "PROBLEM", 97, 103], ["devastating", "OBSERVATION_MODIFIER", 161, 172]]], ["While many people are no longer in employment, either temporarily or permanently, in many developed economies, the impact on the many millions of low wage workers in the service industries in many less developed countries, is particularly damaging.", [["people", "ORGANISM", 11, 17], ["people", "SPECIES", 11, 17], ["no longer", "UNCERTAINTY", 22, 31]]], ["Here, workers rarely have the sort of government funded income support and organized labour protection available in some developed economies and they, and their families, will be thrown into the poverty abyss and that will further exacerbate already wide inequalities.", [["abyss", "DISEASE", 203, 208], ["organized labour protection", "TREATMENT", 75, 102]]], ["These economies would experience sharp increases in unemployment rates affecting the livelihood of low\u2010skilled workers and the more vulnerable segments of society that depend on income from tourism\u2010related activities.\u201dSUSTAINABILITY AND THE COVID\u201019 CRISISThis tension illustrates one of the fundamental paradoxes of sustainable development in that it exposes the internal contradictions within the concept.", [["sharp increases in unemployment rates", "PROBLEM", 33, 70], ["sharp", "OBSERVATION_MODIFIER", 33, 38], ["increases", "OBSERVATION_MODIFIER", 39, 48], ["more vulnerable segments", "OBSERVATION_MODIFIER", 127, 151], ["sustainable", "OBSERVATION_MODIFIER", 317, 328], ["internal", "OBSERVATION_MODIFIER", 364, 372], ["contradictions", "OBSERVATION", 373, 387]]], ["Collectively the 17 SDGs have been described as \u201cthe blueprint to achieve a better and more sustainable future for all\u201d and they look to \u201caddress the global challenges we face, including those related to poverty, inequality, climate, environmental degradation, prosperity, and peace and justice\u201d (United Nations News, 2020).", [["poverty", "DISEASE", 204, 211]]], ["Hickel (2019), for example, argued that there is a contradiction between \u201ccalls for humanity to achieve harmony with nature and to protect the planet from degradation, with specific targets laid out in Goals 6, 12, 13, 14, and 15\u201d and \u201ccalls for continued global economic growth equivalent to 3% per year, as outlined in Goal 8, as a method for achieving human development objectives.\u201d", [["human", "ORGANISM", 355, 360], ["human", "SPECIES", 355, 360], ["human", "SPECIES", 355, 360]]], ["Further Hickel (2019) suggested \u201cthe SDGs assume that efficiency improvements will suffice to reconcile the tension between growth and ecological sustainability.\u201dSUSTAINABILITY AND THE COVID\u201019 CRISISThe COVID\u201019 crisis highlights the need to extend the scope of sustainable development, and here there is the issue of the role of sustainable development in preventing future pandemics.", [["the tension between growth", "PROBLEM", 104, 130], ["crisis", "PROBLEM", 213, 219]]], ["While Di Marco et al. (2020), for example, drew attention to the links between the environmental, social and economic elements of sustainable development, they pointedly observed that \u201clittle attention has been paid to the interactions between environmental change and infectious disease emergence\u201d and such interactions are \u201cnot customarily integrated into planning for sustainable development.\u201d", [["infectious disease", "DISEASE", 269, 287]]], ["This echoes Amekudzi\u2010Kennedy, Labi, Woodall, Chester, and Singh's (2020) belief that one of the lessons for sustainability from COVID\u201019 is that \u201csustainable development and planning and analytical frameworks must be comprehensive for long term sustainability.\u201dSUSTAINABILITY AND THE COVID\u201019 CRISISMore specifically, Di Marco et al. (2020) claimed that the emergence of diseases \u201cis driven by anthropogenic changes such as deforestation and expansion of agricultural land (i.e., land\u2010use change), intensification of livestock production, and increased hunting and trading of wildlife.\u201d", [["long term sustainability", "PROBLEM", 235, 259], ["diseases", "PROBLEM", 371, 379], ["livestock production", "PROBLEM", 517, 537], ["increased hunting", "PROBLEM", 543, 560], ["diseases", "OBSERVATION", 371, 379], ["anthropogenic", "OBSERVATION", 394, 407], ["expansion", "OBSERVATION_MODIFIER", 442, 451], ["livestock production", "OBSERVATION", 517, 537], ["increased", "OBSERVATION_MODIFIER", 543, 552], ["hunting", "OBSERVATION", 553, 560]]], ["Looking to the future, Di Marco et al. (2020) claimed that human health could be more effectively integrated within sustainable development planning but argued this required \u201ca cross\u2010disciplinary research approach,\u201d which would involve \u201csocioeconomic change, pathogen dynamics, and biological and behavioural aspects of humans, wildlife, and livestock.\u201d", [["human", "ORGANISM", 59, 64], ["humans", "ORGANISM", 320, 326], ["human", "SPECIES", 59, 64], ["humans", "SPECIES", 320, 326], ["human", "SPECIES", 59, 64], ["humans", "SPECIES", 320, 326]]], ["Such businesses may be well placed to facilitate scientific research in such areas, which may, in turn, contribute to sustainable development by helping to enhance awareness and understanding of the relationships between environmental change and the emergence of diseases.SUSTAINABILITY AND THE COVID\u201019 CRISISIn recent years, corporate sustainability has assumed increasing importance within the business community and many of the leading players in the retail industry, for example, have pursued sustainability programmes designed to incorporate environmental, social and governance issues into their business strategies (e.g., Jones, Comfort, & Hillier, 2011) and to address a number of the SDGs 2019).", [["diseases", "PROBLEM", 263, 271], ["increasing", "OBSERVATION_MODIFIER", 364, 374]]], ["On one hand, these challenges include the need to respond to investors' demands to promote long term reductions in corporate carbon emissions and pollution levels, greater employment of renewable energy resources, a clearer commitment to waste recycling and the development of circular economy principles, all of which may force changes in conventional business models within the service industries.", [["carbon", "CHEMICAL", 125, 131], ["long term reductions", "TREATMENT", 91, 111], ["corporate carbon emissions", "TREATMENT", 115, 141], ["pollution levels", "TEST", 146, 162], ["circular economy principles", "TREATMENT", 277, 304], ["long term", "OBSERVATION_MODIFIER", 91, 100]]], ["Here, extensive, high profile and costly marketing campaigns designed to promote facilities, events and attractions and to re\u2010engage with customers, and investment to try to ensure that returning customers are provided with high quality experiences, may well take precedence over the environmental and social agendas within corporate sustainability strategies and programmes.SUSTAINABILITY AND THE COVID\u201019 CRISISIn some ways fashion retailing seems particularly vulnerable, not least because it relies so heavily on discretionary spending.", [["high profile", "OBSERVATION_MODIFIER", 17, 29]]], ["Writing under the banner of Vogue Business, Rachel Cernansky (2020), for example, suggested \u201cin a global crisis, retailers across all sectors are forced to cut costs and shift priorities.", [["a global crisis", "PROBLEM", 96, 111]]], ["That pressure can lead to sustainability initiatives being put on the backburner\u201d and that \u201cby conventional calculations, the odds that fashion will continue trying to reduce its environmental impacts in the face of the coronavirus pandemic seem bleak.\u201d", [["coronavirus", "DISEASE", 220, 231], ["coronavirus", "ORGANISM", 220, 231], ["coronavirus", "OBSERVATION", 220, 231]]], ["In the medium term, this may encourage large companies to push back their existing commitments to the SDGs.", [["medium term", "OBSERVATION_MODIFIER", 7, 18]]], ["On the other hand, in those areas of the less developed world where the need for many of the SDG's focused, for example, on the eradication of poverty and hunger, on the widespread availability of clean water and sanitation, and on the promotion of gender equality are greatest, many of the limited gains made since 2015 may well have been lost in the wake of the COVID\u201019 crisis.", [["poverty", "DISEASE", 143, 150], ["hunger", "DISEASE", 155, 161], ["hunger", "PROBLEM", 155, 161], ["clean water and sanitation", "TREATMENT", 197, 223]]], ["Such concerns are surely heightened at a time when the Sustainable Development Solutions Network/Institute for European Environmental Policy (2019) reported that none of the countries within the European Union, let alone the less developed world, were on track to meet their SDG targets.SUSTAINABILITY AND THE COVID\u201019 CRISISKumar (2020), Chief Environmental Economist, United Nations Environment Programme, was reported as outlining the value of trade off analysis, which attempts to quantify the trade\u2010off between development and sustainability.", [["SDG", "SIMPLE_CHEMICAL", 275, 278]]], ["In suggesting that \u201cthe outbreak of epidemics like COVID\u201019 reveal the fundamental tenets of the trade\u2010off we consistently face: humans have unlimited needs, but the planet has limited capacity to satisfy them.\u201d", [["humans", "ORGANISM", 129, 135], ["humans", "SPECIES", 129, 135], ["humans", "SPECIES", 129, 135], ["epidemics", "PROBLEM", 36, 45]]], ["Further Kumar (2020) argued \u201cthe emergence of COVID\u201019 has underscored the mutually\u2010affective relationship between people and nature,\u201d that \u201cwe must try to understand and appreciate the limits to which humans can push nature, before the impact is negative\u201d and arguably more controversially that \u201cthose limits must be embraced by our consumption and production aspiration.\u201dSUSTAINABILITY AND THE COVID\u201019 CRISISRetailing can be seen to be fundamental in any move to sustainable consumption and there is certainly a growing awareness that retailers have a vital role to play in promoting more sustainable patterns of consumption, not least in that they effectively act as gatekeepers between producers and consumers (Wiese, Zielke, & Toporowski, 2015).", [["people", "ORGANISM", 115, 121], ["humans", "ORGANISM", 202, 208], ["people", "SPECIES", 115, 121], ["humans", "SPECIES", 202, 208], ["humans", "SPECIES", 202, 208], ["production aspiration", "PROBLEM", 350, 371], ["aspiration", "OBSERVATION", 361, 371]]], ["In acknowledging \u201cwe are now struggling to anticipate the impacts of COVID\u201019\u201d as \u201cmajor financial markets are gyrating and international supply chains are in turmoil,\u201d Cohen (2020), for example, pointed out that \u201cwhile the present situation is being treated as an emergent economic crisis, it merits acknowledging that sustainability scientists and policy makers have implicitly been seeking to achieve over the past decade broadly similar objectives\u2026 In the form of a sustainable consumption transition.\u201dSUSTAINABILITY AND THE COVID\u201019 CRISISFurther, Cohen (2020) argued \u201cwhile it may seem fanciful and insolent, Covid\u201019 is an opportunity to reduce over the longer term the prevalence of lifestyle premised on large volumes of energy and material throughput\u201d and concludes \u201cpolicy makers should work to ensure that the coronavirus outbreak contributes to a sustainable consumption transition.\u201d", [["coronavirus", "DISEASE", 822, 833], ["coronavirus", "ORGANISM", 822, 833], ["an emergent economic crisis", "PROBLEM", 262, 289], ["the coronavirus outbreak", "PROBLEM", 818, 842]]], ["At the present time neither the majority of businesses within these industries, nor their customers, seem likely to take such an opportunity or to have much enthusiasm for policy makers who advocate such a future.CONCLUSIONThe COVID\u201019 crisis has effectively wrought economic and social havoc in most parts of the world and while all sectors of the economy have been badly hit, problems in the service industries seem particularly acute.", [["crisis", "PROBLEM", 236, 242], ["acute", "OBSERVATION_MODIFIER", 431, 436]]], ["In recent years the concept of sustainability has offered academics and practitioners a framework to explore crises, though such work has traditionally been focused on national economies and local environments.", [["crises", "PROBLEM", 109, 115]]], ["As such, the Covid\u201019 crisis has not only posed a range of complex major global challenges for the service industries but it has also exposed some new perspectives in the relationships between these industries and sustainability.", [["new", "OBSERVATION_MODIFIER", 147, 150]]], ["On the one hand, the hope is for a return to normality, though, at the time of writing, the time scale and the extent, of such a return remains very uncertain.", [["the time scale", "TEST", 88, 102]]], ["Here government and corporate sustainability programmes may effectively be put on hold as capital resources are focused on economic recovery.", [["corporate sustainability programmes", "TREATMENT", 20, 55]]], ["On the other hand, The COVID\u201019 crisis has opened a window on some of the relationships between the service industries and sustainability, it has signalled some environmental changes that may be central to a transition to a more sustainable future and it has offered some radical solutions to the challenges of sustainable development.", [["crisis", "PROBLEM", 32, 38], ["some radical solutions", "TREATMENT", 267, 289]]], ["Whether the millions of businesses within the service industries, or the vast majority of their customers, will want to recognize the significance of such signals and have any genuine enthusiasm for such solutions remains very much to be seen.", [["such solutions", "PROBLEM", 199, 213]]]], "PMC7194857": [["Impact on surgical residency and fellowship programsThe \u201cnormal\u201d daily, weekly, monthly, and annual schedules planned by programs, which were to be in effect at this time, have been severely affected.", [["severely affected", "PROBLEM", 182, 199], ["normal", "OBSERVATION", 57, 63], ["severely", "OBSERVATION_MODIFIER", 182, 190], ["affected", "OBSERVATION", 191, 199]]], ["This is certainly true in Seattle, New York City, and other cities in the vanguard of the pandemic, but it is also true in cities that have, so far, a relatively low incidence of the disease.", [["the disease", "PROBLEM", 179, 190], ["certainly", "UNCERTAINTY", 8, 17], ["true", "OBSERVATION_MODIFIER", 18, 22], ["New", "OBSERVATION_MODIFIER", 35, 38], ["pandemic", "OBSERVATION", 90, 98], ["low", "OBSERVATION_MODIFIER", 162, 165], ["disease", "OBSERVATION", 183, 190]]], ["Residents and fellows have been, or will be, placed on rotating shifts, both consistent with current clinical demands for surgical services and to minimize their exposure to the virus.", [["surgical services", "TREATMENT", 122, 139], ["the virus", "PROBLEM", 174, 183]]], ["Residents, fellows, and attending surgeons are being, and will be, sidelined by quarantine due to exposure to the virus or recovering from SARS COV2 infections themselves.", [["SARS", "DISEASE", 139, 143], ["infections", "DISEASE", 149, 159], ["the virus", "PROBLEM", 110, 119], ["SARS COV2 infections themselves", "PROBLEM", 139, 170]]], ["Although to date, none have been reported, there will predictably be deaths of surgical residents, fellows, and attendings as a result of SARS COV2 infections acquired in performing their clinical duties.Alteration in activities to meet Accreditation Council for Graduate Medical Education (ACGME) program requirementsIt is clear that, at least during the remainder of the 2019\u20132020 academic year, most residents and fellows will not be able to accomplish clinical rotations, operative case log minima, and nonoperative patient care encounters as set forth in the requirements for program accreditation.", [["deaths", "DISEASE", 69, 75], ["SARS", "DISEASE", 138, 142], ["infections", "DISEASE", 148, 158], ["patient", "ORGANISM", 520, 527], ["patient", "SPECIES", 520, 527], ["SARS COV2 infections", "PROBLEM", 138, 158], ["clear", "OBSERVATION", 324, 329]]], ["And the degree of impact will be inversely correlated to the length of the training program.", [["the training program", "TREATMENT", 71, 91]]], ["A few months of curtailed clinical activity for residents in a 7-year neurological surgery program might be relatively easily overcome.", [["neurological", "ANATOMY", 70, 82], ["neurological surgery program", "TREATMENT", 70, 98], ["few", "OBSERVATION_MODIFIER", 2, 5]]], ["The period of March through June, though, constitutes one-third of a colon and rectal surgery program and all of the 1-year surgical fellowship programs.Annual ACGME resident, fellow, and faculty surveys ::: Impact on accreditation activities at the program levelThe ACGME\u2019s annual resident, fellow, and faculty surveys are used to monitor parameters of clinical education and provide early warning of potential noncompliance with ACGME accreditation requirements.", [["colon", "ANATOMY", 69, 74], ["rectal", "ANATOMY", 79, 85], ["colon", "ORGAN", 69, 74], ["rectal", "ORGAN", 79, 85], ["rectal surgery program", "TREATMENT", 79, 101], ["accreditation activities", "TREATMENT", 218, 242], ["clinical education", "TREATMENT", 354, 372], ["ACGME accreditation requirements", "TREATMENT", 431, 463], ["colon", "ANATOMY", 69, 74], ["rectal", "ANATOMY", 79, 85], ["surgery", "OBSERVATION", 86, 93]]], ["The \u201cwindow\u201d closed in February for the surveys in colon and rectal surgery, otolaryngology, obstetrics and gynecology, plastic surgery, and the subspecialties of each.", [["colon", "ANATOMY", 51, 56], ["rectal", "ANATOMY", 61, 67], ["colon", "MULTI-TISSUE_STRUCTURE", 51, 56], ["rectal", "ORGAN", 61, 67], ["rectal surgery", "TREATMENT", 61, 75], ["colon", "ANATOMY", 51, 56], ["rectal", "ANATOMY", 61, 67], ["surgery", "OBSERVATION", 68, 75]]], ["Therefore, surveys in those programs were completed when the virus had been detected in very few cities.", [["surveys in those programs", "TEST", 11, 36], ["the virus", "PROBLEM", 57, 66]]], ["The \u201cwindow\u201d for surveys in orthopaedic surgery, surgery, thoracic surgery, urology, and all of their subspecialties closed on March 15, just as the pandemic began to grip a few metropolitan areas.", [["thoracic", "ANATOMY", 58, 66], ["surgery", "TREATMENT", 49, 56], ["thoracic surgery", "TREATMENT", 58, 74], ["thoracic", "ANATOMY", 58, 66], ["few", "OBSERVATION_MODIFIER", 174, 177]]], ["The \u201cwindow\u201d scheduled for neurological surgery, ophthalmology, and their subspecialties was to be March 9 to April 12, clearly at a time when the pandemic began to broadly reshape the activities of surgical trainees and programs.", [["neurological", "ANATOMY", 27, 39], ["neurological surgery", "TREATMENT", 27, 47], ["surgical trainees", "TREATMENT", 199, 216]]], ["As the national response pool to the 2020 surveys will predictably be quite truncated, it remains to be seen what survey data will be made available to review committees for use in their 2021 accreditation decisions.Telesupervision ::: Impact on accreditation activities at the program levelRevisions in the Common Program Requirements that allow and foster greater use of telesupervision were adopted by the ACGME Board of Directors in February 2020 and were to become effective July 1, 2020.", [["accreditation activities", "TREATMENT", 246, 270]]], ["As the pandemic unfolded in the US, it became clear that telesupervision of residents/fellows could positively affect the delivery of care to patients while mitigating the risks to those residents, fellows, and other healthcare providers.", [["patients", "ORGANISM", 142, 150], ["patients", "SPECIES", 142, 150], ["the delivery of care", "TREATMENT", 118, 138]]], ["Accordingly, the Common Program Requirements regarding telesupervision were made effective as of March 18, rather than waiting for the original effective date of July 1.3", [["telesupervision", "TREATMENT", 55, 70]]]], "0ed2c41c3728dac9545af1c1b608fb25063c617a": [["INTRODUCTION, PLANT VIRUSES FROM PATHOGENS TO BIOLOGICAL TOOLKITVirology began in 1892 with D. Ivanovsky's paper describing the retention of virulence in leaf sap extracted from Crimean tobacco with mosaic leaf disease (Lustig and Levine, 1992) .", [["leaf sap", "ANATOMY", 154, 162], ["leaf", "ANATOMY", 206, 210], ["mosaic leaf disease", "DISEASE", 199, 218], ["leaf sap", "ORGANISM_SUBSTANCE", 154, 162], ["tobacco", "ORGANISM", 186, 193], ["leaf", "ORGAN", 206, 210], ["tobacco", "SPECIES", 186, 193], ["Crimean tobacco", "SPECIES", 178, 193], ["mosaic leaf disease", "PROBLEM", 199, 218], ["VIRUSES", "OBSERVATION", 20, 27], ["leaf sap", "OBSERVATION", 154, 162], ["mosaic leaf disease", "OBSERVATION", 199, 218]]], ["Even though the extracted sap had been passed through bacteria-retaining filters, the filtrate retrained the ability to replicate within living plants (Beijerinck, 1898) .", [["sap", "ANATOMY", 26, 29], ["the extracted sap", "PROBLEM", 12, 29], ["bacteria", "PROBLEM", 54, 62], ["retaining filters", "TREATMENT", 63, 80], ["the filtrate", "TREATMENT", 82, 94], ["retaining filters", "OBSERVATION", 63, 80]]], ["Later, Vinson (1927) succeeded in precipitating the pathogen of tobacco mosaic disease, and experiments in 1936 by Bawden and Pirie revealed that this pathogen contained RNA and protein components (Bawden et al., 1936; Bawden and Pirie, 1937) .", [["tobacco mosaic disease", "DISEASE", 64, 86], ["tobacco", "ORGANISM", 64, 71], ["tobacco", "SPECIES", 64, 71], ["tobacco", "SPECIES", 64, 71], ["this pathogen", "PROBLEM", 146, 159], ["tobacco mosaic disease", "OBSERVATION", 64, 86]]], ["Further experiments in 1956 demonstrated that genetic information was stored in RNA molecules (Fraenkel-Conrat et al., 1957 ) and later the concept of self-assembly of RNA and coat protein (CP) into particles was established (Butler and Klug, 1971) .", [["coat protein", "GENE_OR_GENE_PRODUCT", 176, 188], ["RNA molecules", "PROTEIN", 80, 93], ["RNA", "RNA", 168, 171], ["coat protein", "PROTEIN", 176, 188], ["CP", "PROTEIN", 190, 192], ["RNA and coat protein (CP) into particles", "PROBLEM", 168, 208]]], ["This pathogen is known as tobacco mosaic virus (TMV) and is one of the prominent viruses in plant molecular pharming.INTRODUCTION, PLANT VIRUSES FROM PATHOGENS TO BIOLOGICAL TOOLKITTobacco mosaic virus belongs to the Tobamovirus genus with a positive sense, single-stranded genomic RNA (gRNA) with a 7-methylguanosine-5-triphosphate cap at the 5 terminus (Dunigan and Zaitlin, 1990 ) and a 3 untranslated region (UTR) harboring a transfer RNA (tRNA)-like structure (Takamatsu et al., 1990) as shown in Figure 1A .", [["7-methylguanosine-5-triphosphate", "CHEMICAL", 300, 332], ["7-methylguanosine-5-triphosphate", "CHEMICAL", 300, 332], ["tobacco mosaic virus", "ORGANISM", 26, 46], ["TMV", "ORGANISM", 48, 51], ["TOOLKITTobacco mosaic virus", "ORGANISM", 174, 201], ["7-methylguanosine-5-triphosphate", "SIMPLE_CHEMICAL", 300, 332], ["positive sense, single-stranded genomic RNA", "RNA", 242, 285], ["gRNA", "RNA", 287, 291], ["7-methylguanosine-5-triphosphate cap", "DNA", 300, 336], ["5 terminus", "DNA", 344, 354], ["Dunigan", "PROTEIN", 356, 363], ["3 untranslated region", "DNA", 390, 411], ["UTR", "DNA", 413, 416], ["tobacco mosaic virus", "SPECIES", 26, 46], ["tobacco mosaic virus", "SPECIES", 26, 46], ["TMV", "SPECIES", 48, 51], ["TOOLKITTobacco mosaic virus", "SPECIES", 174, 201], ["This pathogen", "PROBLEM", 0, 13], ["tobacco mosaic virus", "PROBLEM", 26, 46], ["BIOLOGICAL TOOLKITTobacco mosaic virus", "PROBLEM", 163, 201], ["a positive sense", "PROBLEM", 240, 256], ["a 7-methylguanosine", "TREATMENT", 298, 317], ["triphosphate cap", "TREATMENT", 320, 336], ["Zaitlin", "TREATMENT", 368, 375], ["a 3 untranslated region (UTR)", "TREATMENT", 388, 417], ["a transfer RNA (tRNA)", "TREATMENT", 428, 449], ["mosaic virus", "OBSERVATION", 34, 46], ["prominent", "OBSERVATION_MODIFIER", 71, 80], ["viruses", "OBSERVATION", 81, 88], ["plant molecular pharming", "OBSERVATION", 92, 116], ["VIRUSES", "OBSERVATION", 137, 144]]], ["It encodes a total of four proteins two of which are involved in RNA replication plus a movement protein (MP) and a CP (Goelet et al., 1982) .", [["MP", "GENE_OR_GENE_PRODUCT", 106, 108], ["movement protein", "PROTEIN", 88, 104], ["MP", "PROTEIN", 106, 108], ["four proteins", "TREATMENT", 22, 35], ["RNA replication", "TREATMENT", 65, 80], ["a CP", "PROBLEM", 114, 118]]], ["Inside the plant cell, the gRNA acts as a messenger RNA (mRNA) template for expressing a 126 kDa protein containing methyltransferase and helicase domains plus a 183 kDa (readthrough) protein containing a polymerase domain (Osman and Buck, 1996; Lewandowski and Dawson, 2000) .", [["cell", "ANATOMY", 17, 21], ["plant cell", "CELL", 11, 21], ["gRNA", "CELLULAR_COMPONENT", 27, 31], ["methyltransferase", "GENE_OR_GENE_PRODUCT", 116, 133], ["gRNA", "RNA", 27, 31], ["messenger RNA", "RNA", 42, 55], ["mRNA", "RNA", 57, 61], ["126 kDa protein", "PROTEIN", 89, 104], ["methyltransferase", "PROTEIN", 116, 133], ["helicase domains", "PROTEIN", 138, 154], ["183 kDa (readthrough) protein", "PROTEIN", 162, 191], ["polymerase domain", "PROTEIN", 205, 222], ["the gRNA acts", "TREATMENT", 23, 36], ["a messenger RNA (mRNA) template", "TREATMENT", 40, 71], ["a 126 kDa protein containing methyltransferase", "TREATMENT", 87, 133], ["helicase domains", "TREATMENT", 138, 154], ["plant cell", "OBSERVATION", 11, 21]]], ["The 126 kDa and the 183 kDa replication proteins bind to the terminal tRNA-like structure initiating transcription of complementary (negative-sense) template (Lewandowski and Dawson, 2000; Osman and Buck, 2003) .", [["126 kDa", "PROTEIN", 4, 11], ["183 kDa replication proteins", "PROTEIN", 20, 48], ["terminal tRNA", "PROTEIN", 61, 74], ["complementary (negative-sense) template", "DNA", 118, 157], ["The 126 kDa", "TEST", 0, 11], ["the 183 kDa replication proteins", "TREATMENT", 16, 48], ["the terminal tRNA", "TREATMENT", 57, 74], ["terminal tRNA", "OBSERVATION", 61, 74]]], ["This negative-sense RNA acts as a template for the synthesis of fulllength positive strands and subgenomic RNAs containing MP and CP open reading frames (ORFs) (Ishikawa et al., 1991) .", [["MP", "GENE_OR_GENE_PRODUCT", 123, 125], ["negative-sense RNA", "RNA", 5, 23], ["fulllength positive strands", "RNA", 64, 91], ["subgenomic RNAs", "RNA", 96, 111], ["MP and CP open reading frames", "DNA", 123, 152], ["ORFs", "DNA", 154, 158], ["fulllength positive strands", "PROBLEM", 64, 91], ["subgenomic RNAs containing MP", "PROBLEM", 96, 125], ["CP", "PROBLEM", 130, 132], ["subgenomic RNAs", "OBSERVATION", 96, 111]]], ["The MP is an RNA binding protein involved in cell-to-cell spreading of the virus (Citovsky et al., 1990; Chen et al., 2000) while the CP enhances the formation of replication complexes (Asurmendi et al., 2004) , long-distance movement (Saito et al., 1990; Hilf and Dawson, 1993) , and viral particle assembly (Bloomer et al., 1978; Butler, 1999) .INTRODUCTION, PLANT VIRUSES FROM PATHOGENS TO BIOLOGICAL TOOLKITDuring the 1980s, the field of plant molecular pharming was born (Franken et al., 1997) and various pharmaceuticals such as human hormones (Barta et al., 1986) , antibodies (Hiatt et al., 1989) , and vaccines (Thanavala et al., 1995) , were produced using transgenic plants.", [["cell", "ANATOMY", 45, 49], ["cell", "ANATOMY", 53, 57], ["MP", "GENE_OR_GENE_PRODUCT", 4, 6], ["cell", "CELL", 45, 49], ["cell", "CELL", 53, 57], ["human", "ORGANISM", 535, 540], ["MP", "PROTEIN", 4, 6], ["RNA binding protein", "PROTEIN", 13, 32], ["replication complexes", "PROTEIN", 163, 184], ["antibodies", "PROTEIN", 573, 583], ["human", "SPECIES", 535, 540], ["human", "SPECIES", 535, 540], ["an RNA binding protein", "TEST", 10, 32], ["the CP", "PROBLEM", 130, 136], ["various pharmaceuticals", "TREATMENT", 503, 526], ["vaccines", "TREATMENT", 611, 619], ["PLANT VIRUSES", "OBSERVATION", 361, 374]]], ["Currently, several proteins manufactured in plants are commercialized such as bovine trypsin TrypZean expressed in maize and commercialized by Sigma-Aldrich (#T3568, Sigma-Aldrich Corporation, United States), the 2006 USDA approved Newcastle disease virus for poultry produced in tobacco cell-suspension by Dow AgroSciences (Vermij and Waltz, 2006) , and the 2012 FDA approved taliglucerase alfa (Elelyso R ) for the management of type 1 Gaucher's disease produced in carrot cells by Protalix Biotherapeutics Inc. (Maxmen, 2012) .INTRODUCTION, PLANT VIRUSES FROM PATHOGENS TO BIOLOGICAL TOOLKITHowever, the generation and selection of stably transformed plants for heterologous protein expression is quite elaborate and time-consuming which lead scientists to research exploiting viruses for this purpose.", [["cell", "ANATOMY", 288, 292], ["carrot cells", "ANATOMY", 468, 480], ["TrypZean", "CHEMICAL", 93, 101], ["Newcastle disease virus", "DISEASE", 232, 255], ["taliglucerase alfa", "CHEMICAL", 377, 395], ["Elelyso R", "CHEMICAL", 397, 406], ["Gaucher's disease", "DISEASE", 438, 455], ["bovine", "ORGANISM", 78, 84], ["trypsin", "GENE_OR_GENE_PRODUCT", 85, 92], ["maize", "ORGANISM", 115, 120], ["Sigma-Aldrich", "ORGANISM", 143, 156], ["Sigma-Aldrich Corporation", "ORGANISM", 166, 191], ["Newcastle disease virus", "ORGANISM", 232, 255], ["tobacco", "ORGANISM", 280, 287], ["cell", "CELL", 288, 292], ["taliglucerase alfa", "SIMPLE_CHEMICAL", 377, 395], ["Elelyso R", "SIMPLE_CHEMICAL", 397, 406], ["carrot cells", "CELL", 468, 480], ["bovine trypsin TrypZean", "PROTEIN", 78, 101], ["carrot cells", "CELL_TYPE", 468, 480], ["bovine", "SPECIES", 78, 84], ["maize", "SPECIES", 115, 120], ["poultry", "SPECIES", 260, 267], ["tobacco", "SPECIES", 280, 287], ["bovine", "SPECIES", 78, 84], ["maize", "SPECIES", 115, 120], ["Newcastle disease virus", "SPECIES", 232, 255], ["poultry", "SPECIES", 260, 267], ["tobacco", "SPECIES", 280, 287], ["carrot", "SPECIES", 468, 474], ["bovine trypsin TrypZean", "TREATMENT", 78, 101], ["Newcastle disease virus", "PROBLEM", 232, 255], ["taliglucerase alfa (Elelyso R )", "TREATMENT", 377, 408], ["the management", "TREATMENT", 413, 427], ["type 1 Gaucher's disease", "PROBLEM", 431, 455], ["heterologous protein expression", "PROBLEM", 665, 696], ["proteins manufactured", "OBSERVATION", 19, 40], ["tobacco cell", "OBSERVATION", 280, 292], ["carrot cells", "OBSERVATION", 468, 480], ["VIRUSES", "OBSERVATION", 550, 557]]], ["Plant viruses such as TMV (Takamatsu et al., 1987) and cowpea mosaic virus (CPMV) (Gopinath et al., 2000) were first adapted as full-virus vector then as a deconstructed-virus vector for recombinant protein expression.", [["cowpea mosaic virus", "DISEASE", 55, 74], ["TMV", "ORGANISM", 22, 25], ["cowpea mosaic virus", "ORGANISM", 55, 74], ["recombinant protein", "PROTEIN", 187, 206], ["cowpea mosaic virus", "SPECIES", 55, 74], ["TMV", "SPECIES", 22, 25], ["cowpea mosaic virus", "SPECIES", 55, 74], ["CPMV", "SPECIES", 76, 80], ["Plant viruses", "PROBLEM", 0, 13], ["TMV", "TEST", 22, 25], ["cowpea mosaic virus", "PROBLEM", 55, 74], ["full-virus vector", "TREATMENT", 128, 145], ["a deconstructed-virus vector", "TREATMENT", 154, 182], ["recombinant protein expression", "PROBLEM", 187, 217], ["viruses", "OBSERVATION", 6, 13]]], ["Later on, as we understood more of viral structure and capsid assembly, non-enveloped plant viruses were also manipulated for the generation of chimeric viral particles, nanoagents for carriage of various compounds and nanostructures building blocks.", [["non-enveloped plant viruses", "ORGANISM", 72, 99], ["viral structure", "PROBLEM", 35, 50], ["non-enveloped plant viruses", "PROBLEM", 72, 99], ["chimeric viral particles", "TREATMENT", 144, 168], ["nanoagents", "TREATMENT", 170, 180], ["carriage of various compounds", "PROBLEM", 185, 214], ["viral structure", "OBSERVATION", 35, 50]]], ["Furthermore, recently enveloped plant viruses, such as rhabdoviruses, have been recovered from agroinfiltrated cDNA, adding a viral particle with an amendable lipid envelope to the arsenal of available systems.PLANT VIRUSES IN RECOMBINANT EXPRESSION TECHNOLOGY, FIRST-GENERATION VECTORSAdopting plant viruses as vectors for transient expression offered many advantages over the transgenic system such as ability for application in various plant species (Hamamoto et al., 1993) , reduced gene-to-product time (Hendy et al., 1999) , and increased yields (Maclean et al., 2007) .", [["rhabdoviruses", "GENE_OR_GENE_PRODUCT", 55, 68], ["agroinfiltrated cDNA", "DNA", 95, 115], ["plant viruses", "PROBLEM", 32, 45], ["rhabdoviruses", "PROBLEM", 55, 68], ["agroinfiltrated cDNA", "PROBLEM", 95, 115], ["a viral particle", "TREATMENT", 124, 140], ["an amendable lipid envelope", "TREATMENT", 146, 173], ["FIRST-GENERATION VECTORSAdopting plant viruses", "TREATMENT", 262, 308], ["the transgenic system", "TREATMENT", 374, 395], ["plant viruses", "OBSERVATION", 32, 45], ["VIRUSES", "OBSERVATION", 216, 223]]], ["At first, the host cells were infected with a full copy of plant virus (either DNA or in vitro transcribed RNA) into which the heterogenous sequence or gene of interest (GOI) was cloned.", [["cells", "ANATOMY", 19, 24], ["host cells", "CELL", 14, 24], ["DNA", "CELLULAR_COMPONENT", 79, 82], ["host cells", "CELL_TYPE", 14, 24], ["vitro transcribed RNA", "RNA", 89, 110], ["GOI", "DNA", 170, 173], ["the host cells", "PROBLEM", 10, 24], ["plant virus", "PROBLEM", 59, 70], ["host cells", "OBSERVATION", 14, 24], ["plant virus", "OBSERVATION", 59, 70]]], ["The first published virus-based vector was a gene-replacement model in which the GOI replaced the CP of brome mosaic virus (BMV) (French et al., 1986) .", [["brome mosaic virus", "ORGANISM", 104, 122], ["BMV", "ORGANISM", 124, 127], ["GOI", "DNA", 81, 84], ["brome mosaic virus", "SPECIES", 104, 122], ["brome mosaic virus", "SPECIES", 104, 122], ["BMV", "SPECIES", 124, 127], ["a gene-replacement model", "TREATMENT", 43, 67], ["brome mosaic virus", "TREATMENT", 104, 122]]], ["However, lacking the CP, the recombinant virus was unable to spread, and infection was limited to inoculated cells.", [["cells", "ANATOMY", 109, 114], ["infection", "DISEASE", 73, 82], ["recombinant virus", "ORGANISM", 29, 46], ["cells", "CELL", 109, 114], ["inoculated cells", "CELL_TYPE", 98, 114], ["the CP", "PROBLEM", 17, 23], ["the recombinant virus", "PROBLEM", 25, 46], ["infection", "PROBLEM", 73, 82], ["inoculated cells", "PROBLEM", 98, 114], ["infection", "OBSERVATION", 73, 82], ["inoculated cells", "OBSERVATION", 98, 114]]], ["Further attempts followed using TMVbased vectors in which the GOI was inserted upstream the inherent CP gene and controlled by an additional subgenomic RNA promoter (the inherent CP subgenomic promoter was duplicated) (Dawson et al., 1988) .", [["GOI", "GENE_OR_GENE_PRODUCT", 62, 65], ["TMVbased vectors", "DNA", 32, 48], ["GOI", "DNA", 62, 65], ["CP gene", "DNA", 101, 108], ["subgenomic RNA promoter", "DNA", 141, 164], ["CP subgenomic promoter", "DNA", 179, 201], ["TMVbased vectors", "TREATMENT", 32, 48], ["the GOI", "TREATMENT", 58, 65], ["an additional subgenomic RNA promoter", "TREATMENT", 127, 164], ["the inherent CP subgenomic promoter", "TREATMENT", 166, 201]]], ["Still this design was unstable and homologous recombination resulted in the loss of inserted sequence and reversion to the wild-type virus (Dawson et al., 1989) .", [["wild-type virus", "ORGANISM", 123, 138], ["homologous recombination", "PROBLEM", 35, 59], ["the loss of inserted sequence", "PROBLEM", 72, 101]]], ["A third approach was to create a hybrid virus-vector containing different subgenomic promoter sequences from two tobamoviruses [TMV and odontoglossum ringspot virus (ORSV) ].", [["tobamoviruses", "GENE_OR_GENE_PRODUCT", 113, 126], ["TMV", "ORGANISM", 128, 131], ["odontoglossum ringspot virus", "ORGANISM", 136, 164], ["subgenomic promoter sequences", "DNA", 74, 103], ["odontoglossum ringspot virus", "SPECIES", 136, 164], ["TMV", "SPECIES", 128, 131], ["odontoglossum ringspot virus", "SPECIES", 136, 164], ["ORSV", "SPECIES", 166, 170], ["A third approach", "TREATMENT", 0, 16], ["a hybrid virus-vector", "TREATMENT", 31, 52], ["different subgenomic promoter sequences", "TREATMENT", 64, 103], ["two tobamoviruses", "PROBLEM", 109, 126], ["TMV and odontoglossum ringspot virus", "TREATMENT", 128, 164]]], ["This hybrid design resulted in a more stable vector that succeeded in the systemic expression of the recombinant protein (Donson et al., 1991) .", [["recombinant protein", "PROTEIN", 101, 120], ["stable", "OBSERVATION_MODIFIER", 38, 44]]], ["Other designs included fusing the recombinant protein to the TMV CP either at the C-terminal (Roder et al., 2017) or at the N-terminal downstream a leaky stop codon (Sugiyama et al., 1995) .", [["N", "CHEMICAL", 124, 125], ["TMV CP", "ORGANISM", 61, 67], ["recombinant protein", "PROTEIN", 34, 53], ["TMV CP", "PROTEIN", 61, 67], ["C-terminal", "PROTEIN", 82, 92], ["N-terminal downstream", "DNA", 124, 145], ["leaky stop codon", "DNA", 148, 164], ["the recombinant protein", "TREATMENT", 30, 53], ["the TMV CP", "PROBLEM", 57, 67], ["leaky", "OBSERVATION", 148, 153]]], ["Figures 1B-F, show the above described modification approaches applied to TMV.", [["TMV", "ORGANISM", 74, 77], ["TMV", "SPECIES", 74, 77]]], ["Table 1 lists a number of plant-made pharmaceutical proteins expressed using full-viral vectors.PLANT VIRUSES IN RECOMBINANT EXPRESSION TECHNOLOGY, SECOND-GENERATION VECTORSAlthough viral vectors based on a full-genome demonstrated success in producing recombinant proteins, constructs with large inserts showed instability and low systemic spread (Shivprasad et al., 1999; Avesani et al., 2007) .", [["plant-made pharmaceutical proteins", "PROTEIN", 26, 60], ["recombinant proteins", "PROTEIN", 253, 273], ["pharmaceutical proteins", "TREATMENT", 37, 60], ["full-viral vectors", "TREATMENT", 77, 95], ["viral vectors", "TREATMENT", 182, 195], ["instability", "PROBLEM", 312, 323], ["low systemic spread", "PROBLEM", 328, 347], ["VIRUSES", "OBSERVATION", 102, 109], ["instability", "OBSERVATION", 312, 323], ["low", "OBSERVATION_MODIFIER", 328, 331], ["systemic", "OBSERVATION_MODIFIER", 332, 340], ["spread", "OBSERVATION_MODIFIER", 341, 347]]], ["Together with biosafety concerns (Scholthof et al., 1996) , these limitations lead to the development of second-generation vectors in which the virus genome was deconstructed into a replicon containing the essential viral genomic components for replication and gene expression while plant-infection was initiated exogenously.", [["infection", "DISEASE", 289, 298], ["virus genome", "DNA", 144, 156], ["second-generation vectors", "TREATMENT", 105, 130], ["the virus genome", "PROBLEM", 140, 156], ["a replicon", "TREATMENT", 180, 190], ["plant-infection", "PROBLEM", 283, 298], ["virus genome", "OBSERVATION", 144, 156], ["essential", "OBSERVATION_MODIFIER", 206, 215], ["viral genomic components", "OBSERVATION", 216, 240], ["infection", "OBSERVATION", 289, 298]]], ["In this system, viral MP and/or CP genes were replaced by the recombinant GOI and the vector was introduced into plants as part of Agrobacterium delivered T-DNA , biolistic bombardment (Komarova et al., 2006) or as chromosome-inserted replicon (Ca\u00f1izares et al., 2006) .", [["chromosome", "ANATOMY", 215, 225], ["MP", "GENE_OR_GENE_PRODUCT", 22, 24], ["CP", "GENE_OR_GENE_PRODUCT", 32, 34], ["GOI", "GENE_OR_GENE_PRODUCT", 74, 77], ["DNA", "CELLULAR_COMPONENT", 157, 160], ["chromosome", "CELLULAR_COMPONENT", 215, 225], ["viral MP and/or CP genes", "DNA", 16, 40], ["recombinant GOI", "DNA", 62, 77], ["viral MP", "TEST", 16, 24], ["CP genes", "PROBLEM", 32, 40], ["the vector", "TREATMENT", 82, 92], ["Agrobacterium", "PROBLEM", 131, 144], ["biolistic bombardment", "TREATMENT", 163, 184], ["chromosome-inserted replicon", "TREATMENT", 215, 243], ["viral MP", "OBSERVATION", 16, 24]]], ["Lacking the CP, the deconstructed-virus based vectors lacked the ability to encapsidate into viral particles, however, they retained the ability to replicate, transcribe, and translate as shown in Figure 2 .PLANT VIRUSES IN RECOMBINANT EXPRESSION TECHNOLOGY, SECOND-GENERATION VECTORSAmong the monopartite RNA viruses, potato virus X (PVX) (Komarova et al., 2006) and TMV (Lindbo, 2007) were first to be adopted as a deconstructed-virus vectors.", [["potato virus X", "ORGANISM", 319, 333], ["PVX", "ORGANISM", 335, 338], ["TMV", "ORGANISM", 368, 371], ["potato virus", "SPECIES", 319, 331], ["potato virus", "SPECIES", 319, 331], ["PVX", "SPECIES", 335, 338], ["TMV", "SPECIES", 368, 371], ["the CP", "PROBLEM", 8, 14], ["the deconstructed-virus based vectors", "TREATMENT", 16, 53], ["the monopartite RNA viruses", "PROBLEM", 290, 317], ["potato virus", "PROBLEM", 319, 331], ["a deconstructed-virus vectors", "TREATMENT", 415, 444], ["VIRUSES", "OBSERVATION", 213, 220], ["monopartite RNA viruses", "OBSERVATION", 294, 317]]], ["Deconstructed-TMV based vectors were further commercially pursued by Icon Genetics as magnifection technology (trademarked as magnICON R ) .", [["TMV", "ORGANISM", 14, 17], ["TMV based vectors", "TREATMENT", 14, 31]]], ["The modifications included using a hybrid RdRP [from turnip vein-clearing virus (TVCV)] and Arabidopsis actin 2 (ACT2) as a promoter together with removal of cryptic thymine-rich intron sites plus selective introduction of introns .", [["thymine", "CHEMICAL", 166, 173], ["thymine", "CHEMICAL", 166, 173], ["turnip vein-clearing virus (TVCV", "GENE_OR_GENE_PRODUCT", 53, 85], ["Arabidopsis actin 2", "GENE_OR_GENE_PRODUCT", 92, 111], ["ACT2", "GENE_OR_GENE_PRODUCT", 113, 117], ["hybrid RdRP", "PROTEIN", 35, 46], ["Arabidopsis actin 2", "PROTEIN", 92, 111], ["ACT2", "PROTEIN", 113, 117], ["cryptic thymine-rich intron sites", "DNA", 158, 191], ["introns", "DNA", 223, 230], ["turnip", "SPECIES", 53, 59], ["turnip vein-clearing virus", "SPECIES", 53, 79], ["TVCV", "SPECIES", 81, 85], ["Arabidopsis", "SPECIES", 92, 103], ["The modifications", "TREATMENT", 0, 17], ["a hybrid RdRP", "TREATMENT", 33, 46], ["turnip vein", "TREATMENT", 53, 64], ["clearing virus (TVCV)", "TREATMENT", 65, 86], ["Arabidopsis actin 2 (ACT2)", "TREATMENT", 92, 118], ["a promoter", "TREATMENT", 122, 132], ["removal", "TREATMENT", 147, 154], ["cryptic thymine", "TREATMENT", 158, 173], ["rich intron sites", "TREATMENT", 174, 191], ["selective introduction of introns", "TREATMENT", 197, 230], ["vein", "ANATOMY", 60, 64], ["cryptic thymine", "OBSERVATION", 158, 173]]], ["Magnifection of hybrid TMV-based vectors yielded 4 g/kg of fresh weight tissue (FWT) of recombinant protein and 4.8 g/kg FWT of full immunoglobulin G (IgG) in less than 2 weeks (Bendandi et al., 2010) .PLANT VIRUSES IN RECOMBINANT EXPRESSION TECHNOLOGY, SECOND-GENERATION VECTORSSimilarly, a deconstructed virus strategy was developed for the bipartite RNA1/RNA2 CPMV.", [["tissue", "ANATOMY", 72, 78], ["TMV", "ORGANISM", 23, 26], ["tissue", "TISSUE", 72, 78], ["immunoglobulin G", "GENE_OR_GENE_PRODUCT", 133, 149], ["IgG", "GENE_OR_GENE_PRODUCT", 151, 154], ["RNA1", "GENE_OR_GENE_PRODUCT", 353, 357], ["RNA2", "GENE_OR_GENE_PRODUCT", 358, 362], ["recombinant protein", "PROTEIN", 88, 107], ["immunoglobulin G", "PROTEIN", 133, 149], ["IgG", "PROTEIN", 151, 154], ["bipartite RNA1/RNA2 CPMV", "DNA", 343, 367], ["hybrid TMV-based vectors", "TREATMENT", 16, 40], ["fresh weight tissue", "TREATMENT", 59, 78], ["recombinant protein", "TREATMENT", 88, 107], ["full immunoglobulin G (IgG", "TREATMENT", 128, 154], ["SECOND-GENERATION VECTORSSimilarly", "TREATMENT", 254, 288], ["a deconstructed virus strategy", "TREATMENT", 290, 320], ["RNA2 CPMV", "TREATMENT", 358, 367], ["hybrid TMV", "OBSERVATION", 16, 26], ["VIRUSES", "OBSERVATION", 208, 215], ["bipartite RNA1", "OBSERVATION", 343, 357], ["RNA2 CPMV", "OBSERVATION", 358, 367]]], ["Early research was based on maintaining an unmodified RNA-1 while introducing the recombinant gene to the RNA-2 construct.", [["RNA-1", "GENE_OR_GENE_PRODUCT", 54, 59], ["RNA-2", "GENE_OR_GENE_PRODUCT", 106, 111], ["unmodified RNA-1", "DNA", 43, 59], ["recombinant gene", "DNA", 82, 98], ["RNA-2 construct", "DNA", 106, 121]]], ["Recombinant expression was achieved using this methodology with both full-length and defective versions of RNA-2 coding plasmids (Roder et al., 2017) .", [["RNA-2", "GENE_OR_GENE_PRODUCT", 107, 112], ["RNA-2 coding plasmids", "DNA", 107, 128], ["defective versions of RNA", "TREATMENT", 85, 110]]], ["(C) Recombinant epitope (RE) fused to the CP C-terminus using leaky UAG stop codon (Sugiyama et al., 1995) .", [["C", "CHEMICAL", 45, 46], ["Recombinant epitope", "PROTEIN", 4, 23], ["RE", "PROTEIN", 25, 27], ["CP C-terminus", "PROTEIN", 42, 55], ["leaky UAG stop codon", "DNA", 62, 82], ["Recombinant epitope (RE)", "TREATMENT", 4, 28], ["the CP C", "PROBLEM", 38, 46], ["leaky UAG", "TREATMENT", 62, 71], ["CP", "ANATOMY", 42, 44]]], ["(D) Coding region of RP cloned in place of the virus CP gene (Takamatsu et al., 1987) .", [["RP", "DNA", 21, 23], ["virus CP gene", "DNA", 47, 60], ["RP", "PROBLEM", 21, 23], ["RP cloned", "OBSERVATION", 21, 30]]], ["(E) Coding region of RP downstream a subgenomic RNA promoter and placed between the MP and the CP genes (Dawson et al., 1989) .", [["MP", "GENE_OR_GENE_PRODUCT", 84, 86], ["RP", "DNA", 21, 23], ["subgenomic RNA promoter", "DNA", 37, 60], ["MP and the CP genes", "DNA", 84, 103], ["a subgenomic RNA promoter", "TREATMENT", 35, 60], ["subgenomic RNA promoter", "OBSERVATION", 37, 60], ["CP genes", "ANATOMY", 95, 103]]], ["(F) Coding region of RP cloned downstream TMV subgenomic RNA promoter and placed between TMV MP gene and a heterogeneous CP (H-CP) gene.", [["TMV MP", "GENE_OR_GENE_PRODUCT", 89, 95], ["H-CP", "GENE_OR_GENE_PRODUCT", 125, 129], ["RP cloned downstream TMV subgenomic RNA promoter", "DNA", 21, 69], ["TMV MP gene", "DNA", 89, 100], ["CP (H-CP) gene", "DNA", 121, 135], ["TMV", "SPECIES", 89, 92], ["RP", "PROBLEM", 21, 23], ["TMV subgenomic RNA promoter", "TREATMENT", 42, 69], ["TMV MP gene", "TREATMENT", 89, 100], ["a heterogeneous CP", "PROBLEM", 105, 123], ["TMV subgenomic", "OBSERVATION", 42, 56], ["RNA promoter", "OBSERVATION", 57, 69], ["heterogeneous", "OBSERVATION_MODIFIER", 107, 120]]], ["The latter was cloned into the TMV vector together with its heterogeneous subgenomic promoter from odontoglossum ringspot virus (ORSV) (Donson et al., 1991) .", [["TMV", "ORGANISM", 31, 34], ["odontoglossum ringspot virus", "ORGANISM", 99, 127], ["ORSV", "ORGANISM", 129, 133], ["TMV vector", "DNA", 31, 41], ["subgenomic promoter", "DNA", 74, 93], ["odontoglossum ringspot virus", "SPECIES", 99, 127], ["TMV", "SPECIES", 31, 34], ["odontoglossum ringspot virus", "SPECIES", 99, 127], ["ORSV", "SPECIES", 129, 133], ["the TMV vector", "TREATMENT", 27, 41], ["its heterogeneous subgenomic promoter", "PROBLEM", 56, 93], ["heterogeneous", "OBSERVATION_MODIFIER", 60, 73], ["subgenomic promoter", "OBSERVATION", 74, 93]]], ["Surprisingly, vector systems based on deleted regions of RNA-2 (delRNA-2) achieved higher expression yields than those obtained with full-length RNA-2 vectors .", [["RNA-2", "GENE_OR_GENE_PRODUCT", 57, 62], ["delRNA-2", "GENE_OR_GENE_PRODUCT", 64, 72], ["RNA-2", "GENE_OR_GENE_PRODUCT", 145, 150], ["RNA-2", "DNA", 57, 62], ["delRNA", "DNA", 64, 70], ["full-length RNA-2 vectors", "DNA", 133, 158], ["vector systems", "TREATMENT", 14, 28], ["RNA", "TEST", 57, 60], ["delRNA", "TEST", 64, 70], ["full-length RNA", "TREATMENT", 133, 148]]], ["Further experiments revealed that replication of delRNA-2 based molecules was not essential and high yields of recombinant protein expression was still achieved in the absence of RNA-1 .", [["delRNA-2", "GENE_OR_GENE_PRODUCT", 49, 57], ["RNA-1", "GENE_OR_GENE_PRODUCT", 179, 184], ["delRNA-2 based molecules", "PROTEIN", 49, 73], ["recombinant protein", "PROTEIN", 111, 130], ["Further experiments", "TEST", 0, 19], ["replication of delRNA-2 based molecules", "PROBLEM", 34, 73], ["recombinant protein expression", "PROBLEM", 111, 141]]], ["The modified delRNA-2-based mRNA was \"hyper-translated\" providing approximately 0.3 g/kg FWT of fully assembled monoclonal antibody within 6 days after agroinfection .", [["delRNA-2", "GENE_OR_GENE_PRODUCT", 13, 21], ["modified delRNA-2", "DNA", 4, 21], ["mRNA", "RNA", 28, 32], ["monoclonal antibody", "PROTEIN", 112, 131], ["The modified delRNA", "TREATMENT", 0, 19], ["hyper", "PROBLEM", 38, 43], ["agroinfection", "PROBLEM", 152, 165]]], ["Table 2 lists a number of plant-made pharmaceutical proteins expressed using deconstructed-viral vectors.", [["plant-made pharmaceutical proteins", "PROTEIN", 26, 60], ["deconstructed-viral vectors", "DNA", 77, 104], ["pharmaceutical proteins", "TREATMENT", 37, 60], ["deconstructed-viral vectors", "TREATMENT", 77, 104], ["viral vectors", "OBSERVATION", 91, 104]]], ["Agroinfiltration of pro-vector modules for in planta assembly Gils et al., 2005 The CPMV RNA2-based expression system allowed an elegant extension in which the genome-integrated cDNA of RNA-2 was amplified using agroinfiltrated RNA-1 constructs or by crossing with RNA-1 transgenic plants (Ca\u00f1izares et al., 2006) .", [["RNA2", "GENE_OR_GENE_PRODUCT", 89, 93], ["RNA-2", "GENE_OR_GENE_PRODUCT", 186, 191], ["RNA-1", "GENE_OR_GENE_PRODUCT", 228, 233], ["RNA-1", "GENE_OR_GENE_PRODUCT", 265, 270], ["pro-vector modules", "DNA", 20, 38], ["RNA2", "PROTEIN", 89, 93], ["cDNA", "DNA", 178, 182], ["RNA-2", "DNA", 186, 191], ["agroinfiltrated RNA-1 constructs", "DNA", 212, 244], ["pro-vector modules", "PROBLEM", 20, 38], ["The CPMV RNA2", "TREATMENT", 80, 93], ["agroinfiltrated RNA", "TREATMENT", 212, 231], ["CPMV RNA2", "OBSERVATION", 84, 93]]], ["This method of an inducible-replicon system, or dormant viral cassette, was also applied with a tomato mosaic virus (ToMV) system in suspension-cultured plant cells (Dohi et al., 2006) .", [["cells", "ANATOMY", 159, 164], ["tomato mosaic virus", "ORGANISM", 96, 115], ["ToMV", "ORGANISM", 117, 121], ["plant cells", "CELL", 153, 164], ["dormant viral cassette", "DNA", 48, 70], ["suspension-cultured plant cells", "CELL_LINE", 133, 164], ["tomato mosaic virus", "SPECIES", 96, 115], ["tomato mosaic virus", "SPECIES", 96, 115], ["an inducible-replicon system", "TREATMENT", 15, 43], ["dormant viral cassette", "TREATMENT", 48, 70], ["a tomato mosaic virus (ToMV) system", "TREATMENT", 94, 129]]], ["Other applications included development of dormant viral cassettes which can be activated at a custom-chosen stage using chemical inducers, such as ethanol ( Zhang and Mason, 2006) , or via a Cre-LoxP recombination system (Tremblay et al., 2007) .PLANT VIRUSES AS BIOLOGICAL PARTICLES, THE CASE OF NON-ENVELOPED VIRUSESThe plant viruses first exploited in biotechnology were nonenveloped and consist of CP subunits that have the ability to self-assemble into filamentous structures such as TMV (Alonso et al., 2013) or hollow symmetric icosahedral structures such as CCMV (Zandi et al., 2004) as shown in Figures 3A,B .", [["filamentous structures", "ANATOMY", 459, 481], ["ethanol", "CHEMICAL", 148, 155], ["ethanol", "CHEMICAL", 148, 155], ["ethanol", "SIMPLE_CHEMICAL", 148, 155], ["TMV", "ORGANISM", 490, 493], ["dormant viral cassettes", "DNA", 43, 66], ["CP subunits", "PROTEIN", 403, 414], ["dormant viral cassettes", "TREATMENT", 43, 66], ["chemical inducers", "TREATMENT", 121, 138], ["The plant viruses", "PROBLEM", 319, 336], ["CP subunits", "PROBLEM", 403, 414], ["TMV", "PROBLEM", 490, 493], ["hollow symmetric icosahedral structures", "PROBLEM", 519, 558], ["viral cassettes", "OBSERVATION", 51, 66], ["VIRUSES", "OBSERVATION", 253, 260], ["NON-ENVELOPED VIRUSES", "OBSERVATION", 298, 319], ["plant viruses", "OBSERVATION", 323, 336], ["CCMV", "OBSERVATION", 567, 571]]], ["With better understanding of particle architecture, biophysical properties, and ability to manipulate their genomic material, these viruses also became exploited as virus-like particles (VLP), self-assembled structures devoid of any genomic material (Huang et al., 2009 ) and further developed as virus-based nanoparticles (VNP) (Steinmetz et al., 2009) .", [["VLP", "ORGANISM", 187, 190], ["based nanoparticles", "SIMPLE_CHEMICAL", 303, 322], ["VNP", "SIMPLE_CHEMICAL", 324, 327], ["these viruses", "PROBLEM", 126, 139], ["virus-like particles", "PROBLEM", 165, 185], ["self-assembled structures", "PROBLEM", 193, 218], ["any genomic material", "PROBLEM", 229, 249], ["particle architecture", "OBSERVATION", 29, 50], ["viruses", "OBSERVATION", 132, 139]]], ["For instance, the detailed molecular structure knowledge of filamentous viruses such as TMV (Namba et al., 1989) , PVX (Parker et al., 2002) , TVCV (Lartey et al., 1994) , and PapMV (Yang et al., 2012) permitted their use for various applications such as vaccines (Smolenska et al., 1998; Petukhova et al., 2013; Therien et al., 2017) , fluorescent markers (Yi et al., 2005) , biocatalysts (Carette et al., 2007) , nanoparticles for biologics purification (Werner et al., 2006) , nanoparticles for in vivo imaging (Niehl et al., 2015) , and assembly units for memory devices (Tseng et al., 2006) , as shown in Figure 4 .PLANT VIRUSES AS BIOLOGICAL PARTICLES, THE CASE OF NON-ENVELOPED VIRUSESNon-enveloped plant viruses have been engineered in three different ways: modification of the outer capsid (whether through genetic manipulation, chemical modification of capsid's amino acids moieties, or through a combination of both), incorporation of heterologous cargo in the inner cavity, or particle integration into multivalent structures.", [["inner cavity", "ANATOMY", 972, 984], ["amino acids", "CHEMICAL", 872, 883], ["amino acids", "CHEMICAL", 872, 883], ["TMV", "ORGANISM", 88, 91], ["PVX", "ORGANISM", 115, 118], ["amino acids", "AMINO_ACID", 872, 883], ["inner cavity", "MULTI-TISSUE_STRUCTURE", 972, 984], ["outer capsid", "PROTEIN", 786, 798], ["capsid's amino acids moieties", "PROTEIN", 863, 892], ["heterologous cargo", "PROTEIN", 946, 964], ["TMV", "SPECIES", 88, 91], ["PVX", "SPECIES", 115, 118], ["filamentous viruses", "PROBLEM", 60, 79], ["PVX", "PROBLEM", 115, 118], ["various applications", "TREATMENT", 226, 246], ["biologics purification", "TREATMENT", 433, 455], ["nanoparticles", "TREATMENT", 480, 493], ["vivo imaging", "TEST", 501, 513], ["memory devices", "TREATMENT", 560, 574], ["NON-ENVELOPED VIRUSESNon", "PROBLEM", 671, 695], ["the outer capsid", "PROBLEM", 782, 798], ["genetic manipulation", "TREATMENT", 816, 836], ["capsid's amino acids moieties", "TREATMENT", 863, 892], ["heterologous cargo in the inner cavity", "TREATMENT", 946, 984], ["filamentous viruses", "OBSERVATION", 60, 79], ["VIRUSES", "OBSERVATION", 626, 633], ["plant viruses", "OBSERVATION", 706, 719], ["outer capsid", "OBSERVATION_MODIFIER", 786, 798], ["inner cavity", "ANATOMY", 972, 984]]], ["Table 3 provides examples of some current VNP that are being developed as agents used in gene delivery (Azizgolshani et al., 2013) , chemotherapy (S\u00e1nchez-S\u00e1nchez et al., 2014) , immunotherapy (Venuti et al., 2015) , vaccines (Phelps et al., 2007) , and plant virus-assisted sensors (reviewed in Eiben et al., 2018) .PLANT VIRUSES AS BIOLOGICAL PARTICLES, THE CASE OF NON-ENVELOPED VIRUSESProduction of plant virus based VLPs as vaccines received the attention since the early 1990 (Usha et al., 1993) .", [["VNP", "CANCER", 42, 45], ["plant virus", "ORGANISM", 403, 414], ["VLPs", "ORGANISM", 421, 425], ["chemotherapy", "TREATMENT", 133, 145], ["immunotherapy", "TREATMENT", 179, 192], ["vaccines", "TREATMENT", 217, 225], ["plant virus based VLPs", "TREATMENT", 403, 425], ["VIRUSES", "OBSERVATION", 323, 330]]], ["Plant RNA viruses such as TMV (Koo et al., 1999) , CPMV (Mclain et al., 1995) , CMV (Nuzzaci et al., 2007) , plum pox potyvirus (PPV) (Fern\u00e1ndez-Fern\u00e1ndez et al., 1998) , potato virus X (PVX) (Lico et al., 2009) , and tomato bushy stunt virus (TBSV) (Joelson et al., 1997) have been adapted for the production of vaccines and tested in various animal models.", [["plum pox potyvirus", "DISEASE", 109, 127], ["TMV", "ORGANISM", 26, 29], ["CMV", "ORGANISM", 80, 83], ["plum pox potyvirus", "ORGANISM", 109, 127], ["potato virus X", "ORGANISM", 171, 185], ["PVX", "ORGANISM", 187, 190], ["tomato bushy stunt virus", "ORGANISM", 218, 242], ["TBSV", "ORGANISM", 244, 248], ["plum pox potyvirus", "SPECIES", 109, 127], ["potato virus", "SPECIES", 171, 183], ["tomato bushy stunt virus", "SPECIES", 218, 242], ["TMV", "SPECIES", 26, 29], ["plum pox potyvirus", "SPECIES", 109, 127], ["potato virus", "SPECIES", 171, 183], ["PVX", "SPECIES", 187, 190], ["tomato bushy stunt virus", "SPECIES", 218, 242], ["TBSV", "SPECIES", 244, 248], ["Plant RNA viruses", "PROBLEM", 0, 17], ["TMV", "TEST", 26, 29], ["CMV", "TEST", 80, 83], ["plum pox potyvirus", "TEST", 109, 127], ["PPV", "TEST", 129, 132], ["Fern\u00e1ndez", "TEST", 135, 144], ["potato virus X (PVX", "PROBLEM", 171, 190], ["the production of vaccines", "TREATMENT", 295, 321], ["RNA viruses", "OBSERVATION", 6, 17]]], ["Studies conducted on the biodistribution and clearance of TMV (Bruckman et al., 2014) , PVX and tomato bushy (Blandino et al., 2015) in animal models showed no VLP induced pathological damage.", [["TMV", "ORGANISM", 58, 61], ["PVX", "ORGANISM", 88, 91], ["tomato bushy", "ORGANISM", 96, 108], ["tomato", "SPECIES", 96, 102], ["TMV", "SPECIES", 58, 61], ["PVX", "SPECIES", 88, 91], ["tomato", "SPECIES", 96, 102], ["Studies", "TEST", 0, 7], ["the biodistribution", "TEST", 21, 40], ["TMV", "TEST", 58, 61], ["PVX", "PROBLEM", 88, 91], ["VLP induced pathological damage", "PROBLEM", 160, 191], ["no", "UNCERTAINTY", 157, 159], ["VLP", "OBSERVATION", 160, 163], ["damage", "OBSERVATION", 185, 191]]], ["Plant viruses are not pathogenic to mammals but are recognized by the pathogen associated molecular pattern (PAMP) receptors of the innate immune system (Acosta-Ram\u00edrez et al., 2008) .", [["Plant viruses", "ORGANISM", 0, 13], ["pathogen associated molecular pattern (PAMP) receptors", "GENE_OR_GENE_PRODUCT", 70, 124], ["pathogen associated molecular pattern (PAMP) receptors", "PROTEIN", 70, 124], ["Plant viruses", "PROBLEM", 0, 13], ["pathogenic", "PROBLEM", 22, 32], ["viruses", "OBSERVATION", 6, 13], ["not", "UNCERTAINTY", 18, 21], ["pathogenic", "OBSERVATION", 22, 32]]], ["They were shown to elicit a humoral response when administered by parenteral (Brennan et al., 1999b) or mucosal routes (Brennan et al., 1999a ) and a cell mediated response (Yusibov et al., 2005; Kemnade et al., 2014) .", [["mucosal", "ANATOMY", 104, 111], ["cell", "ANATOMY", 150, 154], ["mucosal", "ORGAN", 104, 111], ["cell", "CELL", 150, 154]]], ["For instance, PapMV-CP-M2e VLP can induced murine anti-M2e antibodies that recognized influenza-infected cells and provided 100% protection (Denis et al., 2008) without any PapMV VLP induced cellular toxicity (Rioux et al., 2014) .", [["cells", "ANATOMY", 105, 110], ["cellular", "ANATOMY", 191, 199], ["influenza-infected", "DISEASE", 86, 104], ["toxicity", "DISEASE", 200, 208], ["PapMV", "GENE_OR_GENE_PRODUCT", 14, 19], ["VLP", "ORGANISM", 27, 30], ["murine", "ORGANISM", 43, 49], ["cells", "CELL", 105, 110], ["cellular", "CELL", 191, 199], ["PapMV", "PROTEIN", 14, 19], ["M2e VLP", "PROTEIN", 23, 30], ["murine anti-M2e antibodies", "PROTEIN", 43, 69], ["influenza-infected cells", "CELL_TYPE", 86, 110], ["murine", "SPECIES", 43, 49], ["PapMV", "TEST", 14, 19], ["CP", "PROBLEM", 20, 22], ["M2e VLP", "TREATMENT", 23, 30], ["murine anti-M2e antibodies", "PROBLEM", 43, 69], ["influenza", "PROBLEM", 86, 95], ["infected cells", "PROBLEM", 96, 110], ["cellular toxicity", "PROBLEM", 191, 208], ["infected cells", "OBSERVATION", 96, 110], ["cellular toxicity", "OBSERVATION", 191, 208]]], ["The production of plant virus based VLP(s) were not limited to plants, and a variety of heterologous systems such as insect cells (Lamb et al., 1996) , yeast (Brumfield et al., 2004) or Escherichia coli (Denis et al., 2008) have been employed to produce recombinant potato leafroll virus (PLRV), CCMV, and PapMV CP that assemble into viral particles indistinguishable from their plant produced counterparts.", [["cells", "ANATOMY", 124, 129], ["plant virus", "ORGANISM", 18, 29], ["VLP", "ORGANISM", 36, 39], ["insect cells", "CELL", 117, 129], ["Escherichia coli", "ORGANISM", 186, 202], ["potato leafroll virus", "ORGANISM", 266, 287], ["PLRV", "ORGANISM", 289, 293], ["CCMV", "GENE_OR_GENE_PRODUCT", 296, 300], ["PapMV CP", "ORGANISM", 306, 314], ["insect cells", "CELL_TYPE", 117, 129], ["yeast", "SPECIES", 152, 157], ["Escherichia coli", "SPECIES", 186, 202], ["potato leafroll virus", "SPECIES", 266, 287], ["yeast", "SPECIES", 152, 157], ["Escherichia coli", "SPECIES", 186, 202], ["potato leafroll virus", "SPECIES", 266, 287], ["PLRV", "SPECIES", 289, 293], ["CCMV", "SPECIES", 296, 300], ["PapMV", "SPECIES", 306, 311], ["plant virus", "PROBLEM", 18, 29], ["heterologous systems", "PROBLEM", 88, 108], ["insect cells", "PROBLEM", 117, 129], ["Lamb et al.", "TEST", 131, 142], ["yeast", "PROBLEM", 152, 157], ["Escherichia coli", "PROBLEM", 186, 202], ["recombinant potato leafroll virus", "PROBLEM", 254, 287], ["CCMV", "PROBLEM", 296, 300], ["PapMV CP", "PROBLEM", 306, 314], ["viral particles", "PROBLEM", 334, 349], ["plant virus", "OBSERVATION", 18, 29], ["Escherichia coli", "OBSERVATION", 186, 202], ["CCMV", "OBSERVATION", 296, 300]]], ["Nevertheless, plantproduced VLPs remain the most economical choice, as plant production is scalable and cost-effective with production costs lower than those in E. coli or eukaryotic-based systems (Kusnadi et al., 1997; Tus\u00e9 et al., 2014) , and has substantial safety advantage compared to mammalian-cells produced alternatives (Ma et al., 2003) .TOWARD ENVELOPED VIRUS LIKE PARTICLESIn the last decade, VLPs have been extensively developed as recombinant vaccines in different systems whether in plants or mammalian (Soulie et al., 1991) , insects (Le Tallec et al., 2009) , yeast (Agnandji et al., 2011) , and E. coli (Fiers et al., 2009) .", [["mammalian-cells", "ANATOMY", 290, 305], ["VLPs", "ORGANISM", 28, 32], ["E. coli", "ORGANISM", 161, 168], ["mammalian-cells", "CELL", 290, 305], ["VLPs", "ORGANISM", 404, 408], ["E. coli", "ORGANISM", 612, 619], ["mammalian-cells", "CELL_TYPE", 290, 305], ["E. coli", "SPECIES", 161, 168], ["yeast", "SPECIES", 576, 581], ["E. coli", "SPECIES", 612, 619], ["E. coli", "SPECIES", 161, 168], ["yeast", "SPECIES", 576, 581], ["E. coli", "SPECIES", 612, 619], ["plantproduced VLPs", "TREATMENT", 14, 32], ["production costs", "PROBLEM", 124, 140], ["VLPs", "TREATMENT", 404, 408], ["recombinant vaccines", "TREATMENT", 444, 464], ["Le Tallec et al.", "TEST", 550, 566], ["yeast (Agnandji et al.", "TEST", 576, 598], ["E. coli", "PROBLEM", 612, 619], ["VIRUS", "OBSERVATION", 364, 369], ["E. coli", "ANATOMY", 612, 619]]], ["They have proven to be immunogenic and few are currently available on the market such as Engerix R [for hepatitis B virus (HBV)] (Keating and Noble, 2003) , and Cervarix R [for human papillomavirus (HPV)] (Szarewski, 2010) , produced by GlaxoSmithKline, or their respective equivalents Recombivax HB R (Venters et al., 2004) , and Gardasil R (Tomljenovic and Shaw, 2012) produced by Merck.TOWARD ENVELOPED VIRUS LIKE PARTICLESNevertheless, producing VLPs whether through genetic fusion or chemical conjugation remains challenging, especially for complex multimeric antigens (Jagu et al., 2013; Benen et al., 2014) , full length glycoproteins that adopt different conformations (Kwong et al., 2002; Cullen et al., 2017) , large epitopes (Werner et al., 2006) , or have termini that are involved in protein folding (Pejawar-Gaddy et al., 2010) and might interrupt the capsid synchronized assembly (Zlotnick, 1994; Rold\u00e3o et al., 2012) , while post-expression chemical conjugation has the drawback of further increasing downstream processing costs (Buonaguro and Butler-Ransohoff, 2010; Wilken and Nikolov, 2012; Sabalza et al., 2014; Buyel et al., 2015) .", [["hepatitis B", "DISEASE", 104, 115], ["human papillomavirus (HPV)]", "DISEASE", 177, 204], ["GlaxoSmithKline", "CHEMICAL", 237, 252], ["Engerix R [for hepatitis B virus", "ORGANISM", 89, 121], ["HBV", "ORGANISM", 123, 126], ["Cervarix R", "GENE_OR_GENE_PRODUCT", 161, 171], ["human papillomavirus", "ORGANISM", 177, 197], ["HPV", "ORGANISM", 199, 202], ["VLPs", "ORGANISM", 450, 454], ["complex multimeric antigens", "PROTEIN", 546, 573], ["hepatitis B virus", "SPECIES", 104, 121], ["human", "SPECIES", 177, 182], ["papillomavirus", "SPECIES", 183, 197], ["hepatitis B virus", "SPECIES", 104, 121], ["HBV", "SPECIES", 123, 126], ["human papillomavirus (HPV)", "SPECIES", 177, 203], ["immunogenic", "PROBLEM", 23, 34], ["hepatitis B virus", "PROBLEM", 104, 121], ["human papillomavirus (HPV)", "TREATMENT", 177, 203], ["ENVELOPED VIRUS LIKE PARTICLESNevertheless", "PROBLEM", 396, 438], ["VLPs", "TREATMENT", 450, 454], ["genetic fusion", "TREATMENT", 471, 485], ["chemical conjugation", "TREATMENT", 489, 509], ["VIRUS", "OBSERVATION", 406, 411], ["large", "OBSERVATION_MODIFIER", 721, 726]]], ["Furthermore, chimeric VLPs expressing recombinant peptides were found to induce reduced neutralizing antibodies titre when compared to the full domain vaccines (Gedvilaite et al., 2015) .", [["chimeric VLPs", "ORGANISM", 13, 26], ["chimeric VLPs", "PROTEIN", 13, 26], ["chimeric VLPs", "TREATMENT", 13, 26], ["recombinant peptides", "PROBLEM", 38, 58], ["reduced neutralizing antibodies titre", "PROBLEM", 80, 117], ["the full domain vaccines", "TREATMENT", 135, 159]]], ["Even among plant-virus based VLP(s), for instance, alfalfa mosaic virus-based Plasmodium falciparum Pfs25 VLP, although it was shown to induce P. falciparum blocking antibodies in mice (Jones et al., 2013) , in Phase I clinical trial it was shown to provide a low protection level (Chichester et al., 2018) .TOWARD ENVELOPED VIRUS LIKE PARTICLESIn line with those difficulties and limitations, and considering that some of these are not encountered with enveloped VLPs (eVLPs), there has been a growing trend toward the use of eVLPs as production platform (Gheysen et al., 1989 ).", [["Plasmodium falciparum", "DISEASE", 78, 99], ["P. falciparum", "DISEASE", 143, 156], ["plant-virus based VLP", "ORGANISM", 11, 32], ["alfalfa mosaic virus", "ORGANISM", 51, 71], ["Plasmodium falciparum", "ORGANISM", 78, 99], ["Pfs25 VLP", "ORGANISM", 100, 109], ["P. falciparum", "ORGANISM", 143, 156], ["mice", "ORGANISM", 180, 184], ["VLPs", "GENE_OR_GENE_PRODUCT", 464, 468], ["eVLPs", "GENE_OR_GENE_PRODUCT", 470, 475], ["eVLPs", "SIMPLE_CHEMICAL", 527, 532], ["P. falciparum blocking antibodies", "PROTEIN", 143, 176], ["alfalfa mosaic virus", "SPECIES", 51, 71], ["Plasmodium falciparum", "SPECIES", 78, 99], ["P. falciparum", "SPECIES", 143, 156], ["mice", "SPECIES", 180, 184], ["alfalfa mosaic virus", "SPECIES", 51, 71], ["Plasmodium falciparum", "SPECIES", 78, 99], ["P. falciparum", "SPECIES", 143, 156], ["mice", "SPECIES", 180, 184], ["alfalfa mosaic virus", "TREATMENT", 51, 71], ["Plasmodium falciparum Pfs25 VLP", "TREATMENT", 78, 109], ["falciparum blocking antibodies", "TREATMENT", 146, 176], ["PARTICLESIn line", "TREATMENT", 336, 352], ["VIRUS", "OBSERVATION", 325, 330], ["PARTICLESIn line", "OBSERVATION", 336, 352], ["growing", "OBSERVATION_MODIFIER", 495, 502]]], ["In this system, structural viral proteins are expressed and incorporated into host membranes released as particles.", [["membranes", "ANATOMY", 83, 92], ["membranes", "CELLULAR_COMPONENT", 83, 92], ["structural viral proteins", "PROTEIN", 16, 41], ["structural viral proteins", "PROBLEM", 16, 41], ["viral proteins", "OBSERVATION", 27, 41], ["host membranes", "OBSERVATION", 78, 92]]], ["The envelope provides the flexibility for integration of complete envelope-proteins and glycoproteins resembling the native virus (Yamshchikov et al., 1995; Baumert et al., 1998; Latham and Galarza, 2001) .", [["envelope-proteins", "PROTEIN", 66, 83], ["glycoproteins", "PROTEIN", 88, 101], ["glycoproteins", "TREATMENT", 88, 101]]], ["Along this idea attempts have been made to produce various eVLPs for vaccine purposes, e.g., against influenza virus (production of eVLPs in insect cells expressing influenza virus structural proteins) (Khurana et al., 2011) , HIV (based on virosome, in vitro associated/spiked with an HIV1 gp41-derived peptide) (Leroux-Roels et al., 2013) and breast cancer (based on in vitro association of antigenic peptides to synthesized phospholipid membranes) (Wiedermann et al., 2010) .", [["cells", "ANATOMY", 148, 153], ["breast cancer", "ANATOMY", 345, 358], ["phospholipid membranes", "ANATOMY", 427, 449], ["influenza virus", "DISEASE", 101, 116], ["breast cancer", "DISEASE", 345, 358], ["eVLPs", "GENE_OR_GENE_PRODUCT", 59, 64], ["influenza virus", "ORGANISM", 101, 116], ["eVLPs", "GENE_OR_GENE_PRODUCT", 132, 137], ["insect cells", "CELL", 141, 153], ["influenza virus", "ORGANISM", 165, 180], ["HIV", "ORGANISM", 227, 230], ["HIV1", "GENE_OR_GENE_PRODUCT", 286, 290], ["breast cancer", "CANCER", 345, 358], ["eVLPs", "PROTEIN", 59, 64], ["eVLPs", "PROTEIN", 132, 137], ["insect cells", "CELL_TYPE", 141, 153], ["influenza virus structural proteins", "PROTEIN", 165, 200], ["gp41", "PROTEIN", 291, 295], ["influenza virus", "SPECIES", 101, 116], ["influenza virus", "SPECIES", 165, 180], ["HIV", "SPECIES", 227, 230], ["influenza virus", "SPECIES", 101, 116], ["HIV", "SPECIES", 227, 230], ["vaccine purposes", "TREATMENT", 69, 85], ["influenza virus", "PROBLEM", 101, 116], ["eVLPs in insect cells", "PROBLEM", 132, 153], ["influenza virus structural proteins", "PROBLEM", 165, 200], ["HIV", "PROBLEM", 227, 230], ["an HIV1 gp41", "TREATMENT", 283, 295], ["breast cancer", "PROBLEM", 345, 358], ["antigenic peptides to synthesized phospholipid membranes", "TREATMENT", 393, 449], ["breast", "ANATOMY", 345, 351], ["cancer", "OBSERVATION", 352, 358]]], ["Influenza eVLPs have been produced from the co-expression of the two major antigenic envelope proteins hemagglutinin (HA) and neuraminidase (NA) plus matrix 1 (M1) (Pushko et al., 2005) or from the co-expression of HA and M1 to enable budding (Galarza et al., 2005) .", [["Influenza", "ORGANISM", 0, 9], ["eVLPs", "GENE_OR_GENE_PRODUCT", 10, 15], ["hemagglutinin", "GENE_OR_GENE_PRODUCT", 103, 116], ["neuraminidase (NA) plus matrix 1", "GENE_OR_GENE_PRODUCT", 126, 158], ["HA", "GENE_OR_GENE_PRODUCT", 215, 217], ["Influenza eVLPs", "PROTEIN", 0, 15], ["antigenic envelope proteins", "PROTEIN", 75, 102], ["hemagglutinin", "PROTEIN", 103, 116], ["HA", "PROTEIN", 118, 120], ["neuraminidase", "PROTEIN", 126, 139], ["NA", "PROTEIN", 141, 143], ["HA", "PROTEIN", 215, 217], ["M1", "PROTEIN", 222, 224], ["Influenza", "SPECIES", 0, 9], ["Influenza eVLPs", "TEST", 0, 15], ["hemagglutinin (HA)", "TREATMENT", 103, 121], ["neuraminidase (NA) plus matrix", "TREATMENT", 126, 156], ["HA", "PROBLEM", 215, 217]]], ["Most of these attempts have been performed in animal cell systems, but recently plants have also been used as platform for producing eVLPs against avian H5N1 Influenza .", [["cell", "ANATOMY", 53, 57], ["Influenza", "DISEASE", 158, 167], ["cell", "CELL", 53, 57], ["eVLPs", "GENE_OR_GENE_PRODUCT", 133, 138], ["avian H5N1 Influenza", "ORGANISM", 147, 167], ["eVLPs", "PROTEIN", 133, 138], ["avian H5N1 Influenza", "SPECIES", 147, 167], ["Influenza", "PROBLEM", 158, 167]]], ["HA-based influenza VLPs were found to be budding from the plasma membrane of plant cells expressing HA only, without the need of further viral proteins , due to the absence of glycoprotein sialylation in plants (S\u00e9veno et al., 2004) .", [["plasma membrane", "ANATOMY", 58, 73], ["cells", "ANATOMY", 83, 88], ["HA", "GENE_OR_GENE_PRODUCT", 0, 2], ["influenza VLPs", "ORGANISM", 9, 23], ["plasma membrane", "CELLULAR_COMPONENT", 58, 73], ["plant cells", "CELL", 77, 88], ["HA", "GENE_OR_GENE_PRODUCT", 100, 102], ["plant cells", "CELL_TYPE", 77, 88], ["HA", "PROTEIN", 100, 102], ["viral proteins", "PROTEIN", 137, 151], ["HA", "PROBLEM", 0, 2], ["based influenza VLPs", "PROBLEM", 3, 23], ["HA", "PROBLEM", 100, 102], ["further viral proteins", "PROBLEM", 129, 151], ["glycoprotein sialylation", "TREATMENT", 176, 200], ["influenza", "OBSERVATION", 9, 18], ["plant cells", "OBSERVATION", 77, 88]]], ["Moreover, and importantly, these plantproduced HA based eVLP vaccines were found to elicit durable and cross-reactive T cell responses and are currently undergoing clinical trials by Medicago (Landry et al., 2014) .", [["T cell", "ANATOMY", 118, 124], ["eVLP", "SIMPLE_CHEMICAL", 56, 60], ["T cell", "CELL", 118, 124], ["these plantproduced HA", "TREATMENT", 27, 49], ["eVLP vaccines", "TREATMENT", 56, 69], ["cross-reactive T cell responses", "OBSERVATION", 103, 134]]], ["These findings support and strengthen the development and exploitation of enveloped plant virus-based vector systems, amenable for genetic manipulation, in plant molecular pharming.", [["enveloped plant virus", "PROBLEM", 74, 95], ["genetic manipulation", "TREATMENT", 131, 151]]], ["Few plant viruses exist that have a naturally occurring envelope.", [["Few plant viruses", "PROBLEM", 0, 17], ["viruses", "OBSERVATION", 10, 17]]], ["They classify within the orders Bunyavirales and Mononegavirales, of which the family Rhabdoviridae, and have a negative strand RNA genome (King et al., 2018) .", [["Rhabdoviridae", "GENE_OR_GENE_PRODUCT", 86, 99], ["negative strand RNA genome", "DNA", 112, 138]]], ["Considering that monopartite rhabdoviruses are easier to handle and a reverse genetics system has recently been established for a plant infecting rhabdovirus, they present the most attractive platform for development of pseudotyped viral-vaccines upon which their inherent envelope will provide the needed flexibility to incorporate large and complex antigens.PLANT VIRUSES AS BIOLOGICAL PARTICLES, THE CASE OF INHERENTLY ENVELOPED VIRUSES -RHABDOVIRUSES AS AN EXAMPLEThe Rhabdoviridae family contains an ecologically diverse group of viruses infecting hosts from a wide plethora of aquatic and terrestrial vertebrates and plants (Kuzmin et al., 2009) ; rhabdoviruses from different kingdoms are listed Table 4 .", [["pseudotyped", "ORGANISM", 220, 231], ["complex antigens", "PROTEIN", 343, 359], ["monopartite rhabdoviruses", "PROBLEM", 17, 42], ["a plant infecting rhabdovirus", "PROBLEM", 128, 157], ["pseudotyped viral-vaccines", "TREATMENT", 220, 246], ["large and complex antigens", "PROBLEM", 333, 359], ["rhabdoviruses", "PROBLEM", 654, 667], ["monopartite rhabdoviruses", "OBSERVATION", 17, 42], ["large", "OBSERVATION_MODIFIER", 333, 338], ["VIRUSES", "OBSERVATION", 366, 373], ["VIRUSES", "OBSERVATION", 432, 439], ["wide", "OBSERVATION_MODIFIER", 566, 570], ["terrestrial vertebrates", "OBSERVATION", 595, 618]]], ["Plant rhabdoviruses, like all other viruses of the Rhabdoviridae family are enveloped, negative-sense RNA viruses (Jackson et al., 2005) .", [["Rhabdoviridae", "GENE_OR_GENE_PRODUCT", 51, 64], ["Plant rhabdoviruses", "PROBLEM", 0, 19], ["rhabdoviruses", "OBSERVATION", 6, 19], ["viruses", "OBSERVATION", 36, 43]]], ["They have a bacilliform shape defined by two major structural components: an outer envelope made of the host lipid bilayer embedded with surface projections of the virus glycoprotein and a tightly coiled internal nucleocapsid composed of genomic RNA (gRNA) together nucleoprotein, phosphoprotein, and the polymerase protein (Wolanski et al., 1967) (Figure 5 , traditionally, plant rhabdoviruses were divided into Cytorhabdovirus or Nucleorhabdovirus genera, depending on the virus propagation sites within the cell while recently two new genera Dichorhavirus and Varicosavirus, with bipartite genomes, were added (Dietzgen et al., 2017; Whitfield et al., 2018) .PLANT VIRUSES AS BIOLOGICAL PARTICLES, THE CASE OF INHERENTLY ENVELOPED VIRUSES -RHABDOVIRUSES AS AN EXAMPLEMany of the plant rhabdoviruses are transmitted by arthropods in a persistent propagative way in which the virus enters and replicates within the insect before transmission (Sylvester and Richardson, 1992; Creamer et al., 1997; Redinbaugh et al., 2002) while dichorhaviruses are transmitted ) showing the 3 leader, the N, P, 4b, M, G, and L genes, the 5 trailer (sequential genes separated by a gene junction) and the transcription gradient.", [["bacilliform", "ANATOMY", 12, 23], ["lipid bilayer", "ANATOMY", 109, 122], ["surface", "ANATOMY", 137, 144], ["cell", "ANATOMY", 510, 514], ["lipid bilayer", "CELLULAR_COMPONENT", 109, 122], ["cell", "CELL", 510, 514], ["Varicosavirus", "GENE_OR_GENE_PRODUCT", 563, 576], ["dichorhaviruses", "GENE_OR_GENE_PRODUCT", 1029, 1044], ["virus glycoprotein", "PROTEIN", 164, 182], ["tightly coiled internal nucleocapsid", "PROTEIN", 189, 225], ["genomic RNA", "RNA", 238, 249], ["gRNA", "RNA", 251, 255], ["nucleoprotein", "PROTEIN", 266, 279], ["phosphoprotein", "PROTEIN", 281, 295], ["polymerase protein", "PROTEIN", 305, 323], ["N, P, 4b, M, G, and L genes", "DNA", 1089, 1116], ["5 trailer", "DNA", 1122, 1131], ["a bacilliform shape", "PROBLEM", 10, 29], ["the host lipid bilayer", "TREATMENT", 100, 122], ["the virus glycoprotein", "PROBLEM", 160, 182], ["a tightly coiled internal nucleocapsid", "PROBLEM", 187, 225], ["phosphoprotein", "TEST", 281, 295], ["the polymerase protein", "TEST", 301, 323], ["plant rhabdoviruses", "TREATMENT", 375, 394], ["Nucleorhabdovirus genera", "TREATMENT", 432, 456], ["the virus propagation sites", "PROBLEM", 471, 498], ["new genera Dichorhavirus", "TREATMENT", 534, 558], ["Varicosavirus", "TREATMENT", 563, 576], ["bipartite genomes", "TREATMENT", 583, 600], ["the plant rhabdoviruses", "PROBLEM", 778, 801], ["a persistent propagative way", "PROBLEM", 835, 863], ["the virus", "PROBLEM", 873, 882], ["the transcription gradient", "TEST", 1184, 1210], ["virus glycoprotein", "OBSERVATION", 164, 182], ["internal nucleocapsid", "ANATOMY", 204, 225], ["genomic RNA", "OBSERVATION", 238, 249], ["VIRUSES", "OBSERVATION", 668, 675], ["ENVELOPED", "OBSERVATION_MODIFIER", 724, 733], ["VIRUSES", "OBSERVATION", 734, 741], ["RHABDOVIRUSES", "OBSERVATION", 743, 756], ["plant rhabdoviruses", "OBSERVATION", 782, 801], ["virus", "OBSERVATION", 877, 882], ["L genes", "ANATOMY", 1109, 1116], ["transcription gradient", "OBSERVATION", 1188, 1210]]], ["Genomic RNA is first replicated into agRNA (positive-sense), which is used as template for the production of (accumulating amounts of) progeny gRNA (negative-sense).", [["agRNA", "GENE_OR_GENE_PRODUCT", 37, 42], ["Genomic RNA", "RNA", 0, 11], ["agRNA", "DNA", 37, 42], ["progeny gRNA", "RNA", 135, 147], ["Genomic RNA", "PROBLEM", 0, 11]]], ["(C) Legend of panel (B).PLANT VIRUSES AS BIOLOGICAL PARTICLES, THE CASE OF INHERENTLY ENVELOPED VIRUSES -RHABDOVIRUSES AS AN EXAMPLEby mites and varicosaviruses by soil-borne fungi (Latham et al., 2004) .", [["AN EXAMPLEby mites", "TEST", 122, 140], ["varicosaviruses", "PROBLEM", 145, 160], ["VIRUSES", "OBSERVATION", 30, 37], ["VIRUSES", "OBSERVATION", 96, 103]]], ["The typical symptoms of viral infection are necrosis, mosaic mottling of leaf tissue, and vein clearing (Jackson et al., 2009) .", [["leaf tissue", "ANATOMY", 73, 84], ["vein", "ANATOMY", 90, 94], ["viral infection", "DISEASE", 24, 39], ["necrosis", "DISEASE", 44, 52], ["leaf tissue", "TISSUE", 73, 84], ["vein", "MULTI-TISSUE_STRUCTURE", 90, 94], ["The typical symptoms", "PROBLEM", 0, 20], ["viral infection", "PROBLEM", 24, 39], ["necrosis", "PROBLEM", 44, 52], ["mosaic mottling of leaf tissue", "PROBLEM", 54, 84], ["viral", "OBSERVATION_MODIFIER", 24, 29], ["infection", "OBSERVATION", 30, 39], ["necrosis", "OBSERVATION", 44, 52], ["mosaic", "OBSERVATION_MODIFIER", 54, 60], ["mottling", "OBSERVATION_MODIFIER", 61, 69], ["leaf tissue", "OBSERVATION", 73, 84], ["vein", "ANATOMY", 90, 94], ["clearing", "OBSERVATION_MODIFIER", 95, 103]]], ["Plant rhabdovirus gRNA encodes the rhabdoviruses canonical genes: Nucleoprotein (N), Phosphoprotein (P), Matrix (M), Glycoprotein (G), and Large Polymerase (L) , in addition to accessory genes (Walker et al., 2011) such as those coding for a cell-to-cell MP such as the 4b gene in lettuce necrotic yellow virus (LNYV) (Dietzgen et al., 2007) , gene 3 of rice yellow stunt rhabdovirus (RYSV) (Huang et al., 2005) .", [["cell", "ANATOMY", 242, 246], ["cell", "ANATOMY", 250, 254], ["necrotic", "DISEASE", 289, 297], ["Nucleoprotein (N)", "GENE_OR_GENE_PRODUCT", 66, 83], ["Phosphoprotein", "GENE_OR_GENE_PRODUCT", 85, 99], ["Matrix (M)", "GENE_OR_GENE_PRODUCT", 105, 115], ["Glycoprotein (G)", "GENE_OR_GENE_PRODUCT", 117, 133], ["Large Polymerase (L)", "GENE_OR_GENE_PRODUCT", 139, 159], ["cell", "CELL", 242, 246], ["MP", "GENE_OR_GENE_PRODUCT", 255, 257], ["4b", "GENE_OR_GENE_PRODUCT", 270, 272], ["lettuce necrotic yellow virus", "ORGANISM", 281, 310], ["rice yellow stunt rhabdovirus", "ORGANISM", 354, 383], ["Plant rhabdovirus gRNA", "RNA", 0, 22], ["rhabdoviruses canonical genes", "DNA", 35, 64], ["Nucleoprotein (N), Phosphoprotein (P)", "PROTEIN", 66, 103], ["Matrix", "DNA", 105, 111], ["Glycoprotein (G)", "DNA", 117, 133], ["Large Polymerase (L)", "DNA", 139, 159], ["accessory genes", "DNA", 177, 192], ["4b gene", "DNA", 270, 277], ["yellow virus", "SPECIES", 298, 310], ["rice", "SPECIES", 354, 358], ["yellow stunt rhabdovirus", "SPECIES", 359, 383], ["lettuce necrotic yellow virus", "SPECIES", 281, 310], ["LNYV", "SPECIES", 312, 316], ["rice yellow stunt rhabdovirus", "SPECIES", 354, 383], ["RYSV", "SPECIES", 385, 389], ["Plant rhabdovirus gRNA", "TREATMENT", 0, 22], ["Nucleoprotein (N)", "TREATMENT", 66, 83], ["Phosphoprotein (P), Matrix (M)", "TREATMENT", 85, 115], ["Glycoprotein (G)", "TREATMENT", 117, 133], ["Large Polymerase (L)", "TREATMENT", 139, 159], ["a cell", "TEST", 240, 246], ["lettuce necrotic yellow virus", "PROBLEM", 281, 310], ["rhabdovirus gRNA", "OBSERVATION", 6, 22], ["necrotic", "OBSERVATION_MODIFIER", 289, 297], ["yellow virus", "OBSERVATION", 298, 310]]], ["Furthermore, the gRNA is flanked by UTRs termed 3 leader and 5 trailer (Fu, 2005) (Figure 5B) .", [["gRNA", "DNA", 17, 21], ["UTRs", "DNA", 36, 40], ["the gRNA", "TREATMENT", 13, 21], ["gRNA", "OBSERVATION", 17, 21]]], ["The leader and trailer sequences are partially complementary and contain cis-acting signals involved in transcription and replication (Zuidema et al., 1986; Choi et al., 1994; Wang et al., 1999 ) while short intergenic sequences regulate mRNA synthesis and sequential transcription of the canonical genes (Wetzel et al., 1994; Bandyopadhyay et al., 2010) .Rhabdoviruses TranscriptionTheoretical models that explain rhabdovirus transcription and replication were built upon experiments on mammalian rhabdoviruses, and one of the most well studied is Vesicular Stomatitis virus (VSV) (Emerson, 1987; Wertz et al., 1987) .", [["Vesicular Stomatitis", "DISEASE", 549, 569], ["rhabdovirus", "GENE_OR_GENE_PRODUCT", 415, 426], ["Vesicular Stomatitis virus", "ORGANISM", 549, 575], ["VSV", "ORGANISM", 577, 580], ["leader and trailer sequences", "DNA", 4, 32], ["short intergenic sequences", "DNA", 202, 228], ["canonical genes", "DNA", 289, 304], ["Vesicular Stomatitis virus", "SPECIES", 549, 575], ["VSV", "SPECIES", 577, 580], ["The leader and trailer sequences", "TREATMENT", 0, 32], ["short intergenic sequences", "TREATMENT", 202, 228], ["mRNA synthesis", "TREATMENT", 238, 252], ["Rhabdoviruses", "TREATMENT", 356, 369], ["rhabdovirus transcription", "TREATMENT", 415, 440], ["replication", "TREATMENT", 445, 456], ["mammalian rhabdoviruses", "TREATMENT", 488, 511], ["Vesicular Stomatitis virus", "PROBLEM", 549, 575], ["cis-acting signals", "OBSERVATION", 73, 91], ["rhabdovirus transcription", "OBSERVATION", 415, 440], ["Vesicular Stomatitis virus", "OBSERVATION", 549, 575]]], ["The ribonucleoprotein (RNP) unit, consisting of viral RNA associated with the N, L, and P proteins, acts as the template for viral transcription and replication (Yang et al., 1998 (Yang et al., , 1999 Kawai et al., 1999) .", [["RNP", "CELLULAR_COMPONENT", 23, 26], ["N, L", "GENE_OR_GENE_PRODUCT", 78, 82], ["ribonucleoprotein (RNP) unit", "DNA", 4, 32], ["viral RNA", "RNA", 48, 57], ["N, L, and P proteins", "PROTEIN", 78, 98], ["The ribonucleoprotein (RNP) unit", "TREATMENT", 0, 32], ["viral RNA", "PROBLEM", 48, 57], ["the N, L, and P proteins", "PROBLEM", 74, 98], ["viral transcription", "TREATMENT", 125, 144], ["ribonucleoprotein", "OBSERVATION", 4, 21], ["viral RNA", "OBSERVATION", 48, 57]]], ["Virion-associated L protein transcribes the NC into mRNA of distinct proteins (Moyer and Banerjee, 1975; Toriyama and Peters, 1980) .", [["Virion-associated L protein", "GENE_OR_GENE_PRODUCT", 0, 27], ["Virion-associated L protein", "PROTEIN", 0, 27], ["mRNA", "RNA", 52, 56], ["Virion", "TEST", 0, 6], ["associated L protein transcribes", "PROBLEM", 7, 39], ["L", "ANATOMY_MODIFIER", 18, 19], ["protein transcribes", "OBSERVATION", 20, 39], ["distinct proteins", "OBSERVATION", 60, 77]]], ["The transcription direction and gradient follow the order of genes in the virus genome and are controlled by the untranslated 3 -leader sequence (Emerson, 1982) and the non-translated inter-genomic regions respectively as shown in Figure 5B (Barr et al., 1997; Finke et al., 2000) .", [["virus genome", "DNA", 74, 86], ["untranslated 3 -leader sequence", "DNA", 113, 144], ["non-translated inter-genomic regions", "DNA", 169, 205], ["virus genome", "OBSERVATION", 74, 86]]], ["Transcription of the viral genes results in the generation of monocistronic 5 -capped and polyadenylated mRNAs.Rhabdoviruses ReplicationLater during the infection, the N-P complex inhibits transcription and switches the function of the L protein from that of transcription to replication (La Ferla and Peluso, 1989; Gupta and Banerjee, 1997) .", [["infection", "DISEASE", 153, 162], ["viral genes", "DNA", 21, 32], ["monocistronic 5 -capped and polyadenylated mRNAs", "RNA", 62, 110], ["N-P complex", "PROTEIN", 168, 179], ["L protein", "PROTEIN", 236, 245], ["the viral genes", "PROBLEM", 17, 32], ["monocistronic 5 -capped and polyadenylated mRNAs", "TREATMENT", 62, 110], ["Rhabdoviruses", "TREATMENT", 111, 124], ["the infection", "PROBLEM", 149, 162], ["the N-P complex inhibits transcription", "TREATMENT", 164, 202], ["the L protein", "TREATMENT", 232, 245], ["viral genes", "OBSERVATION", 21, 32], ["polyadenylated mRNAs", "OBSERVATION", 90, 110], ["infection", "OBSERVATION", 153, 162]]], ["First, the gRNA is replicated into an antigenomic sense RNA (agRNA) template, which is full positivesense RNA without a cap and poly (A) tail and is encapsidated by the N protein (Arnheiter et al., 1985; Zhang et al., 2008) .", [["gRNA", "CELLULAR_COMPONENT", 11, 15], ["agRNA", "GENE_OR_GENE_PRODUCT", 61, 66], ["poly (A) tail", "GENE_OR_GENE_PRODUCT", 128, 141], ["gRNA", "RNA", 11, 15], ["antigenomic sense RNA (agRNA) template", "RNA", 38, 76], ["positivesense RNA", "RNA", 92, 109], ["poly (A) tail", "PROTEIN", 128, 141], ["N protein", "PROTEIN", 169, 178], ["the gRNA", "TREATMENT", 7, 15], ["gRNA", "OBSERVATION", 11, 15], ["antigenomic", "OBSERVATION_MODIFIER", 38, 49], ["sense RNA", "OBSERVATION", 50, 59], ["encapsidated", "OBSERVATION", 149, 161]]], ["Later, agRNA functions as a template for progeny negativesense gRNA (Albertini et al., 2008; Ivanov et al., 2011) .", [["agRNA", "GENE_OR_GENE_PRODUCT", 7, 12], ["agRNA", "PROTEIN", 7, 12]]], ["With the progeny gRNA assembled as RNP, the M protein converts the extended helical RNP into a condensed form (Kaptur et al., 1991) , resulting in the bullet-shape morphology of rhabdoviruses (Mebatsion et al., 1999) .", [["RNP", "ANATOMY", 84, 87], ["RNP", "CELLULAR_COMPONENT", 35, 38], ["RNP", "PROTEIN", 35, 38], ["M protein", "PROTEIN", 44, 53], ["helical RNP", "PROTEIN", 76, 87], ["the M protein", "TEST", 40, 53], ["progeny gRNA", "OBSERVATION", 9, 21], ["bullet", "OBSERVATION", 151, 157], ["shape", "OBSERVATION_MODIFIER", 158, 163], ["morphology", "OBSERVATION_MODIFIER", 164, 174], ["rhabdoviruses", "OBSERVATION_MODIFIER", 178, 191]]], ["Finally, the G protein tail is incorporated into the assembled M-RNP complex, aiding the budding of progeny virus particles (Whitt et al., 1989; Schnell et al., 1998) .Recovery of Rhabdoviruses From cDNAInitial attempts to generate rhabdoviruses from cDNA were based on mammalian rhabdoviruses.", [["G protein", "GENE_OR_GENE_PRODUCT", 13, 22], ["M-RNP", "GENE_OR_GENE_PRODUCT", 63, 68], ["rhabdoviruses", "GENE_OR_GENE_PRODUCT", 232, 245], ["G protein tail", "PROTEIN", 13, 27], ["M-RNP complex", "PROTEIN", 63, 76], ["Rhabdoviruses", "DNA", 180, 193], ["rhabdoviruses", "DNA", 232, 245], ["cDNA", "DNA", 251, 255], ["the G protein tail", "TEST", 9, 27], ["Rhabdoviruses", "PROBLEM", 180, 193], ["rhabdoviruses from cDNA", "TREATMENT", 232, 255], ["mammalian rhabdoviruses", "PROBLEM", 270, 293], ["tail", "OBSERVATION_MODIFIER", 23, 27], ["RNP complex", "OBSERVATION_MODIFIER", 65, 76], ["progeny virus", "OBSERVATION", 100, 113], ["Rhabdoviruses", "OBSERVATION", 180, 193], ["mammalian rhabdoviruses", "OBSERVATION", 270, 293]]], ["Research on VSV revealed that genomic RNA must be encapsidated with the viral N protein to be a functional template for RNA-dependent RNA polymerase (Emerson and Wagner, 1972) .", [["VSV", "ORGANISM", 12, 15], ["genomic RNA", "RNA", 30, 41], ["viral N protein", "PROTEIN", 72, 87], ["RNA-dependent RNA polymerase", "PROTEIN", 120, 148], ["VSV", "SPECIES", 12, 15], ["VSV", "TREATMENT", 12, 15], ["genomic RNA", "PROBLEM", 30, 41], ["the viral N protein", "TREATMENT", 68, 87], ["a functional template", "TREATMENT", 94, 115], ["genomic RNA", "OBSERVATION", 30, 41]]], ["This discovery was followed by a set of experiments that enabled the first rescue (reverse genetics system) of VSV defective interfering (DI) particles from cells co-transfected with the five canonical proteins Wertz, 1990, 1991) .", [["cells", "ANATOMY", 157, 162], ["VSV", "ORGANISM", 111, 114], ["cells", "CELL", 157, 162], ["VSV defective interfering (DI) particles", "CELL_LINE", 111, 151], ["VSV", "SPECIES", 111, 114], ["VSV defective interfering (DI) particles from cells", "PROBLEM", 111, 162], ["VSV defective", "OBSERVATION", 111, 124]]], ["Research on rabies virus (RABV) demonstrated the expression of a reporter gene cloned between the viral 3 and 5 termini in cells co-transfected with plasmids encoding for the three helper proteins N, P, and L .", [["cells", "ANATOMY", 123, 128], ["plasmids", "ANATOMY", 149, 157], ["rabies virus", "ORGANISM", 12, 24], ["RABV", "ORGANISM", 26, 30], ["cells", "CELL", 123, 128], ["reporter gene", "DNA", 65, 78], ["viral 3 and 5 termini", "DNA", 98, 119], ["plasmids", "DNA", 149, 157], ["helper proteins", "PROTEIN", 181, 196], ["N, P, and L", "PROTEIN", 197, 208], ["rabies virus", "SPECIES", 12, 24], ["rabies virus", "SPECIES", 12, 24], ["RABV", "SPECIES", 26, 30], ["rabies virus", "PROBLEM", 12, 24], ["the viral 3", "PROBLEM", 94, 105], ["plasmids", "TREATMENT", 149, 157], ["L", "ANATOMY_MODIFIER", 207, 208]]], ["This finding was followed by the recovery of infectious, enveloped rabies virus particles from cDNA .", [["rabies", "ORGANISM", 67, 73], ["cDNA", "DNA", 95, 99], ["rabies virus", "SPECIES", 67, 79], ["infectious", "PROBLEM", 45, 55], ["enveloped rabies virus particles", "PROBLEM", 57, 89], ["infectious", "OBSERVATION", 45, 55]]], ["Similarly, this strategy was subsequently used to rescue other vertebrate rhabdoviruses, such as VSV (Whelan et al., 1995) , Snakehead rhabdovirus (SHRV) (Johnson et al., 2000) , infectious haematopoietic necrosis virus (IIHNV) (Br\u00e9mont, 2005) , and haemorrhagic septicaemia virus (VHSV) (Kim et al., 2011) .Recovery of Rhabdoviruses From cDNASimilar attempts to reconstitute a plant rhabdovirus started at Jackson's laboratory, where N. benthamiana cellulose-digested protoplasts were found to be suitable for studying sonchus yellow net virus (SYNV) replication (Jones and Jackson, 1990) .", [["protoplasts", "ANATOMY", 469, 480], ["infectious haematopoietic necrosis", "DISEASE", 179, 213], ["haemorrhagic septicaemia", "DISEASE", 250, 274], ["VHSV", "DISEASE", 282, 286], ["rhabdoviruses", "GENE_OR_GENE_PRODUCT", 74, 87], ["VSV", "ORGANISM", 97, 100], ["Snakehead rhabdovirus", "ORGANISM", 125, 146], ["infectious haematopoietic necrosis virus", "ORGANISM", 179, 219], ["haemorrhagic septicaemia virus", "ORGANISM", 250, 280], ["VHSV", "ORGANISM", 282, 286], ["N. benthamiana", "ORGANISM", 435, 449], ["protoplasts", "CELL", 469, 480], ["sonchus yellow net virus", "ORGANISM", 520, 544], ["SYNV", "ORGANISM", 546, 550], ["haemorrhagic septicaemia virus", "SPECIES", 250, 280], ["VHSV", "SPECIES", 282, 286], ["N. benthamiana", "SPECIES", 435, 449], ["VSV", "SPECIES", 97, 100], ["Snakehead rhabdovirus", "SPECIES", 125, 146], ["SHRV", "SPECIES", 148, 152], ["infectious haematopoietic necrosis virus", "SPECIES", 179, 219], ["IIHNV", "SPECIES", 221, 226], ["haemorrhagic septicaemia virus", "SPECIES", 250, 280], ["VHSV", "SPECIES", 282, 286], ["N. benthamiana", "SPECIES", 435, 449], ["sonchus yellow net virus", "SPECIES", 520, 544], ["SYNV", "SPECIES", 546, 550], ["other vertebrate rhabdoviruses", "PROBLEM", 57, 87], ["Snakehead rhabdovirus", "PROBLEM", 125, 146], ["infectious haematopoietic necrosis virus", "PROBLEM", 179, 219], ["haemorrhagic septicaemia virus", "PROBLEM", 250, 280], ["Rhabdoviruses", "PROBLEM", 320, 333], ["a plant rhabdovirus", "PROBLEM", 376, 395], ["N. benthamiana cellulose", "TREATMENT", 435, 459], ["digested protoplasts", "PROBLEM", 460, 480], ["yellow net virus", "PROBLEM", 528, 544], ["rhabdoviruses", "OBSERVATION", 74, 87], ["infectious", "OBSERVATION_MODIFIER", 179, 189], ["haematopoietic necrosis", "OBSERVATION", 190, 213], ["haemorrhagic", "OBSERVATION_MODIFIER", 250, 262], ["septicaemia virus", "OBSERVATION", 263, 280], ["Rhabdoviruses", "OBSERVATION", 320, 333], ["rhabdovirus", "OBSERVATION", 384, 395]]], ["However, the real challenge was the co-delivery of all plasmids needed for the recovery of recombinant viruses into a single cell.", [["plasmids", "ANATOMY", 55, 63], ["cell", "ANATOMY", 125, 129], ["cell", "CELL", 125, 129], ["plasmids", "DNA", 55, 63], ["all plasmids", "TREATMENT", 51, 63], ["recombinant viruses", "PROBLEM", 91, 110]]], ["This difficulty was circumvented by using Agrobacterium infiltration to co-deliver vectors expressing SYNV helper proteins into N. benthamiana leaves (Goodin et al., 2002) .", [["leaves", "ANATOMY", 143, 149], ["SYNV helper proteins", "GENE_OR_GENE_PRODUCT", 102, 122], ["N. benthamiana", "ORGANISM", 128, 142], ["leaves", "ORGANISM", 143, 149], ["SYNV helper proteins", "PROTEIN", 102, 122], ["N. benthamiana", "SPECIES", 128, 142], ["N. benthamiana", "SPECIES", 128, 142], ["Agrobacterium infiltration to co-deliver vectors", "TREATMENT", 42, 90]]], ["In 2013, the same group demonstrated the success of the first plant rhabdovirus SYNV minireplicon (MR) strategy (Ganesan et al., 2013) .", [["MR", "PROTEIN", 99, 101], ["the first plant rhabdovirus SYNV minireplicon", "TREATMENT", 52, 97]]], ["Plasmids harboring a positive-sense MR cassette containing two sequentially cloned reporter genes between the SYNV 3 and 5 termini together with SYNV helper proteins were co-infiltrated into N. benthamiana.", [["SYNV 3", "GENE_OR_GENE_PRODUCT", 110, 116], ["SYNV", "GENE_OR_GENE_PRODUCT", 145, 149], ["N. benthamiana", "ORGANISM", 191, 205], ["positive-sense MR cassette", "DNA", 21, 47], ["reporter genes", "DNA", 83, 97], ["SYNV 3 and 5 termini", "DNA", 110, 130], ["SYNV helper proteins", "PROTEIN", 145, 165], ["N. benthamiana", "SPECIES", 191, 205], ["N. benthamiana", "SPECIES", 191, 205], ["MR cassette", "TREATMENT", 36, 47], ["SYNV helper proteins", "TREATMENT", 145, 165], ["benthamiana", "ANATOMY", 194, 205]]], ["The fluorescence signal was detected in 5-6 days post-infiltration and was restricted to single cells only.", [["cells", "ANATOMY", 96, 101], ["cells", "CELL", 96, 101], ["The fluorescence signal", "TEST", 0, 23]]], ["This promising success culminated in 2015 when infectious SYNV was recovered from the upper leaves of N. benthamiana plants agroinfiltrated with four plasmids harboring positivesense SYNV cDNA together with helper protein plasmids (Wang et al., 2015) .Animal Rhabdoviruses as a Potential Model for Plant Rhabdoviruses in Plant Molecular PharmingAs mentioned earlier, mammalian rhabdoviruses, and in particular vesicular stomatitis virus (VSV), remains the prototype for reverse engineering and molecular adaptation of rhabdoviruses.", [["plasmids", "ANATOMY", 150, 158], ["vesicular stomatitis", "DISEASE", 410, 430], ["SYNV", "ORGANISM", 58, 62], ["upper leaves", "ORGANISM_SUBDIVISION", 86, 98], ["N. benthamiana", "ORGANISM", 102, 116], ["SYNV", "GENE_OR_GENE_PRODUCT", 183, 187], ["mammalian rhabdoviruses", "ORGANISM", 367, 390], ["vesicular stomatitis virus", "ORGANISM", 410, 436], ["VSV", "ORGANISM", 438, 441], ["rhabdoviruses", "GENE_OR_GENE_PRODUCT", 518, 531], ["plasmids", "DNA", 150, 158], ["positivesense SYNV cDNA", "DNA", 169, 192], ["helper protein plasmids", "DNA", 207, 230], ["N. benthamiana", "SPECIES", 102, 116], ["vesicular stomatitis virus", "SPECIES", 410, 436], ["SYNV", "SPECIES", 58, 62], ["N. benthamiana", "SPECIES", 102, 116], ["SYNV", "SPECIES", 183, 187], ["stomatitis virus", "SPECIES", 420, 436], ["VSV", "SPECIES", 438, 441], ["N. benthamiana plants", "TREATMENT", 102, 123], ["helper protein plasmids", "TREATMENT", 207, 230], ["Animal Rhabdoviruses", "PROBLEM", 252, 272], ["Plant Rhabdoviruses", "PROBLEM", 298, 317], ["mammalian rhabdoviruses", "PROBLEM", 367, 390], ["particular vesicular stomatitis virus", "PROBLEM", 399, 436], ["reverse engineering", "TREATMENT", 470, 489], ["rhabdoviruses", "PROBLEM", 518, 531], ["upper", "ANATOMY_MODIFIER", 86, 91], ["benthamiana plants", "OBSERVATION", 105, 123], ["Rhabdoviruses", "OBSERVATION", 259, 272], ["Rhabdoviruses", "OBSERVATION", 304, 317], ["mammalian rhabdoviruses", "OBSERVATION", 367, 390], ["vesicular stomatitis", "ANATOMY", 410, 430]]], ["Like all other rhabdoviruses it has the canonical N, P, M, G, and L genes in a negative sense single stranded RNA genome ( Figure 6A) .", [["rhabdoviruses", "GENE_OR_GENE_PRODUCT", 15, 28], ["G", "GENE_OR_GENE_PRODUCT", 59, 60], ["rhabdoviruses", "DNA", 15, 28], ["canonical N, P, M, G, and L genes", "DNA", 40, 73], ["negative sense single stranded RNA genome", "DNA", 79, 120], ["all other rhabdoviruses", "PROBLEM", 5, 28], ["rhabdoviruses", "OBSERVATION", 15, 28], ["RNA genome", "OBSERVATION", 110, 120]]], ["VSV was successfully rescued from cDNA in 1995 (Whelan et al., 1995) and in 1996 it was first engineered to express a reporter gene placed between those of the viral glycoprotein and the polymerase (Schnell et al., 1996b) .", [["VSV", "ORGANISM", 0, 3], ["cDNA", "DNA", 34, 38], ["reporter gene", "DNA", 118, 131], ["viral glycoprotein", "PROTEIN", 160, 178], ["polymerase", "PROTEIN", 187, 197], ["VSV", "SPECIES", 0, 3], ["the viral glycoprotein", "TREATMENT", 156, 178]]], ["Later in the same year, recombinant VSV (rVSV) was successfully produced incorporating a foreign protein, in addition to the VSV inherent glycoprotein, in viral envelope (Schnell et al., 1996a) .", [["recombinant VSV", "ORGANISM", 24, 39], ["rVSV", "ORGANISM", 41, 45], ["VSV", "ORGANISM", 125, 128], ["rVSV", "PROTEIN", 41, 45], ["foreign protein", "PROTEIN", 89, 104], ["VSV inherent glycoprotein", "PROTEIN", 125, 150], ["VSV", "SPECIES", 36, 39], ["rVSV", "SPECIES", 41, 45], ["VSV", "SPECIES", 125, 128], ["a foreign protein", "PROBLEM", 87, 104], ["the VSV inherent glycoprotein", "PROBLEM", 121, 150], ["foreign protein", "OBSERVATION", 89, 104]]], ["In these recombinant VSV particles, two designs were considered.", [["VSV", "ORGANISM", 21, 24], ["VSV", "SPECIES", 21, 24], ["recombinant", "OBSERVATION_MODIFIER", 9, 20], ["VSV particles", "OBSERVATION", 21, 34]]], ["The first was with the full foreign protein incorporated into the VSV envelope ( Figure 6B ) while the second was the exoplasmic domain of the foreign protein fused upstream of the transmembrane domain and the cytoplasmic tail of the VSV glycoprotein ( Figure 6C) .", [["transmembrane", "ANATOMY", 181, 194], ["cytoplasmic tail", "ANATOMY", 210, 226], ["VSV", "ORGANISM", 66, 69], ["transmembrane", "CELLULAR_COMPONENT", 181, 194], ["cytoplasmic", "ORGANISM_SUBSTANCE", 210, 221], ["VSV glycoprotein", "GENE_OR_GENE_PRODUCT", 234, 250], ["foreign protein", "PROTEIN", 28, 43], ["exoplasmic domain", "PROTEIN", 118, 135], ["foreign protein", "PROTEIN", 143, 158], ["transmembrane domain", "PROTEIN", 181, 201], ["cytoplasmic tail", "PROTEIN", 210, 226], ["VSV glycoprotein", "PROTEIN", 234, 250], ["Figure 6C", "PROTEIN", 253, 262], ["the full foreign protein", "TREATMENT", 19, 43], ["the transmembrane domain", "TEST", 177, 201], ["foreign protein fused", "OBSERVATION", 143, 164], ["cytoplasmic tail", "OBSERVATION", 210, 226]]], ["Furthermore, in 1997, recombinant VSV lacking its inherent glycoprotein and expressing CD4 receptor to infect and kill HIV-1 infected T-cells was successfully rescued (Schnell et al., 1997) (Figure 6D) .", [["T-cells", "ANATOMY", 134, 141], ["VSV", "ORGANISM", 34, 37], ["CD4 receptor", "GENE_OR_GENE_PRODUCT", 87, 99], ["HIV-1", "ORGANISM", 119, 124], ["T-cells", "CELL", 134, 141], ["glycoprotein", "PROTEIN", 59, 71], ["CD4 receptor", "PROTEIN", 87, 99], ["HIV-1 infected T-cells", "CELL_TYPE", 119, 141], ["HIV-1", "SPECIES", 119, 124], ["VSV", "SPECIES", 34, 37], ["HIV-1", "SPECIES", 119, 124], ["kill HIV", "TEST", 114, 122]]], ["The ability to rescue VSV without its inherent G protein (VSV G) gave the opportunity to generate safer nonpropagating VSV based vaccines (Roberts et al., 1999) .", [["VSV", "ORGANISM", 22, 25], ["G protein", "GENE_OR_GENE_PRODUCT", 47, 56], ["VSV", "ORGANISM", 119, 122], ["G protein", "PROTEIN", 47, 56], ["VSV G", "PROTEIN", 58, 63], ["VSV", "SPECIES", 22, 25], ["VSV", "SPECIES", 119, 122], ["rescue VSV", "TREATMENT", 15, 25], ["safer nonpropagating VSV based vaccines", "TREATMENT", 98, 137]]], ["Moreover, further attenuation strategies based on malleability of the rhabdovirus genome, strategies such as decreasing the expression level of viral genes by manipulating their position down the expression gradient (Flanagan et al., 2003) or by G gene truncations and N gene translocations (Clarke et al., 2007) were also considered.", [["G gene", "GENE_OR_GENE_PRODUCT", 246, 252], ["rhabdovirus genome", "DNA", 70, 88], ["viral genes", "DNA", 144, 155], ["G gene truncations", "DNA", 246, 264], ["N gene translocations", "DNA", 269, 290], ["further attenuation strategies", "TREATMENT", 10, 40], ["the rhabdovirus genome", "TREATMENT", 66, 88], ["viral genes", "PROBLEM", 144, 155], ["G gene truncations and N gene translocations", "PROBLEM", 246, 290], ["rhabdovirus genome", "OBSERVATION", 70, 88], ["viral genes", "OBSERVATION", 144, 155]]], ["For instance, inserting the foreign gene upstream of the VSV N gene (Figure 6E) , or inserting the foreign gene upstream the N gene while relocating the N gene downstream the M gene and truncating VSV G protein ( Figure 6F ) were also adapted to rescue a recombinant VSV based HIV-1 vaccine (Cooper et al., 2008) .Animal Rhabdoviruses as a Potential Model for Plant Rhabdoviruses in Plant Molecular PharmingThe inherent genomic characteristics of rhabdoviruses, such as having well-defined transcription start/stop signals (Stillman and Whitt, 1997) , and the ability to accommodate large inserts while retaining high level expression rates (Haglund et al., 2000) , together with negligible seropositivity in the human population (Roberts et al., 1999) made VSV a lucrative candidate for vaccine development and as vector for a number of biomedical applications such as recombinant viral vaccines (Safronetz et al., 2015; Lauretti et al., 2016) , gene delivery vectors (Beier et al., 2013) , or oncolytic vectors (Bridle et al., 2009 ) as exemplified in Table 5 .", [["VSV N", "GENE_OR_GENE_PRODUCT", 57, 62], ["Figure 6E", "GENE_OR_GENE_PRODUCT", 69, 78], ["VSV G protein ( Figure 6F", "GENE_OR_GENE_PRODUCT", 197, 222], ["VSV", "ORGANISM", 267, 270], ["HIV-1", "ORGANISM", 277, 282], ["human", "ORGANISM", 713, 718], ["VSV", "ORGANISM", 758, 761], ["foreign gene upstream", "DNA", 28, 49], ["VSV N gene", "DNA", 57, 67], ["Figure 6E", "DNA", 69, 78], ["foreign gene", "DNA", 99, 111], ["N gene", "DNA", 125, 131], ["N gene downstream", "DNA", 153, 170], ["M gene", "DNA", 175, 181], ["VSV G protein", "PROTEIN", 197, 210], ["Figure 6F", "PROTEIN", 213, 222], ["HIV-1", "SPECIES", 277, 282], ["human", "SPECIES", 713, 718], ["VSV", "SPECIES", 267, 270], ["HIV-1", "SPECIES", 277, 282], ["human", "SPECIES", 713, 718], ["VSV", "SPECIES", 758, 761], ["the N gene downstream the M gene and truncating VSV G protein ( Figure 6F", "TREATMENT", 149, 222], ["a recombinant VSV", "TREATMENT", 253, 270], ["Animal Rhabdoviruses", "PROBLEM", 314, 334], ["Plant Rhabdoviruses", "TREATMENT", 360, 379], ["rhabdoviruses", "PROBLEM", 447, 460], ["large inserts", "PROBLEM", 583, 596], ["vaccine development", "TREATMENT", 788, 807], ["biomedical applications", "TREATMENT", 838, 861], ["recombinant viral vaccines", "TREATMENT", 870, 896], ["Rhabdoviruses", "OBSERVATION", 321, 334], ["Rhabdoviruses", "OBSERVATION", 366, 379], ["rhabdoviruses", "OBSERVATION", 447, 460]]], ["Currently, there are a number of on-going clinical trials based on VSV 1 , such as Phase I/II clinical trials for VSV based Ebola virus vaccines (rVSV-ZEBOV) (Huttner et al., 2018) .Animal Rhabdoviruses as a Potential Model for Plant Rhabdoviruses in Plant Molecular PharmingNowadays VSV is commonly considered a very successful and widely used platform for heterologous expression of more complex and interesting pharmaceuticals and biomolecules, and for the generation of (pseudo) typed eVLPs for vaccine purposes.", [["Ebola virus", "DISEASE", 124, 135], ["VSV", "ORGANISM", 67, 70], ["VSV based", "ORGANISM", 114, 123], ["Ebola virus vaccines", "ORGANISM", 124, 144], ["rVSV-ZEBOV", "ORGANISM", 146, 156], ["VSV", "ORGANISM", 284, 287], ["eVLPs", "GENE_OR_GENE_PRODUCT", 489, 494], ["Ebola virus", "SPECIES", 124, 135], ["VSV", "SPECIES", 67, 70], ["VSV", "SPECIES", 114, 117], ["Ebola virus", "SPECIES", 124, 135], ["rVSV", "SPECIES", 146, 150], ["ZEBOV", "SPECIES", 151, 156], ["VSV", "SPECIES", 284, 287], ["VSV", "TEST", 67, 70], ["VSV based Ebola virus vaccines", "TREATMENT", 114, 144], ["Animal Rhabdoviruses", "PROBLEM", 182, 202], ["Plant Rhabdoviruses", "TREATMENT", 228, 247], ["heterologous expression", "TREATMENT", 358, 381], ["vaccine purposes", "TREATMENT", 499, 515], ["Rhabdoviruses", "OBSERVATION", 189, 202], ["Rhabdoviruses", "OBSERVATION", 234, 247]]], ["It is expected that the availability and exploitation of enveloped plant viruses as biological particles, in analogy to VSV, will give a boost to the exploitation of plant-based production platforms for more complex (glyco)proteins.CONCLUDING REMARKSPlant molecular pharming has materialized as a reliable and cost-effective platform for the production of pharmaceuticals, vaccines, and biobetter products with a number of plantproduced proteins starting to be commercialized (Ratner, 2010; Yusibov et al., 2011) .", [["VSV", "ORGANISM", 120, 123], ["complex (glyco)proteins", "PROTEIN", 208, 231], ["plantproduced proteins", "PROTEIN", 423, 445], ["VSV", "SPECIES", 120, 123], ["enveloped plant viruses", "PROBLEM", 57, 80], ["a boost", "TREATMENT", 135, 142], ["the production of pharmaceuticals", "TREATMENT", 338, 371], ["vaccines", "TREATMENT", 373, 381], ["biobetter products", "TREATMENT", 387, 405], ["plantproduced proteins", "TREATMENT", 423, 445]]], ["Simultaneously, the development of viral vectors, together with agroinfection, culminated in rapid transient expression systems that successfully express high levels 1 https://clinicaltrials.gov of large and complex pharmaceutical proteins and antimicrobial peptides (Fischer and Emans, 2000; Chen et al., 2013; Peyret and Lomonossoff, 2013; Loh et al., 2017; Leite et al., 2019) and enabled the production of plant-virus based VLPs against chronic and infectious diseases (Hefferon, 2018; Sahithi et al., 2019) .", [["chronic and infectious diseases", "DISEASE", 441, 472], ["plant-virus", "ORGANISM", 410, 421], ["VLPs", "ORGANISM", 428, 432], ["viral vectors", "PROBLEM", 35, 48], ["agroinfection", "PROBLEM", 64, 77], ["rapid transient expression systems", "PROBLEM", 93, 127], ["large and complex pharmaceutical proteins", "TREATMENT", 198, 239], ["plant-virus", "TREATMENT", 410, 421], ["chronic and infectious diseases", "PROBLEM", 441, 472], ["viral vectors", "OBSERVATION", 35, 48], ["large", "OBSERVATION_MODIFIER", 198, 203], ["infectious", "OBSERVATION", 453, 463]]], ["However, as with their comparative systems counterparts, plantvirus based VLP(s) are inherently constrained in their ability to present complex antigens and glycoproteins.", [["plantvirus based VLP", "ORGANISM", 57, 77], ["complex antigens", "PROTEIN", 136, 152], ["glycoproteins", "PROTEIN", 157, 170]]], ["Moreover, in the case of rapidly evolving viruses, such as influenza, selective pressure will drive viral evasion of immune response induced by VLP vaccines based on few amino acids or antigens that cannot reproduce native conformational epitopes.", [["influenza", "DISEASE", 59, 68], ["amino acids", "CHEMICAL", 170, 181], ["amino acids", "CHEMICAL", 170, 181], ["amino acids", "AMINO_ACID", 170, 181], ["antigens", "PROTEIN", 185, 193], ["native conformational epitopes", "PROTEIN", 216, 246], ["rapidly evolving viruses", "PROBLEM", 25, 49], ["influenza", "PROBLEM", 59, 68], ["selective pressure", "TREATMENT", 70, 88], ["viral evasion", "TREATMENT", 100, 113], ["immune response", "PROBLEM", 117, 132], ["VLP vaccines", "TREATMENT", 144, 156], ["few amino acids", "TREATMENT", 166, 181], ["native conformational epitopes", "PROBLEM", 216, 246], ["rapidly", "OBSERVATION_MODIFIER", 25, 32], ["evolving", "OBSERVATION_MODIFIER", 33, 41], ["viruses", "OBSERVATION", 42, 49]]], ["Furthermore, attempts to produce plant-made eVLP, such as influenza HA VLP, has been so far proven successful only because of the inherent characteristics of the influenza virus HA and its ease of detachment as eVLP from plants cell surface (D'Aoust et al., 2010); a basis for success not necessary applicable in other cases.", [["cell surface", "ANATOMY", 228, 240], ["eVLP", "CHEMICAL", 44, 48], ["influenza", "DISEASE", 162, 171], ["eVLP", "SIMPLE_CHEMICAL", 44, 48], ["influenza HA VLP", "ORGANISM", 58, 74], ["influenza virus HA", "ORGANISM", 162, 180], ["eVLP", "SIMPLE_CHEMICAL", 211, 215], ["cell surface", "CELL", 228, 240], ["eVLP", "PROTEIN", 211, 215], ["influenza virus", "SPECIES", 162, 177], ["eVLP", "TREATMENT", 44, 48], ["influenza HA VLP", "TREATMENT", 58, 74], ["the influenza virus HA", "PROBLEM", 158, 180], ["detachment", "PROBLEM", 197, 207], ["influenza", "OBSERVATION", 162, 171], ["detachment", "OBSERVATION", 197, 207]]], ["Therefore, developments in reverse engineering inherently enveloped plant-viruses such as rhabdoviruses is expected to give plant molecular pharming a platform for a wide range of biotechnological applications, most relevant of which is expressing enveloped VLPs exposing chimeric and complex antigens.CONCLUDING REMARKSConsidering VSV as prototype, the inherent rhabdovirus characteristics of being enveloped, with defined genomic transcription units (Schnell et al., 1996b) , genome stability (Walker et al., 2015) , and an ability to stably incorporate recombinant glycoprotein into their envelope (Schnell et al., 1996a ) make them ideal for various biotechnological applications.", [["REMARKSConsidering VSV", "ORGANISM", 313, 335], ["enveloped VLPs", "PROTEIN", 248, 262], ["chimeric and complex antigens", "PROTEIN", 272, 301], ["recombinant glycoprotein", "PROTEIN", 556, 580], ["VSV", "SPECIES", 332, 335], ["rhabdoviruses", "PROBLEM", 90, 103], ["biotechnological applications", "TREATMENT", 180, 209], ["chimeric and complex antigens", "PROBLEM", 272, 301], ["various biotechnological applications", "TREATMENT", 646, 683], ["rhabdovirus", "OBSERVATION", 363, 374], ["stability", "OBSERVATION_MODIFIER", 485, 494]]], ["Plant rhabdoviruses, share such inherent characteristics, together with dispensability of the G protein for systemic plant-infection as demonstrated with SNYV (Wang et al., 2015) .", [["plant-infection", "DISEASE", 117, 132], ["G protein", "GENE_OR_GENE_PRODUCT", 94, 103], ["G protein", "PROTEIN", 94, 103], ["Plant rhabdoviruses", "PROBLEM", 0, 19], ["the G protein", "TREATMENT", 90, 103], ["systemic plant-infection", "PROBLEM", 108, 132], ["rhabdoviruses", "OBSERVATION", 6, 19], ["infection", "OBSERVATION", 123, 132]]], ["The G protein is required for virus entry and subsequent propagation within the arthropods vector (Hogenhout et al., 2003) , while only the carboxyl-terminal domain of the G protein, together with M protein are required for the morphogenesis and the budding of the enveloped particles (Sun et al., 2018) .", [["carboxyl", "CHEMICAL", 140, 148], ["G protein", "GENE_OR_GENE_PRODUCT", 4, 13], ["G protein", "GENE_OR_GENE_PRODUCT", 172, 181], ["M protein", "GENE_OR_GENE_PRODUCT", 197, 206], ["G protein", "PROTEIN", 4, 13], ["carboxyl-terminal domain", "PROTEIN", 140, 164], ["G protein", "PROTEIN", 172, 181], ["M protein", "PROTEIN", 197, 206], ["The G protein", "TREATMENT", 0, 13], ["virus entry", "PROBLEM", 30, 41], ["the G protein", "TREATMENT", 168, 181], ["M protein", "TREATMENT", 197, 206], ["the morphogenesis", "TREATMENT", 224, 241]]], ["Hence these additional characteristics will enable large scale production of recombinant rhabdovirus based eVLP in which the (exposed) ectodomain of the G has been exchanged for another gene-of-interest (GOI) glycoprotein.", [["eVLP", "GENE_OR_GENE_PRODUCT", 107, 111], ["G", "GENE_OR_GENE_PRODUCT", 153, 154], ["recombinant rhabdovirus based eVLP", "PROTEIN", 77, 111], ["ectodomain", "PROTEIN", 135, 145], ["gene-of-interest (GOI) glycoprotein", "PROTEIN", 186, 221], ["large scale production", "TREATMENT", 51, 73], ["recombinant rhabdovirus based eVLP", "TREATMENT", 77, 111], ["the (exposed) ectodomain of the G", "TREATMENT", 121, 154]]], ["Such chimeric viruses are contained within the plant and require less stringent containment controls.", [["Such chimeric viruses", "PROBLEM", 0, 21], ["less stringent containment controls", "TREATMENT", 65, 100], ["viruses", "OBSERVATION", 14, 21], ["less", "OBSERVATION_MODIFIER", 65, 69], ["stringent", "OBSERVATION_MODIFIER", 70, 79], ["containment", "OBSERVATION_MODIFIER", 80, 91]]], ["Similarly to VSV-recombinant design, plant rhabdovirus vector constructs can also be constructed containing a GOI at different gene positions for various expression purposes (Figure 6 ).", [["VSV", "ORGANISM", 13, 16], ["plant rhabdovirus vector constructs", "DNA", 37, 72], ["GOI", "DNA", 110, 113], ["VSV", "SPECIES", 13, 16], ["plant rhabdovirus vector constructs", "TREATMENT", 37, 72], ["VSV", "OBSERVATION", 13, 16], ["rhabdovirus vector", "OBSERVATION", 43, 61]]], ["All these advantages together with the establishment of plant molecular pharming as cost effective and reliable production platform, make plant rhabdoviruses promising candidates in biotechnology in general and in the field of plant-made recombinant viral vaccines in specific.AUTHOR CONTRIBUTIONSAI wrote the first draft of the manuscript.", [["plant rhabdoviruses", "PROBLEM", 138, 157], ["recombinant viral vaccines", "TREATMENT", 238, 264]]], ["AI, VO, and RK contributed to manuscript revision, and also read and approved the submitted version.", [["AI", "PROBLEM", 0, 2], ["manuscript revision", "TREATMENT", 30, 49], ["revision", "OBSERVATION", 41, 49]]]], "daf32e013d325a6feb80e83d15aabc64a48fae33": [["IntroductionThe term metapopulation was coined by Levins [1] in 1969 to describe a population dynamics model of insect pests in farmlands, yet the perspective has been broadly applied to study the effect of spatially distributed factors on evolutionary dynamics [2] , including genetic drift, pattern formation, extinction and recolonization, etc. The development of metapopulation theory, in conjunction with the fast development of complex networks theory, lead to the innovative application of the networked metapopulation in modeling largescale spatial transmission of emerging diseases.", [["insect pests", "DISEASE", 112, 124], ["spatially distributed factors", "PROBLEM", 207, 236], ["genetic drift", "PROBLEM", 278, 291], ["pattern formation", "PROBLEM", 293, 310], ["extinction", "PROBLEM", 312, 322], ["recolonization", "PROBLEM", 327, 341], ["the networked metapopulation", "TREATMENT", 497, 525], ["emerging diseases", "PROBLEM", 573, 590], ["extinction", "OBSERVATION_MODIFIER", 312, 322], ["metapopulation theory", "OBSERVATION", 367, 388]]], ["New insights are contributed to understanding the spatial dynamics of epidemic spreading, which provides valuable support to public healthcare.IntroductionThis review presents a survey of recent advances in the emergent discipline of networked metapopulation epidemiology, which is organized as follows.", [["epidemic spreading", "PROBLEM", 70, 88]]], ["Section 3 specifies the validity of networked metapopulation.", [["metapopulation", "OBSERVATION", 46, 60]]], ["The application in evaluating the performance of intervention strategies is presented in Section 5, and some outlooks are provided at last. models have been proposed [3, 4] .", [["intervention strategies", "TREATMENT", 49, 72]]], ["The compartment model is one of the simplest yet basic epidemic models, which was first introduced by Bernoulli [5] in the 18th century.IntroductionAssuming that a population of individuals is mixed homogeneously, this model organizes the persons into different compartments (states), according to their health status, e.g., susceptible (denoted by S, those healthy ones who may acquire the infection), infectious (I, those infected ones who are contagious), and recovered (R, those who are recovered from the disease).", [["infection", "DISEASE", 391, 400], ["persons", "ORGANISM", 239, 246], ["persons", "SPECIES", 239, 246], ["IntroductionAssuming", "TREATMENT", 136, 156], ["the infection", "PROBLEM", 387, 400], ["the disease)", "PROBLEM", 506, 518], ["compartment model", "OBSERVATION", 4, 21], ["one", "OBSERVATION_MODIFIER", 25, 28], ["epidemic", "OBSERVATION_MODIFIER", 55, 63], ["mixed", "OBSERVATION_MODIFIER", 193, 198], ["homogeneously", "OBSERVATION_MODIFIER", 199, 212], ["infection", "OBSERVATION", 391, 400], ["infectious", "OBSERVATION", 403, 413], ["disease", "OBSERVATION", 510, 517]]], ["The transitions between different compartments depend on the specific transition rates.", [["The transitions between different compartments", "PROBLEM", 0, 46]]], ["For example, the transmission rate \u03b2 represents the infection probability for a susceptible individual that encounters an infectious person, and the recovery rate \u00b5 represents the probability with which an infectious individual is recovered.", [["infection", "DISEASE", 52, 61], ["person", "SPECIES", 133, 139], ["the transmission rate", "TEST", 13, 34], ["the infection probability", "PROBLEM", 48, 73], ["the recovery rate", "TEST", 145, 162], ["infection", "OBSERVATION", 52, 61], ["infectious", "OBSERVATION_MODIFIER", 122, 132], ["infectious", "OBSERVATION", 206, 216]]], ["If the disease could not endow recovered persons with a long lasting immunity but infect them again, e.g., seasonal flu, asthma, gonorrhoea, the related epidemic reactions are well described by the so called SIS model; otherwise, if recovered people become immune permanently to the disease, e.g., pandemic influenza, pertussis, smallpox, the epidemic dynamics can be characterized by the SIR model properly.", [["seasonal flu", "DISEASE", 107, 119], ["asthma", "DISEASE", 121, 127], ["gonorrhoea", "DISEASE", 129, 139], ["influenza", "DISEASE", 307, 316], ["pertussis", "DISEASE", 318, 327], ["smallpox", "DISEASE", 329, 337], ["people", "ORGANISM", 243, 249], ["persons", "SPECIES", 41, 48], ["people", "SPECIES", 243, 249], ["the disease", "PROBLEM", 3, 14], ["seasonal flu", "PROBLEM", 107, 119], ["asthma", "PROBLEM", 121, 127], ["gonorrhoea", "PROBLEM", 129, 139], ["the related epidemic reactions", "PROBLEM", 141, 171], ["the disease", "PROBLEM", 279, 290], ["pandemic influenza", "PROBLEM", 298, 316], ["pertussis", "PROBLEM", 318, 327], ["smallpox", "PROBLEM", 329, 337], ["disease", "OBSERVATION", 7, 14], ["asthma", "OBSERVATION", 121, 127], ["gonorrhoea", "OBSERVATION", 129, 139]]], ["Figures 1(a) -(b) illustrate the relevant compartment transitions in the SIS and SIR models, respectively.", [["Figures", "TEST", 0, 7], ["compartment transitions", "OBSERVATION", 42, 65]]], ["The dynamical evolution of these models can be simply delineated by ordinary differential equations [3] .IntroductionOne key parameter characterizing the severity of a disease is the basic reproductive number, R 0 , which identifies the expected number of infected individuals generated by introducing an infectious carrier into an entire susceptible population.", [["a disease", "PROBLEM", 166, 175], ["an infectious carrier", "PROBLEM", 302, 323], ["disease", "OBSERVATION", 168, 175], ["number", "OBSERVATION_MODIFIER", 246, 252], ["infected", "OBSERVATION", 256, 264], ["infectious", "OBSERVATION", 305, 315], ["entire", "OBSERVATION_MODIFIER", 332, 338], ["susceptible", "OBSERVATION_MODIFIER", 339, 350], ["population", "OBSERVATION", 351, 361]]], ["This parameter signifies the epidemic threshold applied for predicting whether or not an infectious disease will prevail.", [["an infectious disease", "PROBLEM", 86, 107], ["infectious", "OBSERVATION", 89, 99]]], ["If R 0 < 1, the disease dies out quickly, which implies that the population remains at the disease-free state.Network epidemiology.Due to the ubiquity of complex systems in modern society, the study of complex networks becomes prosperous [6] [7] [8] [9] .", [["[6] [7] [8] [9]", "SIMPLE_CHEMICAL", 238, 253], ["the disease dies", "PROBLEM", 12, 28], ["the study", "TEST", 189, 198], ["disease", "OBSERVATION", 16, 23]]], ["The Internet and human friendship networks are just a few examples that can be regarded as systems comprised of a large number of connected dynamical units.", [["human", "ORGANISM", 17, 22], ["friendship networks", "MULTI-TISSUE_STRUCTURE", 23, 42], ["human", "SPECIES", 17, 22], ["human", "SPECIES", 17, 22], ["large", "OBSERVATION_MODIFIER", 114, 119]]], ["The most intuitive approach of modeling such complex systems is to treat them as networks, where nodes represent component units and edges represent connectivity.", [["nodes", "ANATOMY", 97, 102], ["nodes", "OBSERVATION", 97, 102], ["component", "OBSERVATION_MODIFIER", 113, 122]]], ["Importantly, empirical findings have unraveled the presence of universal features in most socio-technical networks, e.g., small-world [10] , scale-free (SF) [11] , which inspires extensive studies towards a better understanding about the impact of population infrastructures (network connectivity) on dynamical processes [12] [13] [14] [15] , including robustness [16, 17] , synchronization [18] [19] [20] , consensus [21] [22] [23] [24] , control [25] [26] [27] [28] , evolutionary game [29] [30] [31] [32] [33] [34] [35] [36] , traffic routing [37] [38] [39] , selforganized criticality [40] [41] [42] [43] , etc.Network epidemiology.Assuming that interactive individuals are mixed homogeneously, the aforementioned epidemic compartment model neglects the significance of population connectivity.", [["[12] [13] [14] [15]", "SIMPLE_CHEMICAL", 321, 340], ["[18] [19] [20]", "SIMPLE_CHEMICAL", 391, 405], ["[21] [22] [23] [24]", "SIMPLE_CHEMICAL", 418, 437], ["[25] [26] [27] [28]", "SIMPLE_CHEMICAL", 448, 467], ["[29] [30] [31] [32] [33] [34] [35] [36]", "SIMPLE_CHEMICAL", 488, 527], ["[37] [38] [39]", "SIMPLE_CHEMICAL", 546, 560], ["selforganized criticality [40] [41] [42] [43]", "SIMPLE_CHEMICAL", 563, 608], ["universal features", "PROBLEM", 63, 81], ["dynamical processes", "TEST", 301, 320], ["robustness", "TEST", 353, 363], ["evolutionary game", "TEST", 470, 487], ["selforganized criticality", "TEST", 563, 588], ["small", "OBSERVATION_MODIFIER", 122, 127]]], ["Similar matters have been observed in diverse systems, ranging from the web of human sexual relations to vaccination campaigns [4] .", [["human", "ORGANISM", 79, 84], ["human", "SPECIES", 79, 84], ["human", "SPECIES", 79, 84]]], ["One key factor inducing such problems is the scale-free property of the networked systems, which causes a serious trouble that the threshold of disease outbreak vanishes [45] .", [["such problems", "PROBLEM", 24, 37], ["disease outbreak vanishes", "PROBLEM", 144, 169]]], ["Within complex networks, the basic reproductive number is R sf 0 = R 0 [1 + (CV ) 2 ], with CV identifying the coefficient of variation of the degree distribution (degree represents the number of edges k per node) [46] .", [["degree", "OBSERVATION_MODIFIER", 143, 149], ["distribution", "OBSERVATION_MODIFIER", 150, 162], ["node", "OBSERVATION", 208, 212]]], ["For large networks taking on a scalefree heterogeneous topology, R 0 is always larger than 1 no matter how small the transmission rate may be, due to the infinite variance of the degree distribution.Network epidemiology.This meaningful finding has motivated the research of network epidemiology, which concerns particularly the spreading of epidemics in human social networks [4, 14, 47] .", [["human", "ORGANISM", 354, 359], ["human", "SPECIES", 354, 359], ["human", "SPECIES", 354, 359], ["large", "OBSERVATION_MODIFIER", 4, 9], ["networks", "OBSERVATION", 10, 18], ["larger", "OBSERVATION_MODIFIER", 79, 85], ["small", "OBSERVATION_MODIFIER", 107, 112], ["degree", "OBSERVATION_MODIFIER", 179, 185], ["distribution", "OBSERVATION_MODIFIER", 186, 198]]], ["Many subsequent works investigated extensively the epidemic threshold on networks with special topological features, such as degree correlations [48] , small world [49] , community [50] , edge length [51] , and K-core [52] .", [["edge length", "TEST", 188, 199], ["K-core", "TEST", 211, 217]]], ["[53, 54] demonstrated that the vanishing epidemic threshold of the SIS model derives from the active behavior of the largest hub, which acts as a self-sustained source of the infection.", [["infection", "DISEASE", 175, 184], ["the infection", "PROBLEM", 171, 184], ["active", "OBSERVATION_MODIFIER", 94, 100], ["largest", "OBSERVATION_MODIFIER", 117, 124], ["infection", "OBSERVATION", 175, 184]]], ["Such disastrous effect of highly connected hubs can also be observed in reality, such as the presence of core groups in the propagation of sexually transmitted diseases, and the appearance of the patient zero that induces the dissemination of human immunodeficiency virus (HIV).", [["sexually transmitted diseases", "DISEASE", 139, 168], ["human immunodeficiency virus (HIV)", "DISEASE", 243, 277], ["patient", "ORGANISM", 196, 203], ["human immunodeficiency virus", "ORGANISM", 243, 271], ["HIV", "ORGANISM", 273, 276], ["patient", "SPECIES", 196, 203], ["human immunodeficiency virus", "SPECIES", 243, 271], ["HIV", "SPECIES", 273, 276], ["human immunodeficiency virus", "SPECIES", 243, 271], ["HIV", "SPECIES", 273, 276], ["sexually transmitted diseases", "PROBLEM", 139, 168], ["human immunodeficiency virus", "PROBLEM", 243, 271], ["disastrous", "OBSERVATION", 5, 15]]], ["Considering that the threshold condition generally predicts the final state of the epidemic evolution, Li and Wang [49] studied the relaxation behavior of epidemic spreading before reaching a final disease-free or endemic phase.Networked metapopulation.Although the performance of public healthcare systems has been improved prominently to weaken the threat of emerging diseases, it is impossible to entail a world free of infectious pathogens [55] .", [["Li", "CHEMICAL", 103, 105], ["the threshold condition", "PROBLEM", 17, 40], ["epidemic spreading", "PROBLEM", 155, 173], ["emerging diseases", "PROBLEM", 361, 378], ["infectious pathogens", "PROBLEM", 423, 443], ["metapopulation", "OBSERVATION", 238, 252], ["diseases", "OBSERVATION", 370, 378]]], ["From the beginning of this new century, we have already witnessed several cases of the large-scale geographic transmission of pandemics.", [["pandemics", "DISEASE", 126, 135], ["pandemics", "PROBLEM", 126, 135], ["large", "OBSERVATION_MODIFIER", 87, 92]]], ["In 2003, through the international airline network, the SARS coronavirus (SARS-CoV) was rapidly transmitted from Hong Kong to more than 30 countries [56, 57] .", [["SARS coronavirus", "DISEASE", 56, 72], ["SARS", "DISEASE", 74, 78], ["airline network", "MULTI-TISSUE_STRUCTURE", 35, 50], ["SARS coronavirus", "ORGANISM", 56, 72], ["SARS-CoV", "ORGANISM", 74, 82], ["SARS coronavirus", "SPECIES", 56, 72], ["SARS-CoV", "SPECIES", 74, 82], ["the SARS coronavirus", "PROBLEM", 52, 72]]], ["Several years later, in 2009, the A(H1N1) swept across the world through public transportation networks again: With only 3 to 4 months, it had spread over about 200 countries [58] [59] [60] [61] .", [["A(H1N1)", "ORGANISM", 34, 41]]], ["Recent potential invasion of avian influenza A(H7N9) poses a new challenge [62] [63] [64] [65] .", [["avian influenza A", "DISEASE", 29, 46], ["avian influenza A", "ORGANISM", 29, 46], ["avian influenza A", "SPECIES", 29, 46], ["Recent potential invasion of avian influenza A", "PROBLEM", 0, 46], ["invasion", "OBSERVATION", 17, 25]]], ["It seems that the widespread risk of emerging diseases is higher than before.", [["emerging diseases", "PROBLEM", 37, 54], ["widespread", "OBSERVATION_MODIFIER", 18, 28], ["emerging", "OBSERVATION_MODIFIER", 37, 45], ["diseases", "OBSERVATION", 46, 54], ["higher", "OBSERVATION_MODIFIER", 58, 64]]], ["This urgent circumstance stems from the changes of human social ecology in population distribution as well as human mobility patterns [66, 67] .", [["human", "ORGANISM", 51, 56], ["human", "ORGANISM", 110, 115], ["human", "SPECIES", 51, 56], ["human", "SPECIES", 110, 115], ["human", "SPECIES", 51, 56], ["human", "SPECIES", 110, 115]]], ["Crowded metropolises resulting from the urbanization process induce people's frequent contacts, and the fast development of massive transportation (e.g., civil aviation) generates a nonlocal pattern of human mobility, sharply reducing the time of travel as well as the distance between populous cities.Networked metapopulation.It is not convincing to describe the large-scale spatial pandemic spreading by directly following the routine of network epidemiology, since the network perspective still concerns the epidemic outbreak in a single population, despite considering the connectivity structure among hosts.", [["people", "ORGANISM", 68, 74], ["human", "ORGANISM", 202, 207], ["people", "SPECIES", 68, 74], ["human", "SPECIES", 202, 207], ["human", "SPECIES", 202, 207], ["Crowded metropolises", "PROBLEM", 0, 20], ["human mobility", "PROBLEM", 202, 216], ["the epidemic outbreak", "PROBLEM", 507, 528], ["massive", "OBSERVATION_MODIFIER", 124, 131], ["human mobility", "OBSERVATION", 202, 216], ["metapopulation", "OBSERVATION", 312, 326], ["not convincing to", "UNCERTAINTY", 333, 350], ["large", "OBSERVATION_MODIFIER", 364, 369], ["epidemic", "OBSERVATION_MODIFIER", 511, 519]]], ["This can hardly capture the key features of spatial transmission of infectious diseases: epidemics prevails inside separate locations such as cities, each of which can be regarded as a pop-ulation, and is transmitted among populations through the travel of infected individuals.Networked metapopulation.Spatial distribution of populations and human mobility among connected locations are the pivotal elements mediating the transmission of pandemic diseases.", [["infectious diseases", "DISEASE", 68, 87], ["pandemic diseases", "DISEASE", 439, 456], ["human", "ORGANISM", 343, 348], ["human", "SPECIES", 343, 348], ["human", "SPECIES", 343, 348], ["infectious diseases", "PROBLEM", 68, 87], ["epidemics", "PROBLEM", 89, 98], ["infected individuals", "PROBLEM", 257, 277], ["Spatial distribution of populations", "PROBLEM", 303, 338], ["human mobility", "PROBLEM", 343, 357], ["pandemic diseases", "PROBLEM", 439, 456], ["infectious", "OBSERVATION", 68, 78], ["infected", "OBSERVATION", 257, 265], ["metapopulation", "OBSERVATION", 288, 302], ["distribution", "OBSERVATION_MODIFIER", 311, 323], ["populations", "OBSERVATION_MODIFIER", 327, 338], ["mobility", "OBSERVATION_MODIFIER", 349, 357], ["pandemic diseases", "OBSERVATION", 439, 456]]], ["To introduce spatially distributed factors into modeling substrates, it is intuitive to generalize the network model by defining each node as a subpopulation that has a specific location, in which a population of individuals interplays according to the compartment rule.", [["node", "ANATOMY", 134, 138], ["the compartment rule", "TEST", 249, 269], ["node", "OBSERVATION", 134, 138]]], ["People are also permitted to transfer among subpopulations through mobility networks.", [["People", "ORGANISM", 0, 6], ["People", "SPECIES", 0, 6]]], ["This individualnetwork frame organizes the entire system into networked populations, leading to an important class of model in modern epidemiology, namely, the networked metapopulation.", [["individualnetwork frame", "DNA", 5, 28]]], ["Figure 2 illustrates the basic modeling structure.Validity of networked metapopulationAside from the above conceptual descriptions, it is also essential to verify the validity of the model from theoretical as well as empirical perspectives.Validity of networked metapopulationDeveloping a probabilistic metapopulation with the consideration of long-range human migrations via a worldwide aviation network composed of 500 largest airports, Hufnagel et al. [68] first demonstrated the feasibility of forecasting the real-world transmission of SARS through computational approaches.", [["SARS", "DISEASE", 541, 545], ["human", "ORGANISM", 355, 360], ["human", "SPECIES", 355, 360], ["human", "SPECIES", 355, 360], ["metapopulation", "OBSERVATION", 72, 86], ["metapopulation", "OBSERVATION_MODIFIER", 262, 276]]], ["To study the spatiotemporal patterns of the transmission process, Colizza et al. [69] defined a statistical measure based on the information entropy, which quantifies the disorder level encoded in the evolution profiles of disease prevalence.", [["disorder", "DISEASE", 171, 179], ["the disorder level", "PROBLEM", 167, 185], ["disease prevalence", "PROBLEM", 223, 241], ["disease", "OBSERVATION", 223, 230]]], ["Comparing the pandemic spreading on a datadriven networked metapopulation with that on random reshuffled models providing null hypotheses, the authors unveiled the presence of a high-level heterogeneity in the geographic transmission of epidemics. author/funder.", [["null hypotheses", "PROBLEM", 122, 137], ["a high-level heterogeneity", "PROBLEM", 176, 202], ["epidemics", "PROBLEM", 237, 246], ["high", "OBSERVATION_MODIFIER", 178, 182], ["heterogeneity", "OBSERVATION_MODIFIER", 189, 202]]], ["No reuse allowed without permission.Validity of networked metapopulationThe copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/003889 doi: bioRxiv preprintValidity of networked metapopulationTo assess the predictability of metapopulation models, one typical approach focuses on the coincident extent between the simulation results and the realistic surveillance reports for each contaminated region, which is an arduous task due to the sophisticated calibration of parameters as well as the unavoidable noise presented in the surveillance process.", [["https://doi.org/10.1101/003889", "CHEMICAL", 150, 180], ["The copyright holder", "TREATMENT", 72, 92], ["metapopulation models", "PROBLEM", 270, 291], ["the unavoidable noise", "PROBLEM", 534, 555], ["metapopulation", "OBSERVATION_MODIFIER", 58, 72], ["metapopulation", "OBSERVATION", 224, 238], ["metapopulation", "OBSERVATION", 270, 284]]], ["Concerning the logistical feasibility of the model, one can resort to an alternative simple means of inspecting the evolution of related scaling laws [70] , which is relevant to critical transition patterns.", [["critical transition", "OBSERVATION", 178, 197]]], ["The scaling theory concerns the functional relations describing the data collapsing onto a power-law curve, and the relations of the critical-point exponents [71] .Validity of networked metapopulationThe Zipf's law and the Heaps' law are two representative scaling laws that usually emerge together in various complex systems, however, their joint emergence has hardly been clarified [72] .", [["joint", "ANATOMY", 342, 347]]], ["Using the data of laboratory confirmed cases of SARS, H5N1, and A(H1N1) to analyze the joint emergence of these two scalings in the evolution process of large-scale geographic transmissions, Wang et al. [70] unraveled a universal feature that the Zipf's law and the Heaps' law are naturally shaped to coexist at the initial stage of an outbreak, while a crossover comes with their incoherence later before reaching a stable state, where the Heaps' law still presents with the wane of the strict Zipf's law.", [["SARS", "DISEASE", 48, 52], ["H5N1", "DISEASE", 54, 58], ["A(H1N1)", "ORGANISM", 64, 71], ["A(H1N1)", "SPECIES", 64, 71], ["SARS", "PROBLEM", 48, 52], ["H5N1", "PROBLEM", 54, 58], ["A(H1N1)", "TREATMENT", 64, 71], ["these two scalings", "PROBLEM", 106, 124], ["joint", "ANATOMY", 87, 92], ["two", "OBSERVATION_MODIFIER", 112, 115], ["scalings", "OBSERVATION", 116, 124], ["large", "OBSERVATION_MODIFIER", 153, 158], ["outbreak", "OBSERVATION", 336, 344], ["stable", "OBSERVATION_MODIFIER", 417, 423]]], ["With the census populations and domestic air transportation data of the United States (US) [73, 74] , a data-driven metapopulation network model on the US country level is developed to analyze the evolution patterns of scaling emergence.", [["a data", "TEST", 102, 108], ["domestic air", "OBSERVATION", 32, 44]]], ["In contrast with a random reshuffled model with a homogeneous structure, the data-driven heterogeneous metapopulation successfully reproduced the scaling transitions observed in the real-world pandemics.", [["the data", "TEST", 73, 81], ["heterogeneous metapopulation", "PROBLEM", 89, 117], ["the scaling transitions", "PROBLEM", 142, 165], ["heterogeneous", "OBSERVATION_MODIFIER", 89, 102], ["metapopulation", "OBSERVATION", 103, 117], ["scaling", "OBSERVATION_MODIFIER", 146, 153], ["transitions", "OBSERVATION_MODIFIER", 154, 165]]], ["This demonstrates that the high-level heterogeneity of infrastructure plays a key role in characterizing the spatial transmission of infectious diseases, which also provides a new insight to clarifying the interdependence between the Zipf's and Heaps' scaling laws.Validity of networked metapopulationWithin each subpopulation, the individuals are mixed homogeneously, according to the coarse-grained approximation of the metapopulation framework.", [["infectious diseases", "DISEASE", 133, 152], ["infectious diseases", "PROBLEM", 133, 152], ["the Zipf's", "TREATMENT", 230, 240], ["high", "OBSERVATION_MODIFIER", 27, 31], ["heterogeneity", "OBSERVATION_MODIFIER", 38, 51], ["infrastructure", "OBSERVATION", 55, 69], ["infectious", "OBSERVATION", 133, 143], ["subpopulation", "OBSERVATION_MODIFIER", 313, 326], ["mixed", "OBSERVATION_MODIFIER", 348, 353], ["homogeneously", "OBSERVATION_MODIFIER", 354, 367]]], ["Interestingly, this assumption can be supported by recent empirical studies on the intra-urban human mobility.", [["human", "ORGANISM", 95, 100], ["human", "SPECIES", 95, 100], ["human", "SPECIES", 95, 100], ["recent empirical studies", "TEST", 51, 75], ["the intra-urban human mobility", "TREATMENT", 79, 109]]], ["The analysis of the data generated by the mobile phone or GPS shows that human movement in the urban scale (e.g., inside a city) generally has an exponential or binomial trip-length distribution [75] [76] [77] [78] [79] .", [["human", "ORGANISM", 73, 78], ["human", "SPECIES", 73, 78], ["human", "SPECIES", 73, 78], ["The analysis", "TEST", 0, 12]]], ["Although this does not simply mean that short-range human mobility is random, the related dynamical feature is similar with that of the Boltzmann gas, if the relevance among individuals is so weak as to be negligible [76, 80, 81] .", [["human", "ORGANISM", 52, 57], ["human", "SPECIES", 52, 57], ["human", "SPECIES", 52, 57], ["the Boltzmann gas", "TEST", 132, 149]]], ["Accordingly, the homogeneous mixing (within each subpopulation) assumption is adopted to ease the computation.Validity of networked metapopulationMore promisingly, full-scales computational models become increasingly popular, due to the continuous increase of computer power as well as the fast technical developments of data collection and processing [82] [83] [84] .", [["homogeneous", "OBSERVATION_MODIFIER", 17, 28], ["mixing", "OBSERVATION", 29, 35], ["metapopulation", "OBSERVATION_MODIFIER", 132, 146]]], ["In some cases, the real-time forecast of pandemic spreading is becoming reality [85] .", [["pandemic", "DISEASE", 41, 49], ["pandemic spreading", "PROBLEM", 41, 59]]], ["Technical details for the estimation and validation of a large number of parameters in these models are beyond the interest of this review.", [["the estimation", "TEST", 22, 36], ["large", "OBSERVATION_MODIFIER", 57, 62]]], ["Next section focuses on the recent theoretical progress of metapopulation dynamics.Two scales of dynamics: Recent progressAs stated in Section 2, the networked metapopulation model is constructed with the individual-network frame, where the individuals are organized into social units (e.g., villages, towns, cities) defined as subpopulations, which are connected by transportation networks that identify the mobility routes.", [["social units", "OBSERVATION_MODIFIER", 272, 284]]], ["The disease prevails inside each subpopulation due to interpersonal contacts, and is transmitted among subpopulations through the mobility of infected individuals.", [["The disease prevails", "PROBLEM", 0, 20], ["infected individuals", "PROBLEM", 142, 162], ["disease", "OBSERVATION", 4, 11], ["infected", "OBSERVATION", 142, 150]]], ["Typically, the model is comprised of two scales of dynamics: (i) disease invasion among different subpopulations; (ii) disease reaction within each subpopulation.", [["disease invasion", "PROBLEM", 65, 81], ["different subpopulations", "PROBLEM", 88, 112], ["(ii) disease reaction", "PROBLEM", 114, 135], ["two", "OBSERVATION_MODIFIER", 37, 40], ["scales", "OBSERVATION_MODIFIER", 41, 47], ["invasion", "OBSERVATION_MODIFIER", 73, 81], ["different", "OBSERVATION_MODIFIER", 88, 97], ["subpopulations", "OBSERVATION_MODIFIER", 98, 112], ["subpopulation", "OBSERVATION_MODIFIER", 148, 161]]], ["Recent progresses on these two aspects are specified here.Inter-subpopulation invasion.The substrate of metapopulation depends on the spatial structure of social environment, such as transport infrastructures and mobility patterns.", [["subpopulation", "OBSERVATION_MODIFIER", 64, 77], ["invasion", "OBSERVATION", 78, 86], ["metapopulation", "OBSERVATION", 104, 118], ["social environment", "OBSERVATION", 155, 173]]], ["The lack of fine-grained data capturing structural features of human mobility systems leads to the traditional application of random graphs or regular lattices, which assumes homogeneous infrastructures for the mobility substrates.", [["human", "ORGANISM", 63, 68], ["human", "SPECIES", 63, 68], ["human", "SPECIES", 63, 68], ["human mobility systems", "PROBLEM", 63, 85], ["random graphs", "TEST", 126, 139], ["human mobility", "OBSERVATION", 63, 77], ["homogeneous", "OBSERVATION_MODIFIER", 175, 186], ["infrastructures", "OBSERVATION", 187, 202]]], ["To generalize metapopulation models with network approaches, the first attempt was contributed by Rvachev and Longini [86] , in which 52 major cities worldwide in that epoch were connected through an intercity aviation transportation network.", [["network approaches", "TREATMENT", 41, 59], ["metapopulation", "OBSERVATION", 14, 28]]], ["They applied this mathematical model to simulate the global spread of the 1968-1969 Hong Kong (H3N2) flu.Inter-subpopulation invasion.Subsequently, comparing the effect of non-local human anomalous diffusion with that of the ordinary diffusion behavior, Brockmann et al. unraveled that long-range human mobility and interactions generate novel irregular spreading patterns without an apparent wavefront [87] .", [["human", "ORGANISM", 182, 187], ["human", "ORGANISM", 297, 302], ["human", "SPECIES", 182, 187], ["human", "SPECIES", 297, 302], ["Hong Kong (H3N2) flu", "SPECIES", 84, 104], ["human", "SPECIES", 182, 187], ["human", "SPECIES", 297, 302], ["this mathematical model", "TREATMENT", 13, 36], ["flu", "PROBLEM", 101, 104], ["non-local human anomalous diffusion", "PROBLEM", 172, 207], ["novel irregular spreading patterns", "PROBLEM", 338, 372], ["subpopulation", "OBSERVATION_MODIFIER", 111, 124], ["invasion", "OBSERVATION", 125, 133], ["anomalous diffusion", "OBSERVATION", 188, 207]]], ["Such complex dynamical features require a mathematical description of fractional diffusion equations, and they are also well captured by the networked metapopulations.", [["Such complex dynamical features", "PROBLEM", 0, 31], ["fractional diffusion equations", "PROBLEM", 70, 100]]], ["They studied the predictability and the reliability of the pandemic forecast with respect to the intrinsic stochasticity, and declared that the topological heterogeneity reduces the predictability, whereas author/funder.", [["the topological heterogeneity", "PROBLEM", 140, 169], ["predictability", "OBSERVATION_MODIFIER", 182, 196]]], ["No reuse allowed without permission.Inter-subpopulation invasion.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/003889 doi: bioRxiv preprint the high-level heterogeneity of traffic flows improves the pandemic predictability.Inter-subpopulation invasion.As illustrated by Fig. 3 a, air traffic network acts as a major channel serving human long-range travels, which mediates the pandemic transmission on a large geographic scale.", [["pandemic", "DISEASE", 433, 441], ["https://doi.org/10.1101/003889", "CHEMICAL", 143, 173], ["human", "ORGANISM", 388, 393], ["human", "SPECIES", 388, 393], ["human", "SPECIES", 388, 393], ["The copyright holder", "TREATMENT", 65, 85], ["bioRxiv", "TREATMENT", 179, 186], ["traffic flows", "PROBLEM", 228, 241], ["the pandemic predictability", "PROBLEM", 251, 278], ["a large geographic scale", "TREATMENT", 458, 482], ["subpopulation", "OBSERVATION_MODIFIER", 42, 55], ["invasion", "OBSERVATION", 56, 64], ["traffic flows", "OBSERVATION", 228, 241], ["pandemic", "OBSERVATION_MODIFIER", 255, 263], ["predictability", "OBSERVATION_MODIFIER", 264, 278], ["subpopulation", "OBSERVATION_MODIFIER", 285, 298], ["invasion", "OBSERVATION", 299, 307]]], ["The epidemic dynamics occurred under this scenario is well characterized by the reaction-diffusion processes [88] , which are also widely applied to model phenomena as diverse as genetic drift, chemical reactions, and population evolution [2] .Inter-subpopulation invasion.From a theoretical viewpoint, it is significant to analyze the epidemic threshold, which is instructive for the assessment of the disease transmissibility as well as the outbreak potential.", [["The epidemic dynamics", "PROBLEM", 0, 21], ["the reaction-diffusion processes", "PROBLEM", 76, 108], ["model phenomena", "PROBLEM", 149, 164], ["genetic drift", "PROBLEM", 179, 192], ["chemical reactions", "PROBLEM", 194, 212], ["the assessment", "TEST", 381, 395], ["the disease transmissibility", "PROBLEM", 399, 427], ["drift", "OBSERVATION_MODIFIER", 187, 192], ["chemical reactions", "OBSERVATION", 194, 212], ["subpopulation", "OBSERVATION_MODIFIER", 250, 263], ["invasion", "OBSERVATION", 264, 272], ["disease", "OBSERVATION", 403, 410]]], ["Such information is also important to regulate the implementation of intervention strategies.", [["intervention strategies", "TREATMENT", 69, 92]]], ["Based on the empirical evidences that the topology of various socio-technical networks including the airline network presents a high-level heterogeneity, Colizza et al. [88] studied the effect of general heterogeneous networks, demonstrating that the epidemic threshold is significantly decreased with the augmentation of topological fluctuations.", [["airline network", "MULTI-TISSUE_STRUCTURE", 101, 116], ["a high-level heterogeneity", "PROBLEM", 126, 152], ["heterogeneous", "OBSERVATION", 204, 217], ["significantly", "OBSERVATION_MODIFIER", 273, 286], ["decreased", "OBSERVATION_MODIFIER", 287, 296], ["topological fluctuations", "OBSERVATION", 322, 346]]], ["Considering that the theory developed in Colizza et al. [88] is based on the simplification that individual diffusion rate per subpopulation is inversely proportional to the degree of subpopulations, Colizza and Vespignani [89] generalized the study by introducing more realistic diffusion rules, such as the traffic-and the population-dependent patterns.", [["individual diffusion rate", "TEST", 97, 122], ["generalized the study", "TEST", 228, 249], ["subpopulations", "OBSERVATION", 184, 198], ["dependent", "OBSERVATION_MODIFIER", 336, 345]]], ["Importantly, using the approach of branching process, Colizza and Vespignani [89] proposed a global invasion threshold, R \u22c6 , which distinguishes the lower bound condition for transmitting the infections to downstream unaffected subpopulations.", [["infections", "DISEASE", 193, 203], ["Colizza and Vespignani", "TREATMENT", 54, 76], ["a global invasion threshold", "PROBLEM", 91, 118], ["the lower bound condition", "PROBLEM", 146, 171], ["the infections", "PROBLEM", 189, 203], ["branching process", "OBSERVATION", 35, 52], ["global", "OBSERVATION_MODIFIER", 93, 99], ["invasion", "OBSERVATION", 100, 108], ["infections", "OBSERVATION", 193, 203]]], ["No reuse allowed without permission.Inter-subpopulation invasion.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/003889 doi: bioRxiv preprint can be summarized as R \u22c6 = E(R 0 , \u00b5)T (k, \u03b8, \u03c9 0 ), which combines the epidemiology factors E(R 0 , \u00b5) with the diffusion properties of mobility networks T (k, \u03b8, \u03c9 0 ).", [["https://doi.org/10.1101/003889", "CHEMICAL", 143, 173], ["The copyright holder", "TREATMENT", 65, 85], ["bioRxiv preprint", "TREATMENT", 179, 195], ["k", "TEST", 236, 237], ["\u03b8", "TEST", 239, 240], ["the diffusion properties", "TEST", 305, 329], ["T", "TEST", 351, 352], ["k", "TEST", 354, 355], ["subpopulation", "OBSERVATION_MODIFIER", 42, 55], ["invasion", "OBSERVATION", 56, 64]]], ["For large networks with a high-level topological heterogeneity, the mobility item T diverges, i.e., T \u22121 \u2192 0, thus R \u22c6 is always larger than unity, which leads to a decreased epidemic threshold.", [["R \u22c6", "GENE_OR_GENE_PRODUCT", 115, 118], ["large networks", "PROBLEM", 4, 18], ["a high-level topological heterogeneity", "PROBLEM", 24, 62], ["a decreased epidemic threshold", "PROBLEM", 163, 193], ["decreased", "OBSERVATION_MODIFIER", 165, 174], ["epidemic", "OBSERVATION_MODIFIER", 175, 183]]], ["Based on the observation that human beings usually do not perform random walks, yet have specific travel destinations, Tang et al. [90] addressed the effect of objective traveling behavior which enlarges the final morbidity.Inter-subpopulation invasion.The above studies mainly concern the influence of human random diffusion, usually defining the mobility scheme as a Markovian memoryless diffusive process [91] .", [["human", "ORGANISM", 30, 35], ["human", "ORGANISM", 303, 308], ["human", "SPECIES", 30, 35], ["human", "SPECIES", 303, 308], ["human", "SPECIES", 30, 35], ["human", "SPECIES", 303, 308], ["objective traveling behavior", "PROBLEM", 160, 188], ["The above studies", "TEST", 253, 270], ["human random diffusion", "PROBLEM", 303, 325], ["the mobility scheme", "PROBLEM", 344, 363], ["a Markovian memoryless diffusive process", "PROBLEM", 367, 407], ["subpopulation", "OBSERVATION_MODIFIER", 230, 243], ["invasion", "OBSERVATION", 244, 252]]], ["Recent empirical findings on human mobility have shown the crucial role of commuting mobility in human daily transportation, which is reflected by the individual recurrent movement between frequently visited locations such as household, school, and workplace [92] [93] [94] [95] .", [["[92] [93] [94]", "CHEMICAL", 259, 273], ["human", "ORGANISM", 29, 34], ["human", "ORGANISM", 97, 102], ["human", "SPECIES", 29, 34], ["human", "SPECIES", 97, 102], ["human", "SPECIES", 29, 34], ["human", "SPECIES", 97, 102]]], ["Evidently, the structural features are different between the commuting network and the air transportation network.Inter-subpopulation invasion.It might be infeasible to analyze the non-Markovian properties of human commuting with previous reaction-diffusion theory.", [["air transportation network", "MULTI-TISSUE_STRUCTURE", 87, 113], ["human", "ORGANISM", 209, 214], ["human", "SPECIES", 209, 214], ["human", "SPECIES", 209, 214], ["previous reaction", "PROBLEM", 230, 247], ["different", "OBSERVATION_MODIFIER", 39, 48], ["air transportation", "OBSERVATION", 87, 105], ["subpopulation", "OBSERVATION_MODIFIER", 120, 133], ["invasion", "OBSERVATION", 134, 142]]], ["In this regard, Balcan and Vespignani [91] extended the metapopulation framework by considering the impact of human recurrent commuting, which assumes that individuals remember their subpopulations of residence, with a constraint that commuters staying at their destination subpopulations cannot continue moving to other places but return to the residences with a certain rate.", [["human", "ORGANISM", 110, 115], ["human", "SPECIES", 110, 115], ["human", "SPECIES", 110, 115]]], ["The approach of timescale separation is applied to perform theoretical analysis, since in reality the number of frequent commuters only accounts for a small fraction of local populations.", [["timescale separation", "TREATMENT", 16, 36], ["theoretical analysis", "TEST", 59, 79], ["small", "OBSERVATION_MODIFIER", 151, 156], ["fraction", "OBSERVATION_MODIFIER", 157, 165], ["local populations", "OBSERVATION", 169, 186]]], ["Generalizing the theory of branching process, Balcan and Vespignani [97] obtained the global invasion threshold for the reaction-commuting networked metapopulation systems, which establishes a new threshold relevant to the typical visiting duration of commuters.", [["the reaction", "PROBLEM", 116, 128], ["branching process", "OBSERVATION", 27, 44]]], ["With a high return rate, the sojourn time (i.e., length of stay) of infected commuters might be too short to transmit the infection to susceptibles in adjacent unaffected subpopulations.Inter-subpopulation invasion.To study the dynamical differences between the reactioncommuting and the reaction-diffusion processes, Belik et al. [98] analyzed their respective traveling wave solutions on the one dimensional lattice.", [["infection", "DISEASE", 122, 131], ["the infection", "PROBLEM", 118, 131], ["the reaction-diffusion processes", "PROBLEM", 284, 316], ["infected", "OBSERVATION", 68, 76], ["infection", "OBSERVATION", 122, 131], ["unaffected", "OBSERVATION_MODIFIER", 160, 170], ["subpopulations", "OBSERVATION", 171, 185], ["subpopulation", "OBSERVATION_MODIFIER", 192, 205], ["invasion", "OBSERVATION", 206, 214]]], ["As the diffusion rate increases, spatially constrained human commuting generates a saturated threshold of the wave front velocity, whereas the reactiondiffusion model has an unbounded front velocity threshold.", [["human", "ORGANISM", 55, 60], ["human", "SPECIES", 55, 60], ["human", "SPECIES", 55, 60], ["the diffusion rate", "TEST", 3, 21], ["wave", "OBSERVATION_MODIFIER", 110, 114], ["front", "OBSERVATION_MODIFIER", 115, 120], ["velocity", "OBSERVATION_MODIFIER", 121, 129], ["unbounded", "OBSERVATION_MODIFIER", 174, 183], ["front velocity", "OBSERVATION", 184, 198]]], ["Since airline traffic and ground commuting networks both serve human routine transportation, Balcan et al. [94] developed a multiscale networked metapopulation model, where the commuting networks in about 30 countries were embedded into the worldwide long-range air transportation network.", [["human", "ORGANISM", 63, 68], ["human", "SPECIES", 63, 68], ["human", "SPECIES", 63, 68]]], ["The introduction of short-range commuting mobility enhances the synchronization of epidemic evolution profiles for subpopulations in close geographical proximity.Inter-subpopulation invasion.Human beings are intelligent.", [["Human", "ORGANISM", 191, 196], ["Human", "SPECIES", 191, 196], ["Human", "SPECIES", 191, 196], ["short-range commuting mobility", "TREATMENT", 20, 50], ["subpopulation", "OBSERVATION_MODIFIER", 168, 181], ["invasion", "OBSERVATION", 182, 190]]], ["Their risk perception and adaptive abilities promote the active response to epidemic outbreaks, which might in turn alter the disease propagation [99] [100] [101] .", [["adaptive abilities", "PROBLEM", 26, 44], ["epidemic outbreaks", "PROBLEM", 76, 94]]], ["Many works [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] have investigated the effect of disease-behavior mutual feedback on compartment models as well as network epidemiology, and recent research topics also begin the generalization to deal with human behavior of mobility response.", [["human", "ORGANISM", 261, 266], ["human", "SPECIES", 261, 266], ["human", "SPECIES", 261, 266], ["disease", "PROBLEM", 103, 110]]], ["For example, [112, 113] analyzed the impact of self-initiated mobility on the invasion threshold, showing a counterintuitive phenomenon that the mobility change of avoiding infected locations with high prevalences enhances the disease spreading to the entire system.Intra-subpopulation contagion.The above studies focus on understanding the influence of inter-subpopulation human mobility patterns, generally assuming that the individuals behave identically in each subpopulation.", [["human", "ORGANISM", 374, 379], ["human", "SPECIES", 374, 379], ["human", "SPECIES", 374, 379], ["the invasion threshold", "TEST", 74, 96], ["a counterintuitive phenomenon", "PROBLEM", 106, 135], ["the mobility change", "PROBLEM", 141, 160], ["the disease", "PROBLEM", 223, 234], ["The above studies", "TEST", 296, 313], ["counterintuitive phenomenon", "OBSERVATION", 108, 135], ["mobility", "OBSERVATION_MODIFIER", 145, 153], ["infected", "OBSERVATION", 173, 181], ["high", "OBSERVATION_MODIFIER", 197, 201], ["disease", "OBSERVATION", 227, 234]]], ["However, the diversity of individual behaviors in different subpopulations also affects the pandemic spreading.Intra-subpopulation contagion.Although it is well-known that human contacts have crucial impact on the spatiotemporal dynamics of infectious diseases in a population [3] , previous works assumed that individual contact patterns are identical among all subpopulations.", [["infectious diseases", "DISEASE", 241, 260], ["human", "ORGANISM", 172, 177], ["human", "SPECIES", 172, 177], ["human", "SPECIES", 172, 177], ["individual behaviors", "PROBLEM", 26, 46], ["the pandemic spreading", "PROBLEM", 88, 110], ["infectious diseases", "PROBLEM", 241, 260], ["diversity", "OBSERVATION_MODIFIER", 13, 22], ["different", "OBSERVATION_MODIFIER", 50, 59], ["subpopulations", "OBSERVATION_MODIFIER", 60, 74], ["pandemic", "OBSERVATION_MODIFIER", 92, 100], ["spreading", "OBSERVATION_MODIFIER", 101, 110], ["infectious", "OBSERVATION_MODIFIER", 241, 251]]], ["Since the basic reproductive number, R 0 , is equivalent to the same constant in all subpopulations, it is predictable that the epidemic attack rates as well as evolution profiles in different areas are similar, as one can clearly observe in [114] .Intra-subpopulation contagion.At the intra-subpopulation scale, aside from the empirical support from the data analysis of intra-urban human mobility (see Section 3), the feasibility of the \"well-mixed\" contacts assumption is also consistent with the recent findings on interactive patterns of human contact.", [["human", "ORGANISM", 384, 389], ["human", "ORGANISM", 543, 548], ["human", "SPECIES", 384, 389], ["human", "SPECIES", 543, 548], ["human", "SPECIES", 384, 389], ["human", "SPECIES", 543, 548], ["the epidemic attack rates", "PROBLEM", 124, 149], ["the intra-subpopulation scale", "TREATMENT", 282, 311], ["the empirical support", "TREATMENT", 324, 345], ["the data analysis", "TEST", 351, 368], ["intra-urban human mobility", "PROBLEM", 372, 398], ["reproductive", "OBSERVATION_MODIFIER", 16, 28], ["number", "OBSERVATION_MODIFIER", 29, 35], ["equivalent", "OBSERVATION_MODIFIER", 46, 56], ["different", "OBSERVATION_MODIFIER", 183, 192], ["areas", "OBSERVATION_MODIFIER", 193, 198], ["consistent with", "UNCERTAINTY", 480, 495]]], ["For example, diverse digital instruments, e.g., wireless sensors [115] , active Radio Frequency Identification (RFID) devices [116, 117] , and WiFi [118] [119] [120] (we resort to the WiFi technology in our social experiments, due to its ubiquity in urban areas), have been deployed in realistic social circumstances to collect the data of human close proximity contacts [121] .", [["human", "ORGANISM", 340, 345], ["human", "SPECIES", 340, 345], ["human", "SPECIES", 340, 345], ["wireless sensors", "TEST", 48, 64], ["WiFi", "TEST", 143, 147], ["diverse", "OBSERVATION_MODIFIER", 13, 20]]], ["The data analyses have unveiled an unexpected feature that the squared coefficient of variance is quite small for the distribution of the number of distinct persons each individual author/funder.", [["persons", "SPECIES", 157, 164], ["The data analyses", "TEST", 0, 17], ["small", "OBSERVATION_MODIFIER", 104, 109]]], ["No reuse allowed without permission.Intra-subpopulation contagion.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/003889 doi: bioRxiv preprint Origin-driven contact scenario g g Fig. 4 (Color online) Effect of location-specific human contact patterns. a-b illustrate the structure of the phenomenological metapopulation model used in [124] , where the reaction-commuting processes couple two typical subpopulations x,y.", [["https://doi.org/10.1101/003889", "CHEMICAL", 144, 174], ["human", "ORGANISM", 282, 287], ["human", "SPECIES", 282, 287], ["human", "SPECIES", 282, 287], ["The copyright holder", "TREATMENT", 66, 86], ["the reaction", "PROBLEM", 402, 414], ["typical", "OBSERVATION_MODIFIER", 446, 453], ["subpopulations", "OBSERVATION_MODIFIER", 454, 468]]], ["In the destination-driven scenario (a), individual characteristic contact rates (cx, cy) depend on the visited locations, while in the origin-driven scenario (b), the contacts of individuals correlate to their subpopulations of residence. c-d present the phase diagrams of the global R g 0 under these two scenarios, respectively.", [["cx", "TEST", 81, 83]]], ["The white dashed curve in each panel shows the global threshold R g 0 = 1 obtained through the NGM analysis.", [["The white dashed curve", "TEST", 0, 22], ["each panel", "TEST", 26, 36], ["the NGM analysis", "TEST", 91, 107]]], ["[124] .Intra-subpopulation contagion.encounters per day [115] [116] [117] [118] [119] , which implies the presence of a characteristic contact rate within each subpopulation.Intra-subpopulation contagion.Note that the characteristic contact rate might vary evidently in different subpopulations.", [["different", "OBSERVATION_MODIFIER", 270, 279], ["subpopulations", "OBSERVATION", 280, 294]]], ["As illustrated by empirical studies [122, 123] , in reality, location-specific factors are the potential drivers resulting in a substantial variation of disease incidences between populations.", [["empirical studies", "TEST", 18, 35], ["disease incidences between populations", "PROBLEM", 153, 191], ["disease", "OBSERVATION", 153, 160]]], ["Inspired by this finding, Wang et al. [124, 125] introduced two categories of location-specific human contact patterns into a phenomenological reaction-commuting metapopulation model.", [["human", "ORGANISM", 96, 101], ["human", "SPECIES", 96, 101], ["human", "SPECIES", 96, 101], ["a phenomenological reaction", "PROBLEM", 124, 151]]], ["A simple destination-driven scenario is considered first, where individual contact features are determined by the visited locations.", [["A simple destination", "TREATMENT", 0, 20], ["simple", "OBSERVATION_MODIFIER", 2, 8]]], ["Figures 4(a) -(b) illustrate the modeling structures of these two scenarios.Intra-subpopulation contagion.In these cases, it is infeasible to analyze the invasion threshold through the theory of branching process, since the prerequisite of identical basic reproductive number in all subpopulations is invalid.", [["Figures", "TEST", 0, 7], ["the invasion threshold", "PROBLEM", 150, 172], ["invasion", "OBSERVATION", 154, 162], ["branching", "OBSERVATION_MODIFIER", 195, 204], ["process", "OBSERVATION", 205, 212], ["basic", "OBSERVATION_MODIFIER", 250, 255], ["reproductive", "OBSERVATION_MODIFIER", 256, 268], ["number", "OBSERVATION_MODIFIER", 269, 275], ["all", "OBSERVATION_MODIFIER", 279, 282], ["subpopulations", "OBSERVATION", 283, 297]]], ["Instead, the next generation matrix (NGM) approach [126] can be applied to analyze the global outbreak threshold R g 0 here.", [["matrix", "CELLULAR_COMPONENT", 29, 35], ["the next generation matrix (NGM) approach", "TREATMENT", 9, 50]]], ["Due to the mixing of individuals with heterogeneous contact capacities in each subpopulation, which is analogous to the effect induced by annealed heterogeneous networks [45] , the addressed locationspecific contact patterns reduce the epidemic threshold significantly, and thus favor disease outbreaks in contrast to the traditional homogeneous cases.", [["heterogeneous contact capacities", "PROBLEM", 38, 70], ["disease outbreaks in contrast", "PROBLEM", 285, 314], ["heterogeneous", "OBSERVATION_MODIFIER", 38, 51], ["contact capacities", "OBSERVATION", 52, 70], ["heterogeneous", "OBSERVATION_MODIFIER", 147, 160]]], ["4 c-d show the phase diagrams of the global R g 0 under these two types of contact patterns, respectively.", [["the phase diagrams", "TEST", 11, 29], ["contact patterns", "OBSERVATION", 75, 91]]], ["Interestingly, the variance of disease prevalence under the destination-driven scenario has a monotonic dependence on the characteristic contact rates, whereas under the origin-driven scenario, counterintuitively, the increase of contact rates weakens the disease prevalence in some parametric ranges.", [["disease prevalence", "PROBLEM", 31, 49], ["a monotonic dependence", "PROBLEM", 92, 114], ["the disease prevalence", "PROBLEM", 252, 274], ["disease", "OBSERVATION", 31, 38], ["increase", "OBSERVATION_MODIFIER", 218, 226], ["parametric ranges", "OBSERVATION", 283, 300]]], ["This topic was also extended to study the metapopulation network, which unraveled a new problem of disease localization, i.e., the epidemic might be localized on a finite number of highly connected hubs. author/funder.", [["disease localization", "PROBLEM", 99, 119], ["new", "OBSERVATION_MODIFIER", 84, 87], ["disease", "OBSERVATION", 99, 106]]], ["No reuse allowed without permission.Intra-subpopulation contagion.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/003889 doi: bioRxiv preprintIntra-subpopulation contagion.Other types of human behavioral diversity have also been considered recently.", [["https://doi.org/10.1101/003889", "CHEMICAL", 144, 174], ["human", "ORGANISM", 241, 246], ["human", "SPECIES", 241, 246], ["human", "SPECIES", 241, 246], ["The copyright holder", "TREATMENT", 66, 86], ["bioRxiv", "TREATMENT", 180, 187], ["human behavioral diversity", "PROBLEM", 241, 267]]], ["Motivated by the evidence that the diversity of travel habits or trip durations might yield heterogeneity in the sojourn time spent at destinations, Poletto et al. [127] studied the impact of large fluctuations of visiting durations on the epidemic threshold, finding that the positively-correlated and the negatively-correlated degreebased staying durations lead to distinct invasion paths to global outbreaks.", [["distinct invasion paths", "PROBLEM", 367, 390], ["large", "OBSERVATION_MODIFIER", 192, 197], ["distinct", "OBSERVATION_MODIFIER", 367, 375], ["invasion", "OBSERVATION", 376, 384], ["global", "OBSERVATION_MODIFIER", 394, 400], ["outbreaks", "OBSERVATION", 401, 410]]], ["Based on the observation that the specific curing (recovery) condition depends on the available medical resources supplied by local health sectors, Shen et al. [128] studied the effect of degree-dependent curing rates, which demonstrates that an optimal intervention performance with the largest epidemic threshold is obtained by designing the heterogeneous distribution of curing rates as a superlinear mode.", [["degree-dependent curing rates", "PROBLEM", 188, 217], ["a superlinear mode", "TREATMENT", 390, 408], ["largest", "OBSERVATION_MODIFIER", 288, 295], ["heterogeneous", "OBSERVATION_MODIFIER", 344, 357], ["distribution", "OBSERVATION_MODIFIER", 358, 370]]], ["Since the epidemic spreading is also relevant to casual contacts during public gatherings, Cao et al. [129] introduced the rendezvous effect into a bipartite metapopulation network, and showed that the rendezvous-induced transmission accelerates the pandemic outbreaks.Performance of intervention strategiesThe study of metapopulation model not only expands our knowledge on the dynamics of spatial epidemic spreading, but also manifests the power in evaluating the performance of intervention strategies.", [["the rendezvous", "TREATMENT", 198, 212], ["the pandemic outbreaks", "PROBLEM", 246, 268], ["intervention strategies", "TREATMENT", 284, 307], ["The study", "TEST", 307, 316], ["intervention strategies", "TREATMENT", 481, 504], ["pandemic", "OBSERVATION_MODIFIER", 250, 258]]], ["For example, although the strategy of travel ban is usually deployed during a pandemic outbreak in reality, it is unclear whether the effectiveness is excellent enough in limiting the pandemic spreading.", [["the pandemic spreading", "PROBLEM", 180, 202], ["pandemic", "OBSERVATION_MODIFIER", 184, 192], ["spreading", "OBSERVATION_MODIFIER", 193, 202]]], ["Counterintuitively, recent studies have unraveled the limited utility of travel restrictions: Even if the worldwide air traffic is decreased to an unprecedented low level, e.g., less than 10 %, the disease landing to unaffected regions is only postponed several weeks [130] [131] [132] [133] ; the contribution to reducing the morbity is also quite limited [130, 131, 134] .", [["recent studies", "TEST", 20, 34], ["the disease landing to unaffected regions", "PROBLEM", 194, 235], ["disease", "OBSERVATION", 198, 205]]], ["Such findings are consistent with the aforementioned fact that the global invasion threshold is decreased significantly by the presence of the high-level topological heterogeneity.Performance of intervention strategiesIt thus becomes urgent to study the controllability of intra-subpopulation measures, such as the usage of vaccine or antiviral drugs, and the implementation of communitybased interventions, which are typical containment strategies suggested by the World Health Organization (WHO) [55] .", [["the global invasion threshold", "PROBLEM", 63, 92], ["the high-level topological heterogeneity", "PROBLEM", 139, 179], ["intervention strategies", "TREATMENT", 195, 218], ["intra-subpopulation measures", "TREATMENT", 273, 301], ["vaccine", "TREATMENT", 324, 331], ["antiviral drugs", "TREATMENT", 335, 350], ["communitybased interventions", "TREATMENT", 378, 406], ["consistent with", "UNCERTAINTY", 18, 33], ["global", "OBSERVATION_MODIFIER", 67, 73], ["invasion", "OBSERVATION", 74, 82], ["decreased", "OBSERVATION_MODIFIER", 96, 105], ["high", "OBSERVATION_MODIFIER", 143, 147], ["topological heterogeneity", "OBSERVATION", 154, 179]]], ["To estimate and also to improve the performance of disease response plans on decreasing the morbidity, large-scale computational simulations have been performed extensively to study various types of pharmaceutical interventions [4, 14, 56, 57, 60, 68, [134] [135] [136] [137] [138] [139] , which aid in identifying the targetedgroups and guiding the deployment of limited resources.Performance of intervention strategiesDespite technical difficulties, it is probable to analyze the delaying effect of different strategies.", [["disease response", "PROBLEM", 51, 67], ["pharmaceutical interventions", "TREATMENT", 199, 227], ["intervention strategies", "TREATMENT", 397, 420], ["technical difficulties", "PROBLEM", 428, 450], ["different strategies", "TREATMENT", 501, 521]]], ["This is a rational approximation of the initial stage of an outbreak.", [["outbreak", "OBSERVATION", 60, 68]]], ["It is shown that with a short response time, the intra-subpopulation measures perform much better than that of the inter-subpopulation travel restrictions.", [["the intra-subpopulation measures", "TREATMENT", 45, 77]]], ["However, this advantage is weakened considerably as the response time increases.Performance of intervention strategiesRecent clinical evidences obtained from the real-world pandemic campaigns have uncovered new problems on the prompt response with pharmaceutical interventions.", [["intervention strategies", "TREATMENT", 95, 118], ["new problems", "PROBLEM", 207, 219], ["pharmaceutical interventions", "TREATMENT", 248, 276], ["new", "OBSERVATION_MODIFIER", 207, 210]]], ["For example, there presents an unavoidable delay of 4-6 months for developing the proper vaccine against a particular pandemic virus [141] [142] [143] ; and an extensive usage of antiviral drugs might induce the prevalence of antiviral resistance [144] [145] [146] .", [["the proper vaccine", "TREATMENT", 78, 96], ["a particular pandemic virus", "PROBLEM", 105, 132], ["antiviral drugs", "TREATMENT", 179, 194], ["antiviral resistance", "PROBLEM", 226, 246], ["antiviral resistance", "OBSERVATION", 226, 246]]], ["Therefore, it is crucial to thoroughly examine the effectiveness of community-based interventions by using the models of networked metapopulation, which deserves more efforts in near future.Conclusions & outlooksNetworked metapopulation contributes an ideal epidemic modeling platform, which promotes our understanding on the dynamics of large-scale geographic transmission of emergent diseases.", [["community-based interventions", "TREATMENT", 68, 97], ["networked metapopulation", "TREATMENT", 121, 145], ["emergent diseases", "PROBLEM", 377, 394], ["diseases", "OBSERVATION", 386, 394]]], ["The models have the potential to be applied in the real-time numerical pandemic forecast, and are also very useful in evaluating the effectiveness of disease response strategies.Conclusions & outlooksRecently, the good, the bad and the ugly facts of the Big Data have triggered extensive debates around the world.", [["disease response strategies", "TREATMENT", 150, 177], ["good", "OBSERVATION_MODIFIER", 214, 218]]], ["The interdisciplinary research of metapopulation epidemiology establishes a paradigm for the study of data science, since one remarkable progress in this field is the innovative usage of fine-grained data in verifying key assumptions and in establishing model substrates.", [["the study", "TEST", 89, 98]]], ["Technical developments in the data collection, processing and analysis not only offer key insights into the dynamical properties of human mobility infrastructures as well as human behavioral diversity, but also raise new questions referring to their influences on the spatial transmission of emerging infectious diseases.", [["infectious diseases", "DISEASE", 301, 320], ["human", "ORGANISM", 132, 137], ["human", "ORGANISM", 174, 179], ["human", "SPECIES", 132, 137], ["human", "SPECIES", 174, 179], ["human", "SPECIES", 132, 137], ["human", "SPECIES", 174, 179], ["emerging infectious diseases", "PROBLEM", 292, 320], ["infectious", "OBSERVATION", 301, 311]]], ["Such methodology can be applied to study diverse types of contagion phenomena, including the spreading of computer viruses, information, innovations, emotion, behavior, crisis, culture, etc.Conclusions & outlooksAt the end of discussions, some open questions still deserve to be addressed.", [["contagion phenomena", "PROBLEM", 58, 77], ["crisis", "PROBLEM", 169, 175], ["culture", "TEST", 177, 184], ["contagion phenomena", "OBSERVATION", 58, 77]]], ["The development of the sophisticated computational techniques and the consideration of detailed human/population dynamics are quite important for the research of spatial epidemiology.", [["human", "ORGANISM", 96, 101], ["human", "SPECIES", 96, 101], ["human", "SPECIES", 96, 101]]], ["No reuse allowed without permission.Conclusions & outlooksThe copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/003889 doi: bioRxiv preprint define a unified mathematical framework that can characterize different kinds of spatial dynamics models of emerging diseases.Conclusions & outlooksIt is also probable to generalize present theoretical results to deal with reverse problems, such as the identification of infection sources [147] [148] [149] , possible mobility networks [150] , and disease invasion process.", [["infection", "DISEASE", 460, 469], ["https://doi.org/10.1101/003889", "CHEMICAL", 136, 166], ["The copyright holder", "TREATMENT", 58, 78], ["bioRxiv", "TREATMENT", 172, 179], ["emerging diseases", "PROBLEM", 297, 314], ["reverse problems", "PROBLEM", 412, 428], ["infection sources", "PROBLEM", 460, 477], ["mobility networks", "PROBLEM", 507, 524], ["disease invasion process", "PROBLEM", 537, 561], ["spatial dynamics", "OBSERVATION", 270, 286], ["disease", "OBSERVATION_MODIFIER", 537, 544], ["invasion", "OBSERVATION", 545, 553]]], ["Such inference problems are valuable to establish an optimal response plan for tracing and preventing the pandemics.", [["Such inference problems", "PROBLEM", 0, 23], ["tracing", "TEST", 79, 86], ["the pandemics", "PROBLEM", 102, 115]]]], "64f5af205494b75764762ed86fd202387c77b0b7": [["The disease is characterized by large skin nodules covering the entire body of the animal, emaciation, poor milk production, and abortion.", [["skin nodules", "ANATOMY", 38, 50], ["body", "ANATOMY", 71, 75], ["milk", "ANATOMY", 108, 112], ["emaciation", "DISEASE", 91, 101], ["skin nodules", "PATHOLOGICAL_FORMATION", 38, 50], ["body", "ORGANISM_SUBDIVISION", 71, 75], ["milk", "ORGANISM_SUBSTANCE", 108, 112], ["The disease", "PROBLEM", 0, 11], ["large skin nodules", "PROBLEM", 32, 50], ["emaciation", "PROBLEM", 91, 101], ["poor milk production", "PROBLEM", 103, 123], ["abortion", "PROBLEM", 129, 137], ["disease", "OBSERVATION", 4, 11], ["large", "OBSERVATION_MODIFIER", 32, 37], ["skin", "ANATOMY", 38, 42], ["nodules", "OBSERVATION", 43, 50], ["entire body", "ANATOMY_MODIFIER", 64, 75], ["emaciation", "OBSERVATION", 91, 101], ["poor milk production", "OBSERVATION", 103, 123]]], ["The severity of the clinical symptoms varies from acute to subclinical forms (1) (2) (3) .", [["the clinical symptoms", "PROBLEM", 16, 37], ["severity", "OBSERVATION_MODIFIER", 4, 12], ["acute", "OBSERVATION_MODIFIER", 50, 55]]], ["Due to its observed economic impacts on the global cattle industry (4, 5) , the World Organization of Animal Health (OIE) has classified LSDV as a notifiable disease.", [["cattle", "SPECIES", 51, 57], ["cattle", "SPECIES", 51, 57], ["LSDV", "SPECIES", 137, 141], ["a notifiable disease", "PROBLEM", 145, 165], ["economic", "OBSERVATION_MODIFIER", 20, 28], ["impacts", "OBSERVATION_MODIFIER", 29, 36]]], ["LSDV is mainly transmitted via arthropod vectors.", [["LSDV", "CHEMICAL", 0, 4], ["LSDV", "GENE_OR_GENE_PRODUCT", 0, 4], ["LSDV", "SPECIES", 0, 4], ["arthropod vectors", "OBSERVATION", 31, 48]]], ["LSDV outbreaks are typically associated with wet and warm seasons (6) and mosquitoes such as Aedes aegypti are efficient mechanical vector for the transmission and maintenance of LSDV (7) .", [["Aedes aegypti", "ORGANISM", 93, 106], ["Aedes aegypti", "SPECIES", 93, 106], ["LSDV", "SPECIES", 0, 4], ["Aedes aegypti", "SPECIES", 93, 106], ["LSDV", "SPECIES", 179, 183], ["LSDV outbreaks", "PROBLEM", 0, 14], ["wet and warm seasons", "PROBLEM", 45, 65], ["mechanical vector", "TREATMENT", 121, 138], ["maintenance of LSDV", "TREATMENT", 164, 183]]], ["The virus can infect other small ruminants such as sheep and goats, but does not cause clinical disease (9, 10) .", [["sheep", "ORGANISM", 51, 56], ["goats", "ORGANISM", 61, 66], ["sheep", "SPECIES", 51, 56], ["goats", "SPECIES", 61, 66], ["sheep", "SPECIES", 51, 56], ["goats", "SPECIES", 61, 66], ["The virus", "PROBLEM", 0, 9], ["clinical disease", "PROBLEM", 87, 103], ["virus", "OBSERVATION", 4, 9], ["small", "OBSERVATION_MODIFIER", 27, 32], ["ruminants", "OBSERVATION", 33, 42], ["does not cause", "UNCERTAINTY", 72, 86]]], ["However, contact of cattle herds with sheep and goat in grazing/ watering areas has been implicated as a potential risk factor for mechanical transmission of LSDV (11) .", [["cattle", "ORGANISM", 20, 26], ["herds", "ORGANISM_SUBDIVISION", 27, 32], ["sheep", "ORGANISM", 38, 43], ["goat", "ORGANISM", 48, 52], ["cattle", "SPECIES", 20, 26], ["sheep", "SPECIES", 38, 43], ["goat", "SPECIES", 48, 52], ["cattle", "SPECIES", 20, 26], ["sheep", "SPECIES", 38, 43], ["goat", "SPECIES", 48, 52], ["LSDV", "SPECIES", 158, 162], ["grazing/ watering areas", "TREATMENT", 56, 79], ["mechanical transmission of LSDV", "TREATMENT", 131, 162]]]], "2da5ff515585873c0a373806241a6b5c7c670028": [["IntroductionExperimental autoimmune encephalomyelitis (EAE) is an inflammatory disease of the central nervous system (CNS) in which CD4+ Tcells recognizing myelin proteins e.g. myelin basic protein (MBP) are crucial for disease induction [ 11.", [["central nervous system", "ANATOMY", 94, 116], ["CNS", "ANATOMY", 118, 121], ["autoimmune encephalomyelitis", "DISEASE", 25, 53], ["EAE", "DISEASE", 55, 58], ["disease of the central nervous system", "DISEASE", 79, 116], ["central nervous system", "ANATOMICAL_SYSTEM", 94, 116], ["CNS", "ANATOMICAL_SYSTEM", 118, 121], ["CD4", "GENE_OR_GENE_PRODUCT", 132, 135], ["Tcells", "GENE_OR_GENE_PRODUCT", 137, 143], ["myelin proteins", "GENE_OR_GENE_PRODUCT", 156, 171], ["myelin basic protein", "GENE_OR_GENE_PRODUCT", 177, 197], ["MBP", "GENE_OR_GENE_PRODUCT", 199, 202], ["CD4", "PROTEIN", 132, 135], ["myelin proteins", "PROTEIN", 156, 171], ["myelin basic protein", "PROTEIN", 177, 197], ["MBP", "PROTEIN", 199, 202], ["IntroductionExperimental autoimmune encephalomyelitis", "PROBLEM", 0, 53], ["an inflammatory disease of the central nervous system", "PROBLEM", 63, 116], ["myelin proteins", "PROBLEM", 156, 171], ["myelin basic protein", "PROBLEM", 177, 197], ["MBP", "TEST", 199, 202], ["disease induction", "PROBLEM", 220, 237], ["autoimmune encephalomyelitis", "OBSERVATION", 25, 53], ["inflammatory", "OBSERVATION_MODIFIER", 66, 78], ["central", "ANATOMY_MODIFIER", 94, 101], ["nervous system", "ANATOMY", 102, 116], ["CNS", "ANATOMY", 118, 121]]], ["The disease serves as a model for multiple sclerosis in humans.", [["multiple sclerosis", "DISEASE", 34, 52], ["humans", "ORGANISM", 56, 62], ["humans", "SPECIES", 56, 62], ["humans", "SPECIES", 56, 62], ["The disease serves", "PROBLEM", 0, 18], ["multiple sclerosis in humans", "PROBLEM", 34, 62], ["disease", "OBSERVATION", 4, 11], ["multiple", "OBSERVATION_MODIFIER", 34, 42], ["sclerosis", "OBSERVATION", 43, 52]]], ["The pathogenic CD4+ T cells are activated by recognition of myelin protein peptide bound to MHC class I1 molecules.", [["CD4+ T cells", "ANATOMY", 15, 27], ["CD4", "GENE_OR_GENE_PRODUCT", 15, 18], ["pathogenic CD4+ T cells", "CELL_TYPE", 4, 27], ["MHC class I1 molecules", "PROTEIN", 92, 114], ["The pathogenic CD4", "TEST", 0, 18], ["T cells", "PROBLEM", 20, 27], ["myelin protein peptide", "PROBLEM", 60, 82]]], ["In the LEWIS strain the MBP 63-88 peptide bound to the B (corresponding to DQ) class11 molecules is preferentially recognized after immunization [I 117511 with rat or guinea pig MBP .", [["63-88 peptide", "CHEMICAL", 28, 41], ["MBP", "GENE_OR_GENE_PRODUCT", 24, 27], ["B", "GENE_OR_GENE_PRODUCT", 55, 56], ["DQ", "GENE_OR_GENE_PRODUCT", 75, 77], ["class11", "GENE_OR_GENE_PRODUCT", 79, 86], ["rat", "ORGANISM", 160, 163], ["guinea pig", "ORGANISM", 167, 177], ["MBP", "GENE_OR_GENE_PRODUCT", 178, 181], ["MBP", "PROTEIN", 24, 27], ["B (corresponding to DQ) class11 molecules", "PROTEIN", 55, 96], ["rat or guinea pig MBP", "PROTEIN", 160, 181], ["rat", "SPECIES", 160, 163], ["guinea pig", "SPECIES", 167, 177], ["rat", "SPECIES", 160, 163], ["pig", "SPECIES", 174, 177], ["the MBP", "TEST", 20, 27], ["immunization", "TREATMENT", 132, 144], ["guinea pig MBP", "TREATMENT", 167, 181]]], ["The LEWIS strain is highly susceptible to EAE after immunization with MBP and not only MHC but also non-MHC genes are believed to be important .", [["EAE", "DISEASE", 42, 45], ["MBP", "GENE_OR_GENE_PRODUCT", 70, 73], ["MBP", "PROTEIN", 70, 73], ["MHC", "PROTEIN", 87, 90], ["MHC genes", "DNA", 104, 113], ["The LEWIS strain", "PROBLEM", 0, 16], ["immunization", "TREATMENT", 52, 64], ["MBP", "TEST", 70, 73]]], ["Studies using guinea pig spinal cord homogenate for immunization have shown that only the LEWIS strain develops clinical EAE as compared to several MHC congenic strains on the LEWIS background [6] and that background genes influence the disease susceptibility in the order of DA > LEWIS > BN [5] .IntroductionHowever, the guinea pig spinal cord homogenate or guinea pig MBP contain a large number of antigens which may activate the immune system differently in the various rat strains.", [["spinal cord homogenate", "ANATOMY", 25, 47], ["spinal cord homogenate", "ANATOMY", 333, 355], ["immune system", "ANATOMY", 432, 445], ["EAE", "DISEASE", 121, 124], ["DA", "CHEMICAL", 276, 278], ["guinea pig", "ORGANISM", 14, 24], ["spinal cord", "ORGAN", 25, 36], ["homogenate", "ORGANISM_SUBSTANCE", 37, 47], ["DA", "SIMPLE_CHEMICAL", 276, 278], ["guinea pig", "ORGANISM", 322, 332], ["spinal cord", "ORGAN", 333, 344], ["homogenate", "ORGANISM_SUBSTANCE", 345, 355], ["guinea pig", "ORGANISM", 359, 369], ["MBP", "GENE_OR_GENE_PRODUCT", 370, 373], ["rat", "ORGANISM", 473, 476], ["MHC", "PROTEIN", 148, 151], ["guinea pig MBP", "PROTEIN", 359, 373], ["antigens", "PROTEIN", 400, 408], ["guinea pig", "SPECIES", 14, 24], ["guinea pig", "SPECIES", 322, 332], ["guinea pig", "SPECIES", 359, 369], ["rat", "SPECIES", 473, 476], ["guinea", "SPECIES", 14, 20], ["pig", "SPECIES", 21, 24], ["guinea pig", "SPECIES", 322, 332], ["pig", "SPECIES", 366, 369], ["rat", "SPECIES", 473, 476], ["Studies", "TEST", 0, 7], ["guinea pig spinal cord homogenate", "TREATMENT", 14, 47], ["immunization", "TREATMENT", 52, 64], ["the LEWIS strain", "PROBLEM", 86, 102], ["clinical EAE", "PROBLEM", 112, 124], ["several MHC congenic strains", "PROBLEM", 140, 168], ["the disease susceptibility", "PROBLEM", 233, 259], ["Introduction", "TREATMENT", 297, 309], ["the guinea pig spinal cord homogenate", "TREATMENT", 318, 355], ["guinea pig MBP", "TEST", 359, 373], ["a large number of antigens", "PROBLEM", 382, 408], ["spinal cord", "ANATOMY", 25, 36], ["spinal cord", "ANATOMY", 333, 344], ["large", "OBSERVATION_MODIFIER", 384, 389]]], ["In addition, it is not yet clarified which RT1 haplotypes permit responses to the immunodominant MBP 63-88 and whether such immune responses lead to disease or not.", [["RT1", "GENE_OR_GENE_PRODUCT", 43, 46], ["MBP", "GENE_OR_GENE_PRODUCT", 97, 100], ["RT1", "PROTEIN", 43, 46], ["immunodominant MBP 63-88", "PROTEIN", 82, 106], ["the immunodominant MBP", "TEST", 78, 100], ["such immune responses", "PROBLEM", 119, 140], ["disease", "PROBLEM", 149, 156]]], ["Susceptibility to disease after immunization with an immunodominant self peptide may be directly related to its capacity to bind to the MHC class I1 molecule in question leading to activation of pathogenic T cells.", [["T cells", "ANATOMY", 206, 213], ["T cells", "CELL", 206, 213], ["MHC class I1 molecule", "PROTEIN", 136, 157], ["pathogenic T cells", "CELL_TYPE", 195, 213], ["Susceptibility to disease", "PROBLEM", 0, 25], ["immunization", "TREATMENT", 32, 44], ["an immunodominant self peptide", "TREATMENT", 50, 80], ["its capacity", "PROBLEM", 108, 120], ["pathogenic T cells", "PROBLEM", 195, 213], ["pathogenic T cells", "OBSERVATION", 195, 213]]], ["However, it is also possible that different class 11 molecules, upon binding to the peptide, trigger T cell activation of different quality, i.e. the responding T cell may produce different sets of cytokines.The functional division of T helper cells intoTHl cells producing IL-2, IFN-y and lymphotoxin and TH2 cells producing IL-4, IL-5 and IL-6 [8] has boosted the interest in this area.", [["T cell", "ANATOMY", 101, 107], ["T cell", "ANATOMY", 161, 167], ["T helper cells intoTHl cells", "ANATOMY", 235, 263], ["TH2 cells", "ANATOMY", 306, 315], ["T cell", "CELL", 101, 107], ["T cell", "CELL", 161, 167], ["T helper cells", "CELL", 235, 249], ["intoTHl cells", "CELL", 250, 263], ["IL-2", "GENE_OR_GENE_PRODUCT", 274, 278], ["IFN", "GENE_OR_GENE_PRODUCT", 280, 283], ["lymphotoxin", "GENE_OR_GENE_PRODUCT", 290, 301], ["TH2 cells", "CELL", 306, 315], ["IL-4", "GENE_OR_GENE_PRODUCT", 326, 330], ["IL-5", "GENE_OR_GENE_PRODUCT", 332, 336], ["IL-6", "GENE_OR_GENE_PRODUCT", 341, 345], ["class 11 molecules", "PROTEIN", 44, 62], ["T cell", "CELL_TYPE", 161, 167], ["cytokines", "PROTEIN", 198, 207], ["T helper cells", "CELL_TYPE", 235, 249], ["intoTHl cells", "CELL_TYPE", 250, 263], ["IL-2", "PROTEIN", 274, 278], ["IFN", "PROTEIN", 280, 283], ["lymphotoxin", "PROTEIN", 290, 301], ["TH2 cells", "CELL_TYPE", 306, 315], ["IL", "PROTEIN", 326, 328], ["IL", "PROTEIN", 332, 334], ["different class 11 molecules", "PROBLEM", 34, 62], ["cells", "TEST", 258, 263], ["IL", "TEST", 274, 276], ["IFN-y", "TEST", 280, 285], ["lymphotoxin", "TEST", 290, 301], ["TH2 cells", "TEST", 306, 315], ["IL", "TEST", 326, 328], ["IL", "TEST", 332, 334], ["IL", "TEST", 341, 343], ["lymphotoxin", "ANATOMY", 290, 301]]], ["During certain infections, preferential recruitment of either subset is genetically regulated and has profound influence on the outcome of the infection [9] .", [["infections", "DISEASE", 15, 25], ["infection", "DISEASE", 143, 152], ["certain infections", "PROBLEM", 7, 25], ["the infection", "PROBLEM", 139, 152], ["infections", "OBSERVATION", 15, 25], ["preferential", "OBSERVATION_MODIFIER", 27, 39], ["recruitment", "OBSERVATION_MODIFIER", 40, 51], ["profound", "OBSERVATION_MODIFIER", 102, 110], ["influence", "OBSERVATION_MODIFIER", 111, 120], ["infection", "OBSERVATION", 143, 152]]], ["A direct role of the MHC class11 genes to determine the outcome of cytokine secretion TH1 or TH2 pattern in the T cell response has earlier been demonstrated for the recognition of a type IV collagen peptide [lo] .", [["T cell", "ANATOMY", 112, 118], ["TH1", "GENE_OR_GENE_PRODUCT", 86, 89], ["TH2", "GENE_OR_GENE_PRODUCT", 93, 96], ["T cell", "CELL", 112, 118], ["type IV collagen", "GENE_OR_GENE_PRODUCT", 183, 199], ["MHC class11 genes", "DNA", 21, 38], ["cytokine", "PROTEIN", 67, 75], ["cytokine secretion", "TEST", 67, 85], ["a type IV collagen peptide", "TREATMENT", 181, 207]]], ["In EAE there are several lines of evidence suggesting that IFNy-producing T cells promote disease development (for reviews see [ l l , 121) whereas IL-4-and TGF-fkproducing T cells have no or possibly a down-regulating role [13-151.", [["T cells", "ANATOMY", 74, 81], ["TGF-fkproducing T cells", "ANATOMY", 157, 180], ["EAE", "DISEASE", 3, 6], ["IFNy", "GENE_OR_GENE_PRODUCT", 59, 63], ["T cells", "CELL", 74, 81], ["IL-4", "GENE_OR_GENE_PRODUCT", 148, 152], ["TGF", "GENE_OR_GENE_PRODUCT", 157, 160], ["T cells", "CELL", 173, 180], ["IFNy-producing T cells", "CELL_TYPE", 59, 81], ["TGF", "PROTEIN", 157, 160], ["T cells", "CELL_TYPE", 173, 180], ["IFNy", "PROBLEM", 59, 63], ["T cells", "PROBLEM", 74, 81], ["IL", "TEST", 148, 150], ["TGF", "TEST", 157, 160], ["several", "OBSERVATION_MODIFIER", 17, 24], ["lines", "OBSERVATION", 25, 30]]], ["It has recently been shown that cloned MBP-reactive TH1 cells but not TH2 cells transfer disease [15] .", [["TH1 cells", "ANATOMY", 52, 61], ["TH2 cells", "ANATOMY", 70, 79], ["MBP", "GENE_OR_GENE_PRODUCT", 39, 42], ["TH1 cells", "CELL", 52, 61], ["TH2 cells", "CELL", 70, 79], ["MBP", "PROTEIN", 39, 42], ["TH1 cells", "CELL_TYPE", 52, 61], ["TH2 cells", "CELL_LINE", 70, 79], ["cloned MBP", "TEST", 32, 42], ["reactive TH1 cells", "PROBLEM", 43, 61], ["TH2 cells transfer disease", "PROBLEM", 70, 96], ["reactive", "OBSERVATION_MODIFIER", 43, 51], ["TH1 cells", "OBSERVATION", 52, 61], ["not", "UNCERTAINTY", 66, 69], ["TH2 cells", "OBSERVATION", 70, 79]]], ["EAE downregulatory properties of certain cytokines have been suggested from experiments in which CD4+ Tcells could suppress IFN-y producing effector T cells by producing IL-4 and TGF-fi in a class 11-restricted fashion [16, 171.", [["Tcells", "ANATOMY", 102, 108], ["effector T cells", "ANATOMY", 140, 156], ["EAE", "DISEASE", 0, 3], ["CD4", "GENE_OR_GENE_PRODUCT", 97, 100], ["Tcells", "GENE_OR_GENE_PRODUCT", 102, 108], ["IFN", "GENE_OR_GENE_PRODUCT", 124, 127], ["effector T cells", "CELL", 140, 156], ["IL-4", "GENE_OR_GENE_PRODUCT", 170, 174], ["TGF-fi", "GENE_OR_GENE_PRODUCT", 179, 185], ["cytokines", "PROTEIN", 41, 50], ["CD4", "PROTEIN", 97, 100], ["IFN", "PROTEIN", 124, 127], ["effector T cells", "CELL_TYPE", 140, 156], ["IL", "PROTEIN", 170, 172], ["TGF", "PROTEIN", 179, 182], ["certain cytokines", "PROBLEM", 33, 50], ["Tcells", "TEST", 102, 108], ["IFN-y", "TEST", 124, 129], ["IL", "TEST", 170, 172], ["TGF", "TEST", 179, 182]]], ["To specifically address the MHC association of disease susceptibility and the relevance for a possible MHC association of the cytokine pattern of the T cell response we have analyzed a series of MHC congenic LEWIS strains with the immunodominant MBP 63-88 peptide.", [["T cell", "ANATOMY", 150, 156], ["T cell", "CELL", 150, 156], ["MBP", "GENE_OR_GENE_PRODUCT", 246, 249], ["MHC", "PROTEIN", 28, 31], ["MHC", "PROTEIN", 103, 106], ["cytokine", "PROTEIN", 126, 134], ["MHC", "PROTEIN", 195, 198], ["MBP", "PROTEIN", 246, 249], ["disease susceptibility", "PROBLEM", 47, 69], ["MHC congenic LEWIS strains", "TREATMENT", 195, 221], ["the immunodominant MBP", "TEST", 227, 249], ["disease", "OBSERVATION", 47, 54]]], ["We found that susceptibility to the disease correlated with a T H l type of response, whereas resistance to disease was related either to an MBP peptide non-responsiveness or to an additional early appearence of a qualitatively different response with production of IL-4 and TGF-p.Induction and evaluation of EAESpecific pathogen-free LEWIS-congenic strains (LEWIS, LEWl.A, LEWl.F, LEWl.N, LEWl.D, LEW1.C and LEW1.W) were originally provided by the Zentralinstitut f i r Versuchtiersucht (Hannover, Germany) and subsequently bred in the animals department of Biomedical Centre, Uppsala University.The rats were kept in a separate animal room under climate-controlled conditions with a 12-h IightJdark cycle, housed in polystyrene cages containing wood shavings and fed standard rodent chow and water ad libitum.", [["polystyrene", "CHEMICAL", 718, 729], ["MBP", "GENE_OR_GENE_PRODUCT", 141, 144], ["IL-4", "GENE_OR_GENE_PRODUCT", 266, 270], ["TGF-p", "GENE_OR_GENE_PRODUCT", 275, 280], ["D", "SIMPLE_CHEMICAL", 395, 396], ["rats", "ORGANISM", 601, 605], ["MBP", "PROTEIN", 141, 144], ["IL-4", "PROTEIN", 266, 270], ["TGF", "PROTEIN", 275, 278], ["LEW1", "DNA", 398, 402], ["LEW1", "DNA", 409, 413], ["rats", "SPECIES", 601, 605], ["rodent", "SPECIES", 778, 784], ["the disease", "PROBLEM", 32, 43], ["disease", "PROBLEM", 108, 115], ["an MBP peptide non-responsiveness", "PROBLEM", 138, 171], ["IL", "TEST", 266, 268], ["evaluation", "TEST", 295, 305], ["EAESpecific pathogen", "TEST", 309, 329], ["congenic strains", "PROBLEM", 341, 357], ["a 12-h IightJdark cycle", "TREATMENT", 683, 706], ["housed in polystyrene cages", "TREATMENT", 708, 735], ["wood shavings", "TREATMENT", 747, 760], ["disease", "OBSERVATION", 36, 43], ["wood shavings", "OBSERVATION", 747, 760]]], ["The rats were 8-12 weeks old and were age-and sex-matched before the experiment.", [["rats", "ORGANISM", 4, 8], ["rats", "SPECIES", 4, 8]]], ["During the experiment 2-3 rats were housed in each cage.", [["rats", "ORGANISM", 26, 30], ["rats", "SPECIES", 26, 30]]], ["The rat colonies were regularly screened for pathogens and were found to be free from common pathogens including Sendai virus, Hantaan virus, coronavirus, reovirus, cytomegalovirus and Mycoplasma pulmonis.Induction and evaluation of EAEFor induction of EAE, the MBP 63-88 peptide was used.", [["colonies", "ANATOMY", 8, 16], ["Sendai virus", "DISEASE", 113, 125], ["Hantaan virus, coronavirus, reovirus, cytomegalovirus", "DISEASE", 127, 180], ["EAE", "DISEASE", 253, 256], ["MBP 63-88 peptide", "CHEMICAL", 262, 279], ["rat", "ORGANISM", 4, 7], ["Sendai virus", "ORGANISM", 113, 125], ["Hantaan virus", "ORGANISM", 127, 140], ["coronavirus", "ORGANISM", 142, 153], ["reovirus", "ORGANISM", 155, 163], ["cytomegalovirus", "ORGANISM", 165, 180], ["Mycoplasma pulmonis", "ORGANISM", 185, 204], ["MBP", "GENE_OR_GENE_PRODUCT", 262, 265], ["rat colonies", "CELL_LINE", 4, 16], ["MBP", "PROTEIN", 262, 265], ["rat", "SPECIES", 4, 7], ["Sendai virus", "SPECIES", 113, 125], ["Hantaan virus", "SPECIES", 127, 140], ["coronavirus, reovirus", "SPECIES", 142, 163], ["Mycoplasma pulmonis", "SPECIES", 185, 204], ["rat", "SPECIES", 4, 7], ["Sendai virus", "SPECIES", 113, 125], ["Hantaan virus", "SPECIES", 127, 140], ["Mycoplasma pulmonis", "SPECIES", 185, 204], ["The rat colonies", "TEST", 0, 16], ["pathogens", "PROBLEM", 45, 54], ["common pathogens", "PROBLEM", 86, 102], ["Sendai virus", "PROBLEM", 113, 125], ["Hantaan virus", "PROBLEM", 127, 140], ["coronavirus", "PROBLEM", 142, 153], ["reovirus", "PROBLEM", 155, 163], ["cytomegalovirus", "PROBLEM", 165, 180], ["Mycoplasma pulmonis", "PROBLEM", 185, 204], ["evaluation", "TEST", 219, 229], ["EAE", "TEST", 253, 256], ["the MBP", "TEST", 258, 265], ["Sendai virus", "OBSERVATION", 113, 125], ["Hantaan virus", "OBSERVATION", 127, 140], ["cytomegalovirus", "OBSERVATION", 165, 180], ["Mycoplasma pulmonis", "OBSERVATION", 185, 204]]], ["This peptide is known to contain the immunodominant T cell epitope which has precisely been mapped to the 68-88 peptide and which contains earlier identified B cell epitopes [18] .The MBP 63-88 peptide contains the following residues (one letter code): AARTTHYGSLPQKSQR-SQDENPVVHF and represents the guinea pig MBP sequence which differs from the rat homologue at position 79 (T instead of S).", [["T cell", "ANATOMY", 52, 58], ["B cell", "ANATOMY", 158, 164], ["MBP 63-88 peptide", "CHEMICAL", 184, 201], ["T cell", "CELL", 52, 58], ["B cell", "CELL", 158, 164], ["MBP", "GENE_OR_GENE_PRODUCT", 184, 187], ["guinea pig", "ORGANISM", 300, 310], ["MBP", "GENE_OR_GENE_PRODUCT", 311, 314], ["rat", "ORGANISM", 347, 350], ["immunodominant T cell epitope", "PROTEIN", 37, 66], ["B cell epitopes", "PROTEIN", 158, 173], ["MBP", "PROTEIN", 184, 187], ["AARTTHYGSLPQKSQR", "PROTEIN", 253, 269], ["SQDENPVVHF", "PROTEIN", 270, 280], ["guinea pig MBP sequence", "PROTEIN", 300, 323], ["rat homologue", "PROTEIN", 347, 360], ["position 79", "PROTEIN", 364, 375], ["guinea pig", "SPECIES", 300, 310], ["rat", "SPECIES", 347, 350], ["guinea pig", "SPECIES", 300, 310], ["the immunodominant T cell epitope", "PROBLEM", 33, 66], ["The MBP", "TEST", 180, 187], ["SQDENPVVHF", "PROBLEM", 270, 280], ["the guinea pig MBP sequence", "TREATMENT", 296, 323], ["immunodominant T cell epitope", "OBSERVATION", 37, 66], ["B cell epitopes", "OBSERVATION", 158, 173]]], ["This peptide was synthesized on a peptide synthesizer (model 430A; Applied Biosystems, Inc., Foster City, CA) followed by purification on HPLC employing reverse-phase chromatography on the C18 column eluted with acetonitrile gradient (O-60Y0) in 0.1% trifluoroacetic acid.", [["acetonitrile gradient", "CHEMICAL", 212, 233], ["O-60Y0", "CHEMICAL", 235, 241], ["trifluoroacetic acid", "CHEMICAL", 251, 271], ["acetonitrile", "CHEMICAL", 212, 224], ["O-60Y0", "CHEMICAL", 235, 241], ["trifluoroacetic acid", "CHEMICAL", 251, 271], ["acetonitrile", "SIMPLE_CHEMICAL", 212, 224], ["O-60Y0", "SIMPLE_CHEMICAL", 235, 241], ["trifluoroacetic acid", "SIMPLE_CHEMICAL", 251, 271], ["a peptide synthesizer", "TREATMENT", 32, 53], ["HPLC", "TEST", 138, 142], ["the C18 column", "TREATMENT", 185, 199], ["acetonitrile gradient", "TEST", 212, 233]]], ["Amino acid analyses confirmed the correct product.", [["Amino acid", "CHEMICAL", 0, 10], ["Amino acid", "CHEMICAL", 0, 10], ["Amino acid", "AMINO_ACID", 0, 10], ["Amino acid analyses", "TEST", 0, 19]]], ["Another peptide of MBP (MBP 89-101) with a sequence VHFFKNIVTPRTE used in various immunoassays, was also synthesized.", [["MBP 89-101", "CHEMICAL", 24, 34], ["MBP", "GENE_OR_GENE_PRODUCT", 19, 22], ["MBP", "PROTEIN", 19, 22], ["MBP", "PROTEIN", 24, 27], ["VHFFKNIVTPRTE", "PROTEIN", 52, 65], ["MBP", "TEST", 19, 22], ["MBP", "TEST", 24, 27], ["a sequence VHFFKNIVTPRTE", "TEST", 41, 65], ["various immunoassays", "TEST", 74, 94]]], ["Whole guinea pig MBP was prepared as described [19] .", [["guinea pig", "ORGANISM", 6, 16], ["MBP", "GENE_OR_GENE_PRODUCT", 17, 20], ["MBP", "PROTEIN", 17, 20], ["guinea pig", "SPECIES", 6, 16], ["Whole guinea pig", "SPECIES", 0, 16], ["Whole guinea pig MBP", "TREATMENT", 0, 20]]], ["ConA was purchased from Flow (Flow Laboratories, Irvine, Scotland).Induction and evaluation of EAEEach rat was immunized into both hind foot pads with 100 pl of an inoculum, containing in total 1 0 0~1 Freund's incomplete adjuvant (FIA; Difco, Detroit, MI), 2 mg of Mycobacterium tuberculosis (MT), 100 pl saline and 250pg MBP 63-88.Induction and evaluation of EAEClinical grading was done every second day as follows: 0 = no illness, 1 = flaccid tail, 2 = moderate paraparesis, 3 = severe paraparesis, 4 = moribund state or death.", [["hind foot pads", "ANATOMY", 131, 145], ["Mycobacterium tuberculosis", "DISEASE", 266, 292], ["illness", "DISEASE", 426, 433], ["paraparesis", "DISEASE", 466, 477], ["paraparesis", "DISEASE", 490, 501], ["death", "DISEASE", 525, 530], ["ConA", "GENE_OR_GENE_PRODUCT", 0, 4], ["EAEEach", "ORGANISM", 95, 102], ["rat", "ORGANISM", 103, 106], ["Mycobacterium tuberculosis", "ORGANISM", 266, 292], ["rat", "SPECIES", 103, 106], ["Mycobacterium tuberculosis", "SPECIES", 266, 292], ["rat", "SPECIES", 103, 106], ["Mycobacterium tuberculosis", "SPECIES", 266, 292], ["evaluation of EAEEach rat", "TEST", 81, 106], ["an inoculum", "TREATMENT", 161, 172], ["adjuvant (FIA", "TREATMENT", 222, 235], ["MI", "PROBLEM", 253, 255], ["Mycobacterium tuberculosis", "TREATMENT", 266, 292], ["100 pl saline", "TREATMENT", 299, 312], ["MBP", "TEST", 323, 326], ["evaluation of EAEClinical grading", "TEST", 347, 380], ["illness", "PROBLEM", 426, 433], ["moderate paraparesis", "PROBLEM", 457, 477], ["severe paraparesis", "PROBLEM", 483, 501], ["death", "PROBLEM", 525, 530], ["hind foot", "ANATOMY", 131, 140], ["inoculum", "OBSERVATION", 164, 172], ["no", "UNCERTAINTY", 423, 425], ["flaccid tail", "ANATOMY", 439, 451], ["moderate", "OBSERVATION_MODIFIER", 457, 465], ["paraparesis", "OBSERVATION", 466, 477], ["severe", "OBSERVATION_MODIFIER", 483, 489], ["paraparesis", "OBSERVATION", 490, 501]]], ["Rats were killed under ether anaesthesia on day 7 or 14 postimmunization ( p i ) for various immunoassays, while four rats of each strain were observed until day 40 p.i.", [["ether", "CHEMICAL", 23, 28], ["Rats", "ORGANISM", 0, 4], ["rats", "ORGANISM", 118, 122], ["Rats", "SPECIES", 0, 4], ["rats", "SPECIES", 118, 122], ["various immunoassays", "TEST", 85, 105]]], ["Popliteal and inguinal lymph node cells were dissected and lymph node cell (LNC) suspension prepared by standard techniques.Induction and evaluation of EAEFor immunohistochemical grading of the CNS inflammation, segments of the lumbar spinal cord, from 2-4 rats of most congenic strains day 14 p.i., were snap-frozen in liquid nitrogen.", [["Popliteal", "ANATOMY", 0, 9], ["inguinal lymph node cells", "ANATOMY", 14, 39], ["lymph node cell", "ANATOMY", 59, 74], ["LNC", "ANATOMY", 76, 79], ["CNS", "ANATOMY", 194, 197], ["lumbar spinal cord", "ANATOMY", 228, 246], ["inflammation", "DISEASE", 198, 210], ["nitrogen", "CHEMICAL", 327, 335], ["Popliteal", "MULTI-TISSUE_STRUCTURE", 0, 9], ["inguinal lymph node cells", "CELL", 14, 39], ["lymph node cell", "CELL", 59, 74], ["LNC", "CELL", 76, 79], ["CNS inflammation", "PATHOLOGICAL_FORMATION", 194, 210], ["lumbar", "ORGAN", 228, 234], ["spinal cord", "ORGAN", 235, 246], ["rats", "ORGANISM", 257, 261], ["Popliteal and inguinal lymph node cells", "CELL_TYPE", 0, 39], ["rats", "SPECIES", 257, 261], ["Popliteal and inguinal lymph node cells", "PROBLEM", 0, 39], ["lymph node cell (LNC) suspension", "TREATMENT", 59, 91], ["evaluation", "TEST", 138, 148], ["immunohistochemical grading", "TEST", 159, 186], ["the CNS inflammation", "PROBLEM", 190, 210], ["segments of the lumbar spinal cord", "PROBLEM", 212, 246], ["snap", "TEST", 305, 309], ["liquid nitrogen", "TREATMENT", 320, 335], ["inguinal", "ANATOMY", 14, 22], ["lymph node cells", "OBSERVATION", 23, 39], ["lymph node cell", "OBSERVATION", 59, 74], ["CNS", "ANATOMY", 194, 197], ["inflammation", "OBSERVATION", 198, 210], ["segments", "ANATOMY_MODIFIER", 212, 220], ["lumbar", "ANATOMY_MODIFIER", 228, 234], ["spinal cord", "ANATOMY", 235, 246]]], ["Cryostat sections were stained with monoclonal antibodies against a series of T lymphocytes antigens and MHC class I and I1 antigens as described before [20] .", [["Cryostat sections", "ANATOMY", 0, 17], ["T lymphocytes", "ANATOMY", 78, 91], ["Cryostat sections", "CANCER", 0, 17], ["T lymphocytes", "CELL", 78, 91], ["MHC class I", "GENE_OR_GENE_PRODUCT", 105, 116], ["I1 antigens", "GENE_OR_GENE_PRODUCT", 121, 132], ["monoclonal antibodies", "PROTEIN", 36, 57], ["T lymphocytes antigens", "PROTEIN", 78, 100], ["MHC class I and I1 antigens", "PROTEIN", 105, 132], ["Cryostat sections", "TEST", 0, 17], ["monoclonal antibodies", "TEST", 36, 57], ["T lymphocytes antigens", "PROBLEM", 78, 100]]], ["The noted inflammation was roughly categorized into 0 = no inflammation, + = few inflammatory infiltrates, ++ = moderate number of inflammatory infiltrates, + + + = extensive inflammation with dense distribution of foci.T cell-mediated immunity measured by antigen-induced IFN-y secretion and T cell proliferative responseLNC suspensions were washed twice and adjusted to 5 X lo6 viable celldm1 in complete Dulbeccos modified Eagles medium (DMEM) (Flow Labs.) containing 1% (v/v) minimum essential medium (Flow), 50 IU/ml penicillin, 60 pg/ml streptomycin (Gibco, Paisley, Scotland), 2 mM glutamine (Flow) and 5% (v/v) heat-inactivated fetal calf calf serum (Gibco) .T cell-mediated immunity measured by antigen-induced IFN-y secretion and T cell proliferative responseAn immunospot assay that enables detection of single cells secreting IFN-y [21] was adopted to enumerate rat IFN-y secreting cells [22] .", [["foci", "ANATOMY", 215, 219], ["T cell", "ANATOMY", 220, 226], ["T cell", "ANATOMY", 293, 299], ["fetal calf calf serum", "ANATOMY", 636, 657], ["T cell", "ANATOMY", 667, 673], ["T cell", "ANATOMY", 740, 746], ["cells", "ANATOMY", 822, 827], ["cells", "ANATOMY", 894, 899], ["inflammation", "DISEASE", 10, 22], ["inflammation", "DISEASE", 59, 71], ["inflammation", "DISEASE", 175, 187], ["penicillin", "CHEMICAL", 522, 532], ["streptomycin", "CHEMICAL", 543, 555], ["glutamine", "CHEMICAL", 589, 598], ["penicillin", "CHEMICAL", 522, 532], ["streptomycin", "CHEMICAL", 543, 555], ["glutamine", "CHEMICAL", 589, 598], ["T cell", "CELL", 220, 226], ["antigen", "GENE_OR_GENE_PRODUCT", 257, 264], ["IFN", "GENE_OR_GENE_PRODUCT", 273, 276], ["T cell", "CELL", 293, 299], ["penicillin", "SIMPLE_CHEMICAL", 522, 532], ["streptomycin", "SIMPLE_CHEMICAL", 543, 555], ["glutamine", "SIMPLE_CHEMICAL", 589, 598], ["calf", "ORGANISM", 642, 646], ["calf", "ORGANISM_SUBSTANCE", 647, 651], ["serum", "ORGANISM_SUBSTANCE", 652, 657], ["Gibco", "ORGANISM_SUBSTANCE", 659, 664], ["T cell", "CELL", 667, 673], ["antigen", "GENE_OR_GENE_PRODUCT", 704, 711], ["IFN", "GENE_OR_GENE_PRODUCT", 720, 723], ["T cell", "CELL", 740, 746], ["cells", "CELL", 822, 827], ["rat", "ORGANISM", 874, 877], ["IFN", "GENE_OR_GENE_PRODUCT", 878, 881], ["cells", "CELL", 894, 899], ["IFN", "PROTEIN", 273, 276], ["IFN", "PROTEIN", 720, 723], ["IFN", "PROTEIN", 838, 841], ["IFN", "PROTEIN", 878, 881], ["calf", "SPECIES", 642, 646], ["calf", "SPECIES", 647, 651], ["rat", "SPECIES", 874, 877], ["rat", "SPECIES", 874, 877], ["The noted inflammation", "PROBLEM", 0, 22], ["inflammation", "PROBLEM", 59, 71], ["few inflammatory infiltrates", "PROBLEM", 77, 105], ["inflammatory infiltrates", "PROBLEM", 131, 155], ["extensive inflammation", "PROBLEM", 165, 187], ["dense distribution of foci", "PROBLEM", 193, 219], ["T cell", "TEST", 220, 226], ["antigen", "TEST", 257, 264], ["IFN-y secretion", "PROBLEM", 273, 288], ["T cell proliferative responseLNC suspensions", "TREATMENT", 293, 337], ["Flow Labs", "TEST", 448, 457], ["essential medium (Flow)", "TREATMENT", 488, 511], ["penicillin", "TREATMENT", 522, 532], ["streptomycin", "TREATMENT", 543, 555], ["Flow", "TEST", 600, 604], ["heat", "TEST", 619, 623], ["fetal calf calf serum", "TEST", 636, 657], ["T cell", "TEST", 667, 673], ["antigen", "TEST", 704, 711], ["IFN-y secretion", "TEST", 720, 735], ["T cell proliferative responseAn", "TEST", 740, 771], ["immunospot assay", "TEST", 772, 788], ["single cells", "PROBLEM", 815, 827], ["inflammation", "OBSERVATION", 10, 22], ["no", "UNCERTAINTY", 56, 58], ["inflammation", "OBSERVATION", 59, 71], ["few", "OBSERVATION_MODIFIER", 77, 80], ["inflammatory", "OBSERVATION_MODIFIER", 81, 93], ["infiltrates", "OBSERVATION", 94, 105], ["++", "OBSERVATION_MODIFIER", 107, 109], ["moderate", "OBSERVATION_MODIFIER", 112, 120], ["number", "OBSERVATION_MODIFIER", 121, 127], ["inflammatory", "OBSERVATION_MODIFIER", 131, 143], ["infiltrates", "OBSERVATION", 144, 155], ["+ +", "OBSERVATION_MODIFIER", 159, 162], ["extensive", "OBSERVATION_MODIFIER", 165, 174], ["inflammation", "OBSERVATION", 175, 187], ["dense", "OBSERVATION_MODIFIER", 193, 198], ["distribution", "OBSERVATION_MODIFIER", 199, 211], ["foci", "OBSERVATION", 215, 219], ["fetal", "ANATOMY_MODIFIER", 636, 641], ["calf calf", "ANATOMY", 642, 651]]], ["In principle, nitrocellulose-bottom microtiter plates (Millilitre-HAM, Millipore Co., Bedford, MA) were coated with mAb directed against rat IFNy (DB1, a generous gift from Dr. Peter van der Meide,TNO Primate Centre, Rijswijk, The Netherlands) [23] .", [["nitrocellulose", "CHEMICAL", 14, 28], ["rat", "ORGANISM", 137, 140], ["mAb", "PROTEIN", 116, 119], ["rat IFNy", "PROTEIN", 137, 145], ["rat", "SPECIES", 137, 140], ["rat", "SPECIES", 137, 140], ["nitrocellulose-bottom microtiter plates", "TREATMENT", 14, 53], ["mAb", "TREATMENT", 116, 119]]], ["LNC suspensions ( 2 0 0 4 aliquots, lo6 cells/well) were added to duplicate or triplicate wells and antigens added to obtain final concentrations of 10pg/ml of MBP 63-88 and MBP 89-101, and 5 pg of Con A. Other duplicate wells received no exogenous antigen to serve as background controls.", [["LNC suspensions", "ANATOMY", 0, 15], ["lo6 cells", "ANATOMY", 36, 45], ["lo6 cells", "CELL", 36, 45], ["MBP", "GENE_OR_GENE_PRODUCT", 160, 163], ["MBP", "PROTEIN", 160, 163], ["MBP", "PROTEIN", 174, 177], ["Con A.", "SPECIES", 198, 204], ["LNC suspensions", "TREATMENT", 0, 15], ["lo6 cells", "TREATMENT", 36, 45], ["MBP", "TEST", 160, 163], ["MBP", "TEST", 174, 177], ["exogenous antigen", "TREATMENT", 239, 256]]], ["After 48-h culture at 37\u00b0C and 7% C02 in humid atmosphere, the cells were discarded and secreted and bound IFN-y visualized by a rabbit polyclonal anti-rat IFN-y antibody, biotinylated anti-rabbit IgG, avidin-biotin peroxidase complex and peroxidase staining, resulting in stained spots corresponding to single cells that had secreted the cytokine.", [["cells", "ANATOMY", 63, 68], ["cells", "ANATOMY", 311, 316], ["biotin", "CHEMICAL", 209, 215], ["C02", "SIMPLE_CHEMICAL", 34, 37], ["cells", "CELL", 63, 68], ["IFN", "GENE_OR_GENE_PRODUCT", 107, 110], ["rabbit", "ORGANISM", 129, 135], ["avidin", "GENE_OR_GENE_PRODUCT", 202, 208], ["biotin peroxidase complex", "GENE_OR_GENE_PRODUCT", 209, 234], ["peroxidase", "GENE_OR_GENE_PRODUCT", 239, 249], ["cells", "CELL", 311, 316], ["IFN", "PROTEIN", 107, 110], ["rabbit polyclonal anti-rat IFN-y antibody", "PROTEIN", 129, 170], ["biotinylated anti-rabbit IgG", "PROTEIN", 172, 200], ["avidin", "PROTEIN", 202, 208], ["biotin peroxidase complex", "PROTEIN", 209, 234], ["peroxidase", "PROTEIN", 239, 249], ["cytokine", "PROTEIN", 339, 347], ["rabbit", "SPECIES", 129, 135], ["anti-rat", "SPECIES", 147, 155], ["anti-rabbit", "SPECIES", 185, 196], ["rabbit", "SPECIES", 129, 135], ["anti-rabbit", "SPECIES", 185, 196], ["culture", "TEST", 11, 18], ["the cells", "TEST", 59, 68], ["a rabbit polyclonal anti-rat IFN-y antibody", "TEST", 127, 170], ["biotinylated anti-rabbit IgG", "TEST", 172, 200], ["avidin", "TEST", 202, 208], ["biotin peroxidase complex", "PROBLEM", 209, 234], ["peroxidase staining", "PROBLEM", 239, 258], ["stained spots", "PROBLEM", 273, 286], ["single cells", "PROBLEM", 304, 316]]], ["The number of spots were enumerated and expressed as number per lo6 plated LNC.T cell-mediated immunity measured by antigen-induced IFN-y secretion and T cell proliferative responseFor measurement of antigen-induced lymphocyte proliferation, aliquots in triplicates (2OOpl) of LNC suspension were applied in round-bottom 96-well microtiter plates (Nunc Copenhagen, Denmark) at a cell density of 3 x lo6 cells/ml.", [["LNC", "ANATOMY", 75, 78], ["T cell", "ANATOMY", 79, 85], ["T cell", "ANATOMY", 152, 158], ["lymphocyte", "ANATOMY", 216, 226], ["cell", "ANATOMY", 379, 383], ["cells", "ANATOMY", 403, 408], ["T cell", "CELL", 79, 85], ["antigen", "GENE_OR_GENE_PRODUCT", 116, 123], ["IFN", "GENE_OR_GENE_PRODUCT", 132, 135], ["T cell", "CELL", 152, 158], ["antigen", "GENE_OR_GENE_PRODUCT", 200, 207], ["lymphocyte", "CELL", 216, 226], ["cell", "CELL", 379, 383], ["lo6 plated LNC", "CELL_LINE", 64, 78], ["IFN", "PROTEIN", 132, 135], ["T cell", "TEST", 79, 85], ["antigen", "TEST", 116, 123], ["IFN-y secretion", "PROBLEM", 132, 147], ["T cell proliferative response", "PROBLEM", 152, 181], ["antigen-induced lymphocyte proliferation", "TREATMENT", 200, 240], ["LNC suspension", "TREATMENT", 277, 291], ["bottom", "TEST", 314, 320], ["spots", "OBSERVATION", 14, 19], ["cell proliferative response", "OBSERVATION", 154, 181], ["lymphocyte proliferation", "OBSERVATION", 216, 240], ["LNC", "ANATOMY", 277, 280]]], ["The different antigens were added as described above.", [["antigens", "PROTEIN", 14, 22], ["The different antigens", "TREATMENT", 0, 22]]], ["After 60 h of incubation, the cells were pulsed for 10 h with [3H]methyl-thymidine (10~1, 100 pCi/ml; Amersham, Little Chalfont, GB).", [["cells", "ANATOMY", 30, 35], ["[3H]methyl-thymidine", "CHEMICAL", 62, 82], ["[3H]methyl-thymidine", "CHEMICAL", 62, 82], ["cells", "CELL", 30, 35], ["[3H]methyl-thymidine", "SIMPLE_CHEMICAL", 62, 82], ["incubation", "TREATMENT", 14, 24], ["the cells", "TREATMENT", 26, 35], ["methyl-thymidine", "TREATMENT", 66, 82], ["Amersham", "TREATMENT", 102, 110], ["GB", "ANATOMY", 129, 131]]], ["Cells were harvested and thymidine incorporation was counted in a p-scintillation counter.2.3Antigen-induced mRNA expression for IFN-y, and TGF-B2.3For each sampling interval, day 7 and 14 p i , a total of six to eight rats from each strain were used for these studies.Statistical analysisThe non-parametric Mann-Whitney's test was used.MHC association with MBP 63-Wmduced EAEA survey of RT1 class I1 haplotypes and the EAE susceptibility is presented in Table 1 .", [["Cells", "ANATOMY", 0, 5], ["thymidine", "CHEMICAL", 25, 34], ["EAE", "DISEASE", 420, 423], ["thymidine", "CHEMICAL", 25, 34], ["Cells", "CELL", 0, 5], ["thymidine", "SIMPLE_CHEMICAL", 25, 34], ["IFN-y", "GENE_OR_GENE_PRODUCT", 129, 134], ["TGF-B2.3", "GENE_OR_GENE_PRODUCT", 140, 148], ["rats", "ORGANISM", 219, 223], ["MBP", "GENE_OR_GENE_PRODUCT", 358, 361], ["RT1 class I1", "GENE_OR_GENE_PRODUCT", 388, 400], ["IFN", "PROTEIN", 129, 132], ["TGF", "PROTEIN", 140, 143], ["MHC", "PROTEIN", 337, 340], ["MBP", "PROTEIN", 358, 361], ["rats", "SPECIES", 219, 223], ["thymidine incorporation", "TREATMENT", 25, 48], ["a p-scintillation counter", "TREATMENT", 64, 89], ["Antigen", "TEST", 93, 100], ["IFN-y", "TEST", 129, 134], ["TGF", "TEST", 140, 143], ["these studies", "TEST", 255, 268], ["Statistical analysis", "TEST", 269, 289], ["The non-parametric Mann-Whitney's test", "TEST", 289, 327], ["MBP", "TEST", 358, 361], ["the EAE susceptibility", "TEST", 416, 438]]], ["LEWl.A, LEW1.C and LEWIS developed clinical disease.", [["LEWl", "PROTEIN", 0, 4], ["LEW1", "DNA", 8, 12], ["clinical disease", "PROBLEM", 35, 51]]], ["A classical disease pattern was noted with onset of tail weakness, at around day 10 p.i. progressing to paresis and in some cases death, with maximum severity at days 13-15 p i . .", [["tail", "ANATOMY", 52, 56], ["tail weakness", "DISEASE", 52, 65], ["paresis", "DISEASE", 104, 111], ["death", "DISEASE", 130, 135], ["tail", "ORGANISM_SUBDIVISION", 52, 56], ["A classical disease pattern", "PROBLEM", 0, 27], ["tail weakness", "PROBLEM", 52, 65], ["paresis", "PROBLEM", 104, 111], ["some cases death", "PROBLEM", 119, 135], ["maximum severity", "PROBLEM", 142, 158], ["disease", "OBSERVATION", 12, 19], ["tail", "ANATOMY", 52, 56], ["weakness", "OBSERVATION", 57, 65], ["paresis", "OBSERVATION", 104, 111]]], ["The rats had recovered between day16 and 20 p.i.", [["rats", "ORGANISM", 4, 8], ["rats", "SPECIES", 4, 8]]], ["Four rats of each strain were observed to day 40 p i and no disease relapses were noted.The LEW1.C strain had a relatively mild form and not all of these rats showed neurological deficits.", [["neurological", "ANATOMY", 166, 178], ["neurological deficits", "DISEASE", 166, 187], ["rats", "ORGANISM", 5, 9], ["rats", "ORGANISM", 154, 158], ["LEW1", "DNA", 92, 96], ["rats", "SPECIES", 5, 9], ["rats", "SPECIES", 154, 158], ["each strain", "PROBLEM", 13, 24], ["disease relapses", "PROBLEM", 60, 76], ["C strain", "PROBLEM", 97, 105], ["neurological deficits", "PROBLEM", 166, 187], ["no", "UNCERTAINTY", 57, 59], ["disease", "OBSERVATION", 60, 67]]], ["LEWl.D, LEWl.F, LEW1.N and LEW1.W were resistant.MHC association with MBP 63-Wmduced EAEImmunohistochemical studies of spinal cord were performed since it is well known that clinical signs of EAE and the degree of CNS inflammation may sometimes dissociate.", [["spinal cord", "ANATOMY", 119, 130], ["CNS", "ANATOMY", 214, 217], ["EAE", "DISEASE", 192, 195], ["inflammation", "DISEASE", 218, 230], ["LEW1", "GENE_OR_GENE_PRODUCT", 27, 31], ["MBP 63", "GENE_OR_GENE_PRODUCT", 70, 76], ["spinal cord", "ORGAN", 119, 130], ["CNS", "ANATOMICAL_SYSTEM", 214, 217], ["LEW1", "DNA", 16, 20], ["LEW1", "PROTEIN", 27, 31], ["MHC", "PROTEIN", 49, 52], ["MBP", "PROTEIN", 70, 73], ["MBP", "TEST", 70, 73], ["spinal cord", "PROBLEM", 119, 130], ["EAE", "PROBLEM", 192, 195], ["CNS inflammation", "PROBLEM", 214, 230], ["resistant", "OBSERVATION", 39, 48], ["spinal cord", "ANATOMY", 119, 130], ["CNS", "ANATOMY", 214, 217], ["inflammation", "OBSERVATION", 218, 230]]], ["However, in the present experiment these two parameters roughly correlated to each other.T ceU proliferation and IFN-y secretionEarly (7 days) or late (14 days) after immunization with the h4BP 63-88 peptide, cells from draining popliteal and inguinal lymph nodes were challenged in vitro with MBP 63-88 or with MBP 89-101 as a negative control or with Con A as a positive control.The stimulations were assayed by measurement of DNA synthesis, an assay well known to reflect T cell proliferation and EN-y production by enumerating single cells secreting the cytokine (Figs.", [["cells", "ANATOMY", 209, 214], ["popliteal", "ANATOMY", 229, 238], ["inguinal lymph nodes", "ANATOMY", 243, 263], ["T cell", "ANATOMY", 475, 481], ["cells", "ANATOMY", 538, 543], ["h4BP 63-88 peptide", "CHEMICAL", 189, 207], ["MBP 63-88", "CHEMICAL", 294, 303], ["MBP 89-101", "CHEMICAL", 312, 322], ["Con A", "CHEMICAL", 353, 358], ["T ceU", "CELL", 89, 94], ["IFN-y", "GENE_OR_GENE_PRODUCT", 113, 118], ["cells", "CELL", 209, 214], ["draining popliteal", "MULTI-TISSUE_STRUCTURE", 220, 238], ["inguinal lymph nodes", "MULTI-TISSUE_STRUCTURE", 243, 263], ["MBP 89-101", "SIMPLE_CHEMICAL", 312, 322], ["Con A", "SIMPLE_CHEMICAL", 353, 358], ["DNA", "CELLULAR_COMPONENT", 429, 432], ["T cell", "CELL", 475, 481], ["single cells", "CELL", 531, 543], ["IFN", "PROTEIN", 113, 116], ["MBP", "PROTEIN", 294, 297], ["MBP", "PROTEIN", 312, 315], ["cytokine", "PROTEIN", 558, 566], ["T ceU proliferation", "PROBLEM", 89, 108], ["IFN-y secretion", "PROBLEM", 113, 128], ["immunization", "TREATMENT", 167, 179], ["the h4BP", "TEST", 185, 193], ["inguinal lymph nodes", "TREATMENT", 243, 263], ["MBP", "TEST", 294, 297], ["MBP", "TEST", 312, 315], ["a positive control", "TREATMENT", 362, 380], ["DNA synthesis", "PROBLEM", 429, 442], ["an assay", "TEST", 444, 452], ["T cell proliferation", "PROBLEM", 475, 495], ["draining", "ANATOMY_MODIFIER", 220, 228], ["popliteal", "ANATOMY", 229, 238], ["inguinal", "ANATOMY", 243, 251], ["lymph nodes", "OBSERVATION", 252, 263], ["cell proliferation", "OBSERVATION", 477, 495]]], ["Much higher background counts, in cultures receiving no exogenous antigen, were recorded day 7 p.i. than day 14 p.i., probably due to a more conspicuous in vivo activation at the early time interval.", [["exogenous antigen", "PROTEIN", 56, 73], ["Much higher background counts", "PROBLEM", 0, 29], ["cultures", "TEST", 34, 42], ["exogenous antigen", "PROBLEM", 56, 73], ["probably due to", "UNCERTAINTY", 118, 133], ["more conspicuous", "OBSERVATION_MODIFIER", 136, 152], ["vivo activation", "OBSERVATION", 156, 171]]], ["Statistical comparison did not These also showed the highest IFN-y responses at both day 7 and day 14 p.i..", [["IFN", "GENE_OR_GENE_PRODUCT", 61, 64], ["IFN", "PROTEIN", 61, 64]]], ["It is notable, however, that relative magnitudes of the immune response did not correlate with the degree of clinical disease; the LEW1.C rats developed the strongest responses but had the mildest disease.", [["C rats", "ORGANISM", 136, 142], ["LEW1", "PROTEIN", 131, 135], ["rats", "SPECIES", 138, 142], ["clinical disease", "PROBLEM", 109, 125], ["the mildest disease", "PROBLEM", 185, 204], ["notable", "OBSERVATION_MODIFIER", 6, 13]]], ["Among the EAE-resistant strains, the LEW1.W rats developed a significant IFN-y response which was more pronounced late after immunization.", [["EAE", "DISEASE", 10, 13], ["W rats", "ORGANISM", 42, 48], ["IFN", "GENE_OR_GENE_PRODUCT", 73, 76], ["LEW1", "DNA", 37, 41], ["IFN", "PROTEIN", 73, 76], ["rats", "SPECIES", 44, 48], ["the EAE", "TEST", 6, 13], ["resistant strains", "PROBLEM", 14, 31], ["a significant IFN-y response", "PROBLEM", 59, 87], ["immunization", "TREATMENT", 125, 137], ["resistant strains", "OBSERVATION", 14, 31], ["significant", "OBSERVATION_MODIFIER", 61, 72]]], ["There were no responses with MBP 89-101 as an antigen, while high responses to Con A were observed in all strains.IFN-y, IL-4 and TGF-B mRNA expressionTo analyze further the quality of the responding LNC, in situ hybridization was carried out using m y -, IL-4-and approximately tenfold.", [["LNC", "ANATOMY", 200, 203], ["Con A", "SIMPLE_CHEMICAL", 79, 84], ["IFN-y", "GENE_OR_GENE_PRODUCT", 114, 119], ["IL-4", "GENE_OR_GENE_PRODUCT", 121, 125], ["TGF-B", "GENE_OR_GENE_PRODUCT", 130, 135], ["LNC", "CANCER", 200, 203], ["IL-4", "GENE_OR_GENE_PRODUCT", 256, 260], ["MBP", "PROTEIN", 29, 32], ["IFN", "PROTEIN", 114, 117], ["TGF-B mRNA", "RNA", 130, 140], ["LNC", "CELL_TYPE", 200, 203], ["MBP", "TEST", 29, 32], ["an antigen", "TEST", 43, 53], ["IFN", "TEST", 114, 117], ["IL", "TEST", 121, 123], ["TGF", "TEST", 130, 133], ["the responding LNC", "TREATMENT", 185, 203], ["no", "UNCERTAINTY", 11, 13]]], ["This can either be due to different sensitivities in the techniques or to the fact that not all mRNA-expressing cells eventually secreted the formed product.", [["cells", "ANATOMY", 112, 117], ["cells", "CELL", 112, 117], ["mRNA", "RNA", 96, 100], ["expressing cells", "CELL_TYPE", 101, 117], ["expressing cells", "PROBLEM", 101, 117]]], ["The relative responses between different strains were, however, fully consistent between the two techniques.IFN-y, IL-4 and TGF-B mRNA expressionThe detected number of MJ3P 63-88-induced IL-4 and TGF-f3 mRNA-expressing cells was generally much lower than that of IFN-y mRNA-expressing cells.", [["cells", "ANATOMY", 219, 224], ["cells", "ANATOMY", 285, 290], ["MJ3P 63-88", "CHEMICAL", 168, 178], ["IFN", "GENE_OR_GENE_PRODUCT", 108, 111], ["IL-4", "GENE_OR_GENE_PRODUCT", 115, 119], ["TGF-B", "GENE_OR_GENE_PRODUCT", 124, 129], ["IL-4", "GENE_OR_GENE_PRODUCT", 187, 191], ["TGF-f3", "GENE_OR_GENE_PRODUCT", 196, 202], ["cells", "CELL", 219, 224], ["IFN-y", "GENE_OR_GENE_PRODUCT", 263, 268], ["cells", "CELL", 285, 290], ["IFN", "PROTEIN", 108, 111], ["IL-4 and TGF-f3 mRNA", "RNA", 187, 207], ["IFN-y mRNA", "RNA", 263, 273], ["expressing cells", "CELL_TYPE", 274, 290], ["different strains", "PROBLEM", 31, 48], ["IFN-y", "TEST", 108, 113], ["IL", "TEST", 115, 117], ["TGF", "TEST", 124, 127], ["MJ3P", "TEST", 168, 172], ["IL", "TEST", 187, 189], ["TGF", "TEST", 196, 199], ["mRNA", "TEST", 203, 207], ["expressing cells", "PROBLEM", 208, 224], ["IFN-y mRNA", "TEST", 263, 273], ["expressing cells", "OBSERVATION", 274, 290]]], ["The most remarkable finding was that the LEW1.W strain showed the strongest activation of IL-4and TGF-fJ-producing cells especially early in the immune response.", [["cells", "ANATOMY", 115, 120], ["LEW1", "GENE_OR_GENE_PRODUCT", 41, 45], ["IL-4and", "GENE_OR_GENE_PRODUCT", 90, 97], ["TGF-fJ", "GENE_OR_GENE_PRODUCT", 98, 104], ["cells", "CELL", 115, 120], ["LEW1", "DNA", 41, 45], ["IL-4and TGF-fJ-producing cells", "CELL_LINE", 90, 120], ["W strain", "PROBLEM", 46, 54], ["IL", "TEST", 90, 92], ["most remarkable", "OBSERVATION_MODIFIER", 4, 19], ["immune response", "OBSERVATION", 145, 160]]], ["Also the LEWIS strain developed a significant IL-4 and TGF-f3 response, but only late in the immune response.DiscussionWe have here analyzed the role of MHC for EAE susceptibility after induction of the immunodominant MBP 63-88 peptide in a series of MHC congenic LEWIS strains.", [["EAE", "DISEASE", 161, 164], ["IL-4", "GENE_OR_GENE_PRODUCT", 46, 50], ["TGF-f3", "GENE_OR_GENE_PRODUCT", 55, 61], ["MHC", "GENE_OR_GENE_PRODUCT", 153, 156], ["MBP", "GENE_OR_GENE_PRODUCT", 218, 221], ["TGF", "PROTEIN", 55, 58], ["f3", "PROTEIN", 59, 61], ["MHC", "PROTEIN", 153, 156], ["MBP", "PROTEIN", 218, 221], ["MHC", "PROTEIN", 251, 254], ["the LEWIS strain", "TEST", 5, 21], ["a significant IL", "TEST", 32, 48], ["TGF", "TEST", 55, 58], ["the immunodominant MBP", "TEST", 199, 221], ["MHC congenic LEWIS strains", "TREATMENT", 251, 277], ["significant", "OBSERVATION_MODIFIER", 34, 45], ["IL", "OBSERVATION_MODIFIER", 46, 48]]], ["The importance of MHC could be confirmed by the finding that three (with class I1 haplotypes a, c and 1) out of seven investigated congenic strains were susceptible to disease induction.", [["MHC", "GENE_OR_GENE_PRODUCT", 18, 21], ["MHC", "PROTEIN", 18, 21], ["congenic strains", "PROBLEM", 131, 147], ["disease induction", "TREATMENT", 168, 185]]], ["Our results partly confirm previous findings obtained after immunization of LEWIS congenic strains with guinea pig spinal cord homogenate; where only LEWIS (RT1') developed clinical disease while strains with a, f, d and u were resistant [6] .", [["spinal cord homogenate", "ANATOMY", 115, 137], ["LEWIS congenic strains", "ORGANISM", 76, 98], ["guinea pig", "ORGANISM", 104, 114], ["spinal cord", "ORGAN", 115, 126], ["homogenate", "ORGANISM_SUBSTANCE", 127, 137], ["guinea pig", "SPECIES", 104, 114], ["guinea pig", "SPECIES", 104, 114], ["immunization", "TREATMENT", 60, 72], ["LEWIS congenic strains", "TREATMENT", 76, 98], ["guinea pig spinal cord homogenate", "TREATMENT", 104, 137], ["clinical disease", "PROBLEM", 173, 189], ["spinal cord", "ANATOMY", 115, 126]]], ["In other studies it has been shown that DA rats are highly susceptible to EAE induced with guinea pig spinal cord homogenate or with MBP showing that class I1 genes of the a allele are permissive for disease induction although in this strain other background genes are also of great importance [5] .", [["spinal cord homogenate", "ANATOMY", 102, 124], ["DA", "CHEMICAL", 40, 42], ["EAE", "DISEASE", 74, 77], ["DA rats", "ORGANISM", 40, 47], ["guinea pig", "ORGANISM", 91, 101], ["spinal cord", "ORGAN", 102, 113], ["homogenate", "ORGANISM_SUBSTANCE", 114, 124], ["MBP", "GENE_OR_GENE_PRODUCT", 133, 136], ["class I1", "GENE_OR_GENE_PRODUCT", 150, 158], ["MBP", "PROTEIN", 133, 136], ["class I1 genes", "DNA", 150, 164], ["allele", "DNA", 174, 180], ["background genes", "DNA", 248, 264], ["rats", "SPECIES", 43, 47], ["guinea pig", "SPECIES", 91, 101], ["guinea pig", "SPECIES", 91, 101], ["other studies", "TEST", 3, 16], ["guinea pig spinal cord homogenate", "TREATMENT", 91, 124], ["MBP", "TEST", 133, 136], ["disease induction", "TREATMENT", 200, 217], ["spinal cord", "ANATOMY", 102, 113]]], ["Thus the present peptide show that the permissiveness by the a haplotype is related to its ability to recognize this immunodominant peptide.", [["this immunodominant peptide", "PROBLEM", 112, 139]]], ["It should be emphasized that from the present, or previous, results it is not possible to conclude that the class11 genes are responsible for the observed MHC association.", [["MHC", "GENE_OR_GENE_PRODUCT", 155, 158], ["class11 genes", "DNA", 108, 121], ["MHC", "PROTEIN", 155, 158]]], ["Circumstantial evidence is, however, supportive since the disease is Tcell-mediated and since the pathogenicT cells in the LEWIS strain recognized the MBP 63-88 peptide in the context of the MHC class11 B molecules (corresponds to the DQ molecule) [29] .", [["pathogenicT cells", "ANATOMY", 98, 115], ["pathogenicT cells", "CELL", 98, 115], ["LEWIS strain", "ORGANISM", 123, 135], ["MBP", "GENE_OR_GENE_PRODUCT", 151, 154], ["pathogenicT cells", "CELL_TYPE", 98, 115], ["MBP", "PROTEIN", 151, 154], ["MHC class", "PROTEIN", 191, 200], ["B molecules", "PROTEIN", 203, 214], ["DQ molecule", "PROTEIN", 235, 246], ["the disease", "PROBLEM", 54, 65], ["the pathogenicT cells", "PROBLEM", 94, 115], ["the MBP", "TEST", 147, 154], ["disease", "OBSERVATION", 58, 65]]], ["It remains to be investigated whether the B molecule is also used in the a and c haplotype rats, which where here found to be susceptible.", [["B molecule", "GENE_OR_GENE_PRODUCT", 42, 52], ["rats", "ORGANISM", 91, 95], ["B molecule", "PROTEIN", 42, 52], ["rats", "SPECIES", 91, 95], ["the B molecule", "PROBLEM", 38, 52]]], ["It has recently been shown that the B1 and Ba molecules display considerable differences [30] but that the class I1 molecules of a and c are relatively similar.", [["Ba", "CHEMICAL", 43, 45], ["Ba molecules", "GENE_OR_GENE_PRODUCT", 43, 55], ["B1 and Ba molecules", "PROTEIN", 36, 55], ["class I1 molecules", "PROTEIN", 107, 125], ["the B1 and Ba molecules", "TEST", 32, 55], ["relatively", "OBSERVATION_MODIFIER", 141, 151], ["similar", "OBSERVATION_MODIFIER", 152, 159]]], ["Thus, Da and DC share the first domains while the Ba and the BC first domains differ only in the Bg chain [31] .", [["DC", "ANATOMY", 13, 15], ["Ba", "CHEMICAL", 50, 52], ["Ba", "CHEMICAL", 50, 52], ["DC", "CELL_TYPE", 13, 15], ["Ba", "PROTEIN", 50, 52], ["BC first domains", "PROTEIN", 61, 77], ["Bg chain", "PROTEIN", 97, 105], ["the BC", "TEST", 57, 63]]], ["In addition it has been reported earlier that class 11-restricted T cells from rats with RTIC, in similarity with RT1' rats, recognize the MBP 63-88 peptide in an immunodominant fashion [32] .", [["T cells", "ANATOMY", 66, 73], ["T cells", "CELL", 66, 73], ["rats", "ORGANISM", 79, 83], ["RT1' rats", "ORGANISM", 114, 123], ["MBP", "GENE_OR_GENE_PRODUCT", 139, 142], ["T cells", "CELL_TYPE", 66, 73], ["MBP", "PROTEIN", 139, 142], ["rats", "SPECIES", 79, 83], ["rats", "SPECIES", 119, 123], ["the MBP", "TEST", 135, 142]]], ["From these considerations we conclude that in all three EAE-susceptible haplotypes (a, 1 and c) a class 11-restricted T cell activation in response to the MBP 63-88 peptide occurred.DiscussionSince IFN-y was produced by T cells from haplotypes a, 1 and c, the claim that the pathogenicT cells predominantly exert TH1-like activity is supported [ l l , 15,221.", [["T cell", "ANATOMY", 118, 124], ["T cells", "ANATOMY", 220, 227], ["pathogenicT cells", "ANATOMY", 275, 292], ["EAE", "DISEASE", 56, 59], ["MBP 63-88 peptide", "CHEMICAL", 155, 172], ["T cell", "CELL", 118, 124], ["MBP", "GENE_OR_GENE_PRODUCT", 155, 158], ["IFN", "GENE_OR_GENE_PRODUCT", 198, 201], ["T cells", "CELL", 220, 227], ["c", "GENE_OR_GENE_PRODUCT", 253, 254], ["pathogenicT cells", "CELL", 275, 292], ["TH1", "GENE_OR_GENE_PRODUCT", 313, 316], ["MBP", "PROTEIN", 155, 158], ["IFN", "PROTEIN", 198, 201], ["T cells", "CELL_TYPE", 220, 227], ["pathogenicT cells", "CELL_TYPE", 275, 292], ["TH1", "PROTEIN", 313, 316], ["restricted T cell activation", "TREATMENT", 107, 135], ["the MBP", "TEST", 151, 158], ["the pathogenicT cells", "TEST", 271, 292], ["TH1", "OBSERVATION", 313, 316]]], ["However, among the responder strains, the magnitude of disease did not correlate with the number of IFN-y-producing cells; cells from RTIC showed a more vigorous MBP 63-88 induced IFN-y production than cells from RTla and RTl', despite the fact that the former strain had a milder disease course than the two latter.", [["cells", "ANATOMY", 116, 121], ["cells", "ANATOMY", 123, 128], ["cells", "ANATOMY", 202, 207], ["IFN", "GENE_OR_GENE_PRODUCT", 100, 103], ["cells", "CELL", 116, 121], ["cells", "CELL", 123, 128], ["RTIC", "CELL", 134, 138], ["MBP", "GENE_OR_GENE_PRODUCT", 162, 165], ["IFN", "GENE_OR_GENE_PRODUCT", 180, 183], ["cells", "CELL", 202, 207], ["RTla", "CELL", 213, 217], ["IFN-y-producing cells", "CELL_LINE", 100, 121], ["MBP", "PROTEIN", 162, 165], ["IFN", "PROTEIN", 180, 183], ["disease", "PROBLEM", 55, 62], ["IFN", "TEST", 100, 103], ["RTIC", "TEST", 134, 138], ["vigorous MBP", "TEST", 153, 165], ["IFN-y production than cells", "PROBLEM", 180, 207], ["RTla", "TEST", 213, 217], ["a milder disease course", "PROBLEM", 272, 295], ["disease", "OBSERVATION", 55, 62], ["milder", "OBSERVATION_MODIFIER", 274, 280], ["disease", "OBSERVATION", 281, 288]]], ["The reason(s) for this are unclear, but it is possible that more extended studies might reveal an MHC-directed influence on production of other putative disease up-or down-regulatory cytokines such as lymphotoxin or IL-10.DiscussionAmong the EAE-resistant strains we found that rats with RTld did not mount an immune response to MBP 63-88.", [["EAE", "DISEASE", 242, 245], ["MBP 63-88", "CHEMICAL", 329, 338], ["lymphotoxin", "GENE_OR_GENE_PRODUCT", 201, 212], ["IL-10", "GENE_OR_GENE_PRODUCT", 216, 221], ["rats", "ORGANISM", 278, 282], ["MHC", "PROTEIN", 98, 101], ["regulatory cytokines", "PROTEIN", 172, 192], ["lymphotoxin", "PROTEIN", 201, 212], ["IL-10", "PROTEIN", 216, 221], ["MBP", "PROTEIN", 329, 332], ["rats", "SPECIES", 278, 282], ["other putative disease", "PROBLEM", 138, 160], ["down-regulatory cytokines", "TREATMENT", 167, 192], ["lymphotoxin or IL", "TREATMENT", 201, 218], ["resistant strains", "PROBLEM", 246, 263], ["MBP", "TEST", 329, 332]]], ["In initial experiments we made the same observation with the RTlf haplotype (datanot shown).", [["RTlf haplotype", "DNA", 61, 75]]], ["In contrast, the LEW1.W strain, carrying the RTIU haplotype was resistant to EAE but mounted a significant immune response to MBP 63-88.DiscussionIn initial experiments also the same was noted for RT1\".", [["EAE", "DISEASE", 77, 80], ["MBP 63-88", "CHEMICAL", 126, 135], ["MBP 63-88", "CHEMICAL", 126, 135], ["LEW1", "GENE_OR_GENE_PRODUCT", 17, 21], ["RTIU", "GENE_OR_GENE_PRODUCT", 45, 49], ["MBP 63-88", "GENE_OR_GENE_PRODUCT", 126, 135], ["LEW1", "DNA", 17, 21], ["RTIU haplotype", "DNA", 45, 59], ["MBP", "PROTEIN", 126, 129], ["RT1", "PROTEIN", 197, 200], ["W strain", "PROBLEM", 22, 30], ["MBP", "TEST", 126, 129]]], ["W showed an IL-4 and TGF-fi response as early as 7 days after immunization.", [["IL-4", "GENE_OR_GENE_PRODUCT", 12, 16], ["TGF-fi", "GENE_OR_GENE_PRODUCT", 21, 27], ["TGF", "PROTEIN", 21, 24], ["an IL", "TEST", 9, 14], ["immunization", "TREATMENT", 62, 74]]], ["It is tempting to suggest that this obviously MHC-regulated feature of the immune response might be causally related to the absence of clinical EAE.", [["EAE", "DISEASE", 144, 147], ["MHC", "PROTEIN", 46, 49]]], ["Recent results from other groups supports this interpretation.", [["this interpretation", "TEST", 42, 61]]], ["Direct treatment of rats with TGF-p counteracts EAE and IL-Zmediated proliferation [33] .", [["EAE", "DISEASE", 48, 51], ["rats", "ORGANISM", 20, 24], ["TGF-p", "GENE_OR_GENE_PRODUCT", 30, 35], ["IL-Zmediated", "SIMPLE_CHEMICAL", 56, 68], ["TGF", "PROTEIN", 30, 33], ["rats", "SPECIES", 20, 24], ["Direct treatment of rats", "TREATMENT", 0, 24], ["TGF", "TEST", 30, 33], ["EAE", "PROBLEM", 48, 51]]], ["After recovery of EAE in LEWIS rats CD4+ cells has been isolated, which secretes IL-4 and TGF-fi and suppress IFN-y mediated effects [17] .", [["CD4+ cells", "ANATOMY", 36, 46], ["EAE", "DISEASE", 18, 21], ["rats", "ORGANISM", 31, 35], ["CD4", "GENE_OR_GENE_PRODUCT", 36, 39], ["IL-4", "GENE_OR_GENE_PRODUCT", 81, 85], ["TGF-fi", "GENE_OR_GENE_PRODUCT", 90, 96], ["IFN", "GENE_OR_GENE_PRODUCT", 110, 113], ["CD4", "PROTEIN", 36, 39], ["IL-4", "PROTEIN", 81, 85], ["TGF", "PROTEIN", 90, 93], ["IFN", "PROTEIN", 110, 113], ["rats", "SPECIES", 31, 35], ["EAE", "PROBLEM", 18, 21], ["cells", "PROBLEM", 41, 46], ["IL", "TEST", 81, 83], ["TGF", "TEST", 90, 93]]], ["These data could explain the limitations of the disease course in the LEWIS rats and is compatible with our observation that the peptide-specific response with IL-4 and TGF-fi production tends to increase later in the immune response.", [["LEWIS rats", "ORGANISM", 70, 80], ["IL-4", "GENE_OR_GENE_PRODUCT", 160, 164], ["TGF-fi", "GENE_OR_GENE_PRODUCT", 169, 175], ["IL", "PROTEIN", 160, 162], ["TGF", "PROTEIN", 169, 172], ["rats", "SPECIES", 76, 80], ["the peptide", "TEST", 125, 136], ["IL", "TEST", 160, 162], ["TGF", "TEST", 169, 172], ["disease", "OBSERVATION", 48, 55], ["compatible with", "UNCERTAINTY", 88, 103], ["increase", "OBSERVATION_MODIFIER", 196, 204]]], ["A new finding is that the LEW1.W strain may recognize the MBP 63-88 peptide in a way which triggers an early Tcell expression of IL-4 and TGF-fi mRNA, instead of mounting a pure TH1 type response.", [["LEW1", "GENE_OR_GENE_PRODUCT", 26, 30], ["MBP", "GENE_OR_GENE_PRODUCT", 58, 61], ["IL-4", "GENE_OR_GENE_PRODUCT", 129, 133], ["TGF-fi", "GENE_OR_GENE_PRODUCT", 138, 144], ["TH1", "GENE_OR_GENE_PRODUCT", 178, 181], ["LEW1", "DNA", 26, 30], ["MBP", "PROTEIN", 58, 61], ["IL-4 and TGF-fi mRNA", "RNA", 129, 149], ["the MBP", "TEST", 54, 61], ["IL", "TEST", 129, 131], ["new", "OBSERVATION_MODIFIER", 2, 5]]], ["A close-to-hand explanation is that the peptide may be bound to class I1 molecule of the u haplotype in a different way as compared to binding in haplotypes susceptible to EAE.", [["EAE", "DISEASE", 172, 175], ["class I1 molecule", "PROTEIN", 64, 81], ["the u haplotype", "PROBLEM", 85, 100]]], ["A different affinity, or different processing requirements, may for instance lead to a presentation of the peptide predominantly by B cells, instead of macrophage or dendritic cells leading to another type of T cell response.", [["B cells", "ANATOMY", 132, 139], ["macrophage", "ANATOMY", 152, 162], ["dendritic cells", "ANATOMY", 166, 181], ["T cell", "ANATOMY", 209, 215], ["B cells", "CELL", 132, 139], ["macrophage", "CELL", 152, 162], ["dendritic cells", "CELL", 166, 181], ["T cell", "CELL", 209, 215], ["B cells", "CELL_TYPE", 132, 139], ["macrophage", "CELL_TYPE", 152, 162], ["dendritic cells", "CELL_TYPE", 166, 181], ["A different affinity", "PROBLEM", 0, 20], ["different processing requirements", "PROBLEM", 25, 58], ["the peptide", "PROBLEM", 103, 114], ["B cells", "PROBLEM", 132, 139], ["macrophage", "PROBLEM", 152, 162], ["dendritic cells", "PROBLEM", 166, 181], ["T cell response", "PROBLEM", 209, 224], ["different", "OBSERVATION_MODIFIER", 2, 11], ["affinity", "OBSERVATION_MODIFIER", 12, 20], ["macrophage", "OBSERVATION", 152, 162], ["dendritic cells", "OBSERVATION", 166, 181], ["cell response", "OBSERVATION", 211, 224]]], ["A role for the antigen-presenting effects by B cells is supported by recent experiments in which tolerization to EAE was achieved by specifically addressing the MBP 63-88 peptide to B cells in vivo by usage of an anti4 conjugate [34] .", [["B cells", "ANATOMY", 45, 52], ["B cells", "ANATOMY", 182, 189], ["EAE", "DISEASE", 113, 116], ["B cells", "CELL", 45, 52], ["MBP", "GENE_OR_GENE_PRODUCT", 161, 164], ["B cells", "CELL", 182, 189], ["B cells", "CELL_TYPE", 45, 52], ["MBP", "PROTEIN", 161, 164], ["B cells", "CELL_TYPE", 182, 189], ["the antigen", "TEST", 11, 22], ["B cells", "PROBLEM", 45, 52], ["the MBP", "TEST", 157, 164], ["an anti4 conjugate", "TREATMENT", 210, 228]]], ["Moreover, an MHC influence on the quality of the T cell response has been described for the response to a peptide of type IV collagen in the mouse and in this case this influence has been located to the peptide and MHC class I1 molecule complex [ 10,351.", [["T cell", "ANATOMY", 49, 55], ["T cell", "CELL", 49, 55], ["type IV collagen", "GENE_OR_GENE_PRODUCT", 117, 133], ["mouse", "ORGANISM", 141, 146], ["MHC", "PROTEIN", 13, 16], ["type IV collagen", "PROTEIN", 117, 133], ["MHC class I1 molecule complex", "PROTEIN", 215, 244], ["mouse", "SPECIES", 141, 146], ["mouse", "SPECIES", 141, 146], ["an MHC influence", "PROBLEM", 10, 26], ["a peptide of type IV collagen in the mouse", "TREATMENT", 104, 146]]], ["The present observation is the first made of such a phenomenon in the regulation of an autoimmune disease and adds a new way how MHC association to autoimmune disease may operate.The observed skewing of the immune response in the LEW1.W strain towards IL-4 and TGF-p production may not necessarily, however, be attributed to the class I1 molecule.", [["autoimmune disease", "DISEASE", 87, 105], ["autoimmune disease", "DISEASE", 148, 166], ["IL-4", "GENE_OR_GENE_PRODUCT", 252, 256], ["TGF-p", "GENE_OR_GENE_PRODUCT", 261, 266], ["MHC", "PROTEIN", 129, 132], ["LEW1", "DNA", 230, 234], ["IL", "PROTEIN", 252, 254], ["TGF", "PROTEIN", 261, 264], ["class I1 molecule", "PROTEIN", 329, 346], ["a phenomenon", "PROBLEM", 50, 62], ["an autoimmune disease", "PROBLEM", 84, 105], ["autoimmune disease", "PROBLEM", 148, 166], ["IL", "TEST", 252, 254], ["TGF", "TEST", 261, 264], ["autoimmune", "OBSERVATION", 87, 97], ["autoimmune", "OBSERVATION", 148, 158], ["immune response", "OBSERVATION", 207, 222]]], ["It has earlier been postulated that the induction of oral tolerance in rats is mediated by CD8+ T cells secreting TGF-P locally in the inflammatory region [13] .", [["oral", "ANATOMY", 53, 57], ["CD8+ T cells", "ANATOMY", 91, 103], ["oral", "ORGANISM_SUBDIVISION", 53, 57], ["rats", "ORGANISM", 71, 75], ["CD8", "GENE_OR_GENE_PRODUCT", 91, 94], ["TGF-P", "GENE_OR_GENE_PRODUCT", 114, 119], ["CD8", "PROTEIN", 91, 94], ["T cells", "CELL_TYPE", 96, 103], ["TGF", "PROTEIN", 114, 117], ["rats", "SPECIES", 71, 75], ["inflammatory", "OBSERVATION_MODIFIER", 135, 147]]], ["This would imply a role for class I molecules.", [["class I molecules", "GENE_OR_GENE_PRODUCT", 28, 45], ["class I molecules", "PROTEIN", 28, 45]]], ["This is also compatible with our observations since we have not formally excluded a role either of polymorphism in the MHC class I region, o r of other putatively important polymorphic genes within h4HC.This will be studied by use of F1 hybrids, MHC-recombinant strains and with MHC class I1 transgenic rats.DiscussionIn conclusion we have in the present communication defined MHC association for EAE induced with the major immunogenic peptide MBP 63-88.", [["EAE", "DISEASE", 397, 400], ["MBP 63-88", "CHEMICAL", 444, 453], ["h4HC", "CANCER", 198, 202], ["F1 hybrids", "CELL", 234, 244], ["MHC class I1", "GENE_OR_GENE_PRODUCT", 279, 291], ["rats", "ORGANISM", 303, 307], ["MHC class I region", "DNA", 119, 137], ["polymorphic genes", "DNA", 173, 190], ["h4HC", "DNA", 198, 202], ["F1 hybrids", "CELL_LINE", 234, 244], ["MHC", "PROTEIN", 246, 249], ["MHC class I1", "PROTEIN", 279, 291], ["MHC", "PROTEIN", 377, 380], ["rats", "SPECIES", 303, 307], ["F1 hybrids", "TREATMENT", 234, 244], ["EAE", "PROBLEM", 397, 400], ["MBP", "TEST", 444, 447], ["compatible with", "UNCERTAINTY", 13, 28], ["polymorphic genes", "OBSERVATION", 173, 190]]], ["We have also suggested a new mechanism by which certain MHC haplotype may exert a suppressive influence on the susceptibility to EAE by priming for a qualitatively different response instead of a pure TH1 type of response which normally leads to disease.", [["EAE", "DISEASE", 129, 132], ["TH1", "GENE_OR_GENE_PRODUCT", 201, 204], ["MHC", "PROTEIN", 56, 59], ["disease", "PROBLEM", 246, 253]]]]}